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Glycine max, commonly named the cultivated soybean, is one of the oldest and 
most important food crops in the world. The study of the G. max genome provides 
valuable insight into the molecular mechanisms that govern its reproduction and 
environmental responsiveness, key factors in maximizing crop yield. Since the complete 
sequencing of the genome in 2010, the analysis has become faster and easier, especially 
with the development of numerous web-based, publically accessible bioinformatics tools.  
This research effort utilizes these tools to characterize a small, unannotated G. 
max gene family. Although no definitive evidence was uncovered for the production of a 
functional protein product from these genes, evidence does exist for the transcription of 3 
of 5 genes. Through gene model verification, synonymous substitution calculations, 
structural fold analysis, cis-element identification, and comparisons to molecules of 
known structure, an attempt was made to define the evolutionary history and pinpoint 
putative function of the conceptually translated amino acid sequences from this family of 
genes.  
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A  adenine 
G  guanine 
T  thymine 
C  cytosine 
U  uracil 
R  A or G 
Y  C or T 
W  U or A 
 
Amino Acids 
Symbol Description        Symbol       Description 
A  Ala/alanine 
C  Cys/cysteine 
D  Asp/aspartic acid 
E  Glu/glutamic acid 
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M  Met/methionine 
N  Asn/asparagine 
P  Pro/proline 
Q  Gln/glutamine 
R  Arg/arginine 
S  Ser/serine 
T  Thr/threonine 
V  Val/valine 
W  Try/tryptophan 









1.1. GLYCINE MAX 
 Glycine max (L.) Merr., commonly known as cultivated soybean, is a 
diploidized tetraploid (2n = 40) plant species [1] with agricultural significance in 
Eastern North America [2] and Asia [1]. The classification of this herbaceous, annual 
legume, as reported by the USDA Natural Resource Conservation Service Plants 
Database, is summarized in Table 1.1 [2]. There are two major legume (family 
Fabaceae [2]) lineages, Hologalegina and Phaseoloides (Glycine). From the Phaseoloid 
line, two subgenera diverged [3]. Glycine max and its wild predecessor, Glycine soja, 
belong to the subgenus Soja. These species are capable of hybridizing which has 
implications on gene flow [1].  
 
Table 1.1. Classification of Glycine max (L.) Merr. [2] 
Level Scientific Name Common Name 
Kingdom Plantae Plants 
Subkingdom Tracheobionta Vascular Plants 
Superdivision Spermatophyta Seed Plants 
Division Magnoliophyta Flowering Plants 
Class Magnoliopsida Dicotyledons 
Subclass Rosidae ------------ 
Order Fabales ------------ 
Family Fabaceae Pea, Legume 
Genus Glycine Willd. Soybean 
Species Glycine max (L.) Merr. Cultivated Soybean 
 




Glycine max is native to Asia, specifically northern and central China and is 
considered to be one of the oldest cultivated crops. The first evidence for soybean was 
recorded by Emperor Sheng Nung in 2838 B.C.E. Historical records indicate that the 
domestication of the crop occurred sometime between 1700 and 1100 B.C.E. [4].  
Introduction to the U.S. occurred in 1765 C.E. [5]. Since then, the United 
States has become the world leader in soybean production, producing 90.6 million 
metric tons in 2010, with nearly half (43.27 million metric tons) of the yield being 
exported to other countries. Crop production is measured in bushels. In 2012, 
76,104,000 acres were harvested producing 3,014,998,000 bushels of soybeans [6]. 
The price per bushel in 2012 was $14, making total production value over $43 billion 
[7]. Soybean is second only to corn in the total area planted in the U.S. as of 2010 [6].  
In addition to being a valuable export, soybean has numerous domestic uses. 
Over 100 uses exist for soybean products for edible consumption and nearly as many, 
87, for industrial use. Some edible uses include traditional soy products (such as tofu 
and soymilk), numerous baked good ingredients, baby food, and livestock feed. On the 
industrial side, uses are highly varied, ranging from the mundane, such as candles, 
crayons and cosmetics, to harsher chemicals such as industrial solvents and pesticides. 
Soybeans provide nearly 70% of dietary proteins and nearly 30% of edible vegetable 
oils (68% for the United States) in the world [6]. In more recent years, the crop has 
been recognized as a possible resource for the production of biodiesel, a high-energy 
alternative fuel [8]. According to the National Biodiesel Board, every bushel of 
soybean has the potential to produce 48 pounds of protein-rich food and 1.5 gallons of 
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biodiesel. Since 1999, biodiesel production in the U.S. has been climbing with 
production reaching a peak in 2008 at 691 million gallons [6].  
It was interest in this role as a biodiesel source that prompted a consortium 
supported by the Department of Energy Joint Genome Institute Community Sequence 
Program to initiate the soybean genome project that led to the full sequencing of 
Glycine max in 2010. It was thought that knowledge of the soybean genome would 
provide a means for crop improvements and application towards energy production 
[8].  
Whole genome shotgun sequencing was performed using Sanger protocols and 
an Arachne algorithm used for assembly of sequence reads. The genome consisted of 
1,115 Mega bases, which are assembled into 20 chromosomes. The project resulted in 
the prediction of 46,430 high-confidence gene loci of which 73% were identified as 
orthologs of other angiosperms and were assigned to 12,253 gene families. From the 
angiosperm families, 283 putative legume-specific gene families were identified. Four 
hundred forty-eight Glycine max genes belong to the legume-specific families. In 
addition, 741 soybean-specific families were identified that could contain potential 
soybean-specific genes [9]. The whole genome sequencing of soybean has provided 
scientists with an avenue to understanding the evolution of the species as well as a 
foundation for further exploration into genomics and proteomics using available 






1.2. GENE DUPLICATION AND GENE FAMILIES 
 Gene duplication is the creation of a duplicate copy of a gene within the 
genome. Duplication events include retrotransposition, segmental duplication, and 
whole genome duplication. Retrotransposition occurs when mature RNA undergoes 
reverse transcription and becomes integrated into the DNA resulting in genes that lack 
introns. Segmental duplications can result from unequal crossing over or errors in the 
replication process. Whole genome duplications (WGD) are rare events, but provide 
opportunity for great changes to be made in organismal complexity and behavior [10]. 
A WGD results in a two-fold expansion of the genome and a polypoidy state. It is 
suggested that this state contributes to increased adaptability and tolerance in extreme 
conditions. Genome sequencing of numerous plant species has revealed synteny 
between species, or the retention of tracts of homologous genes between species of the 
same family. Based on this information, the timing of major duplication events can be 
predicted. A WGD event is estimated to have occurred in a number of plant species 
shortly after the mass extinction event at the end of the Cretaceous period, around 65 
million years ago (Mya), providing those plants with an evolutionary advantage in a 
time when selective pressures were leading to the extinction of other species [11].  
 Glycine max (Gm), Medicago truncatula (Mt), and Lotus japonicum (Lj) are 
three species of the Papilionoid subfamily of legumes that have completed genome 
sequences. This subfamily diverged from the two other legume subfamilies around 60 
Mya. By analyzing blocks of synteny between species on a dot-plot matrix, scientists 
have concluded that a WGD occurred around 58 Mya, prior to the divergence of Mt 
and Lj from one another [11]. Speciation creates orthologous genes, ones that share 
5 
	  
homology and were created by the splitting of a lineage, between the species [12]. A 
comparison of Gm and Mt on a similar dot-plot matrix revealed synteny between the 
species but with pairs of syntenic blocks in Gm corresponding to single blocks in Mt. 
This indicates a WGD in Gm after its divergence from Mt [11]. A gene duplication 
event in a single genome produces paralogous genes [12].  
 Gene duplication events can produce closely related genes in a genome that 
encode the same, or very similar, products (generally proteins). Two or more genes 
that meet this criterion are considered to be a gene family. Members of a gene family 
can be located on the same chromosome or dispersed throughout the genome [13].  
Most genes in the genome are vulnerable to selective pressures and because of 
this, most nucleotide changes are deleterious. The creation of a copy of a gene 
provides an opportunity for a new gene, one with a novel function, to arise. As long as 
one copy of a gene maintains the original function, the other copy can accumulate 
mutations without negatively affecting the fitness of the organism. The development 
of a novel function by one copy of a gene while the other retains the original function 
is known as neofunctionalization. In some instances, the original function is not 
wholly retained in either copy; rather, it is divided between the copies so that each 
copy contributes a portion of the function. This is referred to as subfunctionalization 
[10]. 
 Duplicated genes have several possible fates. Those that decrease fitness are 
eventually lost. Duplications that do not provide any benefit or harm will be subject to 
drift and eventually fixed or lost.  A duplicated gene that provides an advantage 
against selective pressures will eventually be fixed. Duplicated genes that are lost can 
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become non-functional, referred to as a pseudogene, through the accumulation of 
degenerative mutations, or be physically lost from the genome. Fixation is not a 
common event; only 1 in every 100 genes becomes fixed every million years. In fact, 
studies show that the window of opportunity for a newly duplicated gene to become 
fixed in a population before degradation commences is very small on the evolutionary 
scale, somewhere in the order of 4 million years [10].  
 Mutations become introduced into and accumulate in the DNA, altering the 
percentage of a gene that retains identity with its paralog(s). One type of mutation is a 
base substitution which can come in two forms: synonymous and nonsynonymous. 
Synonymous substitutions are “silent,” no change occurs in the amino acid that is 
encoded by the codon.  Nonsynonymous substitutions arise from the replacement of a 
nucleotide that results in the DNA encoding a different amino acid or the creation of a 
transcription termination signal [13]. Synonymous substitutions accumulate at a fairly 
steady rate; therefore, the calculation of the substitutions per site (Ks) between 
paralogs can be used as a measure of time since a duplication event [14].  In Gm, 
31,264 of the 46,430 high-confidence genes exist as paralogs with a Ks value of 
approximately 0.13 synonymous substitutions per site. This corresponds to the Gm-
specific WGD at 13 Mya according to the 2010 Schmutz et al. Nature article Genome 
sequence of the palaeopolyploid soybean [9]. Schmutz et al. analyzed synonymous 
substitution rates between soybean gene families with no more than six members that 
have a paralog on another chromosome and found two peaks. Peaks appear on the 
graph at the values 0.13 and 0.59 Ks. The peaks indicate a high percentage of 
homologous pairs of genes within the Glycine max genome. The Ks values correspond 
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to two separate duplication events, the 13 Mya and 59 Mya WGDs. Each value does 
not correspond directly to a different point in time; rather, a range of values can be 
correlated to a particular event. The range of Ks values surrounding the 0.13 peak 
correspond to the 13 Mya WGD. The second peak, and flanking values, in the 
comparison of Glycine max paralogs appears at Ks value 0.59 which corresponds to 
the Papilionoid, or legume, genome duplication at 59 Mya [8]. This evidence 
correlates well with the synteny dot-plot matrix analysis.  
Analysis of paralogs in Glycine max is further complicated by the fact that 
soybean is an allotetraploid. Autopolyploidy can result from somatic doubling in a 
single species, whereas allopolyploidy results from hybridization of different but 
related species followed by somatic doubling to create a fertile derivative [15]. At 
some point after the Papilionoid divergence, two species of legumes existed (proto-G. 
max species) that had n = 10 chromosomes each. Enough molecular compatibility 
existed for the pollen from one species to fertilize the egg of the second, resulting in a 
hybrid plant. Each species would contribute 10 chromosomes, however the hybrid 
would be sterile due to the absence of complete homologous chromosomal pairs. Upon 
somatic doubling, each of the 10 + 10 chromosomes becomes duplicated, chromatids 
following S phase become homologs after a failed anaphase, producing 20 pairs of 
chromosomes and reinstating the ability of the organism (Glycine max) to reproduce. 













Figure 1.1. The hypothesized allotetraploid event that produced Glycine max. 
 
 
1.3. EVIDENCE OF GENE EXPRESSION  
 Predicting the presence of a gene does not prove that the encoded sequence 
becomes a functional protein or that it is even transcribed.  
1.3.1. ESTs.  An expressed sequence tag (EST) is a short/partial sequence 
derived from cDNA [16]. A cDNA is created from the reverse transcription of mature 
mRNA, which is a record of protein-coding DNA. ESTs are created by sequencing a 
short segment (usually 200-500 bp) of a cDNA from the 5’ or 3’ end [17].  Since ESTs 
are created from an experimentally obtained product of gene expression, they provide 
empirical evidence of transcription at minimum, and possibly protein synthesis.  High 
levels of synthesis of a protein require high levels of transcription of the encoding 
gene, i.e. numerous mRNA transcripts. Since ESTs provide a record of transcript 
production in a particular cell, tissue, or organ of an organism [17], they are a 
reflection of gene expression and may provide additional evidence for differential 
expression patterns if tissue treatment is known.  
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Because they are records of a transcript, the EST sequences represent post-
spliced sequences; the introns are removed. This presents a challenge for determining 
the encoding gene. Despite this, the creation of ESTs is an inexpensive means of 
finding new genes, gaining information about expression, and creating genome maps 
[17], making it a convenient tool for studying the genome of organisms that have not 
yet been sequenced [18].  
EST records are produced and maintained by Genbank and are available 
through the EST database at NCBI (dbEST) [19].   
1.3.2. Consensus Data. It has been discovered that some DNA elements and 
signal sequences have motifs that are conserved across many taxonomic boundaries.  
Collections of such consensus sequences can aid in the identification of possible 
regulation of novel genes and can provide additional evidence regarding gene 
expression.  
1.3.2.1. Promoter elements.  The promoter is a region of sequence located 
upstream of the transcription start site. Elements within the promoter contribute to the 
inherent affinity of the region for RNA polymerase, an enzyme that relies on promoter 
recognition by necessary accessory proteins (transcription factors) to initiate 
transcription in the correct location [13].   
The most common element, the TATA box, can be found in up to 50% of 
eukaryotic genes and is generally located between 23 and 33 base pairs (bp) upstream 
from the transcription start site. The eukaryotic TATA box consensus sequence is 
TATAAA, however there are numerous variations of this sequence found between 
species. An Inr box is another element common to eukaryotic genes (40-65%) and 
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straddles the transcription start site. This element is C/T rich and may serve as an 
important protein binding site in the absence of a TATA box. The downstream 
promoter element (DPE) is located 23 and 33 bp after the transcription start site. The 
CAAT box, with the consensus sequence GGNCAATCT, is located between 40 and 
100 bp upstream from the transcription start site if present [16]. The significance of the 
presence of these elements is based on the need for binding sites for proteins that assist 
in RNA polymerase positioning. If transcription factors and other accessory proteins 
that require these elements cannot bind because the elements are deleted or mutated, 
transcription cannot initiate, and a non-functional gene (pseudogene) is the result. 
Thus, the presence or absence of promoter elements can provide evidence for the 
expression of a predicted protein-coding sequence.  
A number of web-based promoter element prediction tools exist. For the scope 
of this project, the Plant Cis-Acting Regulatory DNA Elements (PLACE) database 
was the preferred search tool. FgenesH, a gene prediction tool that is used to construct 
gene models, also predicts a promoter region but not specific elements.  
1.3.2.2. Polyadenylation signals.  The polyadenylation (poly-A) site is a series 
of sequences that signals an endonuclease to cleave a transcript at a specific site 
located 10 – 30 nucleotides downstream from the polyadenylation signal sequence 
[13]. Eukaryotic polyadenylation sites lie in the 3’ UTR of the genes that encode the 
transcripts and are composed of three cis-elements—the poly-A signal, the cleavage 
site, and a downstream element (DSE).  No consensus data has been found for the 
DSE; it is known only to be a U/GU-rich region located 10 – 15 nucleotides 
downstream from the cleavage site [20]. Once an mRNA molecule is cleaved it can 
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undergo essential processing, which includes the addition of a tail composed of 
repeating adenosine residues. This is a vital eukaryotic process that stabilizes the 
molecule and in doing so, promotes efficient translation of the mature transcript into a 
protein [13].  
Studies have revealed that the poly-A signal is a highly conserved 
hexanucleotide in animals with the consensus sequence AWUAAA, where W stands 
for U or A [20]. However, conserved motifs of polyadenylation signals in plant species 
are less conserved and far more difficult to identify. For example, in a 1987 study, the 
sequence AAUAAA was only found to exist in 10% of the transcripts produced from 
Arabidopsis genes [21]. In addition, it has been observed that plant genes may contain 
multiple poly-A sites [22] and studies of Arabidopsis reveal that the DSE may not be 
present in plants [20].   
In 2013, Sherstnev et al. revealed that Arabidopsis does contain multiple poly-
A sites, but there are preferred profiles associated with cleavage sites. For a small 
quantity of cleavage sites, the most common motif was in fact the consensus sequence 
AAUAAA, with the preferred location of 19 nucleotides upstream from the cleavage 
site. For others, the poly-A signal was a similar hexamer, differing in the position of a 
single residue. In addition, a U-rich sequence was found to consistently reside 7 
nucleotides upstream from the cleavage site (USE), as well as a short A-rich sequence 
and a U-rich DSE. It was concluded that the presence and multi-functional purpose of 
the U- and A-rich regions might account for the decreased use of a consensus 
sequence at the poly-A signal [23]. Despite growing knowledge of the poly-A site of 
plant species, currently the best resource for the identification of plant poly-A sites in 
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plants is the analysis of ESTs that contain polyadenylation tracts [22]. However, 
specific algorithms have been, and are being, developed to predict these sites and 
include a Generalized Hidden Markov Model (GHMM), Adaboost, length-variable 
second order Markov model (LVMM2) [22], and Generalized Hidden Markov Model- 
Real Wavelength Transform (GHMM-RWT) [24].  
1.3.2.3. Intron/exon borders. Research into the splicing mechanism led to the 
discovery of consensus sequences at intron/exon borders that are recognized by 
snRNAs within the splicing machinery. At the 5’ splice junction of the primary 
transcript, the consensus sequence is CAG/GUAAGU (/ indicates the border between 
exon and intron). At the 3’ splice junction the consensus sequence is 
UUUUCCCUCCAG/GU. The encoding DNA contains the 5’ and 3’ nucleotide dimers 
GT and AG respectively. Figure 1.2 shows the sequence logo as generated by a motif 




Figure 1.2. Intron/exon border motifs [16]. Original source of illustration: Figure 1. 
From Sakabe NJ, de Souza SJ. Sequence features responsible for intron retention in 
human. BMC Genomics 2007;8.  
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 The intron border consensus data is ubiquitous among eukaryotic organisms 
and is summarized in Figure 1.3.  
 
 
Exon 1 5’ s.j        Intron        3’ s.j. Exon 2 
G GT AG G 
   




1.3.2.4. Splicing signals within introns. In animal species, there are four 
signals intrinsic to the intron that mediate splicing activity. Two of these sequences are 
the 5’ and 3’ splice junction consensus dimers, GT and AG respectively. There are two 
additional signals found near the 3’ splice junction—the polypyrimidine tract and a 
branch point located 17-40 nucleotides upstream of the 3’ end of the intron [25]. 
Spliceosome components recognize and bind these signals. The 5’ splice junction 
sequence is recognized by the U1 snRNP, the 3’ splice junction sequence is 
recognized by the U2AF35 protein, the polypyrimidine tract is recognized by the 
U2AF65 protein, and the branch point is recognized by the U2 snRNP [26]. U2AF35 
and U2AF65 are U2 auxillary factor protein subunits of 35 kDa and 65 kDa of the 
heterodimer U2AF. U2AF65 directly binds the polypyrimidine tract as well as another 
protein, SF-1/mBBP. The complex of these proteins promotes binding of the 
U2snRNP unit to the branch point sequence [28].  
Comparative studies between animals and angiosperms revealed some key 
differences in gene structure. Plants have shorter genes with fewer numbers of exons 
and shorter introns [25]. In addition, the branch point [25] and polypyrimidine tract 
[28] are not always identifiable due to the 3’ region of the intron being rich in U/A 
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residues [25/26].  U/A composition is essential to the functionality of an intron for 
splicing. It was reported by Goodall and Filipowicz in 1991 that the minimum UA 
content for introns in dicots is 59% for splicing efficiency [29]. The U richness of 
intronic elements allows for dual functionality. In the presence of a branch point, the 
U-rich element can serve as a polypyrimidine tract and in the absence of a 
branchpoint, it can serve as a UA-rich element [28].  
Studies have been conducted to determine the optimum consensus sequence for 
the branch point. The loosely conserved consensus sequences for plant and vertebrate 
branch points (of the pre-mRNA) were proposed in 1986 to be CURAY and YURAY 
(where Y stands for C or T and R stands for A or G [32]) [30] and were later 
confirmed in a 2002 mutational analysis [31].  
Due to the fact that intron retention is the most common form of alternative 
splicing event in plants, scientists propose that the signals for splice site recognition 
are likely located in the intron. In addition to the conserved sequences described 
previously, regulatory elements can also mediate splicing activity. These elements are 
referred to as splicing regulatory elements (SRE) and can exist in the intron or exon as 
enhancers or silencers, promoting or preventing the use of a splice site. There has been 
very little effort to date to uncover SRE’s in plants [33]. Some computational tools 
have identified putative exonic splicing enhancers (ESE) in Arabidopsis thaliana [34] 
such as a GAAG repeating region of the intron known to bind the regulatory protein 
SCL33 [33]. ESEs are the most commonly studied SRE, however, their study is 
limited primarily to mammalian species [26]. 
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1.3.3. MicroRNA. MicroRNA (miRNA) is a short (~22 nucleotides long) type 
of non-coding RNA (ncRNA) that is typically involved in post-transcriptional 
regulation of gene expression through mRNA degradation or translational repression. 
Micro RNA can typically be found in a symmetrical structural formation, such as a 
hairpin or cloverleaf, that is the result of dyad symmetry (inverted repeats) within the 
coding sequence. Inverted repeats are thought to be the product of inverted DNA from 
a duplication event. If the function of a miRNA is important, sequence and structure 
are conserved [35].  
MicroRNA-encoding genes are present on all 20 soybean chromosomes and 
are predominantly intergenic [36]. MicroRNAs can be located in the introns of 
functional genes and these intragenic miRNAs have been observed being expressed 
through parent gene preferential expression in root tissue. This is likely due to the 
strong role that legume-specific and nodulation-regulated miRNAs play in root nodule 
development [37]. Legume- and soybean-specific miRNA families tend to be smaller 
and contain fewer members, whereas highly conserved miRNA families tend to be 
larger with more members [36]. In soybean, most of the legume-specific miRNA 
families produce a 21 nucleotide mature miRNA molecule. Also, soybean miRNAs 
exhibit a preference for U at the 5’ most nucleotide of the mature molecule [36].   
Computational analytical tools such as miRseeker, miRScan, miRRim [35], 
and FOMmir [38] exist that use trained algorithms to predict miRNA sequences [35]. 
In 2010 Kandoth et al. presented a novel approach to identify miRNA precursors that 
utilizes an algorithm to search for inverted repeats and then filters the results using 
criteria such as density and length of symmetrical area, and GC content [35].  
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 1.3.4. Dyad Symmetry.  Dyad symmetry exists in a double-stranded DNA 
sequence when a segment of sequence from one strand can be rotated 180 degrees and 
match the sequence of the complimentary strand of the same segment. This implies 
intramolecular base pairing capability, which, for example, can result in the formation 
of structures such as hair-pin loops. In order to determine whether sequences exhibit 
dyad symmetry, a test was developed to determine what type of output dyad symmetry 
would produce in a dot plot matrix. A random selection of nucleic acids was 
assembled into a 50 nt long sequence with a 12 nt internal segment that exhibited dyad 
symmetry. This sequence was plotted against itself, its compliment, and its reverse 
compliment in a dot plot matrix. Plotting against the reverse compliment resulted in a 
distinct graph that would indicate dyad symmetry. The reverse compliment sequence 
can be obtained using a web-based translation tool. 
 
1.4. DATABASES AND OTHER BIOINFORMATIC TOOLS 
 1.4.1. Proteins: PFAM ,Panther, KOG, and PDB. PFAM is a protein family 
database in which a family being defined as “sets of protein regions that share a 
significant degree of sequence similarity” [39]. PFAM contains both manually curated 
and automatically generated families produced from hidden Markov model profiles 
created and searched against the UniProtKB database. The ultimate goal of the PFAM 
database is to assemble a set of annotated families that can be used for genome-
annotation and protein studies [39].  
 PANTHER (Protein Analysis Through Relationships) is another gene family 
database that classifies proteins according to family/subfamily, molecular function, 
17 
	  
biological process, and pathway [40].  It provides three types of annotation—
subfamily membership, protein class, and gene function. The annotations are linked to 
nodes on a phylogenetic tree for each family. PANTHER was originally developed in 
anticipation of the first sequencing of the human genome. The website provides tools 
for the functional analysis of genes and proteins [41]. PANTHER also annotates 
according to gene ontology [41] and is involved with the Gene Ontology Reference 
Genome Project [40]. 
 KOG (euKaryotic Orthologous Groups), which is an update of the original 
system COG (Clusters of Orthologous Groups) [42], is a collection of proteins from 
eukaryotic genomes that are classified according to four functional groups and 
clustered according to orthology and parology [43].  
 The world-wide Protein Data Bank (PDB) is a publically-accessible database 
of macromolecular structural data supported by a collaboration of numerous 
international research organizations including the Research Collaboratory for 
Structural Bioinformatics (RCSB) which is managed by Rutgers, the State University 
of New Jersey, and the San Diego Supercomputer Center at UCSD; the 
Macromolecular Structural Database (MSD) at the European Bioinformatics Institute 
(EBI); and the Protein Data Bank Japan (PDBj) [44].  
 1.4.2. Phytozome. Phytozome is a hub for the comparative studies of plant 
families and evolution. Phytozome is supported by the Department of Energy’s Joint 
Genome Institute (JGI) and the Center for Integrative Genomics (CIG).  Currently 
running in version 9.1, it provides users access to 41 sequenced green plant genomes. 
Annotations based on PFAM, KOG, KEGG, and PANTHER assignments, as well as 
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publicly available annotations from RefSeq, UniProt, TAIR, and JGI, are provided 
where available. Phytozome regularly updates genomic information as it becomes 
available. The web portal is user friendly and offers tools such as a genome browser 
and basic local alignment tools. By selecting a specific gene or transcript, the user 
gains access to basic information, sequence data (genomic, transcript, coding, and 
peptide sequences), protein homologs and gene ancestry [45].  
 1.4.3. NCBI. The National Center for Biotechnology Information (NCBI) was 
established in 1988 as a division of the National Library of Medicine (NLM) at the 
National Institutes of Health (NIH) due to recognition of the need for computerized 
information processing methods in biomedical research. The organization’s mission 
became “finding new approaches to deal with the volume and complexity of data and 
in providing researchers with better access to analysis and computing tools to advance 
understanding of our genetic legacy and its role in health and disease [46].” The 
specific goal of NCBI was focused on:  
creating automated systems for storing and analyzing knowledge about 
molecular biology, biochemistry, and genetics; facilitating the use of 
such databases and software by the research and medical community; 
coordinating efforts to gather biotechnology information both 
nationally and internationally; and performing research into advanced 
methods of computer-based information processing for analyzing the 
structure and function of biologically important molecules [46]. 
 
NCBI has a multi-disciplinary research group that supports the GenBank DNA 
sequence database and a number of other databases including the database of 
expressed sequence tags (dbEST), Online Mendelian Inheritance in Man (OMIM), the 
Molecular Modeling Database (MMDB) of 3D protein structures, the Unique Human 
Gene Sequence Collection (UniGene), a Gene Map of the Human Genome, the 
19 
	  
Taxonomy Browser, and the Cancer Genome Anatomy Project (CGAP), in 
collaboration with the National Cancer Institute [47].” NCBI shares data with the 
European Molecular biology Laboratory (EMBL) and the DNA Database of Japan 
(DDBJ). NCBI is a central hub for access to numerous automated gene and protein 
analysis tools such as BLAST, RefSeq, 1000 genomes browser, an open-reading frame 
finder (ORF-finder), and numerous taxonomy and classification tools. Entrez, a data-
mining tool offered by NCBI, provides users with access to sequence, mapping, 
taxonomy, and structural data [47].  
  1.4.4. DNA Subway. DNA Subway is supported by the Dolan DNA Learning 
Center as part of iPlant Collaborative. It provides a bioinformatics workspace for users 
to analyze sequence data, create annotations, and perform phylogenetic analysis [48]. 
The user-friendly interface facilitates the use of analytical tools by making user 
options available in a step-by-step manner through a mapped out pathway. Users can 
choose pathways for gene annotation, genome prospecting, sequence relationship 
determination, and next generation sequencing. Within the gene annotation tract, the 
user can use predictive algorithm programs (Augustus and FgenesH) to predict genes 
from sequence inputs, upload nucleic acid and peptide sequences for comparison, and 
construct gene models in APOLLO, a curation and annotation tool. Augustus predicts 
a 5’untranslated region for possible promoter location and FgenesH predicts the most 
likely start codon. This makes both tools uniquely valuable as predictive tools [49]. 
 1.4.5. Phylogeny.fr.  Phylogeny.fr is a free website developed for use by non-
specialists for the construction and analysis of phylogenetic relationships between 
sequences. It provides a workflow for users that can be set up to run without any 
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decision-making on behalf of the user or with full control of program selection and 
parameter settings by the user. The output of the workflow is the result of sequence 
processing by a multiple alignment, a curation, a phylogeny, and a tree-rendering tool 
[50].  
1.4.6. ExPASy.  The Expert Protein Analysis System (ExPASy), which is 
supported by the Swiss Institute of Bioinformatics (SIB), is a web portal that offers 
access to databases and other tools for the purpose of analysis within the areas of 
genomics, proteomics, phylogeny, systems biology, population biology, etc. ExPASy 
is the main host for databases developed by the SIB including PROSITE, a database of 
protein families and domains that aids in the identification of novel sequences through 
known protein family annotations [51]. ExPASy databases are cross-referenced with 
other biological resources all over the world and are updated frequently [52].  
1.4.7. MEME.  MEME (Multiple Ems for Motif Elicitation) is a member of 
the MEME suite, a web server that is funded by the National Biomedical Computation 
Resource and hosts tools for motif-based sequence analysis [53].  The MEME tool 
employs an algorithm to identify motifs in a set of DNA or protein sequences. The 
technique involves “expectation maximization to fit a two-component finite mixture 
model” to a set of unaligned sequences. The only required parameter is the selection of 
motif width [54]. This tool is only capable of generating motifs from input sequences 
and does not compare them to known motifs.  
 1.4.8. CLUSTALw. CLUSTALw is a web-based multiple sequence alignment 
tool that is supported by GenomeNet, a network of database and computational 
21 
	  
services operated by the Kyoto University Bioinformatics Center [55]. This tool aligns 
multiple nucleic acid or peptide sequences for phylogenetic analysis [56].  
1.4.9. PAL2NAL.  PAL2NAL is a web-based (also downloadable), program 
that converts a peptide multiple sequence alignment to a codon alignment by 
referencing the peptide sequences to their coding DNA sequences. This is 
accomplished by reverse translation of the peptide sequence to a DNA sequence based 
on regular expression patterns and subsequent comparison of the reverse translation 
product to the input DNA coding sequence to find corresponding coding regions. The 
PAL2NAL server accepts the multiple alignment data in FASTA or CLUSTAL 
format. The resultant codon alignment is useful for calculating synonymous and non-
synonymous substitution rates [57].  
1.4.10. SNAP. The Synonymous Non-synonymous Analysis Program (SNAP) 
v1.1.1 is a tool of the HIV sequence database that calculates synonymous and non-
synonymous substitution rates from a codon alignment [58/59].  
 1.4.11. PLACE.  PLACE (Plant Cis-acting Regulatory DNA Elements) is a 
database of motifs common to known cis-acting regulatory DNA elements of vascular 
plants. Motifs are found by uploading a nucleic acid sequence into a signal scan 
search. All motifs that match or are similar to known motifs will be listed with the 
promoter element/site name, location of the starting nucleotide, whether it is located 
on the + or – strand, the motif/signal sequence, and a PLACE identification number 
(PLACE identifier). The PLACE identifier provides information about the source and 
expression. Motif descriptions are available with accession numbers for any 
information cross-referenced with PubMed or GenBank/EMBL/DDBJ [60/61].  
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1.4.12. CELLO. CELLO is a subcellular localization prediction tool that uses 
a support vector machine (SVM) classification system to predict the location of 
cellular activity of a peptide sequence based on amino acid composition, di-peptide 
composition, partitioned amino acid composition, and physio-chemical properties of 
amino acids. Compared to other subcellular localization prediction methods, CELLO 
displays the highest prediction accuracy [62/63/64]. Subcellular localization can be 
useful for inferring protein function since function is usually related to the location of 
employment [64].  
 1.4.13. PSIPRED Protein Sequence Analysis Workbench. PSIPRED 
(Position-Specific Iterated Prediction) is a secondary structure prediction method that 
annotates sequences with the location of key structural features such as coiled coil, 
helical, and sheet domains.  It employs a two-stage neural network based on position-
specific scoring matrices produced by PSI-BLAST [65]. It is supported by the UCL 
Department Of Computer Science Bioinformatics Group and is currently running 
version 3.3 [66].  
 PSIPRED and numerous other recognition programs can be accessed and 
employed simultaneously through the PSIPRED Protein Sequence Analysis 
Workbench at http://bioinf.cs.ucl.ac.uk/psipred/. Two of these tools, fold recognition 
and fold domain recognition, are useful when analyzing a novel peptide sequence. 
GenTHREADER is a rapid fold recognition tool that can be used to infer tertiary 
structure. It employs a simple neural network to combine sequence alignment score, 
length information and energy potentials and threads them into a single score. The 
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score represents the relationship between two proteins according to CATH (a protein 
structure classification database) designation [67].  
CATH is a hierarchical domain classification system. The four levels of hierarchy 
include [68]: 
• Class - classified according to secondary structure. 
• Architecture – classified according to orientation of secondary structure in 3-
dimensional space.  
• Topology – classified according to fold groups and connection between 
secondary structure. 
• Homologous superfamily – classified according to domain group that is 
thought to share a common ancestor.  
pGenTHREADER (Parametric-GenTHREADER) and pDomTHREADER 
(parametric-DomTHREADER) are improved versions of the GenTHREADER 
program used for protein sequence alignment and recognition. Both use the same core 
algorithm. The fold recognition algorithm is guided by 20 parameters: four for profile-
profile scoring, nine for secondary structure scoring, six for gap penalties, and a 
weighted score. Both versions use the profile-profile score to produce a measure of 
confidence score [69]. pGenTHREADER uses profile-profile alignments and 
secondary structure prediction as input to improve accuracy. pDomTHREADER 
produces domain alignments in an effort to improve accuracy of superfamily 
discrimination [70].  
 1.4.14. DNA Dot Plots.  Dot plots provide a simple, graphical method of 
analysis of sequence similarity between two different sequences, repeats within a 
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single molecule, and potential for intra-molecular base pairing (tertiary structure). The 
comparison matrix is employed by the movement of a window (number of residues 
being considered at one time; defined by user) along two input sequences. The user 
defines the mismatch limit, which is the number of mismatched residues that can exist 
within a window in order to still be defined as a match [71]. For example, if the 
window size is 5 and the mismatch limit is 1, a single mismatch can exist in a 5 base 
sequence and it is still considered a match. Under these parameters, the existence of 2 
mismatches in a 5 base sequence is not considered a match. If the matrix determines a 
match at a single point in the comparison a dot is placed on the matrix. The appearance 
of diagonal lines is an indication of sequence similarity. The appearance of parallel 
lines is often a sign of repeating sequences.  
1.4.15. I-TASSER. The I-TASSER server is an automated online platform for 
predicting the structure and function of proteins. Using an amino acid sequence as the 
query, the program performs a four-stage protocol to determine structure. The first 
stage involves threading the query sequence against solved structure databases to find 
template proteins with similar structure or motifs. A multiple alignment of structural 
homologs is used to create a sequence profile, which is used to predict secondary 
structure and will assist in threading the query against the PDB library. The top 
templates are ranked according to specific score criteria and are further scrutinized 
using tests of statistical significance. The second stage involves threading alignments 
of fragments from templates in order to assemble regions that align well into structural 
conformations. The third stage is model selection and refinement. One function of this 
stage is to refine global topology through removal of steric clashes in the model. In the 
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fourth stage involves functional annotation prediction through a comparison of the 
predicted model with proteins of known structure and function in PDB [72].  
Each stage produces multiple categories of scores that drive the process—
confidence scores, identity scores, statistical scores, etc. The primary scores for 
assessing the predicted 3D model are the C-score, or confidence score, and the TM-
score, a measure of the quality of the final model. Selection criteria for correct model 
topology are a TM-score greater than 0.5 and a C-score greater than -1.5, because the 
false-positive and false-negative rates are low [73].   
I-TASSER has been ranked the number one server for structural and functional 
prediction of proteins in many recent community-wide Critical Assessment of 
Structure Prediction (CASP) experiments [73]. The server ranked number one in 
CASP7, CASP8, CASP9, and CASP10 for structural prediction and in CASP9 for 













2. MATERIALS AND METHODS 
 
2.1. BLAST 
 Sequences were aligned against a target database using a Basic Local 
Alignment Search Tool (BLAST). The types of BLAST searches that were conducted 
are outlined in Table 2.1. Query sequences are input in FASTA format (>glyma03g . . 
. ). For the tblastn searches (predominant BLAST type used), algorithm parameters 
were set as follows: Max target sequences, 100; Expected threshold, 10; Scoring 
matrix, BLOSUM62; Gap costs, Existence: 11 and Extension: 1. For the blastn 
searches, algorithm parameters were set as follows: Max target sequences, 100; 
Expected threshold, 10; Word size, 28; Match/mismatch scores, 1,-2; Gap costs, 
Linear. For the scope of this research effort Phytozome was the preferred genome 
browser, which has a built in BLAST application, but the BLAST tool at the National 
Center for Biotechnology Information (NCBI) was also utilized.  
 
Table 2.1. Summary of database and query requirements for utilized BLAST 
programs. 
 
BLAST Program Query Sequence Database Searched 
blastn Nucleic acid sequence Nucleotide 




2.2. SEQUENCE ALIGNMENTS 
 Sequence alignments were conducted using CLUSTALW. Both DNA and 
protein pairwise alignments and multiple alignments were performed using the 
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slow/accurate alignment option. The protein alignment inputs consisted of the 
conceptually translated peptide sequences of all genes to be aligned in FASTA format. 
The nucleotide alignment inputs consisted of the nucleic acid sequences of all genes to 
be aligned in FASTA format. CLUSTAL was chosen as the output format. Parameter 
settings are outlined in Table 2.2.  
 
Table 2.2. CLUSTALW parameters. 
 Pairwise Alignment Multiple Alignment 
 DNA Protein DNA Protein 
Gap Open Penalty 15 10 15 10 
Gap Ext. Penalty 6.66 0.1 6.66 0.05 
Weight Matrix IUB BLOSUM IUB BLOSUM 
 
 
2.3. CHOICE OF GENE FAMILY AND IDENTIFICATION OF MEMBERS 
 A table of candidate gene families was compiled by cross-referencing 
information from the PFAM database and Supplementary Table 5 [9]. PFAM was 
filtered for all gene families in Glycine max annotated as unknown function and listed 
in descending order according to the gene count. Gene families containing 10 or fewer 
members were further screened as follows. Supplementary Table 5 in Schmutz et al. 
[9] provided additional information concerning the quantitative relationship between 
10 plant species, including Glycine max, and a gene address for a single gene in 
Glycine max for each family. The number of putative genes in a family is compared 
across ten species including Vitis vinifera (Vvi. common grape), Populus trichocarpa 
(Ptr, cottonwood or poplar tree), Medicago truncatula (Mtr, barrel medic), Glycine 
max (Gma, soybean), Arabidopsis thaliana (Ath, thale cress), Arabidopsis lyrata (Aly, 
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rock cress), Carica papaya (Cpa, papaya or pawpaw), Sorghum bicolor (Sbi, 
sorghum), Zea mays (Zma, corn), Brachipodium distachyon (Bdi, purple false brome), 
and Oryza sativa (Osa, rice), and is displayed in a ratio as 
Vvi:Ptr:Mtr:Gma:Ath:Aly:Cpa:Sbi:Zma:Bdi:Osa. Focus was placed on those families 
that had a PFAM functional annotation of UNKNOWN, contained ten or fewer 
members in Glycine max, and displayed expansion in Glycine max relative to the other 
species in the gene family ratio, i.e., fewer than 3 members in any other species.  
 A conceptually translated peptide sequence, obtained from Phytozome, from a 
single family member of each potential family was used as an initial query in a 
BLAST. The query was compared to all sequences in the Glycine max genome. Those 
hits that produce a potential transcript were designated “model genes” and those 
sequences that do not correspond to a putative gene (algorithm-predicted) were 
designated “non-models” (referred to as non-coding sequences throughout this 
manuscript). All hits producing a possible transcript were subsequently used as a query 
using the same BLAST parameters. A family was arbitrarily defined as a group of 
model genes in which each gene registered as a hit for all other potential family 
members.  
 Based on data collected from all aforementioned filters, three families were of 
particular interest, all exhibiting high similarity between members. The sequences of 
those particular family members were placed into MEME (Multiple Em for Motif 
Elicitation), a motif-based sequence analysis tool. The input was conceptually 
translated peptide sequences of all genes in a family in FASTA format. MEME 
parameters were set to find between 2 (minimum) and 20 (maximum) sites per 
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sequence. The width of each motif was limited to a minimum of 6 and a maximum of 
50 with a maximum of 3 motifs per sequence. From those motifs, any conserved 
sequences of ten or more consecutive amino acids were used as queries in a BLAST 
search of the Glycine max genome to ensure that all members of each family had been 
discovered.  
 The Glycine max gene family containing a putative gene at the location 
08g39410, displayed 3 strongly conserved motifs, 2 of which exceeded fifty amino 
acids in length and four out of five family members contain all three motifs.  
 From this point forward all research was limited to the gene family that 
contains glyma08g39410 and the members of the family hereafter referred to as 




2.4. EVOLUTIONARY AND EXPRESSION ANALYSIS FOR GENE MODEL   
       CONSTRUCTION 
 
 2.4.1. Neighbor Gene Analysis. The predicted genes adjacent to each family 
member that lie within 50 kbp on either side of it on the chromosome were examined 
to identify any synteny that might exist between family members.  The following 
information was recorded for each gene adjacent to a gene family member:  
• Gene address. 
• 5’ or 3’ placement on strand relative to the query (with consideration given  
 to the orientation of the query on the + or – strand.)  
• Distance from the query gene in kbp. 
• Annotated function, if any.  
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 The non-coding sequences (LJFnm19, LJFnm11, and LJFnm12) that resulted 
from the original BLAST searches were also analyzed using this method.  
 2.4.2. EST’s. The NCBI website contains the information for all expressed 
sequence tags (EST’s) for Glycine max. The peptide sequences of all gene family 
members were individually aligned through a BLAST search against known Glycine 
max EST’s to determine which EST’s originate from this family. The conceptually 
translated peptide sequences of each gene were used as query against the Glycine max 
EST database. The query sequence used was in FASTA format. The database was 
specified as expressed sequence tag (est) and the organism specified as Glycine max 
(taxid: 3847). The max target algorithm parameter was adjusted to 1000 to ensure all 
EST’s were found.  
 In order to verify that each EST does represent the gene in question, the nucleic 
acid sequence of each of the resultant EST sequence was used as a BLAST query back 
to the Glycine max genome. The nucleic acid sequence of the EST was obtained from 
NCBI through searching the corresponding accession number.  
 The top result is the strongest score and the gene model/sequence that the EST 
corresponds to. If the top hit corresponds to the gene that was the original query, then 
that EST belongs to that gene. If the top hit is not the original query, the EST belongs 
to another gene. All EST accession numbers and max scores corresponding to gene 
family members were recorded.  
 A library was created for EST’s belonging to gene family members. 




 2.4.3. Synonymous and Nonsynonymous Substitution Rates.  SNAP 
(Synonymous Non-synonymous Analysis Program) v 1.1.0, a web-based tool, was 
used to determine the synonymous and non-synonymous substitution rates between all 
genes.  
 The first step was creating a multiple alignment of the putative peptide 
sequences of the genes in the family. The multiple sequence alignment was then used 
as input file 1 for creating a codon alignment using PAL2NAL (protein alignment to 
nucleic acid alignment).  Input file 2 for this tool was the coding nucleotide sequences 
of all gene family members in FASTA format. The codon table was set as universal 
code, gaps and mismatches were not removed, and the output format was set as 
CLUSTAL.  
 The codon alignment output was transferred to the SNAP v 1.1.0 program of 
the HIV sequence database at www.hiv.lanl.gov. SNAP generated a results table with 
synonymous and non-synonymous substitution rates for pairwise comparisons of every 
gene in the family.  
 2.4.4. Glycine max Family Phylogeny.  The following tools were utilized to 
perform the specific tasks for phylogenetic analysis: ClustalW for the multiple 
alignment, Gblocks for alignment curation, PhyML for phylogenetic tree construction, 
and Drawtree for phylogenetic tree visualization. The conceptually translated peptide 
sequences for all genes in the family in FASTA format were provided as input.  
  2.4.5. Plant Species Family Phylogeny.  A cross-species comparison was 
conducted for each gene in the family by conducting a BLAST search using the 
conceptually translated peptide sequence of each gene against 9 plant genomes with 
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varying phylogenetic relationships to Glycine max. The species chosen for the 
comparison were Medicago truncatula, Phaseolus vulgaris, Arabidopsis thaliana, Zea 
mays, Oryza sativa, Sellaginella moellendorfii, Physcomitre patens, Chlamydomonas 
reinhardtii, and Volvox carteri. The resultant transcripts and their percentage 
similarity were recorded. The peptide sequences from these hits were included with 
the Glycine max sequences to estimate phylogenetic trees. Two trees were generated, 
one with the five Glycine max genes and the transcripts from Medicago truncatula and 
Phaseolus vulgaris (closely related legumes) and a second with the five Glycine max 
genes and all of the aforementioned species’ transcripts.   
 2.4.6. Constructing Gene Models.  The specific tools utilized for gene model 
construction were as follows.   
 2.4.6.1. Predicting gene models. For each gene family member, a 10 kbp 
segment of the chromosome with the gene model at near center in FASTA format 
were analyzed. Repeat masker was used to eliminate/block repetive sequences within 
the query that could slow the analysis. Augustus and FgenesH, two predictive 
programs that use unique algorithms, were employed to predict the presence of a gene 
within the input sequence.  
 The nucleic acid sequences for all the ESTs for each gene family member were 
aligned against the 10kbp segment. Aligned ESTs and predicted models were viewed 
using APOLLO, a model building application.  
 2.4.6.2. Verifying intron/exon borders using EST data.   For the three 
family members that had EST data, the EST models were used in addition to plant 
intron/exon border consensus data to verify intron/exon borders in models.  
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 For the two gene family members that had no known ESTs, the predicted 
models and the consensus data were the best available tools for resolving gene 
structure. The conceptually translated peptide sequences for the family members with 
ESTs were also uploaded as a comparison tool.  
 2.4.6.3. Identification of start codon through ORF (open reading frame) 
analysis.  An ORF calculator was used to indicate the longest uninterrupted open 
reading frame that a model can produce. The ORF calculator was accessed through the 
APOLLO tool in DNA Subway.  
 2.4.7. Promoter Element Identification.  Promoter elements, such as the 
TATA and CAAT boxes, were identified using PLACE (Plant Cis-Acting Regulatory 
DNA Elements). A sequence of ~1500 nucleic acids located upstream from each gene 
was used as an input. An overlap of at least 100 nucleotides at the 5’ end of the gene 
was included as a means of measuring distance of elements from the start ATG. The 
“group by signal” option for results output was selected. The following information 
was collected and organized: TATA and CAAT box locations, distance of elements 
from each other in nucleotides, and distance of TATA elements from the start ATG. 
 The PLACE database was searched for elements associated with drought 
treatment and root hair in two separate searches. A record was made of the gene 
family members that contain an upstream element corresponding to the accession 
numbers that resulted from that search. In addition, all accession numbers were cross-
referenced with gene family members according to the presence or absence of ESTs in 
an attempt to unveil expression patterns. Accession numbers corresponding to the 
following patterns were examined: those that belong to all genes with EST data, those 
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that belong to all genes without EST data, and those observed in all members of the 
family regardless of EST data. The information provided for the accession numbers 
meeting these criteria was analyzed for possible tissue-specific expression or 
environmental stress response expression patterns.  
 2.4.8. Evolutionary Analysis of Verified Gene Family Member Resolved 
Models.  An evolutionary analysis of gene family members was conducted after model 
construction using a multiple alignment, codon alignment, phylogenetic tree 
construction, and were calculated using synonymous/non-synonymous substitution 
rates. In addition, pairwise alignments and dot plot comparisons were also utilized.  
2.4.8.1. Multiple and pairwise alignments to analyze coding capacity and 
possible mutation sites.  A multiple alignment of all gene family members was 
conducted using the conceptually translated peptide sequences of each in FASTA 
format as input. A second multiple alignment was carried out using the peptide 
sequence with the addition of conceptually translated amino acid residues on both the 
5’ and the 3’ end of each sequence to make every sequence as long as the longest 
peptide sequence in the family.  
A codon alignment was created using PAL2NAL. Protocol for the use of the 
PAL2NAL tool is outlined in Section 2.4.3.   
 Each gene family member was aligned pairwise against every other family 
member. Input data consisted of the coding nucleic acid sequence plus enough 
nucleotides extending from the 5’ and 3’ ends of the shorter sequence to make it as 
long as the longer sequence. The exonic regions of each gene in the output were 
delineated and the sequences examined for variants and/or mutations.   
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 2.4.8.2. Generation of dot plots to assess similarity of sequence outside of 
the coding area.  All gene family members were compared pairwise through a dot 
plot generator tool. The genomic nucleic acid sequence of each model in FASTA 
format was used as input. Parameters were set as follows: window size, 9; mismatch 
limit, 0. Additional pairwise comparisons were carried out between LJFgene3, 
LJFgene14, and LJFgnee1 to determine the level of sequence similarity of the regions 
of the chromosomes flanking these models. The sequences were extended up to 10kbp. 
The data generated from this tool was compared to the neighbor gene analysis.  
 
2.5. NON-CODING SEQUENCE ANALYSIS 
 The conceptually translated peptide sequences of each non-coding sequence 
were placed into a web-based reverse translation tool (such as the Backtranseq tool 
supported by EMBL-EBI) to produce the corresponding nucleic acid sequences for use 
as a query for a BLASTn search against the Glycine max genome. A record was made 
of the details of the BLAST results including percent identity to gene family members, 
the range of nucleotides of the family members that the non-coding sequences 
corresponded to, and the composition of any other segments of DNA that the non-
coding sequences correspond to outside of the gene family.  
 LJFnm19, LJFnm11, and LJFnm12 were compared to LJFgene3 (the basis for 
comparison for the family) using a dot plot matrix. A segment of nucleic acid 
sequence from chromosomes 19, 11, and 12 that included LJFnm19, LJfnm11, and 
LJfnm12, respectively, and a specified number of flanking nucleotides (enough to 
extend each side of the non-coding sequence to equal the length of LJFgene3 in 
36 
	  
sequence) was dumped to FASTA format and used as input in a dot plot generator. 
Parameters were set as outlined in Section 2.4.7.3.  
 Non-coding nucleic acid sequences of LJFnm19, LJFnm11, and LJFnm12 were 
compared in a multiple alignment to LJFgene3, LJFgene14, and LJFgene1 genomic 
sequences. LJFnm19, LJFnm11, and LJFnm12 were also aligned against each other 
using conceptually translated peptide sequence, coding sequences, and genomic 
sequence as input for multiple alignments. All three non-coding nucleic acid 
sequences were individually plotted against their reverse compliment in a dot lot 
matrix to determine if dyad symmetry exists within the sequences. 
 The nucleic acid sequences of LJFnm19, LJFnm11, and LJFnm12 were 
submitted for analysis through FOMmiR, a web-based prediction tool that uses a 
fixed-order Markov model and is based on secondary structure.  
 A roughly 1kbp segment of DNA flanking the 5’ side of LJFnm19, LJFnm11, 
and LJFnm12 was submitted for a signal scan through PLACE to determine the 
presence of any promoter elements. The query sequences were the nucleic acid 
sequence upstream of LJFnm19, LJFnm11, and LJFnm12 in FASTA format 
containing the LJFnm non-coding sequence as a location reference.  
 
2.6. FUNCTIONAL ANALYSIS 
 SMART was used to search for elements that are already known to be in 
proteins such as domains of similar organization or composition, homologs of known 
structure, or signal sequences. The conceptually translated peptide sequences of all 
gene family members were input independently. The following search options were 
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selected: outlier homologs and homologs of known structures, PFAM domains, signal 
peptides, and internal repeats. The initial MEME results were obtained through search 
parameters that limited the width of a motif to 50 amino acids. A second MEME 
search was executed with the maximum width parameter increased to 100.  
 A subcellular localization prediction tool, CELLO v.2.5, was used to infer 
protein localization in the cell after synthesis through the analysis of the peptide 
sequence produced by a gene. A Prosite search was conducted to compare the 
sequence of each peptide against its collection of known sequence patterns with 
functional annotations. All peptide sequences were input as a single file and the option 
to exclude high occurrence motifs was unselected.  
 Secondary structure and fold prediction was performed using PSIPred, 
pGenTHREADER, and pDomTHREADER, protein structure prediction tools hosted 
by the bioinformatics resource ExPASy.  All three tools can be accessed within the 
PSIPred protein sequence analysis workbench and ran simultaneously through a single 
input of gene family members as conceptually translated peptide sequences in FASTA 
format. Secondary structure and fold prediction was also performed using I-TASSER. 
Only the conceptually translated peptide sequence of the gene family member residing 
on chromosome 3 was used as input.  
 A hydropathy analysis was conducted to research the possibility of the gene 
family protein being a membrane transport protein or integral membrane protein. The 
hydropathy plotting system utilized for this research effort was Protscale, a tool within 
ExPASy. The peptide sequence of LJFgene3 (the family standard) was submitted 
twice for hydropathicity analysis using the Kyte-Doolittle scale, once with window 
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size 19 and once with window size 9. A window size of 19 provides a good means of 
determining whether the protein has transmembrane segments. A window size of 9 is 
used to determine hydrophobic versus hydrophilic regions of the protein as an 
























3.1. CHOICE OF GENE FAMILY AND IDENTIFICATION OF MEMBERS 
 3.1.1. Criteria Match.  Table 3.1 provides a record of PFAM gene families 
meeting three of the criteria used to determine family of study: size of family <10, 
unknown function, and expansion in Glycine max relative to Vitis vinifera (Vvi. The 
common grape), Populus trichocarpa (Ptr, cottonwood or poplar tree), Medicago 
truncatula (Mtr, barrel medic), Arabidopsis thaliana (Ath, thale cress), Arabidopsis 
lyrata (Aly, rock cress), Carica papaya (Cpa, papaya or pawpaw), Sorghum bicolor 
(Sbi, sorghum), Zea mays (Zma, corn), Brachipodium distachyon (Bdi, purple false 
brome), and Oryza sativa (Osa, rice).  The The LJFgene family data is identified by 
bold type.  
 The data from the PFAM database indicates that family PF07386 contains 4 
putative genes. The source of this number is unpublished data released with an earlier 
version of the genome sequence for Glycine max. Generation of this figure took place 
through the use of predictive-algorithms that compared the sequence of the Glycine 
max genome to PFAM domains. The data from Supplimentary Table 5 of the Schmutz 
et al. publication [9] indicates that this family contains 3 putative genes. Data from this 
source was generated using a Phytozome clustering algorithm that analyzes syntenic 
regions between and within species for evidence of orthologs or paralogs that will 

















































































 3.1.2. Association Map Created Using BLAST within Glycine max Genome 
Browser. An association map was created to determine whether all of the resultant 
putative genes are connected to each other based on similarity of sequence. Each gene 
model that results from a BLAST search that is a hit for that query is associated with 
that query, and this relationship can be represented by a connecting line. An 
association map of the gene family in this study can be seen in Figure 3.1. If every 
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gene model displays a connection to every other model, it provides strong support that 
those models belong to the same gene family.  
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Figure 3.1. BLAST results and association map of the LJFgene family. Only predicted 
genes were included in the map. The non-coding sequences were omitted.  
 
 
 Based on sequence similarity indicated by BLAST searches, this family is 
comprised of five protein-coding genes (gene models predicted by algorithms) and 
potentially 3 non-coding sequences in Glycine max. The gene addresses and physical 
locations of putative gene family members are as follows:  
• LJFgene3; sequence spanning from nucleotides 2524864 – 2528471 on 
chromosome 3. 




LJFgene8	   LJFgene9	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• LJFgene14; sequence spanning from nucleotides 5788441 – 5792004 
on chromosome 14. 
• LJFgene1; sequence spanning from nucleotides 46754478 – 46758976 
on chromosome 1. 
• LJFgene8; sequence spanning from nucleotides 38952021 – 38955976	  
on chromosome 8.  
• LJFgene9; sequence spanning from nucleotides 45453546 – 45455058 
on chromosome 9.  
Gene addresses are depicted graphically relative to position on the chromosome in 
Figure 3.2.  
 The number of genes in this Glycine max family is expanded 5:1 compared to 
the orthologous families in the nine other plant species (Vvi, Ptr, Mtr, Ath, Aly, Cpa, 













 3.1.3.  Chromosome Maps. Figure 3.2 depicts the relative position of LJFgene 
family members on their respective chromosomes according to gene address.  
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Figure 3.2. Chromosome maps. (A) Verified gene family members. (B) Non-coding 
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 3.1.4. General Summary of LJFgene Family Member Composition. Table 
3.2 contains a record of the number of exons and introns in each LJFgene family 
member. It also contains a record of the number of residues in the genomic, coding, 
and conceptually translated peptide sequences, as well as the number of ESTs 










Table 3.2. LJFgene family summary. 






sequence	   ESTs	  
LJFgene3	   7	   6	   3396	   708	   236	   7	  
LJFgene14	   6	   5	   3300	   489	   163	   3	  
LJFgene1	   7	   6	   4281	   663	   221	   0	  
LJFgene8	   6	   5	   3621	   639	   213	   0	  
LJFgene9	   4	   3	   1539	   390	   130	   3	  
 
 
3.2. GENE STRUCTURE PREDICTION AND EST EXPRESSION ANALYSIS 
 3.2.1. Constructed Gene Models. Gene models were constructed using 
multiple data sources including algorithm-predicted models from FgenesH, Augustus, 
and GenomeScan, in addition to ESTs, and intron/exon border consensus data. Figure 
3.3 illustrates exon placement and key intragenic coding signals along the genomic 
sequence corresponding to each LJFgene family member. 
 
 




 3.2.2. Decorated Sequences. Decorated sequences are viewable in Appendix 
E.  
 3.2.3. Promoter Element Locations. Well-known promoter elements, TATA 
and CAAT sequences, were predicted by PLACE. The program predicted the presence 
of these elements within a 1500 nucleic acid input sequence upstream of (and 
containing a partial exon 1 sequence) each LJFgene family member. The predicted 
sequences and their relative distances from one another, as well as from the start ATG, 
is recorded in Table 3.3.  
 
 






TATA	  box	   loc	   CAAT	  box	   loc	   distance	  b/w	  elements	   distance	  of	  TATA	  fr	  ATG	  
03g	  
TB5-­‐TTATTT	   1042	   CAAT	   987	   55	   478	  
TB2-­‐TATAAAT	   1493	   CCAAT	   1163	   330	   27	  
TB5-­‐TTATTT	   743	   CAAT	   441	   302	   777	  
14g	  
TB5-­‐TTATTT	   1413	   CAAT	   1279	   134	   9	  
TB2-­‐TATAAAT	   971	   CAAT	   815	   156	   451	  
TB5-­‐TTATTT	   946	   CAAT	   815	   131	   476	  
TB5-­‐TTATTT	   705	   CAAT	   618	   87	   717	  
01g	  
TB5-­‐TTATT	   1491	   CCAAT	   1181	   310	   22	  
TB5-­‐TTATT	   1277	   CCAAT	   1181	   96	   236	  
TB5-­‐TTATT	   753	   CAAT	   504	   249	   760	  
TB5-­‐TTATT	   759	   CAAT	   504	   255	   754	  
08g	  
TB4-­‐TTTATATA	   1439	   CAAT	   1424	   15	   62	  
TB5-­‐TTATTT	   1228	   CAAT	   1078	   150	   273	  
TB2-­‐TATAAAT	   1206	   CAAT	   1078	   128	   295	  
TB5-­‐TTATTT	   1179	   CAAT	   1078	   101	   322	  
TB5-­‐TTATTT	   1179	   CAAT	   1020	   159	   322	  
TB3-­‐TATTAAT	   1092	   CAAT	   1020	   72	   409	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 3.2.4. EST Data for Intron/Exon Border Verification. The coding regions 
were determined using EST sequences where possible. Otherwise, models predicted 
by Augustus and FgenesH were used. The EST sequences for gene family members 
can be located in Appendix F. The NCBI accession numbers that correspond to the 
ESTs are listed below in Table 3.4.  Accession numbers are linked to additional 
information about each EST located in the NCBI database. This information is also 
available in Appendix F.  
 
Table 3.4. LJFgene family EST accession numbers and alignment scores.  
LJFgene3	   LJFgene14	   LJFgene8	   LJFgene9	   LJFgene1	  
AI938349.1	   201	   EV264523.1	   214	   	  	  
	  
CD399608.1	   72	   	  	   	  	  
BE610616.1	   409	   FG993792.1	   218	   	  	  
	  
CF921901.1	   247	   	  	   	  	  
BM176973.1	   398	   HO044862.1	   175	   	  	  
	  
CF923165.1	   133	   	  	   	  	  
BM886799.1	   288	  





	  	   	  	  
CA800126.1	   457	  





	  	   	  	  
CO983876.1	   387	  





	  	   	  	  












TB2-­‐TATAAAT	   986	   CAAT	   945	   41	   515	  
TB4-­‐TTTATATA	   984	   CAAT	   945	   39	   517	  
TB5-­‐TTATT	   880	   CAAT	   569	   311	   621	  
TBSPAL	   559	   CAAT	   355	   204	   942	  
TB5	   552	   CAAT	   355	   197	   949	  
TB5	   410	   CAAT	   300	   110	   1091	  
TB5	   410	   CAAT	   294	   116	   1091	  
TB2-­‐TATAAAT	   343	   CAAT	   294	   49	   1158	  
TB2-­‐TATAAAT	   343	   CAAT	   196	   147	   1158	  
TB2-­‐TATAAAT	   343	   CAAT	   141	   202	   1158	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3.3.	  EVOLUTIONARY ANALYSIS 	  
 3.3.1. Neighbor Gene Analysis.  Figure 3.4 is a spatial representation of both 
confirmed and predicted gene models flanking LJFgene family members (including 
both coding sequences and non-coding sequences) on the 5’ and 3’ sides. Each column 
represents a linear chromosome, each row represents a 5kbp segment of sequence, and 
colored blocks represent genes. The genes are color coded according to their function. 
The full function can be found in the functional annotation color key. A condensation 
of Figure 3.4A was created by removal of extragenic spaces for better pattern 
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Functional	  Annotation	  Color	  Key	  
	  ZF	   	  Zinc	  finger	   	  GRA	   GRAS	  family	  transcription	  factor	  
	  C1	   C1domain/Thioredoxin/nucleoredoxin	  	   	  Corn	   Cornichon	  protein	  
	  Unk	   unknown	   	  MT	   Microtubule-­‐assoc	  protein-­‐anaphase	  
	  Fum	   Fumble,	  pantothenate	  kinase,	  	   	  PEN	   PENTATRICOPEPTIDE	  REPEAT	  
	  ribF	   GTP-­‐binding	  ADP-­‐ribosylation	  factor	   GNE	   Guanine	  nucleotide	  exchange	  factor	  
	  PS	   Proteasome	  subunit	   	  BTB	   BTB/POZ	  domain	  
NFA	   no	  functional	  annotations	   CUP	   Cupin	  domain	  
	  HLH	   Helix-­‐loop-­‐helix	  DNA-­‐binding	   	  CYT	   CYTOCHROME	  
	  Glu	   Glutathione	  S-­‐transferase	   	  bZIP	   bZIP	  transcription	  factor	  
	  Hel	   	  Helicase	   HSP	   SMALL	  HEAT-­‐SHOCK	  PROTEIN	  
	  Ves	   Vesicle	  trafficking	   	  LRR	   Leucine	  Rich	  Repeat	  
	  Cyc	   RNA	  3'-­‐terminal	  phosphate	  cyclase	   	  Terp	   Terpene	  synthase	  
	  Kin	   kinase	  (leucine	  rich	  repeat)	   	  UNC	   uncharacterized	  
	  GTP	   GTP	  binding	   	  WNK	   SERINE/THREONINE-­‐PROTEIN	  KINASE	  	  
	  AP2	   AP2;	  transcription	  factor	  
	  
WNK	  (WITH	  NO	  LYSINE)-­‐RELATED	  
DRB	   double-­‐stranded	  RNA	  binding	   	  Aux	   Auxin	  responsive	  protein	  
	  Ran	   Ran	  binding	  protein	  	   	  L34e	   Ribosomal	  protein	  L34e	  
	  Pro	   ATP-­‐dependent	  protease/peptidase	  
	   	  	  Thio	   Thioredoxin	  
	   	  	  βgal	   Beta-­‐galactosidase	  
	   	  Hox	   	  Homeobox	  domain	  assoc	  w/	  HOX	  
	   	  	  SD	   STEROL	  DESATURASE	  
	   	  wd40	   WD40	  repeat	  protein	  
	   	  	  NAD	   	  NAD	  dependent	  epimerase	  
	   	  	  GlT	   Glycosyl	  transferase	  
	   	  	  
Figure 3.4. (A) Neighbor gene functional analysis. (B) Condensation of Neighbor gene 
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Figure 3.4. (A) Neighbor gene functional analysis. (B) Condensation of Neighbor gene 




3.3.2. Synonymous and Nonsynonymous Substitution Rates. Table 3.5 
contains the calculations for synonymous and nonsynonymous substitutions for each 
possible pairwise comparison between LJFgene family members. Table 3.6 contains 
the calculations for synonymous and nonsynonymous substitutions between LJFgene 
family members and orthologous genes found in the species P. vulgaris, M. 
truncatula, A. thaliana, O. sativa, S. moellendorffii, P. patens, V. carteri, and C. 




Table 3.5. Synonymous and non-synonymous calculations for LJFgene family. 
 
Seq’s compared Sd Sn S N ps pn ds dn ds/dn ps/pn 
LJFgene3 LJFgene14 19.0000 23.0000 106.6667 382.3333 0.1781 0.0602 0.2034 0.0627 3.2431 2.9610 
LJFgene3 LJFgene1 18.5000 9.5000 142.0000 512.0000 0.1303 0.0186 0.1431 0.0188 7.6169 7.0215 
LJFgene3 LJFgene8 40.8333 64.1667 136.5000 490.5000 0.2991 0.1308 0.3817 0.1438 2.6552 2.2867 
LJFgene3 LJFgene9 46.6667 70.3333 84.6667 302.3333 0.5512 0.2326 0.9958 0.2785 3.5755 2.3693 
LJFgene14 LJFgene1 15.0000 23.0000 105.8333 383.1667 0.1417 0.0600 0.1571 0.0626 2.5109 2.3612 
LJFgene14 LJFgene8 26.0000 51.0000 102.5000 368.5000 0.2537 0.1384 0.3096 0.1530 2.0236 1.8328 
LJFgene14 LJFgene9 49.3333 84.6667 83.3333 303.6667 0.5920 0.2788 1.1681 0.3486 3.3507 2.1233 
LJFgene1 LJFgene8 37.1667 68.8333 138.5000 497.5000 0.2684 0.1384 0.3321 0.1529 2.1717 1.9395 
LJFgene1 LJFgene9 44.6667 69.3333 84.1667 302.8333 0.5307 0.2289 0.9222 0.2732 3.3759 2.3180 
LJFgene8 LJFgene9 45.0000 70.0000 84.1667 302.8333 0.5347 0.2312 0.9359 0.2763 3.3866 2.3130 




Table 3.6. Ortholog synonymous substitutions. 
 
Compare	   vs	   	  ps	   	  ps/pn	  
Statistics	  
Mean	  ps	   Mean	  ps/pn	  
	  LJFgene3	   	  LJFgene1	   0.13	   7.02	  
0.27	   N/A	  
LJFgene3	   LJFgene14	   0.18	   2.96	  
	  LJFgene3	   	  LJFgene8	   0.23	   2.28	  
	  LJFgene3	   	  LJFgene9	   0.55	   1.82	  
	  LJFgene1	   LJFgene14	   0.14	   2.36	  
0.3	   N/A	  	  LJFgene1	   	  LJFgene8	   0.19	   1.89	  
	  LJFgene1	   	  LJFgene9	   0.58	   1.97	  
LJFgene14	   	  LJFgene8	   0.25	   1.83	  
0.42	   N/A	  
LJFgene14	   	  LJFgene9	   0.58	   1.66	  
	  LJFgene8	   	  LJFgene9	   0.57	   1.91	   N/A	   N/A	  
	  LJFgene3	   	  Pvu	   0.29	   3.17	  
0.33	   2.83	  
	  LJFgene1	   	  Pvu	   0.27	   3.38	  
LJFgene14	   	  Pvu	   0.27	   3.47	  
	  LJFgene8	   	  Pvu	   0.30	   2.14	  
	  LJFgene9	   	  Pvu	   0.55	   1.97	  
	  LJFgene3	   	  Mtr	   0.40	   3.30	  
0.44	   3.04	  
	  LJFgene1	   	  Mtr	   0.39	   3.55	  
LJFgene14	   	  Mtr	   0.41	   3.88	  
	  LJFgene8	   	  Mtr	   0.41	   2.44	  
	  LJFgene9	   	  Mtr	   0.62	   2.13	  
	   	  	  Pvu	   	  Mtr	   0.40	   2.94	  
	  LJFgene3	   	  Ath	   0.70	   2.91	  
0.7	   2.85	  
	  LJFgene1	   	  Ath	   0.66	   2.75	  
LJFgene14	   	  Ath	   0.72	   4.18	  




Table 3.6. Ortholog synonymous substitutions. (CONT.) 
	  
	  LJFgene9	   	  Ath	   0.75	   2.12	  
	   	  
	  Mtr	   	  Ath	   0.71	   2.77	  
	   	  	  Pvu	   	  Ath	   0.66	   2.78	  
	  LJFgene3	   	  Osa	   0.79	   3.00	  
0.82	   2.96	  
	  LJFgene1	   	  Osa	   0.81	   3.09	  
LJFgene14	   	  Osa	   0.84	   3.68	  
	  LJFgene8	   	  Osa	   0.81	   2.69	  
	  LJFgene9	   	  Osa	   0.76	   2.03	  
	  Pvu	   	  Osa	   0.84	   3.05	  
	  Mtr	   	  Osa	   0.88	   3.16	  
	  Ath	   	  Osa	   0.86	   2.97	  
	  Smo	   	  LJFgene3	   0.83	   3.96	  
0.86	   3.69	  
	  Smo	   	  LJFgene1	   0.88	   4.17	  
	  Smo	   LJFgene14	   0.88	   4.34	  
	  Smo	   	  LJFgene8	   0.89	   3.55	  
	  Smo	   	  LJFgene9	   0.85	   2.11	  
	  Smo	   	  Pvu	   0.87	   4.09	  
	  Smo	   	  Mtr	   0.82	   3.93	  
	  Smo	   	  Ath	   0.86	   3.64	  
	  Smo	   	  Osa	   0.84	   3.38	  
	  LJFgene3	   	  Ppa13v6	   0.83	   1.33	  
0.82	   1.30	  
	  LJFgene1	   	  Ppa13v6	   0.85	   1.34	  
LJFgene14	   	  Ppa13v6	   0.81	   1.33	  
	  LJFgene8	   	  Ppa13v6	   0.82	   1.28	  
	  LJFgene9	   	  Ppa13v6	   0.77	   1.06	  
	  Pvu	   	  Ppa13v6	   0.82	   1.30	  
	  Mtr	   	  Ppa13v6	   0.84	   1.35	  
	  Ath	   	  Ppa13v6	   0.83	   1.30	  
	  Osa	   	  Ppa13v6	   0.83	   1.35	  
	  Smo	   	  Ppa13v6	   0.81	   1.36	  
	  Ppa47v6	   	  LJFgene3	   0.74	   2.12	  
0.77	   2.41	  
	  Ppa47v6	   	  LJFgene1	   0.73	   2.09	  
	  Ppa47v6	   LJFgene14	   0.74	   2.91	  
	  Ppa47v6	   	  LJFgene8	   0.76	   2.02	  
	  Ppa47v6	   	  LJFgene9	   0.80	   1.98	  
	  Ppa47v6	   	  Pvu	   0.76	   2.15	  
	  Ppa47v6	   	  Mtr	   0.79	   2.26	  
	  Ppa47v6	   	  Ath	   0.79	   2.19	  
	  Ppa47v6	   	  Osa	   0.80	   2.19	  
	  Ppa47v6	   	  Smo	   0.86	   5.47	  
	  Ppa47v6	   	  Ppa13v6	   0.72	   1.13	  
	  LJFgene3	   	  Vca	   0.90	   2.17	  
0.88	   2.19	  
	  LJFgene1	   	  Vca	   0.90	   2.13	  
LJFgene14	   	  Vca	   0.98	   2.83	  
	  LJFgene9	   	  Vca	   0.90	   1.82	  
	  LJFgene8	   	  Vca	   0.87	   1.93	  
	  Pvu	   	  Vca	   0.94	   2.32	  
	  Mtr	   	  Vca	   0.90	   2.10	  
	  Ath	   	  Vca	   0.87	   2.08	  
	  Osa	   	  Vca	   0.73	   1.73	  
	  Smo	   	  Vca	   0.86	   3.40	  
	  Ppa13v6	   	  Vca	   0.78	   1.30	  
	   	  	  Ppa47v6	   	  Vca	   0.91	   2.42	  
	  LJFgene3	   	  Cre	   0.88	   2.11	  
0.83	   2.11	  
	  LJFgene1	   	  Cre	   0.89	   2.12	  
LJFgene14	   	  Cre	   0.91	   2.62	  
	  LJFgene8	   	  Cre	   0.89	   1.93	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  LJFgene9	   	  Cre	   0.97	   1.90	  
	   	  	  Pvu	   	  Cre	   0.86	   2.07	  
	   	  
	  Mtr	   	  Cre	   0.91	   2.14	  
	  Ath	   	  Cre	   0.87	   1.96	  
	  Osa	   	  Cre	   0.69	   1.61	  
	  Smo	   	  Cre	   0.80	   2.98	  
	  Ppa13v6	   	  Cre	   0.73	   1.21	  
	  Ppa47v6	   	  Cre	   0.82	   2.01	  
	  Vca	   	  Cre	   0.55	   2.72	  
 
Code Key for Table 3.5 and Table 3.6: 
Sd: number of observed synonymous substitutions 
Sn: number of observed non-synonymous substitutions 
S: number of potential synonymous substitutions 
N: number of potential non-synonymous substitutions 
ps:  proportion of observed synonymous substitutions (Sd/S) 
pn: proportion of observed non-synonymous substitutions (Sn/N) 
ds: Jukes-Cantor correction for multiple ps 
dn: Jukes-Cantor correction for multiple pn 




3.3.3. Phylogenetic Trees. Figure 3.5 illustrates the phylogenetic trees 
generated for the LJFgene family members as well as a tree containing a broader 
























Figure 3.5. Phylogentic results. (A) Phylogenetic tree of diverse plant evolution 
(phenogram). (B) LJFgene family phylogenetic tree (unrooted radial display). (C) 
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Table 3.7 contains the gene addresses of predicted genes in plant species other 
than Glycine max that resulted as BLAST hits when the conceptually translated 
peptide sequence of each LJFgene family member was used as input for searches 
against each species’ genome. The resulting genes are putative orthologs to the genes 
























Table 3.7. BLAST hits in orthologous species. 
 
Species LJFgene3 LJFgene8 LJFgene1 LJFgene14 LJFgene9 












A.	  thaliana	   AT3G60810	   AT3G60810	   AT3G60810	   AT3G60810	   AT3G60810	  
Z.	  mays	   no	  transcript	   no	  transcript	   no	  transcript	   no	  transcript	   no	  transcript	  
O.	  sativa	   LOC_Os03g64140	   LOC_Os03g64140	   LOC_Os03g64140	   LOC_Os03g64140	   LOC_Os03g64140	  
S.	  
Moellendorffii	   101401	   101401	   101401	   101401	   101401	  
P.	  patens	   Pp1s10_47V6	  (72)	  
Pp1s10_47V6	  
(70.1)	   Pp1s10_47V6	  	   Pp1s10_47V6	   Pp1s10_47V6	  	  
	  	   Pp1s223_13V6	  (40.8)	   Pp1s223_13V6	  	   Pp1s223_13V6	  	   	  	  
C.	  reinhardtii	   Cre11.g468750	   Cre11.g468750	   Cre11.g468750	   Cre11.g468750	   Cre11.g468750	  
V.	  carterii	  
Vocar20006092m.




 3.3.4. Potential Coding Capacity. In order to determine whether the 
sequences beyond the coding regions of the genes that appear to produce a truncated 
product (LJFgene14, LJFgene1, LJFgene8, and LJFgene9) once contained coding 
capacity, multiple alignments were conducted using coding sequence plus 5’ and 3’ 
extended flanking sequences. 
 3.3.4.1. Multiple alignment of nucleic acid sequences. Figure 3.6 illustrates 











LJFgene3        CCATAAAAAAGAAAAAAAAAAAGTCCCACCGCCCACCTTCTTTATCACATGATTCACATC 
LJFgene14       --------------------AAGTCCCACCTTC--TTTTATTCATCACATGATTCACATC 
LJFgene1        ------------------------------------------------------------ 
LJFgene8        ------------------------------------------------------------ 
LJFgene9        -----------TAAAAGAGAATATTTTTTTGGTATATGTGTTTTAATTATAATAACTAAT 
                                                                             
 
LJFgene3        TCATTCCTTATATTTGGTTCACATTCTTAAATTAT----AAATA-TTTC----GGTCTGT 
LJFgene14       TCATTTCTTATTTTCGGGTCACTTTGTTAAATTAT----AAATAATTTC----GTTCTGT 
LJFgene1        ---------------GGGTCACATTCTCAAATTATT-ATAACTAATTTC----GTCATGT 
LJFgene8        -----------------ATTGACTTGAAAGATTCTT-GTAGCAATTTGCAGCAGTTTTAT 
LJFgene9        AAATCCACAACGTGTATGCCACTTCCCATTGTCCCGCACATACACTTGAAAAAAGTCCA- 
                                       *       *       *   * **              
 
LJFgene3        GAAGATATAT--GTCCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAAC 
LJFgene14       GAAGGTACACACGTTCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAAC 
LJFgene1        GAAGATAC----GTTCATAAGTTCCTTAATTTTCTTGAACCTTTATTTTCAGCTCCCAAC 
LJFgene8        ATAGATAGTAACATTCTTAAATTAC---GTTTATAAGTTCCTTCATTTTCAGCTCCGAAC 
LJFgene9        --ATTTGCATTTTAGCATTGGTTCGC--ACCTAAGGCACCTTCCCAATTCAGCTTCTAAC 
                  *  *         * *   **        *       * *     ******* * *** 
 
LJFgene3        AACAATGGCTTCAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTTCATCACCAAACC 
LJFgene14       AATAATGGCTTCAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTTTATCACCAAACC 
LJFgene1        AATAATGGCTTCAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTTTATCACCAAACC 
LJFgene8        AA------------TGGCTTCTTCGTTCTCCTTCTGCACCCTCAAGTTTCGCACCAAACC 
LJFgene9        GA------------TGACACTTTGTAGCACGTTTTCCAACTTCAACATTCACAT---ATT 
                 *            ** *   **    * * ** * ** * ****  *   **    *   
 
LJFgene3        CAACAATGGTAGAAGAAGC---------TCTCTTCCCCGTATTGTATTCTGTCAGAAGCA 
LJFgene14       CAACAATGGTAGAAGAAGC---------TCTCTTCGCCGTATTGTATTTTGTCAGAAGCA 
LJFgene1        CAACAACAATGGTAGAACCAATGCTTCTTCTCTTCCCCGTATTGTATTCTGTCAGAAGCA 
LJFgene8        CAACGATAGTAGAAGCAGT---GCTTCCTCTCTTCCCCGTATTCTATTCTGTCACAACCT 
LJFgene9        AAAAAACAACAAGGGTTCC---------TTTTCTCGTCGATTTCAACTCTCTCAGAAGCT 
                 **  *        *             * *  **  **  **  * * * *** ** *  
 
LJFgene3        CCACGATAGCA------CACCCACCGACCAAATCAACCGAAG------------------ 
LJFgene14       TCACGATGACA------CACCCACCGACCAAATCAACCGAAGGTTCTTACTTCTTCACAC 
LJFgene1        CAACGATGACA------CCCCCACCGACCAAATCAACCGAAG------------------ 
LJFgene8        CCACGATGACATTCACACACCCACTGACCAAATCAACCGAAG------------------ 
LJFgene9        GGATGACGATA------ATTTCATTGATAAAATCAAACGAAGGTTCTCACTGATTCTCCC 
                  * **    *          **  **  ******* *****                   
 
LJFgene3        ------------------------------------------------------------ 
LJFgene14       TCACACTTTCTATTTCCTTTCTATTGATTATTCGTAACCATCTTCTGAAATCTCGTTACA 
LJFgene1        ------------------------------------------------------------ 
LJFgene8        ------------------------------------------------------------ 
LJFgene9        TTTAATTTGCCACCTCACATGAATTG------TATAATATATATTTATATTTATGCTTGA 
                                                                             
 
LJFgene3        ------------------------AGAACTCATATTGAGAAGCAGCGAAATAGCGACCAT 
LJFgene14       TTTCAATTCTTTTGTGTATTGAAGAGAACTCATATTGAGAAGCAGCGAAATAGCGACCAT 
LJFgene1        ------------------------AGAACTCATATTGAGAAGCAGTGAAATAGCGACCAT 
LJFgene8        ------------------------ACAACTCATATTGAGAAGCAGCGAAATAGCGACCAT 
LJFgene9        CCTTGAATTGTTCCTATCTTAAAGAGAGCTCATACTGGAAAGTGGAGAATTAGCAACCAT 
                                        * * ****** **  ***  * *** **** ***** 
 
LJFgene3        TGGTGCCATCTTGAACTTCGG--------------------------------------- 
LJFgene14       TGGTGCCATCTTCAACTTCGGGTACCCCTCCTCTGTTTTTGCTCTGTTTTTTTTTCTGGA 
LJFgene1        TGGTGCCATCTTCAACTTCGG--------------------------------------- 
LJFgene8        CGGTGCCATCTTCGACTTCAG--------------------------------------- 
LJFgene9        TGGTGCCATCTTCAACTTTAG--------------------------------------- 
                 ***********  ****  *                                        
 
Figure 3.6. Multiple alignment of coding sequences (bold face type) of gene family 
members extended on both the 3’ and 5’ ends. Dashes (-) represent gaps in sequence 
and a star (*) below a column of nucleotides represents an identity match is present in 





 LJFgene3        ------------------------------------------------------------ 
LJFgene14       AATTTTAGTTTTTCATTTTATTTTGAATGTAAATTAAATTCGAGATTTGATTTTGTTAGT 
LJFgene1        ------------------------------------------------------------ 
LJFgene8        ------------------------------------------------------------ 
LJFgene9        ------------------------------------------------------------ 
                                                                             
 
LJFgene3        ------------------------------------------------------------ 
LJFgene14       GGGTGTTGAGACCCTTTTGGATTTTAGTTTGGGTTGTGTTTTGTATTGGAAATGGGTGGT 
LJFgene1        ------------------------------------------------------------ 
LJFgene8        ------------------------------------------------------------ 
LJFgene9        ------------------------------------------------------------ 
                                                                             
 
LJFgene3        --------------------------TGGGAAAAAACCTGATTATCTTGGAGTGCAGAAA 
LJFgene14       TTGGGTTTTGTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAA 
LJFgene1        --------------------------TGGGAAAAAACCTGATTATCTTGGAGTGCAGAAA 
LJFgene8        --------------------------TGGGAAAAAACCTGATTATCTTGGAGTGCAGAAA 
LJFgene9        --------------------------AGGCAAAAAGCCAGATTATCTTGGAGTGCAGAAA 
                                           ** ***** ** ********************* 
 
LJFgene3        AACCCACCAGCATTAGCTCTGTGCCCGGCAACGAAGAATTGCGTGTCAACCTCTGAGAAT 
LJFgene14       AACCCACCAGCATTAGCTCTGTGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGAGAAT 
LJFgene1        AACCCACCAGCATTAGCTCTGTGTCCGGCAACTAAGAACTGCGTGTCAACCTCTGAGAAT 
LJFgene8        AACCCACCAGCTTTAGCTCTGTGTCCGGTAACTAGGAACTGCGTATCAACCTCTGAGAAT 
LJFgene9        AATCAACCGGCATTAGCACTATGTCCGGCAACTAAGAACTGCATATCGACATCTGAAAAT 
                ** * *** ** ***** ** ** ***  *** * *** *** * ** ** ***** *** 
 
LJFgene3        ATCAGTGATCGCACACATTATGCTCCTCCATGGAACTATAATCCTGAAGGTAGGAAAAAA 
LJFgene14       ATCAGCGATCGCACACATTATGCTCCTCCATGGAACTATAATCCTGAAGGAAGGAAAAAA 
LJFgene1        ATCAGTGATCGCACACATTATGCTCCTCCATGGAACTATAATCCTGAAGGTAGGAAAAAA 
LJFgene8        ATCAGTGATCGCACTCATTATGCTCCTCTTTGGAACTACAATCCTGAAGGTAGGAAAAAC 
LJFgene9        GTCACTAACCTCACACATTACACTCCTCCTTGGAACTACAATCCTGAAGGTAGGAAAGAT 
                 ***   * * *** *****  ******  ******** *********** ****** *  
 
LJFgene3        CCTGTGAACAGAGAGGAAGCAATGGAGGAACTGATAGACGTGATAGAATCAACAACAC-- 
LJFgene14       CCTGTGAGCAGAGAGGAAGCAATGGAGGAACTGATAGACGTGATCGAATCAACAACAC-- 
LJFgene1        CCTGTGAGCAGGGAAGAAGCAATGGAGGAACTTATAGACGTGATAGAATCAACAACAC-- 
LJFgene8        CCTGTGAGCAGAGAAGAGGCAATGGAGGAACTGATAGACGTGATAGAATCAACAACAC-- 
LJFgene9        CATGTGAGCA---AAGAGGCAATGGAGGAACTGATAGATGTGATAGAATCGACAATACTA 
                * ***** **   * ** ************** ***** ***** ***** **** **   
 
LJFgene3        -CAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTAC 
LJFgene14       -CAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTAC 
LJFgene1        -CAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTAC 
LJFgene8        -CAGACAAATTTACACCACGAATAGTTGAAAGGAAGGAAGACTATATTCATGTGGAGTAC 
LJFgene9        CCAGAAAATTTTACACCAAGGATTGTAGAAAGAACAGAAGATTATCTTAGATTGGAATAC 
                 **** ** *** ***** * ** ** ***** *  ***** *** **    **** *** 
 
LJFgene3        CAAAGCTCA-----ATTTTGGGGTTTGTAGATGATGTTG--AGTTCTGGTTCCCACCGGG 
LJFgene14       CAAAGCTCA-----ATCTTGGGGTTTGTGGATGATGTTG--AGTTCTGGTTTCCACCCGG 
LJFgene1        CAAAGCTCA-----ATCTTGGGGTTTGTGGATGATGTTG--AGTTCTGGTTTCCTCCGGG 
LJFgene8        CAAAGCTCA-----ATCTTGGGGTTTGTGCATGATGTTG--AGTTCTGGTTTCCACTGGG 
LJFgene9        CAAAGTGTATACAAGCCACAAATTTTAACTTCAATGTCACCAATATCATTGTATGCAGAA 
                *****   *              ***       ****    * *     *     *     
 
LJFgene3        TAAGGG----------TTCTACTGTGGAGT--ACCGATCTGCATCTCGGTTAGGAAACTT 
LJFgene14       TAAGGG----------TTCTACTGTGGAGT--ATCGATCTGCATCTCGGTTGGGAAACTT 
LJFgene1        TAAGGG----------TTCTACTGTGGAGT--ATCGTTCTGCATCTCGGTTGGGAAACTT 
LJFgene8        TAAGGG----------TTCTACTGTGGAGT--ATCGATCTGCATCTCGGTTGGGGAACTT 
LJFgene9        AAAATGAATAGTAACTTTTTACTATTAGACTGAAAAGCCTGCATCAAGCATTGAAGGAAT 
                 **  *          ** **** *       *     *******  *  * *      * 
 
Figure 3.6. Multiple alignment of coding sequences (bold face type) of gene family 









LJFgene3        TGATTTTGATGTGAACAGAAAAAGAATAAAGGCACTGCGACAAGAGTTGGAG-AAGAAAG 
LJFgene14       TGATTTTGATGTGAACAGAAAAAGAATAAAGGCACTGAGACAAGAGTTGGAG-AAGAAAG 
LJFgene1        TGATTTTGATGTGAACAGAAAAAGAATAAAGGCACTGAGACAAGAGTTGGAG-AAGAAAG 
LJFgene8        TGATTTTGATGTGAATAAGAAAAGAATAAAGGTAT---------GTTTGTAT-CATTCCT 
LJFgene9        GGAGTTTCTT-TGATCATTGGACTGCCCATCTCATAGTAACTCATCTTGAAGCAATTAAT 
                 ** ***  * ***  *    *      *    *            *** *   *      
 
LJFgene3        GATGGGCATCTCAAGACACCATATGATGAATAAACTCAGGCAGAATTAACATCAGCATCT 
LJFgene14       GATGGACATCTCAAGATACCATATGATTAATAAACTCAGGCTGAATTAGCATCAGCATCT 
LJFgene1        GATGGGCATCTCAAGACACCATATGATGAAAAAACTTAGGCAGAATTCACATCAGCATCT 
LJFgene8        TTGTGCTGTCTCGGTAGTTAACATGAAGAAATGATTAAAAGATATTTTGT-----CCTTT 
LJFgene9        GCAGTAAAAACTAACTCATCGTGAAAAGTTCATTCTCTGCTTTATTTAAATTTTTACAGC 
                                         *         *       * **              
 
LJFgene3        AAGCAAATATTATTTCATATACTTTGTGACCTTGTATACATTTGTA-TTAGATACAAA-T 
LJFgene14       AAGCAAATATTATTTCATATACTTTG-GACCTTGTATACTTTTGTA-TTAGATACAAA-T 
LJFgene1        AAGAAAATATTGTTTCATATACATTGTAACCTTGTATACTTTTGTA-TTAGATACAAAAT 
LJFgene8        AGGTTT-TTTGGTTATATTTAGTTTG--ATTTTTTATTTTTTAAAAGTTAAATTTAGTCC 
LJFgene9        AAGTAGATTGGAATGCATGGTTTTTGCCATGTTTTATACTTGACAAAGATAATGCAAACT 
                * *    *     *  **     ***  *  ** ***   *    *     **  *     
 
LJFgene3        CTCAC--- 
LJFgene14       CGCACA-- 
LJFgene1        CTCA---- 
LJFgene8        TT------ 
LJFgene9        ATAAACAC 
 
Figure 3.6. Multiple alignment of coding sequences (bold face type) of gene family 
members extended on both the 5’ and 3’ ends. (CONT.) 
 
 
 3.3.4.2. Multiple alignment of conceptually translated peptide sequences. 
Figure 3.7 illustrates the multiple alignment of the conceptually translated amino acid 





















LJFgene3        ---------------IKKKKKKSHRPPSLSHDSHLIPYIWFTFLNYKYFGLRRYMSISSL 
LJFgene1        ---------------------------------------GHILKLLRLISSCEDTFISSL 
LJFgene14       KSHLLLFITRFTSHFLFSGHFVKLRIISFCEGTHVHKFLNFLEPSFSAPNNNGFNGIFKL 
LJFgene8        ------------------------------------------LTRKILVAICSSFIRIVT 
LJFgene9        ---RKRIFFWYMCFNYNNRRIHNVYATSHCPAHTLEKSPICILALVRTRGTFPIQLLTMT 
                                                                             
 
LJFgene3        IFSNLHFQLPTTMASMASSSSFCN-----------------------------LKFITKP 
LJFgene1        IFLNLYFQLPTIMASMASSSSFCN-----------------------------LKFITKP 
LJFgene14       LLQPQVYHQTQQWRKKLSSPYCILSEASRRHTHRPNQPKVLTSSHSHFLFPFYRLFVTIF 
LJFgene8        FLNYVYKFLHFQLRTMASSFSFCT-----------------------------LKFRTKP 
LJFgene9        LCSTFSNFNIHILKNNKGSFSRRFQLS--------------------------QKLDDDN 
                :             .  .*                                    :     
 
LJFgene3        NNGRRS---SLPRIVFCQKHHD--------STPTDQINRRELILRSSEIATIG------- 
LJFgene1        NNNGRTNASSLPRIVFCQKHND--------DTPTDQINRRELILRSSEIATIG------- 
LJFgene14       RNLVTFQFFCVLKRTHIEKQRN--------SDHWCHLQLRVPLLCFCSVFFSGNFSFSFY 
LJFgene8        ND-SRSSASSLPRILFCHNLHDD------IHTPTDQINRRQLILRSSEIATIG------- 
LJFgene9        FIDKIKRRFSLILPLICHLTRIVRYIFIFMLDLELFLSRRELILESGELATIG------- 
                         .:      .  .               :. *  :*   .:   *        
 
LJFgene3        ------------------------------------AILNFGGKKPDYLGVQKNPPALAL 
LJFgene1        ------------------------------------AIFNFGGKKPDYLGVQKNPPALAL 
LJFgene14       FECKLNSRFDFVSGCRDPFGFRFGLCFVLEMGGLGFVFWWCSGKKPDYLGVQKNPPALAL 
LJFgene8        ------------------------------------AIFDFSGKKPDYLGVQKNPPALAL 
LJFgene9        ------------------------------------AIFNFRGKKPDYLGVQKNQPALAL 
                                                    .:    ************ ***** 
 
LJFgene3        CPATKNCVSTSENISDRTHYAPPWNYNPEGRKKPVNREEAMEELIDVIES-TTPDKFSPR 
LJFgene1        CPATKNCVSTSENISDRTHYAPPWNYNPEGRKKPVSREEAMEELIDVIES-TTPDKFSPR 
LJFgene14       CPPTKNCVSTSENISDRTHYAPPWNYNPEGRKKPVSREEAMEELIDVIES-TTPDKFSPR 
LJFgene8        CPVTRNCVSTSENISDRTHYAPLWNYNPEGRKNPVSREEAMEELIDVIES-TTPDKFTPR 
LJFgene9        CPATKNCISTSENVTNLTHYTPPWNYNPEGRKDHVS-KEAMEELIDVIESTILPENFTPR 
                ** *:**:*****::: ***:* *********. *. :************   *::*:** 
 
LJFgene3        IVERKEDYIRVEYQSS----ILGFVDDVEFWFPPGKGSTVEYRSASRLGNFDFDVNRKRI 
LJFgene1        IVERKEDYIRVEYQSS----ILGFVDDVEFWFPPGKGSTVEYRSASRLGNFDFDVNRKRI 
LJFgene14       IVERKEDYIRVEYQSS----ILGFVDDVEFWFPPGKGSTVEYRSASRLGNFDFDVNRKRI 
LJFgene8        IVERKEDYIHVEYQSS----ILGFVHDVEFWFPLGKGSTVEYRSASRLGNFDFDVNKKRI 
LJFgene9        IVERTEDYLRLEYQSVYKPQILTSMSPISLYAEKMNSNFLLLDRKACIKHRRNGVSLIIG 
                ****.***:::****     **  :  :.::    :.. :     : : :   .*.     
 
LJFgene3        KALRQELEKKGWASQDTIRRINSGRINISIRANIISYTLRPCIHLYRIQIS---- 
LJFgene1        KALRQELEKKGWASQDTIRRKNLGRIHISIRENIVSYTLRPCILLYRIQNL---- 
LJFgene14       KALRQELEKKGWTSQDTIRLINSGRISISIRANIISYTLDLVYFCIRYKSH---- 
LJFgene8        KVCLYHSFVLSRRLTRRNDRKIFCPLGFLVIFSLIFYFLKVKFSP---------- 
LJFgene9        LPISRRLILKQLMQRKLTHREKFILCFIRIFTASRLECMVFAMFYTRQRRCKLRT 
 
Figure 3.7. Multiple alignment of conceptually translated peptide sequences of gene 
family members extended on both the 3’ and 5’ ends. The sequence of LJFgene3 is 
indicated by bold face type. Highlighted residues in other LJFgene sequences indicate 
identity shared with LJFgene3. Residues colored blue (X) indicate the first predicted 
residue of a gene (with the exception of LJFgene3) and residues colored red (X) 
indicate the last predicted residue of a gene (with exception of LJFgene3). Dashes (-) 
between residues represent gaps in sequence; a star (*) below a column of residues 
represents an identity match is present in all aligned sequences at that position, i.e. 
100% conservation; a colon (:) represents strong chemical property conservation 
between residues at a position (based on a scoring matrix threshold); a period (.) 
represents weak chemical property conservation between residues at a position (based 





 3.3.4.3. Codon alignment of gene family members extended on both the 3’  
and 5’ ends. Figure 3.8 illustrates the codon alignment for LJFgene family members.  
 
LJFgene3      ---------------------------------------------ATAAAAAAGAAAAAA 
LJFgene1      ------------------------------------------------------------ 
LJFgene14     AAGTCCCACCTTCTTTTATTCATCACATGATTCACATCTCATTTCTTATTTTCGGGTCAC 
LJFgene8      ------------------------------------------------------------ 
LJFgene9      ---------TAAAAGAGAATATTTTTTTGGTATATGTGTTTTAATTATAATAACTAATAA 
 
LJFgene3      AAAAAGTCCCACCGCCCACCTTCTTTATCACATGATTCACATCTCATTCCTTATATTTGG 
LJFgene1      ---------------------------------------------------------GGT 
LJFgene14     TTTGTTAAATTATAAATAATTTCGTTCTGTGAAGGTACACACGTTCATAAGTTCCTTAAT 
LJFgene8      ------------------------------------------------------------ 
LJFgene9      ATCCACAACGTGTATGCCACTTCCCATTGTCCCGCACATACACTTGAAAAAAGTCCAATT 
 
LJFgene3      TTCACATTCTTAAATTATAAATATTTCGGTCTGTGAAGATATATGTCCATAAGTTCCTTA 
LJFgene1      CACATTCTCAAATTATTATAACTAATTTCGTCATGTGAAGATACGTTCATAAGTTCCTTA 
LJFgene14     TTTCTCGAACCTTCATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTC 
LJFgene8      ------TTGACTTGAAAGATTCTTGTAGCAATTTGCAGCAGTTTTATATAGATAGTAACA 
LJFgene9      TGCATTTTAGCATTGGTTCGCACCTAAGGCACCTTCCCAATTCAGCTTCTAACGATGACA 
 
LJFgene3      ATTTTCTCGAACCTTCATTTTCAGCTCCCAACAACAATGGCTTCAATGGCATCTTCAAGC 
LJFgene1      ATTTTCTTGAACCTTTATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGC 
LJFgene14     CTTCTGCAACCTCAAGTTTATCACCAAACCCAACAATGGTAGAAGAAGCTCTCTTCGCCG 
LJFgene8      TTCTTAAATTACGTTTATAAGTTCCTTCATTTTCAGCTCCGAACAATGGCTTCTTCGTTC 
LJFgene9      CTTTGTAGCACGTTTTCCAACTTCAACATTCACATATTAAAAAACAACAAGGGTTCCTTT 
 
LJFgene3      TCCTTCTGCAAC------------------------------------------------ 
LJFgene1      TCCTTCTGCAAC------------------------------------------------ 
LJFgene14     TATTGTATTTTGTCAGAAGCATCACGATGACACACCCACCGACCAAATCAACCGAAGGTT 
LJFgene8      TCCTTCTGCACC------------------------------------------------ 
LJFgene9      TCTCGTCGATTTCAACTCTCT--------------------------------------- 
 
LJFgene3      ---------------------------------------CTCAAGTTCATCACCAAACCC 
LJFgene1      ---------------------------------------CTCAAGTTTATCACCAAACCC 
LJFgene14     CTTACTTCTTCACACTCACACTTTCTATTTCCTTTCTATTGATTATTCGTAACCATCTTC 
LJFgene8      ---------------------------------------CTCAAGTTTCGCACCAAACCC 
LJFgene9      ---------------------------------------CAGAAGCTGGATGACGATAAT 
 
LJFgene3      AACAATGGTAGAAGAAGC---------TCTCTTCCCCGTATTGTATTCTGTCAGAAGCAC 
LJFgene1      AACAACAATGGTAGAACCAATGCTTCTTCTCTTCCCCGTATTGTATTCTGTCAGAAGCAC 
LJFgene14     TGAAATCTCGTTACATTTCAATTCTTTTGTGTATTGAAGAGAACTCATATTGAGAAGCAG 
LJFgene8      AACGAT---AGTAGAAGCAGTGCTTCCTCTCTTCCCCGTATTCTATTCTGTCACAACCTC 
LJFgene9      TTCATTGATAAAATCAAACGAAGGTTCTCACTGATTCTCCCTTTAATTTGCCACCTCACA 
 
LJFgene3      CACGAT------------------------AGCACACCCACCGACCAAATCAACCGAAGA 
LJFgene1      AACGAT------------------------GACACCCCCACCGACCAAATCAACCGAAGA 
LJFgene14     CGAAAT------------------------AGCGACCATTGGTGCCATCTTCAACTTCGG 
LJFgene8      CACGATGAC------------------ATTCACACACCCACTGACCAAATCAACCGAAGA 
LJFgene9      TGAATTGTATAATATATATTTATATTTATGCTTGACCTTGAATTGTTCCTATCTTAAAGA 
 
LJFgene3      GAACTCATATTGAGAAGCAGCGAAATAGCGACCATTGGT--------------------- 
LJFgene1      GAACTCATATTGAGAAGCAGTGAAATAGCGACCATTGGT--------------------- 
LJFgene14     GTACCCCTCCTCTGTTTTTGCTCTGTTTTTTTTTCTGGAAATTTTAGTTTTTCATTTTAT 
LJFgene8      CAACTCATATTGAGAAGCAGCGAAATAGCGACCATCGGT--------------------- 
LJFgene9      GAGCTCATACTGGAAAGTGGAGAATTAGCAACCATTGGT--------------------- 
Figure 3.8. Codon alignment with extended sequence. All intermittent stops in 
extended sequences were arbitrarily replaced with R (arginine residues) to extend the 
reading frame for acceptance by this program. Red residues represent replaced codons. 




LJFgene3      ------------------------------------------------------------ 
LJFgene1      ------------------------------------------------------------ 
LJFgene14     TTTGAATGTAAATTAAATTCGAGATTTGATTTTGTTAGTGGGTGTTGAGACCCTTTTGGA 
LJFgene8      ------------------------------------------------------------ 
LJFgene9      ------------------------------------------------------------ 
 
LJFgene3      ------------------------------------------------GCCATCTTGAAC 
LJFgene1      ------------------------------------------------GCCATCTTCAAC 
LJFgene14     TTTTAGTTTGGGTTGTGTTTTGTATTGGAAATGGGTGGTTTGGGTTTTGTGTTTTGGTGG 
LJFgene8      ------------------------------------------------GCCATCTTCGAC 
LJFgene9      ------------------------------------------------GCCATCTTCAAC 
 
LJFgene3      TTCGGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCATTAGCTCTG 
LJFgene1      TTCGGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCATTAGCTCTG 
LJFgene14     TGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCATTAGCTCTG 
LJFgene8      TTCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCTTTAGCTCTG 
LJFgene9      TTTAGAGGCAAAAAGCCAGATTATCTTGGAGTGCAGAAAAATCAACCGGCATTAGCACTA 
 
LJFgene3      TGCCCGGCAACGAAGAATTGCGTGTCAACCTCTGAGAATATCAGTGATCGCACACATTAT 
LJFgene1      TGTCCGGCAACTAAGAACTGCGTGTCAACCTCTGAGAATATCAGTGATCGCACACATTAT 
LJFgene14     TGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGAGAATATCAGCGATCGCACACATTAT 
LJFgene8      TGTCCGGTAACTAGGAACTGCGTATCAACCTCTGAGAATATCAGTGATCGCACTCATTAT 
LJFgene9      TGTCCGGCAACTAAGAACTGCATATCGACATCTGAAAATGTCACTAACCTCACACATTAC 
 
LJFgene3      GCTCCTCCATGGAACTATAATCCTGAAGGTAGGAAAAAACCTGTGAACAGAGAGGAAGCA 
LJFgene1      GCTCCTCCATGGAACTATAATCCTGAAGGTAGGAAAAAACCTGTGAGCAGGGAAGAAGCA 
LJFgene14     GCTCCTCCATGGAACTATAATCCTGAAGGAAGGAAAAAACCTGTGAGCAGAGAGGAAGCA 
LJFgene8      GCTCCTCTTTGGAACTACAATCCTGAAGGTAGGAAAAACCCTGTGAGCAGAGAAGAGGCA 
LJFgene9      ACTCCTCCTTGGAACTACAATCCTGAAGGTAGGAAAGATCATGTGAGC---AAAGAGGCA 
 
LJFgene3      ATGGAGGAACTGATAGACGTGATAGAATCA---ACAACACCAGACAAATTTTCACCACGG 
LJFgene1      ATGGAGGAACTTATAGACGTGATAGAATCA---ACAACACCAGACAAATTTTCACCACGG 
LJFgene14     ATGGAGGAACTGATAGACGTGATCGAATCA---ACAACACCAGACAAATTTTCACCACGG 
LJFgene8      ATGGAGGAACTGATAGACGTGATAGAATCA---ACAACACCAGACAAATTTACACCACGA 
LJFgene9      ATGGAGGAACTGATAGATGTGATAGAATCGACAATACTACCAGAAAATTTTACACCAAGG 
 
LJFgene3      ATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCA------------ 
LJFgene1      ATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCA------------ 
LJFgene14     ATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCA------------ 
LJFgene8      ATAGTTGAAAGGAAGGAAGACTATATTCATGTGGAGTACCAAAGCTCA------------ 
LJFgene9      ATTGTAGAAAGAACAGAAGATTATCTTAGATTGGAATACCAAAGTGTATACAAGCCACAA 
 
LJFgene3      ATTTTGGGGTTTGTAGATGATGTTGAGTTCTGGTTCCCACCGGGTAAGGGTTCTACTGTG 
LJFgene1      ATCTTGGGGTTTGTGGATGATGTTGAGTTCTGGTTTCCTCCGGGTAAGGGTTCTACTGTG 
LJFgene14     ATCTTGGGGTTTGTGGATGATGTTGAGTTCTGGTTTCCACCCGGTAAGGGTTCTACTGTG 
LJFgene8      ATCTTGGGGTTTGTGCATGATGTTGAGTTCTGGTTTCCACTGGGTAAGGGTTCTACTGTG 
LJFgene9      ATTTTAACTTCAATGTCACCAATATCATTGTATGCAGAAAAAATGAATAGTAACTTTTTA 
 
LJFgene3      GAGTACCGATCTGCATCTCGGTTAGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATA 
LJFgene1      GAGTATCGTTCTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATA 
LJFgene14     GAGTATCGATCTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATA 
LJFgene8      GAGTATCGATCTGCATCTCGGTTGGGGAACTTTGATTTTGATGTGAATAAGAAAAGAATA 
LJFgene9      CTATTAGACTGAAAAGCCTGCATCAAGCATTGAAGGAATGGAGTTTCTTTGATCATTGGA 
 
LJFgene3      AAGGCACTGCGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGACACCATATGATGA 
LJFgene1      AAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGACACCATATGATGA 
LJFgene14     AAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGATACCATATGATTA 
LJFgene8      AAGGTATGTTTGTATCATTCCTTTGTGCTGTCTCGGTAGTTAACATGAAGAAATGATTAA 
LJFgene9      CTGCCCATCTCATAGTAACTCATCTTGAAGCAATTAATGCAGTAAAAACTAACTCATCGT 
 
LJFgene3      ATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCATATACTTTGTGA 
LJFgene1      AAAAACTTAGGCAGAATTCACATCAGCATCTAAGAAAATATTGTTTCATATACATTGTAA 
LJFgene14     ATAAACTCAGGCTGAATTAGCATCAGCATCTAAGCAAATATTATTTCATATACTTTGGAC 
LJFgene8      AAGATATTTTGTCCTTTAGGTTTTTTGGTTATATTTAGTTTGATTTTTTATTTTTTAAAA 
LJFgene9      GAAAAGTTCATTCTCTGCTTTATTTAAATTTTTACAGCAAGTAGATTGGAATGCATGGTT 




LJFgene3      CCTTGTATACATTTGTATTAGATACAAATCTCA------------ 
LJFgene1      CCTTGTATACTTTTGTATTAGATACAAAATCTC------------ 
LJFgene14     CTTGTATACTTTTGTATTAGATACAAATCGCAC------------ 
LJFgene8      GTTAAATTTAGTCCT------------------------------ 
LJFgene9      TTTGCCATGTTTTATACTTGACAAAGATAATGCAAACTATAAACA 
Figure 3.8. Codon alignment with extended sequence. (CONT.) 
 
3.3.4.4. Pairwise dot plot matrices.  Pairwise dot plot matrices of gene family 
members provide an alternative method of determining sequence similarity both 
within and surrounding the predicted coding sequence. A dot plot matrix of LJFgene3 
plotted against LJFgene14 is illustrated in Figure 3.9. A dot plot matrix of LJFgene3 
plus extended sequence plotted against LJFgene14 plus extended sequence is 
illustrated in Figure 3.10. A dot plot matrix of LJFgene3 plus extended sequence 
plotted against LJFgene14 plus extended sequence and shifted for 3’ boundary 
analysis is illustrated in Figure 3.11. Two dot plot matrices of LJFgene3 plus extended 
sequence plotted against LJFgene1 plus extended sequence are illustrated in Figures 
3.12 and 3.13.  An analysis of a 10 kbp sequence from chromosomes 3 and 
chromosome 1 beginning at the second to last exon of each gene model and extending 
past the 3’ end and up to the most proximal 3’ neighbor gene is illustrated in Figures 
3.14, 3.15, and 3.16. The similarity of the sequences extending beyond the 3’ ends of 
the gene family members does extend into the neighbor gene on chromosome 3, but 








Figure 3.9. Dot plot: LJFgene3 (genomic sequence) vs LJFgene14 (genomic 































Figure 3.10. Dot plot: LJFgene3 genomic sequence plus approximately 2500nt 
extension from both 5’ and 3’ gene model boundaries (x-axis) vs. LJFgene14 genomic 
sequence plus approximately 2500nt extension from both 5’ and 3’ gene model 
boundaries (y-axis). Blue lines indicate boundary between genomic sequence identity 
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Figure 3.11. Dot plot: LJFgene3 genomic sequence plus approximately 2500nt 
extension (x-axis) vs. LJFgene14 genomic sequence plus approximately 2500nt 
extension (y-axis). Adjustment: 5’extention removed to shift plot for similarity 
analysis of sequence beyond 3’ end of genes. Blue lines indicate boundary between 



















LJFgene3 + 2500nt  
	  









Figure 3.12. Dot plot: LJFgene1 genomic sequence plus 1000nt extension from both 5’ 
and 3’ gene model boundaries (x-axis) vs. LJFgene3 genomic sequence plus 1000nt 
extension from both 5’ and 3’ gene model boundaries (y-axis). Blue lines indicate 




















1000nt + LJFgene1 + 1000nt  
	  









Figure 3.13. Dot plot: LJFgene3 genomic sequence plus approximately 3300 
nucleotide extension from both 5’ and 3’ gene model boundaries (x-axis) vs. LJFgene1 
genomic sequence plus approximately 2870 nucleotide extension from both 5’ and 3’ 
gene model boundaries (y-axis). Blue lines indicate boundary between genomic 

















3300nt + LJFgene3 + 3300nt  
	  









Figure 3.14. Dot plot: LJFgene3 vs. LJFgene1. Adjustment: approximately 10 kbp 
sequence from chromosomes 3 (x-axis) and chromosome 1 (y-axis) beginning at the 





















LJFgene3 (Exon 6 and 7) + 10,000nt  
	  









Figure 3.15. Dot plot: LJFgene3 vs. LJFgene1. Adjustment: sequence from 
chromosomes 3 (x-axis) and chromosome 1 (y-axis) beginning at the second to last 
exon of each gene family model and extending past 3’ gene model boundary up to 




















LJFgene3 (Exon 6 and 7) I-------I (3’ neighbor gene) 
	  LJFgene1 (Exon 6 and 7) I---(X







Figure 3.16. Dot plot: LJFgene3 vs. LJFgene1.   Adjustment: sequence from 
chromosomes 3 (x-axis) and chromosome 1 (y-axis) beginning at the second to last 
exon of each gene family model and extending past 3’ gene model boundary up to 




3.4. FUNCTIONAL ANALYSIS 
 
 The effort to identify the function of the putative protein for the LJFgene 
family involves analysis of sequence for conserved motifs, analysis of known DNA 
elements associated with transcription, subcellular localization predictions, and 
threading sequence against databases of known proteins to predict structure.
 3.4.1. Domain Identification Through Conservation of Sequence. Figure 
3.17 shows the results of a conserved motif analysis for the LJFgene family.  
 
LJFgene3 (Exon 6 and 7) I---(X nts = y-axis nts)--I  















Figure 3.17. LJFgene family conserved motifs search results. (A) Motif search using 
50 bit parameter (maximum length of motif 50 residues). Block diagram illustrating 
position of motifs along peptide length accompanied by proportional amino acid 
composition at each position of the motif. (B) Motif search using 100 bit parameter 
(maximum length of motif 100 residues). Block diagram illustrating position of motifs 
along peptide length accompanied by proportional amino acid composition at each 














Figure 3.17. LJFgene family conserved motifs search results. (CONT.) 
 
 3.4.2. Promoter Element Analysis.  The cis-element data has been organized 
in two forms. Those elements that fall into one of three categories  according to gene 
association (only associated with genes with EST data, only associated with genes 
without EST data, or associated with all family members) are organized in Table 3.8. 
Cis-elements that have tissue-specific or treatment-specific themes with overlapping 
appearance in gene family sequences are organized into Table 3.10.  
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Table 3.8. Plant cis-acting elements upstream of LJFgene family members. 
 
Identifier Element Genes w/ ESTs Genes w/o ESTs LJFgene3 LJFgnee14 LJFgene9 LJFgene1 LJFgene8 
S000353 AACAAAC ✓ ✓ ✓     
S000414 ACGTG ✓ ✓ ✓     
S000507 MACGYGB ✓ ✓ ✓     
S000499 GAGAC ✓ ✓ ✓     
S000458 AACGTG ✓ ✓ ✓     
S000400 TATTTAA ✓ ✓ ✓     
S000308 AAACCCTAA       ✓ ✓ 
S000472 AAACCCTA       ✓ ✓ 
S000459 GNATATNC       ✓ ✓ 
S000415 ACGT ✓ ✓ ✓ ✓ ✓ 
S000454 NGATT ✓ ✓ ✓ ✓ ✓ 
S000028 CAAT ✓ ✓ ✓ ✓ ✓ 
S000449 YACT ✓ ✓ ✓ ✓ ✓ 
S000030 CCAAT ✓ ✓ ✓ ✓ ✓ 
S000493 GTAC ✓ ✓ ✓ ✓ ✓ 
S000265 AAAG ✓ ✓ ✓ ✓ ✓ 
S000292 ACACNNG ✓ ✓ ✓ ✓ ✓ 
S000144 CANNTG ✓ ✓ ✓ ✓ ✓ 
S000494 GANTTNC ✓ ✓ ✓ ✓ ✓ 
S000039 GATA ✓ ✓ ✓ ✓ ✓ 
S000198 GRWAAW ✓ ✓ ✓ ✓ ✓ 
S000453 GAAAAA ✓ ✓ ✓ ✓ ✓ 
S000378 GTGA ✓ ✓ ✓ ✓ ✓ 
S000199 GATAA ✓ ✓ ✓ ✓ ✓ 
S000395 YTCANTYY ✓ ✓ ✓ ✓ ✓ 
S000067 TTWTWTTWTT ✓ ✓ ✓ ✓ ✓ 
S000413 CATGTG ✓ ✓ ✓ ✓ ✓ 
S000174 CACATG ✓ ✓ ✓ ✓ ✓ 
S000407 CANNTG ✓ ✓ ✓ ✓ ✓ 
S000462 CTCTT ✓ ✓ ✓ ✓ ✓ 
S000468 CTCTT ✓ ✓ ✓ ✓ ✓ 
S000080 AATAAA ✓ ✓ ✓ ✓ ✓ 
S000081 AATTAAA ✓ ✓ ✓ ✓ ✓ 
S000088 AATAAT ✓ ✓ ✓ ✓ ✓ 
S000245 AGAAA ✓ ✓ ✓ ✓ ✓ 
S000450 ACTCAT ✓ ✓ ✓ ✓ ✓ 
S000259 CCTTTT ✓ ✓ ✓ ✓ ✓ 
S000314 CAACA ✓ ✓ ✓ ✓ ✓ 
S000098 ATATT ✓ ✓ ✓ ✓ ✓ 
S000103 RTTTTTR ✓ ✓ ✓ ✓ ✓ 
S000203 TTATTT ✓ ✓ ✓ ✓ ✓ 
S000390 TTGAC ✓ ✓ ✓ ✓ ✓ 
S000442 TGACT ✓ ✓ ✓ ✓ ✓ 
S000457 TGACY ✓ ✓ ✓ ✓ ✓ 




 Table 3.9 outlines treatment data from the ESTs associated with gene family 
members. The ESTs that were generated from cDNAs created through the sampling of 




Table 3.9. Treatment data from EST library.  
 
Gene EST Treatment 
LJFgene3 BM176973 hypersensitive response induced with Pseudomonas 
  BM886799 Drought stress treatment 
  CO983876 exposure to fungal pathogens 
  EV275072 Drought stressed, salt stressed and Pseudomonas-infected 
LJFgene14 EV264523 apical meristem and green seeds 
  FG993792 apical meristem and green seeds 
  HO044862 immature seeds 
LJFgene9 CF921901 root hair treated with nodulating bacteria (Bradyrhizobium) 




Table 3.10. Shared and noteworthy themes of LJFgene family promoter elements. 
 
Interesting 
Characteristic Identifier Species LJFgene(s) 
endosperm 
specific 
S000353 O. sativa (rice) 3,14,9 
S000265 P. sativum (pea) 3,14,9,8,1 
source tissue: 
seed 
S000353 O. sativa (rice) 3,14,9,8,1 
S000028 Z. mays (corn) 3,14,9,8,1 
S000144 B. napus (rapeseed) 3,14,9,8,1 
S000103 G. max (soybean) 3,14,9,8,1 
Response to 
dehydration 
S000414 A. thaliana (Thale cress) 3,14,9 
S000415 A. thaliana (Thale cress) 3,14,9,8,1 
S000413 A. thaliana (Thale cress) 3,14,9,8,1 
S000174 A. thaliana (Thale cress) 3,14,9,8,1 
S000407 A. thaliana (Thale cress) 3,14,9,8,1 
TATA rice 
PAL gene 
S000400 O. sativa (rice) 3,14,9 
Response 
elements 
S000499 A. thaliana (Thale cress) 3,14,9 
S000459 A. thaliana, L. esculentum, M. truncatula, H. vulgare 8,1 
S000493 C. reinhardtii (green algae) 3,14,9,8,1 
S000144 B. napus (rapeseed) 3,14,9,8,1 
S000390 A. thaliana (Thale cress) 3,14,9,8,1 
S000292 A. thaliana (Thale cress), D. carota (carrot) 3,14,9,8,1 
Wound-
induced 
S000458 A. thaliana (thale cress), L. esculentum (tomato) 3,14,9 











S000308 A. thaliana (Thale cress) 3,14,9,8,1 
S000468 M. truncatula (barrel medic), G. max (soybean) 3,14,9,8,1 
S000098 Agrobacterium rhizogenes 3,14,9,8,1 
Axillary bud S000472 A. thaliana (Thale cress) 8,1 
Light-
responsive 
S000039 A. thaliana, O. sativa, P. hybrida (petunia) 3,14,9,8,1 
S000198 P. sativum, A. sativa, O. sativa, N. tabacum, A. thaliana, S. oleracea, bean 3,14,9,8,1 
S000199 N/A 3,14,9,8,1 
S000395 N. tabacum (tobacco) 3,14,9,8,1 
pathogen-
induced 
S000453 G. max (soybean) 3,14,9,8,1 
S000468 M. truncatula (barrel medic), G. max (soybean) 3,14,9,8,1 




3.4.3. Subcellular Localization Predictions. The location of putative protein 
function within the cell was predicted using multiple methods including two computer 
programs and a hydropathy plot.  
3.4.3.1. CELLO. The results of subcellular localization predictions produced 




















Localization Reliability score 
LJFgene3 1 Nuclear 2.264* 
 2 Chloroplast 1.817* 
 3 Mitochondrial 0.371 
LJFgene14 1 Nuclear 1.171* 
 2 Chloroplast 1.068* 
 3 Extracellular 1.010* 
LJFgene1 1 Nuclear 2.391* 
 2 Chloroplast 1.125 
 3 Mitochondrial 0.633 
LJFgene8 1 Nuclear 1.877* 
 2 Mitochondrial 0.967 
 3 Plasma Membrane 0.794 
LJFgene9 1 Nuclear 1.276* 
 2 Cytoplasmic 1.065* 
 3 Extracellular 0.894 
*designates significant scores indicated by CELLO output.  
  
3.4.3.2. Hydropathicity analysis. Hydropathy plots were used to assess 
whether the conceptually translated amino acid sequence of LJFgene3 would fit the 
criteria for an integral membrane protein. The hydropathy plot of LJFgene3, displayed 
in Figure 3.18, was compared to the hydropathy plot of a known integral membrane 





Figure 3.18. Kyte-Doolittle hydropathy plot of LJFgene3. Window size = 19. Peaks 





Figure 3.19. Hydropathy plot of human rhodopsin protein (known transmembrane 
protein). ProtScale input: Human Rhodopsin amino acid sequence accessed by 




3.4.3.3. I-TASSER gene ontology results. The gene ontology data provided 
by I-TASSER classifies the predicted protein product of LJFgene3 as follows: 
• Ontology: Cellular Component  
 
• GO:0071944 Cell Periphery 
 
• Definition: The part of the cell encompassing the cell cortex, the plasma 
membrane, and any external encapsulating structures. 
3.4.4. Secondary Structure Predictions. The arrangement of an amino acid 
sequence into alpha helices and beta sheets was predicted using two programs. The 
output provides the predicted secondary structure at each loci as well as a confidence 
score (1 -10; higher scores indicate more confident predictions). Figure 3.20 displays 
the prediction according to PSIPRED. Figure 3.21 displays the prediction according to 




  AA: MSISSLIFSNLHFQLPTTMASMASSSSFCNLKFITKPNNGRRSSLPRIVFCQKHHDSTPT 





  AA: DQINRRELILRSSEIATIGAILNFGGKKPDYLGVQKNPPALALCPATKNCVSTSENISDR 





  AA: THYAPPWNYNPEGRKKPVNREEAMEELIDVIESTTPDKFSPRIVERKEDYIRVEYQSSIL 





  AA: GFVDDVEFWFPPGKGSTVEYRSASRLGNFDFDVNRKRIKALRQELEKKGWASQDTI 
             190       200       210       220       230   
 
Figure 3.20.  Secondary structure prediction, including confidence scores at each 
position, of PSIPRED HFORMAT (PSIPRED V3.3) on the conceptually translated 
amino acid sequence of LJFgene3. Alpha helices are designated with red H’s and beta 
sheets with blue E’s.  
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Figure 3.21.  Secondary structure prediction, including confidence scores at each 
position, of I-TASSER on the conceptually translated amino acid sequence of 






AA Seq:                  MSISSLIFSNLHFQLPTTMASMASSSSFCNLKFITKPNNGRRSS 
 
PSI PRED:  CCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC  
I-TASSER: CHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC 
AA Seq:                  LPRIVFCQKHHDSTPTDQINRRELILRSSEIATIGAILNFGGKKPDYLGVQKNPP 
 
PSI PRED:  CCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC  
I-TASSER: CCCCCCCCCCCSSCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC 
AA Seq:                  ALALCPATKNCVSTSENISDRTHYAPPWNYNPEGRKKPVNREEAMEELIDVIEST 
 
PSI PRED:  CCCCCCCEEEEEECCEEEEEEEECCCCCCCCEEEEECCCCCCEEEEEECCCCCCC 
I-TASSER: CCCCCCCSSSSCCCCSSSSSSSCCCCCCCCSSSSSSSCCCCCSSSSSSCHCCCCC 
AA Seq:  TPDKFSPRIVERKEDYIRVEYQSSILGFVDDVEFWFPPGKGSTVEYRSASRLGNF 
 
PSI PRED:  CHHHHHHHHHHHHHHHHHCCCCCCCCC 
I-TASSER: CCCHHHHHHHHHHHHHHHCCCCCCCCC 
AA Seq:                  DFDVNRKRIKALRQELEKKGWASQDTI 
 
Figure 3.22.  Alignment of prediction tool outputs to determine level of agreement.  
PSI PRED output designates alpha helices with red H’s and beta sheets with blue E’s. 










3.4.5. Tertiary Structure and Function Predictions. Predictions of tertiary 
structure and function of the LJFgene3 conceptually translated peptide sequence were 
conducted using numerous threading programs. The results from submission to 
pDomTHREADER are illustrated in Figures 3.23 and 3.24, as well as in Table 3.12. 
The results from submission to pGenTHREADER are illustrated in Table 3.13. The 
results from submission to I-TASSER are illustrated in Tables 3.14, 3.15, 3.16, 3.17, 






Figure 3.23. Top 3 pDomTHREADER secondary structure alignments of query 
sequence (LJFgene3) against domain codes based on secondary structure similarities 
(as opposed to alignment scores). (A) Secondary structure of the domain with code 
1v5sA00 exhibits the highest level of structural similarity with the query at the 
carboxy- terminus of the query. (B) Secondary structure of the domain with code 
1up8A00 exhibits the highest level of structural similarity with the query at the amino- 
terminus of the query. (C) Secondary structure of the domain with code 1m40A00 






Figure 3.23. Top 3 pDomTHREADER secondary structure alignments of query 
sequence (LJFgene3) against domain codes based on secondary structure similarities 








Figure 3.23. Top 3 pDomTHREADER secondary structure alignments of query 
sequence (LJFgene3) against domain codes based on secondary structure similarities 




Table 3.12. CATH domain summary of pDomTHREADER output. 
 
CATH Level Description Qty 
Class 
Alpha Beta 8 
Mainly Beta 1 
Mainly Alpha 1 
Architecture 
Roll 3 
2-layer Sandwich 2 
3-layer (aba) Sandwich 2 
Sandwich 1 
Orthogonal Bundle 1 
Alpha-Beta Complex 1 
Topology No Agreement 
Homologous 






(A) 1v5sA00 Level CATH Code  Description   
   C  3   Alpha Beta  
   A 3.30   2-Layer Sandwich 
   T 3.30.310  TATA-binding Protein 
   H 3.30.310.80  Kinase-associated Domain 
               
(B) 1up8A00 Level CATH Code  Description   
   C 1   Mainly Alpha 
   A 1.10   Orthogonal Bundle 
   T 1.10.606  Vanadium-containing 
Chloroperoxidase 
   H 1.10.606.10  Vanadium-containing 
       Chloroperoxidase 
 
(C) 1m40A00 Level CATH Code  Description   
   C 3   Alpha Beta 
   A 3.40   3-layer (aba) Sandwich 
   T 3.40.710  Beta-lactamase 
   H 3.40.710.10  DD-peptidase/ β-lactamase 
           
 
Figure 3.24. CATH classification for the 3 pDomTHREADER domains with the most 
secondary structure similarity. (A) 1v5sA00 [76], (B) 1up8A00 [77], and (C) 



























Escherichia coli Transferase 5'-AMP-activated 
protein kinase catalytic 
subunit 



















Not Listed Hydrolase C-lobe of bovine 
lactoferin 







Not Listed Transferase Fatty acid synthase 
4FR9 X-ray 
Diffraction 























1 3w4qA Hydrolase Beta-lactamase 0.14 
2 3w4qA Hydrolase Beta-lactamase 0.09 
3 3w4qA Hydrolase Beta-lactamase 0.13 
4 4gbmA Transferase Sulfotransferase 0.12 
5 3mekA Transferase Methyltransferase 0.11 
6 4btgA Viral protein Capsid coordination 0.13 
7 4m5uA RNA-
binding/inhibitor 
Polymerase PA 0.14 
8 2kixA Transport protein BM2 protein 0.46 
9 3fleA Unknown function Unknown function 0.08 
10 1ef1C Membrane protein Moesin 0.15 












1 3w4qA Hydrolase Beta-lactamase 0.129 0.876 
2 3bydA Hydrolase Beta-lactamase OXY-1 0.121 0.871 
3 3w4oA Hydrolase Beta-lactamase 0.098 0.870 
4 1hzoA Hydrolase Beta-lactamase 0.115 0.870 
5 1bsg Hydrolase Beta-lactamase 0.111 0.870 
6 3dw0B Hydrolase Class A Beta-lactamase KPC-2 0.122 0.869 
7 4eqiA Hydrolase Class A Beta-lactamase SFC-1 0.115 0.869 
8 1iyqA Hydrolase Toho-1 Beta-lactamase 0.117 0.868 







* Rank is based on TM-scores. 
* TM-score measures structural similarity between template and query. 




Table 3.16. Summary of I-TASSER results: Top 5 enzyme homologs. 
 
Rank PDB ID CscoreEC TM-score EC # 
Protein 
Classification Molecule 
1 1iysA 0.215 0.868 3.5.2.6 Hydrolase Beta-lactamase 
2 3lezA 0.209 0.863 3.5.2.6 Hydrolase Beta-lactamase 
3 3c4pA 0.189 0.845 3.5.2.6 Hydrolase Beta-lactamase 
4 3bydA 0.176 0.871 3.5.2.6 Hydrolase Beta-lactamase 
5 1iyqA 0.175 0.868 3.5.2.6 Hydrolase Beta-lactamase 
* CscoreEC is a measure of confidence in the EC number prediction. Scores range from 0 to 1, with 
numbers closer to 1 indicating more reliable predictions. 













Table 3.17. Summary of I-TASSER results: gene ontology prediction. 
 
 GO Term GO score Description 
Molecular Function GO:0008800 0.71 Beta-lactamase activity 
Biological Process 
GO:0046677 0.71 Response to antibiotic 
GO:0030655 0.71 Beta-lactam antibiotic catabolic 
process 
Cellular Location GO:0071944 0.41 Cell periphery 
* GO score is assigned based on weighted CscoreGO scores for the GO terms. Scores range from 0 to 1, 




Table 3.18. Summary of I-TASSER results: Top 10 templates with binding sites 
similar to the query. 
 






1 3sh8B 0.50 0.93 72, 74, 175 -178, 183 Hydrolase/ antibiotic 
Beta-
lactamase 
2 3hlwA 0.46 1.02 72, 74, 108, 113, 156, 174, 175 - 179 Hydrolase  
Beta-
lactamase 










5 1blcA 0.23 0.94 72, 156, 174 – 177 Hydrolase Beta-lactamase 
6 3ny4A 0.04 1.13 205, 210 – 212, 214 Hydrolase/ antibiotic 
Beta-
lactamase 





8 1jtg0 0.04 1.00 
38, 39, 41, 52 - 54, 
71, 72, 108, 113, 156, 
174 – 179, 183 
Hydrolase Beta-lactamase 
9 3g35B 0.04 0.96 84, 85, 90, 91 Hydrolase/ inhibitor 
Beta-
lactamase 
10 3huoB 0.04 1.05 144, 145, 148, 149, 152, 190 Hydrolase 
Beta-
lactamase 
*CscoreLB is a measure of confidence in the prediction of the binding site. Scores range from 0 to 1, 
with numbers closer to 1 indicating more reliable predictions. 
* BS-score is a measure of structural and sequence similarity between query and template binding sites. 






 The 3D protein model predicted for LJFgene3 by I-TASSER is displayed in 
Figure 3.25. A comparison of this structure with the structure of an experimentally 




Figure 3.25. Top I-TASSER generated model for LJFgene3. Confidence score = -2.72. 







Figure 3.26. Side-by-side comparison of tertiary structure of LJFgene3 predicted 
model and beta-lactamase molecule. (a) LJFgene3 model prediction generated by I-
TASSER. (b) Class C beta-lactamase molecule from Enterobacter cloacae 




3.5. NON-CODING SEQUENCE ANALYSIS 
 
 3.5.1. Nucleotide Sequences, Amino Acid Translations, and Putative 
Models for Non-coding Sequences Associated with LJFgene Family.  The sequence 
data for non-coding sequences LJFnm19, LJFnm11, and LJFnm12 are organized in 
Table 3.19. The non-coding sequences were not predicted as genes by FgenesH or 
GenomeScan algorithms; however, they are represented by models in Figure 3.27 for 
comparison with LJFgene3. Figure 3.28 contains alignments of the LJFnm sequences 
(amino acid, coding, and genomic sequences) as an illustration of sequence 
conservation maintained both within possible coding regions and within intronic 






Table 3.19. LJFnm sequences. 
 
Name Seq. Type Sequences 
LJFnm19 



































































LJFnm19         QFWFPPGKGSTVEYRSASRLGNFDFDVNRKRIKALRQELEKKGWTSQDTI 
LJFnm11         QFWFPPGKGSTVEYRFASRLGNFDFDVNRKRIKALRQELEKKGWTSQDTI 
LJFnm12         -FWFPPGKGSTVKYRSASRLGNFDFDVNRKRIKALRQELEKKGWTSQDTI 
                 ***********:** **********************************  
(B)  
LJFnm11         TTCAGTTCTGGTTTCCACCGGGTAAGGGTTCTACTGTGGAGTATCGATTTGCATCTCGGT 
LJFnm19         TTCAGTTCTGGTTTCCACCGGGTAAGGGTTCTACTGTGGAGTATCGATCTGCATCTCGGT 
LJFnm12         TTTAGTTCTGGTTTCCACCGGGTAAGGGTTCTACTGTGAAGTATCGATCTGCATCTCGGT 
                ** *********************************** ********* *********** 
 
LJFnm11         TGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGCACTGAGACAAGAGTTGG 
LJFnm19         TGGGAAACTTTGATTTTGATGTGAATAGAAAAAGAATAAAGGCATTGAGACAAGAGTTGG 
LJFnm12         TGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGCACTGAGACAAGAGTTGG 
                ************************* ****************** *************** 
 
LJFnm11         AGAAGAAAGGATGGACATCTCAAGATACCATATGA 
LJFnm19         AGAAGAAAGGATGGACATCTCAAGATACCATATGA 
LJFnm12         AGAAGAAAGGATGGACATCTCAAGATACCATATGA 
                ***********************************  
 
Figure 3.28. LJFnm sequence alignments. (A) Alignment of LJFnm conceptually 
translated peptide sequences. (B) Alignment of LJFnm coding sequences. (C) 
Alignment of LJFnm genomic sequences. A star (*) indicates 100 percent identity at a 
loci; a colon (:) represents strong chemical property conservation between residues at a 











LJFnm11         TTCAGTTCTGGTTTCCACCGGGTAAGGGTTCTACTGTGGAGTATCGATTTGCATCTCGGT 
LJFnm12         TTTAGTTCTGGTTTCCACCGGGTAAGGGTTCTACTGTGAAGTATCGATCTGCATCTCGGT 
LJFnm19         TTCAGTTCTGGTTTCCACCGGGTAAGGGTTCTACTGTGGAGTATCGATCTGCATCTCGGT 
                ** *********************************** ********* *********** 
 
LJFnm11         TGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATAATTTCATAATTAAT 
LJFnm12         TGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATGATTTCATAATTAAT 
LJFnm19         TGGGAAACTTTGATTTTGATGTGAATAGAAAAAGAATAAAGGTATGATTTCATAATTAGT 
                ************************* ******************* ************ * 
 
LJFnm11         ATGTGCTTTCTTTATAGTTAGATAAAGAAATTCTTGGTTCCAGGGTTATACTCCCCTTCC 
LJFnm12         ATGTGCTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCTAGGGTTATACTCCCCTTCC 
LJFnm19         ATGTGCTTTCTCTATAGTTAGAATAAAGG-------------------TACTCCCCTTCC 
                *********** **********  **                      ************ 
 
LJFnm11         TTCATGTCATGTCAAACATTTTATACTTAAGTAGATTCACTAAATTTGAGTCTGAAATGT 
LJFnm12         CTCATGTGATGTCAAACATTTTATACTTAAGTAGATTCACTAAATTTGAGTCTCAAATGT 
LJFnm19         TTCATGTCATGTCAAACATTTTATACTTAAGTAAATTCACTAAATTTTAGTCTCAAATGT 
                 ****** ************************* ************* ***** ****** 
 
LJFnm11         TTTAACTTTATTCTAAATTAGTCACTTATTTTAACTGAAGGTAAATTTGGTTGACTATGA 
LJFnm12         TTTAACATTATTCTAAATTAGTCACTTATTTTAACTGAAGGTAAATTTGGTTGACTATGA 
LJFnm19         TTTAACTTTATTCTAAATTAGTCACTTATTTTAACTGAAGGTAAATTTGGTTGACTATGA 
                ****** ***************************************************** 
 
LJFnm11         TCAGAAATACACTGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATA 
LJFnm12         TCAGAAATACATTGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTGATGTACAATA 
LJFnm19         TCAGAAATACATTGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATA 
                *********** ************************************* ********** 
 
LJFnm11         AAGAGAGTATTTACTCCAGAGGATGCAAATCCTTTACTAAATATTTTTGTGATTAAAAAT 
LJFnm12         AAGAGAGTACTTACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTGTGATGAAAAAT 
LJFnm19         AAGAGAGTATTTACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTGTGATGAAAAAT 
                ********* ********************** ******************** ****** 
 
LJFnm11         CTTGGTTGCTGACAGGCACTGAGACAAGAGTTAGAGAAGAAAGGATGGACATCTCAAGAT 
LJFnm12         CTTGGTTGCTGAAAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGAT 
LJFnm19         CTTGGTTGCTGACAGGCATTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGAT 
                ************ ***** ************* *************************** 
 
LJFnm11         ACCATATGATTAATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCA 
LJFnm12         ACCATATGATTAATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCA 
LJFnm19         ACCATATGATTAATAAACTCAGGCAGAATTAACATCAACATCTAAGCAAATATTATTTCA 
                ************************************* ********************** 
 
LJFnm11         TATACTTTGTGACCTTGTATACTTTTGTATTAGATACAAATCGCACAGGATCATTGCAAG 
LJFnm12         TATACTTTGTGACCTTGTATACTTTTGTATTAGATACAAAT-------------TGCAAG 
LJFnm19         TATACTTTGTGACCTTGTATACTTTTGTATTAGATACAAATCACACAGGATCATTTCAAG 
                *****************************************             * **** 
 
LJFnm11         CAAACTTTTCTTAGATTTTTGGAATTGTAGAGAAATCATTGAGAACAATACTTCAAACTC 
LJFnm12         CAAACTTTTCTTAGATTTTTG--------------------------------------- 
LJFnm19         CAAACTTTTCTTAGATTTTAGGAATTGTAGAGAAATCATTGAGACAATACTTTAAACTCT 
                ******************* *                                        
 
LJFnm11         TCGGGGAAGGAATGAAATGAAGACCTTG 
LJFnm12         ---------------------------- 
LJFnm19         CGGGGAAGGAATGGAATGAAGACCTTG- 
 






3.5.2. Motif Conservation. When submitted along with confirmed LJFgene 
family members to a conserved motif identification program, the LJFnm sequences all 
correspond to a single motif identified in four out of five of the LJFgenes. The motif 







Figure 3.29. LJFnm motif search results. (A) Block diagram illustrating 100 bit width 
search for conserved motifs of LJFgene family as well as associated non-coding 




3.5.3. Alignment and Dot Plot of LJFnm’s Against LJFgene(s). Figure 3.30 
contains the output from the alignment of LJFgene3, LJFgene14, and LJFgene1 (last 
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two exons, last intron, and sequence extending past STOP codon) against LJFnm19, 
LJFnm11, and LJFnm12.  
 
LJFnm19              ---------------------------TTCAGTTCTGGTTTCCACCGGGTAAGGGTTCTA 
LJFgene3             TCATGTGCTAACAGTTTGTAGATGATGTTGAGTTCTGGTTCCCACCGGGTAAGGGTTCTA 
LJFnm12              ---------------------------TTTAGTTCTGGTTTCCACCGGGTAAGGGTTCTA 
LJFgene14            TCATGTGCTAACAGTTTGTGGATGATGTTGAGTTCTGGTTTCCACCCGGTAAGGGTTCTA 
LJFnm11              ---------------------------TTCAGTTCTGGTTTCCACCGGGTAAGGGTTCTA 
LJFgene1             TCATGTGCTAACAGTTTGTGGATGATGTTGAGTTCTGGTTTCCTCCGGGTAAGGGTTCTA 
                                                ** ********** ** ** ************* 
 
LJFnm19              CTGTGGAGTATCGATCTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAATAGAAAAA 
LJFgene3             CTGTGGAGTACCGATCTGCATCTCGGTTAGGAAACTTTGATTTTGATGTGAACAGAAAAA 
LJFnm12              CTGTGAAGTATCGATCTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAA 
LJFgene14            CTGTGGAGTATCGATCTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAA 
LJFnm11              CTGTGGAGTATCGATTTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAA 
LJFgene1             CTGTGGAGTATCGTTCTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAA 
                     ***** **** ** * ************ *********************** ******* 
 
LJFnm19              GAATAAAGGTATGATTTCATAATTAGTATGTGCTTTCTCTATAGTTAGAATAAA------ 
LJFgene3             GAATAAAGGTGTGATTTCATAATT--CATGTGTTTTCTCTATAGTTAGATAAAGAAATTC 
LJFnm12              GAATAAAGGTATGATTTCATAATTAATATGTGCTTTCTCTATAGTTAGATAAAGAAATTC 
LJFgene14            GAATAAAGGTATGATTTCATAATTAATATGTGCTTTCTCTATAGTTAGATAAAGAAATTC 
LJFnm11              GAATAAAGGTATAATTTCATAATTAATATGTGCTTTCTTTATAGTTAGATAAAGAAATTC 
LJFgene1             GAATAAAGGTATGATTCCATAATTCATATGTGCTTTCTCTATAGTTAGATAAAGAAATTC 
                     ********** * *** *******   ***** ***** **********  **        
 
LJFnm19              ----------GGTA----CTCCCCTTCCTTCATGTCATGTCAAACATTTTATACTTAAGT 
LJFgene3             TTGGTTCCATGGTAAAACTCCTCTTTCCTTCATGTCATGTCAAACATTTTATACTCAAGT 
LJFnm12              TTGGTTCTAGGGTTATA-CTCCCCTTCCCTCATGTGATGTCAAACATTTTATACTTAAGT 
LJFgene14            TTGGTTCCAGGGTAAAA-CTCCCCTTCCTTCATGTCATGTCAAACATTTTATACTTAAGT 
LJFnm11              TTGGTTCCAGGGTTATA-CTCCCCTTCCTTCATGTCATGTCAAACATTTTATACTTAAGT 
LJFgene1             TTGGTTCCAGGGTAAAACTCCCCTTTCCTTCATGTCATGTGAAGCATTTTTTACTCAAGT 
                               ***       * * **** ****** **** ** ****** **** **** 
 
LJFnm19              AAAT---TCACTAAATTTTAGTCTCAAATGTTTTAACTTTATTCTAAAT----TAG---- 
LJFgene3             AGATGATTCACTAAATTTGAGTCTCAAATGTTTTAACTTTATTCTAAAT----TAG---- 
LJFnm12              AGAT---TCACTAAATTTGAGTCTCAAATGTTTTAACATTATTCTAAAT----TAG---- 
LJFgene14            AGAT---TCACTAAATTTGAGTCTCAAATGTTTTAACTTTATTCTAAAT----TAG---- 
LJFnm11              AGAT---TCACTAAATTTGAGTCTGAAATGTTTTAACTTTATTCTAAAT----TAG---- 
LJFgene1             AGAT---CCACTAAATTTGAGTCTCAAATGTTTTAACTTTATTCTAAATGTTTTAACTTT 
                     * **    ********** ***** ************ ***********    **      
 
LJFnm19              ---------TCACTTATTTTAACTGAAGGTAAATTTGGTTGACTATGATCAGAAATACAT 
LJFgene3             ---------TCACTTATTTTAACTGAAGGTAAATTTGGTTAACTATGATCAGAAATACAT 
LJFnm12              ---------TCACTTATTTTAACTGAAGGTAAATTTGGTTGACTATGATCAGAAATACAT 
LJFgene14            ---------TCACTTATTTTAACGGAAGGTAAATTTGGTTGACTATGATGAGAAATACGT 
LJFnm11              ---------TCACTTATTTTAACTGAAGGTAAATTTGGTTGACTATGATCAGAAATACAC 
LJFgene1             ATTTGAGTCTCAAATGTTTTAACTGAAGGTAAATTTGGTTAACTATGATCAGAAATACAT 
                              ***  * ******* **************** ******** ********   
 
Figure 3.30. Partial multiple alignment output of sequences from chromosomes 19, 11, 
and 12 containing LJFnm members against LJFgene3, LJFgene14, and LJFgene1 
beginning in intron 5 of LJFgene family members and extending to 3’ most 
nucleotides of non-coding chromosomal sequences that display strong identity with 
sequences of the LJFgene family members.  Bold type represents coding sequence of 
LJFgene3; grey highlights indicate identity of LJFnm genomic sequence with 








LJFnm19              TGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATAAAGAGAGTATTT 
LJFgene3             TGACATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATAAAGAGAGTATTT 
LJFnm12              TGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTGATGTACAATAAAGAGAGTACTT 
LJFgene14            TGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATAAAGAGAGTATTT 
LJFnm11              TGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATAAAGAGAGTATTT 
LJFgene1             TAACA-------------AGAGTTGAAGAATATTTTTTATGTACAATAAAGAGAGTATTT 
                     * * *             **** * ************ ******************* ** 
 
 LJFnm19              ACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTGTGATGAAAAATCTTGGTTGCTGA 
LJFgene3             ACTCCAGAGGATGTAAATCCCTTGCTAAATATTTTTGTGATGAAAAATCTTGGTTGTTGA 
LJFnm12              ACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTGTGATGAAAAATCTTGGTTGCTGA 
LJFgene14            ACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTGTGATGAAAAATCTTGGTTGCTGA 
LJFnm11              ACTCCAGAGGATGCAAATCCTTTACTAAATATTTTTGTGATTAAAAATCTTGGTTGCTGA 
LJFgene1             GCTCGAGAGAATGTAAATCCTTTTCTAAATATTTTTGTGATGAAAAATAATGGTTGCTGG 
                      *** **** *** ****** ** ***************** ******  ****** **  
 
LJFnm19              CAGGCATTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGATACCATATGATTA 
LJFgene3             CAGGCACTGCGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGACACCATATGATGA 
LJFnm12              AAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGATACCATATGATTA 
LJFgene14            CAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGATACCATATGATTA 
LJFnm11              CAGGCACTGAGACAAGAGTTAGAGAAGAAAGGATGGACATCTCAAGATACCATATGATTA 
LJFgene1             CAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGACACCATATGATGA 
                      ***** ** ********** *************** ********** ********** * 
 
LJFnm19              ATAAACTCAGGCAGAATTAACATCAACATCTAAGCAAATATTATTTCATATACTTTGTGA 
LJFgene3             ATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCATATACTTTGTGA 
LJFnm12              ATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCATATACTTTGTGA 
LJFgene14            ATAAACTCAGGCTGAATTAGCATCAGCATCTAAGCAAATATTATTTCATATACTTTG-GA 
LJFnm11              ATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCATATACTTTGTGA 
LJFgene1             AAAAACTTAGGCAGAATTCACATCAGCATCTAAGAAAATATTGTTTCATATACATTGTAA 
                     * ***** **** *****  ***** ******** ******* ********** ***  * 
 
LJFnm19              CCTTGTATACTTTTGTATTAGATACAAA-TCACACAGGATCATTTCAAGCAAACTTTTCT 
LJFgene3             CCTTGTATACATTTGTATTAGATACAAA-TCTCACAGGATCATTGAAAGCAAACTTTTCT 
LJFnm12              CCTTGTATACTTTTGTATTAGATACAAA-T-------------TGCAAGCAAACTTTTCT 
LJFgene14            CCTTGTATACTTTTGTATTAGATACAAA-TCGCACAGGATCATTGCAAGCAAACTTTTCT 
LJFnm11              CCTTGTATACTTTTGTATTAGATACAAA-TCGCACAGGATCATTGCAAGCAAACTTTTCT 
LJFgene1             CCTTGTATACTTTTGTATTAGATACAAAATCTCACAAGATCATTGAAAGCAAACTCTTCA 
                     ********** ***************** *             *  ********* ***  
 
LJFnm19              TAGATTTTAGGAATTGTAGAGAAATCATTGAGA-CAATACTTTAAACTCTC--GGGGAAG 
LJFgene3             TTGATTATTGGAATTGTAGAGAAATCATTGAGAACAGTACTTCAAACTCTC--GGGGAAG 
LJFnm12              TAGATTTTTG-------------------------------------------------- 
LJFgene14            TAGATTTTTGGAATTGTAGAGAAATCATTGAGAACAGTACTTCAAACTCTCTCGGGGAAG 
LJFnm11              TAGATTTTTGGAATTGTAGAGAAATCATTGAGAACAATACTTCAAACTCTC--GGGGAAG 
LJFgene1             T-GATTATTGGAATTGTAGA--AATGATTGAGAACAGTACTTCAAACTCTCG-GGGGAAG 
                     * **** * *                                                   
 
LJFnm19              GAATGGAATGAAGACCTTG----------------------------------------- 
LJFgene3             GAATGAAATGAAGACCTTGCCCCATATCCTTCTTCAAGTTCATTAATTGGTCCGCTTATT 
LJFnm12              ------------------------------------------------------------ 
LJFgene14            GAATGAAATGAAGACCTTGCGCCATATC-TTCTTCAAGTTCATTAATTGGTCCACTTATT 
LJFnm11              GAATGAAATGAAGACCTTG----------------------------------------- 
LJFgene1             GAATGAAATGAAGATGTTACC--------------------------------------- 
 
Figure 3.30. Partial multiple alignment output of sequences from chromosomes 19, 11, 
and 12 containing LJFnm members against LJFgene3, LJFgene14, and LJFgene1 
beginning in intron 5 of LJFgene family members and extending to 3’ most 
nucleotides of non-coding chromosomal sequences that display strong identity with 
sequences of the LJFgene family members. (CONT.) 
	  
	   	  
	  
	   Figure 3.31 displays a dot plot matrix generated using the genomic sequence of 
LJFgene3 and a 4000 nucleotide segment of chromosome 19 that contains LJFnm19 as 
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input. The position of LJFnm19 relative to the LJFgene3 model is confirmed to be 





Figure 3.31. Dot plot matrix of LJFgene3 genomic sequence (x-axis) vs. 4000nt 
segment of chromosome 19 containing LJFnm19 (y-axis).  
  
 
 3.5.4. MicroRNA Prediction. Of the sequences submitted to the prediction 
tool, LJFnm12 and LJFnm19 were predicted to contain miRNA precursors. Figure 
3.32 illustrates the position and specific sequence predicted to be a miRNA precursor 
within the conceptually transcribed mRNA sequence of LJFnm19 and LJFnm12. 
LJFnm11 was not predicted to contain a miRNA precursor. Additionally, the two 
predicted miRNA precursors do not correspond to the same section of sequence on 
respective LJFnm sequences.  
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Figure 3.32. Results of microRNA prediction by web-based tool using fixed-order 
hidden markov model. (A) LJFnm19 transcribed genomic sequence. (B) LJFnm12 





 3.5.5. Promoter Element Identification. Sequences upstream of the 5’ end 
of the LJFnm sequences were submitted to PLACE for identification of promotor 
elements associated with transcription of a gene. Figures 3.33, 3.34, and 3.35 display 
the findings of this promoter element search for sequences LJFnm19, LJFnm12 and 






























Figure 3.33. Cis-acting elements (highlighted blue) located within a 1Kbp segment of 

























Figure 3.34. Cis-acting elements (highlighted blue) located within a 1Kbp segment of 


























Figure 3.35. Cis-acting elements (highlighted blue) located within a 1Kbp segment of 


































4.1. CHOICE OF GENE FAMILY AND IDENTIFICATION OF MEMBERS 
 
The selection of a single family of interest for the focus of this study was 
conducted by manually searching through multiple databases to identify a family that 
could meet predetermined criteria. The criteria by which the family was chosen are:  
• 10 or fewer gene members  
• shows expansion in Glycine max relative to other plant species 
• unknown functional annotation  
• each potential family member must point to all other potential family 
members during a BLAST search of the genome.  
The purpose of restricting the number of genes and considering only families 
composed of immediate members was to increase the likelihood of correctly 
identifying and incorporating the complete family. Choosing a family that has an 
expanded number of genes in soybean relative to other plant species but no known 
functional data was a matter of personal interest. The hope was that if the family is 
expanded in soybean, it is an indication of increased or novel function and that through 
in depth analysis of the coding sequence a likely gene product form and function could 
be predicted. A record of the partial results of the search by criteria can be located in 






4.2. GENE STRUCTURE PREDICTION AND EST EXPRESSION ANALYSIS 
Once focus was narrowed to a single gene family of interest, a chromosome 
map (Figure 3.2) was generated for each gene within the family. To determine DNA 
composition at the location of gene family members on their respective chromosomes, 
the chromosome maps were then compared to a genomic landscape analysis of the 20 
soybean chromosomes reported in Schmutz et al. [9] The analysis reported the percent 
composition of major DNA elements including transposons, retrotransposons, 
centromeric DNA, and coding DNA at each position of the Glycine max 
chromosomes. Composition was calculated using 0.5 Mb (500 Kbp) windows with a 
0.1 Mb (100 Kbp) shift. The composition of the 100 Kbp regions of the chromosome 
that gene family members lie within are fairly similar. All gene family members lie 
near the ends of the chromosomes where coding sequence composition is roughly 
between 20 and 40 percent, transpsosons and retrotransposons make up a small 
fraction of the sequence, and the majority of the sequence is unclassified DNA.  
FgenesH, GenomeScan, and Augustus were employed to predict gene models 
for family members [9, 48]. These predicted models were then uploaded into the DNA 
Subway annotation tool for refinement. The final model determination took into 
account predicted models, known consensus data concerning intron/exon border 
sequences, open reading frame calculations, and EST data. The best evidence for the 
existence of genes is empirical, and that can be found in the form of expressed 
sequence tags.  
Most of the ESTs available for this gene family (Appendix F) agree with the 
arrangement of introns and exons predicted by the algorithm-generated models.  It was 
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necessary, however, to align the EST nucleic acid sequence from NCBI to the genomic 
regions using the annotation editor. Since ESTs are partial cDNA’s, they reflect a 
sequence from which introns have been spliced out. Alignments made by the 
annotation editor do not break across introns at correct splice junctions. Consensus 
data was used to verify intron/exon borders. 
The gene family member on chromosome 3 has the highest quantity of ESTs of 
all family members at seven ESTs. Genes on chromosomes 14 and 9 have three ESTs 
each and genes on chromosomes 1 and 8 have no representative ESTs (Figure 3.2). 
Due to the majority of the ESTs (evidence of expression) and completeness of the 
model, LJFgene3 is considered most likely to produce a functional gene product and 
therefore the model by which all other gene family members are compared to for 
evolutionary analysis.  
Genes on chromosomes 3 and 14 share >85% sequence identity at the 
nucleotide level. The EST data available for the gene family member on chromosome 
14 disagreed with the algorithm-predicted models on the intron/exon arrangement at 
the 5’ end. All three gene-predicting computer programs with independent algorithms 
produced models for LJFgene14 that have features most closely resembling LJFgene3. 
While algorithms predict a model with 7 exons and 6 introns, EST evidence indicates a 
model with 6 exons and 5 introns. Other evidence, such as PASA-assembled EST data, 
RNA-seq data, and transcription-level expression data, supports the LJFgene14 model 
shown in Figure 4.1.  
The only difference between the two models is the inclusion of the segment of 
DNA that corresponds to intron 2 in the algorithm-predicted model into exon 2 of the 
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EST-derived model. In other words, the sequence spanning exon 2, intron 2, and exon 





Figure 4.1. Algorithm-predicted model of gene family member on chromosome 14 vs. 





4.3. EVOLUTIONARY ANALYSIS 
In either model it can be seen that the position of the start site is affected. In the 
algorithm-generated model, a start methionine cannot be defined at the 5’ end using 
the reading frame that corresponds to the most likely coding arrangement. In the EST-
generated model, the start site is located in the middle of exon 2. Using LJFgene3 as 
the basis for comparison, a pairwise alignment of nucleic acid sequence (Figure 4.2) in 











LJFgene3        -------------------TTTCGGTCTGTGAAGATATAT--GTCCATAAGTTCCTTAAT 
LJFgene14       TTTGTTAAATTATAAATAATTTCGTTCTGTGAAGGTACACACGTTCATAAGTTCCTTAAT 
                          ***** ********* ** *   ** *************** 
 
LJFgene3        TTTCTCGAACCTTCATTTTCAGCTCCCAACAACAATGGCTTCAATGGCATCTTCAAGCTC 
LJFgene14       TTTCTCGAACCTTCATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTC 
       ******************************** *************************** 
 
LJFgene3        CTTCTGCAACCTCAAGTTCATCACCAAACCCAACAATGGTAGAAGAAGCTCTCTTCCCCG 
LJFgene14       CTTCTGCAACCTCAAGTTTATCACCAAACCCAACAATGGTAGAAGAAGCTCTCTTCGCCG 
       ****************** ************************************* *** 
 
LJFgene3        TATTGTATTCTGTCAGAAGCACCACGATAGCACACCCACCGACCAAATCAACCGAAGGTT 
LJFgene14       TATTGTATTTTGTCAGAAGCATCACGATGACACACCCACCGACCAAATCAACCGAAGGTT 
       ********* *********** ******  ****************************** 
 
LJFgene3        CTTATTTCTTCACACTCGCACTTTCTAATTCCTTTCTATGGATTATTCATATCTATTCAT 
LJFgene14       CTTACTTCTTCACACTCACACTTTCTATTTCCTTTCTATTGATTATTCG----------T 
       **** ************ ********* *********** ********           * 
 
LJFgene3        ACCCATCTTCTGAAATCTCTTTATATTTCAATTATTTTGTCTATTGAAGAGAACTCATAT 
LJFgene14       AACCATCTTCTGAAATCTCGTTACATTTCAATTCTTTTGTGTATTGAAGAGAACTCATAT 
       * ***************** *** ********* ****** ******************* 
 
LJFgene3        TGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTGAACTTCGGGTACCCCTCCTCTG 
LJFgene14       TGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGGTACCCCTCCTCTG 
       ************************************* ********************** 
 
LJFgene3        CTTGT------------TTTTGGAAAATTTTTGTTTTTCATTTTATTTTGAATGTAAATT 
LJFgene14       TTTTTGCTCTGTTTTTTTTTCTGGAAATTTTAGTTTTTCATTTTATTTTGAATGTAAATT 
        ** *            ***  * ******* **************************** 
 
LJFgene3        GAATTCAAGATTTGATTTTGTTGGTGGGTTTGAAGACCCTTTTGGTTTTTAATTTCGGTT 
LJFgene14       AAATTCGAGATTTGATTTTGTTAGTGGGTGTTGAGACCCTTTTGGATTTTAGTTTGGGTT 
        ***** *************** ****** *  ************ ***** *** **** 
 
LJFgene3        TTGTTTTGTATTGGACATGGGTGGTGGTTAAAAAAGAGAAAATTGAGTTTGTGTCTTGTG 
LJFgene14       GTGTTTTGTATTGGAAATGGGTGGT-----------------------TTGGGTTTTGTG 
        ************** *********                       *** ** ***** 
 
LJFgene3        TTTTGATGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCA 
LJFgene14       TTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCA 
       ***** ****************************************************** 
 
LJFgene3        TTAGCTCTGTGCCCGGCAACGAAGAATTGCGTGTCAACCTCTGAGAATATCAGTGATCGC 
LJFgene14       TTAGCTCTGTGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGAGAATATCAGCGATCGC 
       *********** *** **** ***** ************************** ****** 
 
LJFgene3        ACACATTATGCTCCTCCATGGTAAAAGTTTCCTTCTTTTTCTTATTTTAATTTTCACCTT 
LJFgene14       ACACATTATGCTCCTCCATGGTAAAAGTTCCCTTCTTTTTCTTATTTTAATTTTCACCTT 
       ***************************** ****************************** 
 
Figure 4.2. Pairwise alignment of 5’ end of LJFgene3 and LJFgene14 nucleic acid 
sequences.  (Nucleic acids corresponding to LJFgene3 model are highlighted in green. 
Nucleic acids corresponding to LJFgene14 model are highlighted in blue. Start ATG 
sequences for each model are in bold face type. Possible key alternative splicing sites 
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 The nucleotide sequence of LJFgene14 that is directly aligned with the 
LJFgene3 start ATG differs by 3 nucleotides. A transition point mutation has occurred 
in LJFgene14 at the T position of LJFgene3 and a two base pair insertion-deletion 
(indel) has disrupted the second and third position of the ATG sequence. It cannot be 
known which mutation occurred first or in which direction, only that they exist in this 
way in their current forms. This explains why neither gene model for the gene family 
member on chromosome 14 has a start site matching LJFgene3.  
 Evidence for intron 2 retention and the location of the start site in exon 2, as 
seen in the EST-derived model, can also be found by examination of the pairwise 
alignment of LJFgene3 and LJFgene14 found in Figure 4.2. For intron 2 to be spliced 
out of the transcript, evidence should exist in the form of sequences corresponding to 
known polypyrimidine (poly-p) tracts, branch point consensus sequences, and/or 
UA/U-rich regions. The function of these elements depends on presence and location. 
If a branch point is present, the UA-rich regions may act as a poly-p tract. In the 
absence of a branch point, the UA-rich regions may act as intronic splice elements 
[28]. In either case, the UA-rich regions must have a minimum U content and be 
separated by a minimum distance to maintain proper splice efficiency. Some plant 
genes such as the potato invertase (invGF) gene contain poly-p tracts in their introns 
that consist of long strings of consecutive U’s (11 in the case of the invGF gene), other 
dicot genes cannot be supported by a single group of consecutive U’s; rather, they 
require multiple, smaller groups of U’s. A mutational study of the invGF gene introns 
provides evidence that two groups of four U’s each that are spaced 3 C’s apart is the 
optimal arrangement [31].  
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 Since the poly-p tract of the transcript is usually a segment of tandemly 
repeating U’s, the DNA sequence that corresponds to it should contain tandem repeats 
of A’s. Since a UA/U-rich region would also resemble this, it becomes difficult to 
distinguish one from the other. Regardless, one should exist within the range of 17 to 
40 nucleotides upstream of the 3’ splice junction (SJ) [25]. This region of repeating 
A’s exists in intron 2 of LJFgene3 from -45 to -33 nucleotides 
(AAAAAAGAGAAAA) upstream of the 3’ SJ.  This sequence meets the requirements 
of U-rich elements acting as a poly-p tract—two groups of four or more U’s separated 
by three pyrimidines (CUC in this case). The section of sequence of LJFgene14 that 
directly aligns with LJFgene3 at this position is represented by gaps, indicating that an 
indel has occurred in this position. The mutation is most likely a deletion based on the 
phylogenetic relationship. In an alignment of LJFgene3 and LJFgene1, this segment of 
sequence is identical. A single deletion occurrence in an ancestor is more 
parsimonious than a deletion followed by reinsertion of sequence.  Logic dictates that 
without a site for the binding of splicesome formation-mediating proteins, the 
splicesome would be unable to form and the intron would not be able to be spliced out. 
This presents a reasonable explanation for the retention of what might have been 
intron 2. As it turns out, the intron retention provides the first possible ATG in the 
open reading frame. In addition, it has been demonstrated that dicot plants require a 
minimum intronic AU content of 59% in order to maintain efficient splicing [29]. The 
region of sequence in LJFgene14 that corresponds to intron 2 of gene LJFgene3 has 
58.65% AU content (intron 2 of LJFgene3 has 65.5% AU content). Although this 
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number is borderline, it could have an impact on splice efficiency and be a possible 
alternate explanation for the intron retention.  
 Branch point sequences exactly matching the experimentally verified branch 
point consensus sequences were not found in the introns of gene family members 
LJFgene3, LJFgene14, or LJFgene1. This does not mean that the branch points do not 
exist, merely that they cannot be identified using this evidence. Even so, in the absence 
of a branch point, the splice machinery still requires a UA/U-rich region for 
recruitment and assembly.  
 The establishment of the correct gene model for the gene family member on 
chromosome 14 is important to understanding the evolutionary history of this family 
and how it affects the assembly of a phylogenetic tree. Two trees were generated for 
this family, one using the original gene models (which were based on conceptually 
translated peptides representing the algorithm generated models and therefore 
characteristic of the nucleotide sequences) and the final gene models (which were 
based on the conceptually translated peptide sequences that correspond to evidence of 
expression). Both trees place LJFgene9 and LJFgene8 as diverging separately from the 
clade including LJFgene1, LJFgene14, and LJFgene3. The trees disagree on the 







Figure 4.3. Comparison of the synonymous substitution rate and resulting phylogentic 
differences between original gene models and final gene models.  
 
 
 The phylogenies differ because the synonymous substitution rate is calculated 
by a program that uses the codon alignment that is based on conceptually translated 
peptide sequences aligned with nucleotide sequences. In the amino acid sequence of 
LJFgene14, it reflects the placement of the start site due to intron retention in the final 
gene model. The final models, therefore, are a better representation of the gene 
product and the original model remains the best representation of the evolutionary 
relationship at the DNA level.    
 In the final phylogenetic model, the divergence pattern of LJFgene3, 
LJFgene14, and LJFgene1 is rearranged. The synonymous substitution rate between 
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LJFgene3 and LJFgene14, a smaller number (indicating a briefer time lapse since 
divergence) in the original calculations, becomes a larger number than the 
synonymous substitution rate for LJFgene1 for the final models. Though not listed in 
Figure 4.3 above, a comparison of gene family members on chromosomes 14 and 1 
yields a synonymous substitution rate of 0.1417 (Table 3.5). LJFgene1 has nearly the 
same synonymous substitution rate when compared to LJFgene14 (0.1417) as it does 
when compared to LJFgene3 (0.1303); however, the rate is still lower between 
LJFgene1 and LJFgene3 indicating fewer mutations have accumulated and therefore 
inferring a shorter amount of time since divergence. 
 Depending on the evidence used, two possible evolutionary trajectories can be 
considered when dissecting the relationship between LJFgene3, LJFgene14, and 
LJFgene1. According to the synonymous substitution rate as calculated for the original 
gene models (it has already been established that these calculations represent the 
evolution of the genes at the nucleotide level), LJFgene14 is more closely related to 
LJFgene3 than LJFgene1. According to this reasoning, the phylogeny should appear as 








LJFgene3        GAAGATATAT--GTCCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAAC 
LJFgene14       GAAGGTACACACGTTCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAAC 
LJFgene1        GAAGATAC----GTTCATAAGTTCCTTAATTTTCTTGAACCTTTATTTTCAGCTCCCAAC 
 
Figure 4.4. Phylogenetic relationship and mutations occurring in functional start site 
between LJFgene3, LJFgene14, and LJFgene1: Scenario 1.  
 
 
 If LJFgene14 diverged before LJFgene1 from the common ancestor of 
LJFgene3, LJFgene14, and LJFgene1, the disruption of the functional start site as seen 
in Figure 4.4 would have begun with a 2 base pair (AC) insertion between the T and G 
in the common ancestor to LJFgene14 and LJFgene1. A 4 base pair deletion of the 
ATAC preceding the G would have occurred in the lineage leading to LJFgene1.  
 The absence of expression data forces the algorithm-predicted model of 
LJFgene1 to be compared to two models for which expression evidence exists. If the 
model for LJFgene1 is not an accurate reflection of the physical gene product (if one is 
produced at all), the synonymous substitution rate could be inaccurate and a phylogeny 
with synonymous substitution rates resembling those of the final gene models might 
be the true lineage.  
 If LJFgene1 diverged before LJFgene14 from the common ancestor of 
LJFgene3, LJFgene14, and LJFgene1, the disruption of the functional start site as seen 
in Figure 4.5 would have begun with a 2 base pair deletion of the AT in LJFgene1. A 2 
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base pair (AC) insertion would have occurred between the T and G in the lineage of 





LJFgene3        GAAGATATAT--GTCCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAAC 
LJFgene14       GAAGGTACACACGTTCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAAC 
LJFgene1        GAAGATAC----GTTCATAAGTTCCTTAATTTTCTTGAACCTTTATTTTCAGCTCCCAAC 
 
Figure 4.5. Phylogenetic relationship and mutations occurring in functional start site 
between LJFgene3, LJFgene14, and LJFgene1: Scenario 2.  
 
 
 Based on the understanding of the clock-like patterns that synonymous 
substitutions produce and the time frames in which researchers believe whole genome 
duplications occurred in the history of Glycine max, the divergence patterns that have 
led to the modern composition of genes in this family can be tentatively associated 
with major genome-impacting events in the Glycine max history. The synonymous 
substitution rates (Table 3.5) for LJFgene3, LJFgene14, and LJFgene1 all fall into a 
commonly accepted range corresponding to the 13 Mya soybean whole genome 
duplication (WGD) [9]. It is possible that these closely related genes could have 
resulted from the WGD being followed by a segmental duplication that produced 3 
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lineages. The synonymous substitution rates for LJFgene8 also fall within the accepted 
range for the 13 Mya WGD; however, the rate is different enough to consider the 
possibility that this gene might have resulted from a segmental duplication prior to the 
WGD. The synonymous substitution rate for LJFgene9 falls within the acceptable 
range of scores corresponding to a 59 Mya WGD that gave rise to the legume clade. 
Although these values can be matched to major duplication events, one must be 
careful not to over interpret the meaning of the values. The synonymous substitution 
rates, as outlined by Schmutz et al. [9], are generated using the entire soybean genome 
in comparison to itself. The synonymous substitution rates generated for the LJFgene 
family are a result of comparing the genes within the family to each other, not to the 
entire genome. The Ks/ps values generated by this research can only be interpreted as 
evidence for the chronological difference between the gene sequences in this family as 
measured by the rate of synonymous substitution accumulation. Far more 
synonymnous mutations have accumulated between the sequences of LJFgene3 and 
LJFgene9 than any other family member comparison indicating that they diverged in 
more distant past. Conversely, the sequences of LJFgene3 and LJFgene1 have the 
lowest rate of synonymous mutations accumulation and are therefore interpreted as 
having diverged from each other most recently.  
 Given that the synonymous substitution rate calculations include a certain 
amount of error, and that the values are so close between LJFgene3, LJFgene14, and 
LJFgene1, this evidence could not be used to conclusively define the divergence 
pattern of these three genes. An analysis of homology between the Glycine max 
chromosomes conducted by Schmutz et al. [9] based on the presence of specific 
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centromeric repeat regions indicates that chromosomes 1 and 3 are homologous and 
more likely to have originated from the 13 Mya soybean WGD. Combined with the 
neighbor gene analysis (intended to analyze syntenic regions on the chromosomes 
flanking gene family members) results that showed a possible syntenic pattern 
between chromosomes 1 and 3, this suggests that LJFgene1 might have originated 
from the soybean-specific WGD. No evidence exists in the data collected to discern 
whether LJFgene14 originated from this event. The Schmutz et al. [9]  homology 
analysis previously mentioned indicates that chromosome 14 shares more homology 
with chromosomes 8 and 9 based on the presence of centromeric repeats.  
 With the exception of the 5’ boundary of the first exon, LJFgene1 exon 
boundaries match LJFgene3 exon boundaries exactly. The sequences within these 
exons are very nearly the same, meaning the gene product of LJFgene1 is nearly the 
same as the gene product of LJFgene3, aside from LJFgene1 theoretically producing a 
truncated protein. This is supported by the multiple alignment of conceptually 
translated peptides located in the Results Section as Figure 3.7. The synonymous 
substitution rate for the comparison of LJFgene3 and LJFgene1 is low because of this 
high degree of sequence similarity within the coding regions of these genes, yet the 
genomic sequence tells a different story. Two sizeable regions of sequence exist in 
LJFgene1 that do not exist in LJFgene3. These indels occur in the middle of introns 3 
and 4. They do not exist in LJFgene14 either, which strongly indicates these extra 
sequences have been inserted into LJFgene1. The insertion in intron 3 is only 184 
nucleotides long and falls nearer to the 5’ splice junction. The insertion in intron 4 is 
more sizeable, nearly a thousand extra nucleotides, and falls closer to the 3’ splice 
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junction. Figure 4.6 illustrates the shift in exon proximity due to increased intron 
length. It appears to insert enough nucleotides upstream from this boundary not to 
disrupt the presence of vital splice elements, however, an insertion this large could 
potentially make the gap between exons large enough to have an effect on splice 
efficiency. Without the necessary expression evidence, it cannot be determined 
whether this anomaly would produce a transcript with extra sequence or not. Perhaps it 




Figure 4.6. Gene models of LJFgene3, LJFgene14, and LJFgene1 displaying close 




 Given that the largest degree of expression was linked to LJFgene3, The 
assumption has been made that this gene is the most likely candidate to produce a 
functional gene product. Differences in sequence, structure, and expression lead to the 
conclusion that the remaining four gene family members are pseudogenes, two of 
which (LJFgene14 and LJFgene9) are still producing mRNA but not a functional 
protein. It is interesting that LJFgene9, which has the lowest percentage of sequence 
similarity to LJFgene3, still produces enough mRNA to account for 3 ESTs; yet 
LJFgene8, which resembles LJFgene3 to a much higher degree, has no ESTs in the 
library. Due to high level of sequence variation between the 5’ and 3’ ends of the gene 
model for LJFgene9 and all other gene family members, the assignment of the gene to 
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this family was brought into question. The nucleic acid sequences of the segments of 
LJFgene9 that are non-congruent with the rest of the family were submitted as a 
BLAST search against the Glycine max genome in an attempt to determine whether 
the gene model resulted from a rearrangement or belongs to another gene family. No 
matches were recorded to any gene models outside of this family.  
 In order to better understand the full coding capacity of these genes and their 
flanking sequences, a multiple sequence alignment was performed that extended the 
query sequence beyond each model’s boundaries far enough to compare a stretch of 
DNA sequence for each model that is at least as long as LJFgene3 (Figure 3.7). The 
conceptually translated amino acid sequences of the extended genes were aligned and 
compared. A summary of sequence extension requirements is located in Figure 4.7.  
 
 Length (a.a.) aa’s added to 5’ aa’s added to 3’ 
LJFgene3 236 ł ----- ----- 
LJFgene14 163 78 0 
LJFgene1 225 14 0 
LJFgene8 213 21 6 
LJFgene9 130 80 31 
ł Length does not account for gaps within the alignment 
 




 When creating a codon alignment using the extended sequences, the 
corresponding nucleic acid sequences must match exactly. Because the amino acid 
sequences in the peptide alignment input field must correspond exactly to the nucleic 
acid sequences in the coding sequence input field, nucleotides were also added to the 
5’ and 3’ ends of coding sequences (not the genomic sequences). The existence of 
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translational stop codons in the extended regions of the sequences interfered with the 
ability of the program to create the alignment. All intermittent stops in the extension 
regions of the peptide sequences were replaced with an R (letter representing an 
arginine residue) to extend the reading frame for acceptance by the PAL2NAL 
program. Arginine was chosen arbitrarily. The program indicated the position of the 
residue and codon sequence that did not correspond, thereby creating a record of the 
discrepancy (Figure 3.8).  
 A multiple alignment was also carried out using the nucleic acid sequences of 
gene family members as input, once with the coding sequence and again with the 
coding sequence plus enough nucleotides extending from the 5’ and 3’ end of each 
gene to make all sequences as long as the longest coding sequence (Figure 3.6). Both 
types of multiple alignment, those conducted using the peptide sequences and those 
conducted using nucleic acid sequences, were done to determine whether coding 
capacity once existed in those genes that appear to be non-functional or produce a 
truncated polypeptide. These alignments are located in Results Section 3.3.5. The 
alignments provide evidence that the sequence similarity between gene family 
members is isolated within the models on the 5’ ends. The extension sequence of 
LJFgene14 used for these alignments is the natural extension of nucleotides of the 
coding reading frame. This input provides evidence that coding capacity does not exist 
beyond the gene border relative to LJFgene3. On the contrary, if the exact same 
alignment is created using a slightly altered sequence for LJFgene14, the coding 
capacity of the sequence upstream of the 5’ start site of LJFgene14 remains intact. The 
sequence referred to uses two different reading frames. Within the model, the 
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sequence matching the open reading frame is used as input. The sequence used for the 
5’ extension corresponds to a second reading frame that matches the original gene 
model. By combining these two segments into a single sequence, evidence exists that 
if some alteration of the sequence (the indel in the start codon and the cause of intron 
retention) had not occurred that lead to a reading frame shift, LJFgene14 and 
LJFgene3 would have nearly identical coding capacity.  
 Evidence for sequence similarity located downstream of the 3’ boundaries 
LJFgene3, LJFgene14, and LJFgene1 were analyzed using dot plot matrices. A 
comparison of the sequence beyond the 3’ borders of genes LJFgene3 and LJFgene1 
reveals that similarity extends nearly 4 Kbp (Figure 3.13). The sequence similarity 
even goes so far that it extends into the most proximal 3’ neighbor gene on 
chromosome 3 (Figure 3.16). In the process of defining the boundaries of the coding 
capacity between models, a region of duplication was identified that contains two gene 
models on chromosome 3 and one model on chromosome 1. A blast search of the 
segment of correspondence from chromosome 3 against the genome does produce a 
match at the segment of chromosome 1 that contains the sequence downstream of 
LJFgene1. The algorithm predicts a gene putatively identified as a phosphotransferase 
on chromosome 3 within this sequence but does not predict a gene on chromosome 1. 
One plausible explanation is that there was a segmental rearrangement that moved this 
segment of LJFgene1 plus sequence extending into the neighbor gene into 
chromosome 1. 
 The family phylogeny was generated as an unrooted tree (Figure 3.5B) in order 
to reduce the likelihood of over interpretation of the relatedness of gene family 
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members. Though the broad plant family tree (Figure 3.5A) gives this family a root 
that indicates that LJFgene9 diverged first from the common ancestor of the entire 
family, followed by LJFgene8, then LJFgene14, LJFgene1, and LJFgene3 (in that 
order), this should not be interpreted as LJFgene9 being the “oldest” and LJFgene3 
being the  “youngest,” or most recent, of the family. On the contrary, LJFgene3 is 
likely the gene that still most resembles the common ancestor to the entire family. 
Given the evidence for expression, it is hypothesized that this gene has been most 
highly conserved throughout its history to preserve function. With this logic in place, 
the phylogeny in Figure 3.5.B can be interpreted as LJFgene9 and LJFgene3 
divergeing first from the common ancestor and the divergences of LJFgene14 and 
LJFgene1 from LJFgene3, as well as LJFgene8 from LJfgene9, came later, resulting in 
the synonymous substitution rates seen.  
 
4.4. STRUCTURE, FUNCTION, AND LOCALIZATION PREDICTIONS  
 Numerous programs were used to attempt to predict the structure, function, and 
cellular location of the gene product for LJFgene3. Only the sequence for LJFgene3 
was used as input for these programs since it is the most likely of the genes to produce 
a functional gene product.  
 Some of the results of these analyses did not agree. Results from CELLO 
(Table 3.11) indicate that the conceptually-translated protein sequence of LJFgene3 
would most likely be localized to the nucleus or a chloroplast. The I-TASSER 
program predicted that the gene ontology (Results Section 3.4.3.3) cellular component 
of the same peptide sequence would most likely be cell periphery, i.e. extracellular. In 
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order to resolve this discrepancy, the reliability and predictive methods were 
evaluated. I-TASSER uses templates of known proteins from various species to make 
predictions. The template that best matches the query sequence in secondary and 
tertiary structure is used to infer function and location. All of the structural templates 
are β-lactamase molecules (Table 3.15), therefore the program predicts that the query 
peptide would act in a similar fashion to and be found in a similar location as a β-
lactamase. CELLO is a program offered specifically for the identification of 
subcellular localization. It also compares an unknown sequence to peptides of known 
function, however the query sequence is first broken into many smaller sequences of 
equal length and each of these classified according to the subcellular location 
associated with amino acid composition. CELLO then uses a multi-level classification 
method based on support vector classifiers. In a comparison to other contemporary 
approaches, CELLO performed very well. In overall performance, (prediction of all 
localization possibilities) CELLO performed with 85% accuracy. However, in the 
prediction of each of the nuclear, plasma membrane, and extracellular locals, the 
accuracy score was over 90% [64]. Based on these methods of determination, the 
localization of the potential protein of LJFgene3 would perhaps be more accurately 
predicted by CELLO, and therefore be associated with some function in the nucleus or 
chloroplast. It is possible that both programs are correct. If the products of these genes 
were acting in a similar capacity to β-lactamase, for instance as an anti-fungal agent 
specific to plants, the possibility exists that their functional location could be 
intracellular as opposed to being secreted like β-lactamase in bacteria. 
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 A Kyte-Doolittle hydropathy plot (Figure 3.18) was generated for LJFgene3 to 
rule out the possibility that the gene product is a transmembrane protein either on the 
plasma or nuclear membrane. The window size used was 19, making the standard 
criteria for hydrophobic regions to be any segment of line above a score of 1.6. Not a 
single line on the plot for LJFgene3 even reached 1.5, confirming that the potential 
peptide is not likely an integral membrane protein. As a model for comparison, a 
hydropathy plot for a known transmembrane protein, human rhodopsin, was included 
in the results. It appears to have 6, possibly 7, peaks that surpass the hydrophobic 
threshold and are composed of enough amino acid residues to span the plasma 
membrane. Human rhodopsin protein is known to have 7 alpha-helical transmembrane 
regions.  
 Both secondary structure prediction tools, PSI PRED and I-TASSER, agree 
with each other strongly and with high confidence (Figure 3.22). The amino terminus 
of the conceptually translated peptide of LJFgene3 appears to have 3 to 4 alpha-helices 
(depending on the program referenced), followed by four short beta sheets and 
terminating in a solitary carboxy-terminus alpha helix.  
 One tool for predicting tertiary structure and function, DomTHREADER, 
aligns the query sequence (conceptually translated peptide sequence of LJFgene3) and 
secondary structure with domains of known proteins linked to the PDB and CATH 
databases. Results for the pDomTHREADER output are located in Table 3.12 and 
Figure 3.24 in Section 3.4.5. All of the resulting domain matches were of low 
confidence and low sequence identity; however, a few of the matching domains had 
very similar secondary structure. The secondary structure of the domain with code 
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1v5sA00 exhibited a high degree of structural similarity to the carboxy-terminus of the 
query peptide sequence. The domain with code 1up8A00 was very similar to the 
animo-terminus and the domain with code 1m40A00 was most similar to the full 
length query than any other hits. The domain with code 1m40A00 has a class of alpha 
beta, architecture of a 3-layer (aba) sandwich, and the topology of a beta-lactamase. 
This is notable due to the results produced by the other predictive tools utilized for this 
study, I-TASSER. 
 I-TASSER uses known proteins as templates upon which unknown input 
sequences are compared based on a secondary structure alignment. The input sequence 
is threaded through a PDB library and subjected to multiple alignment algorithms. 
Profile-profile alignments have been shown to predict the correct topology templates 
even in cases where sequence identity with the query is low [73]. I-TASSER has been 
ranked number one for protein structure and function prediction in the community-
wide Critical Assessment of Structure Prediction (CASP) experiments in recent years 
[74]. The results from this program for the query LJFgene3 conceptually translated 
peptide sequence all had low confidence scores and low identity; however it is 
noteworthy that a common theme persists through the results.   
 Aside from the threading templates (Table 3.14; only the top 3 results are beta-
lactamase), all of the top structural analogs (Table 3.15), enzyme homologs (Table 
3.16), and templates with similar binding sites (Table 3.18) are beta-lactamase 
molecules of bacterial species. Beta-lactamase proteins act as hydrolytic enzymes, 
cleaving a beta-lactam ring, and are a common mechanism of conferring bacterial 
resistance to classes of beta-lactam antibiotics including penicillin [80]. In gram-
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negative bacteria, beta-lactamase molecules reside in the periplasm, the space beyond 
the plasma membrane. The protoenzyme is transported across the membrane in an 
unfolded state using the Sec apparatus or in a folded state using the Tat apparatus 
through recognition of a specific signal sequence that is cleaved post-translocation to 
produce the mature enzyme [81].   
 When comparing the highest scoring I-TASSER-generated structural model for 
gene LJFgene3 to the model of a known beta-lactamase molecule (Figure 3.26), it can 
be confirmed that similarity does exist. This does not imply that Glycine max produces 
an antibiotic beta lactamase. It simply suggests that a protein may be produced that has 
a similar structure and therefore possibly a similar function. Certain families of plants 
are known to produce antifungal and antibiotic molecules. For example the chitinase 
(chi) gene in beans and the ribosome-inactivating protein (rip) gene in barley have 
been transformed into soybean to produce a transgenic plant with multiple resistances 
[82]. Soybean is plagued by many pathogenic infections and naturally produces 
glyceollin, a phytoalexin known to have antibacterial, antinematodal, and antifungal 
activity. The glyceollin molecule is the end product of a pathway that adds a 
dimethylallyl to a pterocarpan precursor. The precursor molecule is (6aS, 11aS)-
3,9,6a-trihydroxypterocarpan [(−)-glycinol] 4-dimethylallyltransferase, or G4DT. 
G4DT has been linked to a cDNA that contains a plastid-targeting signal and is 
presumed to be localized in the chloroplast. The fact that the glyceollin synthetic 
prenyltransferase is localized to the plastid further supports this presumption [83]. The 
second highest ranked possibility for the cellular location of LJFgene3 is in the 
chloroplast (Table 3.11). This detail, combined with the knowledge that the gene 
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product of LJFgene3 is presumed to have a similar function to the molecule produced 
by the biosynthetic pathway that utilizes G4DT, merits further research into any 
potential sequence similarity between genes.  
 An alignment of Glycine max G4DT mRNA-coding sequence and LJFgene3 
coding sequence produced ambiguous results(data not included). A 500 bp difference 
exists between the two sequences. If only the aligned portion is considered, 316 out of 
766, or 41% of,  nucleotides are shared between the two. If the entire sequence of both 
is considered, only 316 out of 1234, or 25.6% of nucleotides shared. Given that the 
likelihood of a nucleotide at any one position in a sequence having a 1 in 4, or 25%, 
chance of being the same as the aligned sequence simply by random chance, these 
results are unimpressive. An alignment of amino acid residues further illustrated the 
differences between these genes and gene products. A BLAST of the G4DT coding 
sequence against the Glycine max genome did not produce any results matching a gene 
family member. The top hits were gene models with annotations linked to proteins of 
the prenyltransferase family. In addition, the tertiary structure (in the form of a ribbon 
diagram) of a pterocarpan (isoflavanone 4'-O-methyltransferase) from a related 
legume, Medicago truncatula, was accessed in PDB. The structure is displayed in 
Figure 4.8. A comparison of this structure with the predicted structural model of 
LJFgene3 from I-TASSER (Figure 3.25) reveals structural differences that likely 
indicate functional differences. It has not been ruled out that the gene product from 
this gene family may be involved in plant defense against pathogens, only that the 









 One of the primary aims of this research effort was to establish a plausible 
reason for the expansion of this family in soybean. The expansion could simply be a 
result of the soybean-specific WGD event predicted to have occurred around 13 Mya 
or could be tied to the function of the LJFgene family peptide. However, without first 
providing definitive evidence for gene product function, any attempts to address 
expansion would be purely speculative.  
 It has been taken into consideration that the gene product for this family may 
lack abundant expression evidence because expression is stress-induced (such as by a 
pathogen of environmental stressor) or tissue-specific. The EST library, found in 
Appendix F, contains information on the plant tissue from which each EST associated 
with this gene family was derived as well as the treatment that was applied to the 
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plant. Some tissues were exposed to drought stress or microorganisms prior to cDNA 
generation. Many of the tissues used came from seedlings, or young plants, but others 
came from specific parts such as root hairs. Table 3.9 contains some treatment data 
from the ESTs for this family. The question to be answered is: Can the tissue and 
treatment data reveal whether expression is tissue-specific or stress-induced? In order 
to perform a statistical test on the data, access to library information from the entire 
EST database for Glycine max is necessary. Without this data, a reliable test could not 
be performed. It is necessary to know what proportion of EST’s for this species came 
from each cultivar, from a particular tissue, and using a certain treatment in order to 
determine the significance of the information found in the library for this gene family.  
 A second statistical test was considered for data collected for this gene family. 
PLACE data was compiled and organized by PLACE identifier and gene family 
member. The number of times a promoter element appears in the sequence upstream 
from the start site of a gene was recorded. Lastly, the data was organized according to 
associations with EST’s. Those elements that appear only in genes that have EST data 
but not in genes without EST data, as well as elements appearing only in genes that 
lack EST data but not appearing in genes with EST data, were of particular interest. A 
statistician was consulted to determine if a statistical analysis could be applied to this 
data to determine whether the frequency of an element or the association of an element 
with only genes with a certain EST status could indicate significant expression 
patterns. Is the presence of an element necessary for transcription? Are elements 
associated with genes lacking EST data binding sites for a repressor? Unfortunately, 
no test could be devised due to the large quantity of data having such small sample 
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sizes. The raw data tables from which frequency data was calculated for cis-element 
identifiers can be found in Appendix G. The information reported in the Results 
Section is limited to identifiers, element sequence, and the genes in which they were 
found to be present in the promoter, and can be found in Table 3.8 in Results Section 
3.4.2.  
 Each element in the PLACE database is distinguishable by an alphanumeric 
code, or identifier. This identifier is linked to descriptive data about the element such 
as whether it is required for expression of a particular gene or is a known binding site 
for a specific molecule, the organism from which the functional information was 
obtained, and citations for published research. Inspiration for possible deductions 
about expression patterns can be obtained from this information. Table 3.10 in Results 
Section 3.4.2 outlines patterns of overlapping occurrence of characteristics between 
cis-elements found in LJFgene family members. It is notable that in all five LJFgene 
family members, stress-induced elements exist in the promoter region such as various 
response elements (including dehydration-response), wound-induced, pathogen-
induced, and light responsive elements.  In addition, all five LJFgenes have elements 
for tissue-specific expression including a root/nodule element and elements found in 
seed or endosperm tissues. Of even more interest are those elements found to be 
present in the promoters of genes that have ESTs but absent in the genes that do not 
have ESTs. Two response elements (dehydration and sulfur) and one wound-induced 
element can be found in those genes with expression evidence. It is also noteworthy 
that a TATA box element found in the rice PAL gene promoter was detected in the 
three LJFgenes with expression evidence. The presence of these elements can be 
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associated with the treatments and tissues used for the soybean plants that produced 
ESTs for LJFgene3, LJFgene14, and LJFgene9. Treatments include pathogen-induced 
sensitivity and drought stress and the tissue source of 5 of the 13 ESTs were seeds, 
meristematic tissues, and root hairs with nodulating bacteria. It brings in to question 
whether any of these elements and treatments can be correlated to infer a source of 
differential expression or possible function. However, without a reliable statistical test, 
such inferences cannot be validated.  
 Transcription-dependent elements located in the promoter regions of the genes 
were researched but not all were added to the decorated models presented in Appendix 
E. Only those elements that were within a reasonably spaced window from the start 
site (or the 5’ boundary of the first exon in the case of LJFgene14) were added to the 
decorated sequence. In addition, only those elements that were a reasonable distance 
from one another were added. In other words, TATA box and CAAT box elements 
that are separated by a distance that most closely correspond to the widely accepted 
data (approximately 100bp) have been added to the decorated sequences. It should be 
noted that only those sequences confirmed by the program were highlighted. These 
concensus sequences are not definitive. Variations from the consensus that are not 
highlighted but may be present in the necessary locations can still possess inherent 
affinity that will promote binding of the RNA polymerase subunits to the strand [15].  
 No polyadenylation signal sequences were highlighted in the decorated 
sequences. Although computer programs have been, and are being, developed to 
identify polyadenylation signals in plants, public access to these tools is not available 
and could not be utilized for the purpose of this study. Submission of a sequence 
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containing LJFgene3 to a prediction tool designed to identify polyA signals in human 
genes produced a record of the locations and sequence of signals known to exist in 
human genes. Only one signal matching the mammalian consensus polyA sequence 
was identified that is positioned within a reasonable distance of the stop codon. 
Without more evidence that cleavage occurs downstream of this site, its functional 
significance cannot be confirmed. Primary efforts to identify the polyA signal 
sequences in the LJFgene family were conducted through manual searches. Given the 
widely unpredictable nature of these signals in plants, a positive identification of their 
sequence and location could not be made with confidence. Although the signal is 
generally accepted to be an A-rich hexamer, a consensus sequence does not exist for 
plants as it does for metazoans making recognition by base sequence alone nearly 
impossible. The best hope of locating the signal was through EST analysis. The EST’s 
for LJFgene3 do not agree on a 3’ end making it difficult to predict a cleavage site. 
Without a definitive cleavage site, the information on accepted distances between the 
cleavage site and key elements cannot be applied.  
 
4.5. NON-CODING SEQUENCE ANALYSIS 
  The non-coding sequences on chromosomes 19, 12, and 11 that resulted from 
the original BLAST searches were all hits for four of the five gene family members 
(Figure 3.1). They also displayed high conservation of sequence with each other as  
well as falling into a family motif (motif 2) as predicted by MEME (Figure 3.29). 
These criteria merited a deeper examination of those sequences. 
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Because the non-coding sequences were not recognized by the algortihms as 
being “genes,” no gene model was available in the genome browser and these 
sequences were referred to as “non-models” and earned the designation of “nm.”  
Due to the strong conservation of sequence exhibited by these non-coding 
sequences (Figure 3.28) despite short sequence lengths, an investigation was 
conducted to determine whether they are microRNAs (miRNAs). High levels of 
conservation and dyad symmetry are two features of miRNAs. The conservation was 
evident, but the existence of dyad symmetry was more difficult to detect. In order to 
determine the patterns that would be produced from a sequence with dyad symmetry 
on a dot plot matrix, a series of tests involving the manipulation of a sequence known 
to have dyad symmetry was conducted. The result was that plotting a sequence with 
dyad symmetry against its reverse complement produced a distinguishable pattern. 
When the sequences for LJFnm19, LJFnm11, and LJFnm12 were plotted against their 
reverse complement, no patterns emerged. Despite lack of symmetry, the sequences 
were used as input in a miRNA prediction tool. The output (Figure 3.32) suggests that 
a short stretch of sequence in both LJFnm19 and LJFnm12 are precursory sequences 
for known miRNAs. This would provide a plausible explanation for the high degree of 
conservation exhibited by these sequences if the stretch of sequence representing the 
miRNA were the same between all three sequences, yet it was not the same sequence 
in LJFnm19 and LJFnm12, and a miRNA-linked sequence was not identified in 
LJFnm11.  
The identity of the LJFnm sequences with LJFgene3 is very high, over 90% in 
all three non-coding sequences in the region of sequence similarity. This can be 
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viewed in the multiple alignment of LJFnm sequences against LJFgene3, LJFgene14, 
and LJFgene1 (Figure 3.30). The LJFnm sequences correspond to the sequence 
spanning the sixth exon, sixth intron, seventh exon, and the 3’ UTR of the LJFgenes. 
Despite spanning two exons of the predicted family gene models (potentially 50 amino 
acids) and corresponding to conserved motifs, models were not predicted for the 
LJFnm sequences using FgenesH and GenomeScan. The question of why the 
algorithms did not predict a gene model for the non-coding sequences cannot be 
answered. Some critical element for gene prediction is likely missing.  
The question is how did such a highly conserved sequence (nearly identical in 
composition and length) corresponding to a possible domain of a known transcribed 
gene end up on three different chromosomes? If patterns of neighboring genes could 
be established between LJFgenes and LJFnms, links could be attributed to duplication 
events. However, this is not the case. And if these sequences were relics of a gene that 
resulted from a duplication, it would be expected that at least some mutational 
differences would be apparent. If the proposed non-coding sequence had been isolated 
to a location on a single chromosome, rather than three, its existence could be 
attributed to a segmental duplication. This also is not the case. The possibility of the 
sequence being a transposable element can be ruled out due to a lack of inverted 
repeating sequences at the boundaries. Although it remains enigmatic, there is some 
important event from which this situation arose and more than likely something to be 





4.6. FINAL CONCLUSIONS 
 The soybean LJFgene family contains five coding (LJFgene3, LJFgene1, 
LJFgene14, LJFgene8, and LJFgene9) and three non-coding sequences (LJFnm19, 
LJFnm11, and LJFnm12). Of the five coding sequences, three have EST data 
associated with them (LJFgene3, LJFgene14, and LJFgene9) and only one of these 
(LJFgene3) is presumed to produce a translated gene product, leaving the remaining 
genes to be considered pseudogenes. Data suggests that LJFgene3 is the most highly 
conserved (and therefore most representative of the original common ancestor of the 
family) and that the genes in the family diverged from this common ancestor in the 
following order: LJFgene9, LJFgene8, LJFgene14, and LJFgene1. Secondary structure 
and fold prediction programs have produced a possible structural model of the gene 
product; however, a high confidence potential function of the molecule could not be 
defined leaving the functional annotation as uncharacterized for now. The closest 
match in structure is a β-lactamase. The next step would be continued research into the 
possibility that this gene family has a role in soybean analogous to the role of β-
lactamase in bacteria.
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Element name Site/Strand/Sequence Identifier link 
-10PEHVPSBD 1251 (+) TATTCT S000392 
-300ELEMENT 899  (+) TGHAAARK S000122 
-300ELEMENT 1050 (+) TGHAAARK S000122 
-300ELEMENT 1145 (+) TGHAAARK S000122 
2SSEEDPROTBANAPA 313  (+) CAAACAC S000143 
AACACOREOSGLUB1 783  (+) AACAAAC S000353 
ABRELATERD1 163  (+) ACGTG S000414 
ABRELATERD1 298  (-) ACGTG S000414 
ABRERATCAL 297  (-) MACGYGB S000507 
ACGTABREMOTIFA2OSEM 296  (-) ACGTGKC S000394 
ACGTATERD1 163  (+) ACGT S000415 
ACGTATERD1 299  (+) ACGT S000415 
ACGTATERD1 163  (-) ACGT S000415 
ACGTATERD1 299  (-) ACGT S000415 
AMMORESIIUDCRNIA1 833  (+) GGWAGGGT S000374 
ANAERO1CONSENSUS 782  (+) AAACAAA S000477 
ARFAT 1202 (-) TGTCTC S000270 
ARR1AT 436  (+) NGATT S000454 
ARR1AT 455  (+) NGATT S000454 
ARR1AT 365  (+) NGATT S000454 
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ARR1AT 704  (+) NGATT S000454 
ARR1AT 1131 (+) NGATT S000454 
ARR1AT 1195 (+) NGATT S000454 
ARR1AT 1450 (+) NGATT S000454 
ARR1AT 523  (-) NGATT S000454 
ARR1AT 696  (-) NGATT S000454 
ARR1AT 1058 (-) NGATT S000454 
ARR1AT 1150 (-) NGATT S000454 
ARR1AT 1235 (-) NGATT S000454 
ARR1AT 1398 (-) NGATT S000454 
BIHD1OS 485  (-) TGTCA S000498 
BOXIIPCCHS 296  (-) ACGTGGC S000229 
BP5OSWX 298  (-) CAACGTG S000436 
CAATBOX1 441  (+) CAAT S000028 
CAATBOX1 987  (+) CAAT S000028 
CAATBOX1 1076 (+) CAAT S000028 
CAATBOX1 1163 (+) CAAT S000028 
CAATBOX1 1572 (+) CAAT S000028 
CAATBOX1 1581 (+) CAAT S000028 
CAATBOX1 64   (-) CAAT S000028 
CAATBOX1 119  (-) CAAT S000028 
CAATBOX1 516  (-) CAAT S000028 
CAATBOX1 996  (-) CAAT S000028 
CAATBOX1 1339 (-) CAAT S000028 
CACTFTPPCA1 76   (+) YACT S000449 
CACTFTPPCA1 288  (+) YACT S000449 
CACTFTPPCA1 1352 (+) YACT S000449 
CACTFTPPCA1 466  (+) YACT S000449 
CACTFTPPCA1 559  (+) YACT S000449 
CACTFTPPCA1 760  (+) YACT S000449 
CACTFTPPCA1 1177 (+) YACT S000449 
CACTFTPPCA1 345  (-) YACT S000449 
CACTFTPPCA1 508  (-) YACT S000449 
CACTFTPPCA1 758  (-) YACT S000449 
CACTFTPPCA1 866  (-) YACT S000449 
CACTFTPPCA1 880  (-) YACT S000449 
CACTFTPPCA1 919  (-) YACT S000449 
CACTFTPPCA1 970  (-) YACT S000449 
CACTFTPPCA1 1125 (-) YACT S000449 
CACTFTPPCA1 1193 (-) YACT S000449 
CACTFTPPCA1 1261 (-) YACT S000449 
CANBNNAPA 313  (+) CNAACAC S000148 
CARGCW8GAT 24   (+) CWWWWWWWWG S000431 
CARGCW8GAT 1402 (+) CWWWWWWWWG S000431 
CARGCW8GAT 1467 (+) CWWWWWWWWG S000431 
CARGCW8GAT 24   (-) CWWWWWWWWG S000431 
CARGCW8GAT 1402 (-) CWWWWWWWWG S000431 
CARGCW8GAT 1467 (-) CWWWWWWWWG S000431 
CARGNCAT 1466 (+) CCWWWWWWWWGG S000446 
CARGNCAT 1466 (-) CCWWWWWWWWGG S000446 
CATATGGMSAUR 800  (+) CATATG S000370 
CATATGGMSAUR 1109 (+) CATATG S000370 
CATATGGMSAUR 800  (-) CATATG S000370 
CATATGGMSAUR 1109 (-) CATATG S000370 
CBFHV 67   (-) RYCGAC S000497 
CCAATBOX1 1162 (+) CCAAT S000030 
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CCAATBOX1 119  (-) CCAAT S000030 
CCAATBOX1 1339 (-) CCAAT S000030 
CELLCYCLESC 1296 (-) CACGAAAA S000031 
CEREGLUBOX2PSLEGA 981  (-) TGAAAACT S000033 
CIACADIANLELHC 690  (+) CAANNNNATC S000252 
CIACADIANLELHC 1581 (+) CAANNNNATC S000252 
CPBCSPOR 860  (+) TATTAG S000491 
CPBCSPOR 938  (-) TATTAG S000491 
CURECORECR 759  (+) GTAC S000493 
CURECORECR 867  (+) GTAC S000493 
CURECORECR 920  (+) GTAC S000493 
CURECORECR 759  (-) GTAC S000493 
CURECORECR 867  (-) GTAC S000493 
CURECORECR 920  (-) GTAC S000493 
DOFCOREZM 8    (+) AAAG S000265 
DOFCOREZM 183  (+) AAAG S000265 
DOFCOREZM 360  (+) AAAG S000265 
DOFCOREZM 386  (+) AAAG S000265 
DOFCOREZM 415  (+) AAAG S000265 
DOFCOREZM 506  (+) AAAG S000265 
DOFCOREZM 617  (+) AAAG S000265 
DOFCOREZM 621  (+) AAAG S000265 
DOFCOREZM 646  (+) AAAG S000265 
DOFCOREZM 667  (+) AAAG S000265 
DOFCOREZM 680  (+) AAAG S000265 
DOFCOREZM 1259 (+) AAAG S000265 
DOFCOREZM 1408 (+) AAAG S000265 
DOFCOREZM 1420 (+) AAAG S000265 
DOFCOREZM 78   (-) AAAG S000265 
DOFCOREZM 91   (-) AAAG S000265 
DOFCOREZM 177  (-) AAAG S000265 
DOFCOREZM 224  (-) AAAG S000265 
DOFCOREZM 468  (-) AAAG S000265 
DOFCOREZM 474  (-) AAAG S000265 
DOFCOREZM 561  (-) AAAG S000265 
DOFCOREZM 659  (-) AAAG S000265 
DOFCOREZM 729  (-) AAAG S000265 
DOFCOREZM 930  (-) AAAG S000265 
DOFCOREZM 1156 (-) AAAG S000265 
DOFCOREZM 1179 (-) AAAG S000265 
DOFCOREZM 1295 (-) AAAG S000265 
DOFCOREZM 1440 (-) AAAG S000265 
DPBFCOREDCDC3 327  (+) ACACNNG S000292 
DRE2COREZMRAB17 67   (-) ACCGAC S000402 
DRECRTCOREAT 67   (-) RCCGAC S000418 
EBOXBNNAPA 99   (+) CANNTG S000144 
EBOXBNNAPA 800  (+) CANNTG S000144 
EBOXBNNAPA 964  (+) CANNTG S000144 
EBOXBNNAPA 1109 (+) CANNTG S000144 
EBOXBNNAPA 1446 (+) CANNTG S000144 
EBOXBNNAPA 99   (-) CANNTG S000144 
EBOXBNNAPA 800  (-) CANNTG S000144 
EBOXBNNAPA 964  (-) CANNTG S000144 
EBOXBNNAPA 1109 (-) CANNTG S000144 
EBOXBNNAPA 1446 (-) CANNTG S000144 
EECCRCAH1 142  (+) GANTTNC S000494 
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EECCRCAH1 600  (+) GANTTNC S000494 
ELRECOREPCRP1 1158 (+) TTGACC S000142 
ERELEE4 960  (+) AWTTCAAA S000037 
EVENINGAT 210  (-) AAAATATCT S000385 
GATABOX 211  (+) GATA S000039 
GATABOX 409  (+) GATA S000039 
GATABOX 999  (+) GATA S000039 
GATABOX 1269 (+) GATA S000039 
GATABOX 1320 (+) GATA S000039 
GATABOX 1515 (+) GATA S000039 
GATABOX 726  (-) GATA S000039 
GATABOX 777  (-) GATA S000039 
GATABOX 842  (-) GATA S000039 
GATABOX 846  (-) GATA S000039 
GATABOX 927  (-) GATA S000039 
GATABOX 935  (-) GATA S000039 
GATABOX 1032 (-) GATA S000039 
GATABOX 1331 (-) GATA S000039 
GATABOX 1355 (-) GATA S000039 
GATABOX 1392 (-) GATA S000039 
GATABOX 1443 (-) GATA S000039 
GT1CONSENSUS 348  (+) GRWAAW S000198 
GT1CONSENSUS 445  (+) GRWAAW S000198 
GT1CONSENSUS 541  (+) GRWAAW S000198 
GT1CONSENSUS 573  (+) GRWAAW S000198 
GT1CONSENSUS 581  (+) GRWAAW S000198 
GT1CONSENSUS 712  (+) GRWAAW S000198 
GT1CONSENSUS 999  (+) GRWAAW S000198 
GT1CONSENSUS 1227 (+) GRWAAW S000198 
GT1CONSENSUS 1342 (+) GRWAAW S000198 
GT1CONSENSUS 1411 (+) GRWAAW S000198 
GT1CONSENSUS 489  (-) GRWAAW S000198 
GT1CONSENSUS 745  (-) GRWAAW S000198 
GT1CONSENSUS 1329 (-) GRWAAW S000198 
GT1CONSENSUS 1538 (-) GRWAAW S000198 
GT1CONSENSUS 1554 (-) GRWAAW S000198 
GT1CONSENSUS 92   (-) GRWAAW S000198 
GT1CONSENSUS 724  (-) GRWAAW S000198 
GT1CONSENSUS 730  (-) GRWAAW S000198 
GT1CONSENSUS 811  (-) GRWAAW S000198 
GT1CONSENSUS 840  (-) GRWAAW S000198 
GT1CONSENSUS 933  (-) GRWAAW S000198 
GT1CONSENSUS 1030 (-) GRWAAW S000198 
GT1CONSENSUS 1382 (-) GRWAAW S000198 
GT1CONSENSUS 1383 (-) GRWAAW S000198 
GT1CONSENSUS 1441 (-) GRWAAW S000198 
GT1GMSCAM4 581  (+) GAAAAA S000453 
GT1GMSCAM4 712  (+) GAAAAA S000453 
GT1GMSCAM4 1411 (+) GAAAAA S000453 
GT1GMSCAM4 92   (-) GAAAAA S000453 
GT1GMSCAM4 730  (-) GAAAAA S000453 
GT1GMSCAM4 1382 (-) GAAAAA S000453 
GTGANTG10 126  (+) GTGA S000378 
GTGANTG10 346  (+) GTGA S000378 
GTGANTG10 357  (+) GTGA S000378 
GTGANTG10 1194 (+) GTGA S000378 
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GTGANTG10 1510 (+) GTGA S000378 
GTGANTG10 75   (-) GTGA S000378 
GTGANTG10 98   (-) GTGA S000378 
GTGANTG10 1285 (-) GTGA S000378 
GTGANTG10 1445 (-) GTGA S000378 
GTGANTG10 1454 (-) GTGA S000378 
GTGANTG10 1479 (-) GTGA S000378 
IBOX 775  (-) GATAAG S000124 
IBOXCORE 999  (+) GATAA S000199 
IBOXCORE 725  (-) GATAA S000199 
IBOXCORE 776  (-) GATAA S000199 
IBOXCORE 841  (-) GATAA S000199 
IBOXCORE 934  (-) GATAA S000199 
IBOXCORE 1031 (-) GATAA S000199 
IBOXCORE 1330 (-) GATAA S000199 
IBOXCORE 1442 (-) GATAA S000199 
INRNTPSADB 74   (+) YTCANTYY S000395 
INRNTPSADB 1460 (+) YTCANTYY S000395 
INRNTPSADB 719  (+) YTCANTYY S000395 
INRNTPSADB 1551 (+) YTCANTYY S000395 
INRNTPSADB 595  (-) YTCANTYY S000395 
INRNTPSADB 1240 (-) YTCANTYY S000395 
LECPLEACS2 212  (-) TAAAATAT S000465 
LRENPCABE 295  (-) ACGTGGCA S000231 
LTRE1HVBLT49 1501 (-) CCGAAA S000250 
LTREATLTI78 66   (-) ACCGACA S000157 
LTRECOREATCOR15 67   (-) CCGAC S000153 
MARABOX1 233  (+) AATAAAYAAA S000063 
MARABOX1 237  (+) AATAAAYAAA S000063 
MARTBOX 266  (+) TTWTWTTWTT S000067 
MARTBOX 884  (+) TTWTWTTWTT S000067 
MARTBOX 906  (+) TTWTWTTWTT S000067 
MARTBOX 947  (+) TTWTWTTWTT S000067 
MARTBOX 276  (-) TTWTWTTWTT S000067 
MARTBOX 582  (-) TTWTWTTWTT S000067 
MARTBOX 584  (-) TTWTWTTWTT S000067 
MARTBOX 587  (-) TTWTWTTWTT S000067 
MARTBOX 1412 (-) TTWTWTTWTT S000067 
MARTBOX 1413 (-) TTWTWTTWTT S000067 
MYB1AT 944  (-) WAACCA S000408 
MYBCOREATCYCB1 1265 (+) AACGG S000502 
MYBST1 408  (+) GGATA S000180 
MYBST1 1268 (+) GGATA S000180 
MYBST1 1319 (+) GGATA S000180 
MYBST1 777  (-) GGATA S000180 
MYBST1 1392 (-) GGATA S000180 
MYCATERD1 99   (-) CATGTG S000413 
MYCATERD1 1446 (-) CATGTG S000413 
MYCATRD22 99   (+) CACATG S000174 
MYCATRD22 1446 (+) CACATG S000174 
MYCCONSENSUSAT 99   (+) CANNTG S000407 
MYCCONSENSUSAT 800  (+) CANNTG S000407 
MYCCONSENSUSAT 964  (+) CANNTG S000407 
MYCCONSENSUSAT 1109 (+) CANNTG S000407 
MYCCONSENSUSAT 1446 (+) CANNTG S000407 
MYCCONSENSUSAT 99   (-) CANNTG S000407 
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MYCCONSENSUSAT 800  (-) CANNTG S000407 
MYCCONSENSUSAT 964  (-) CANNTG S000407 
MYCCONSENSUSAT 1109 (-) CANNTG S000407 
MYCCONSENSUSAT 1446 (-) CANNTG S000407 
NODCON1GM 360  (+) AAAGAT S000461 
NODCON1GM 657  (-) AAAGAT S000461 
NODCON1GM 727  (-) AAAGAT S000461 
NODCON1GM 928  (-) AAAGAT S000461 
NODCON2GM 750  (+) CTCTT S000462 
NODCON2GM 566  (-) CTCTT S000462 
NODCON2GM 755  (-) CTCTT S000462 
NODCON2GM 806  (-) CTCTT S000462 
NTBBF1ARROLB 385  (-) ACTTTA S000273 
OSE1ROOTNODULE 360  (+) AAAGAT S000467 
OSE1ROOTNODULE 657  (-) AAAGAT S000467 
OSE1ROOTNODULE 727  (-) AAAGAT S000467 
OSE1ROOTNODULE 928  (-) AAAGAT S000467 
OSE2ROOTNODULE 750  (+) CTCTT S000468 
OSE2ROOTNODULE 566  (-) CTCTT S000468 
OSE2ROOTNODULE 755  (-) CTCTT S000468 
OSE2ROOTNODULE 806  (-) CTCTT S000468 
POLASIG1 233  (+) AATAAA S000080 
POLASIG1 237  (+) AATAAA S000080 
POLASIG1 241  (+) AATAAA S000080 
POLASIG1 587  (+) AATAAA S000080 
POLASIG1 592  (+) AATAAA S000080 
POLASIG1 1002 (+) AATAAA S000080 
POLASIG1 1230 (+) AATAAA S000080 
POLASIG1 265  (-) AATAAA S000080 
POLASIG1 742  (-) AATAAA S000080 
POLASIG1 888  (-) AATAAA S000080 
POLASIG1 951  (-) AATAAA S000080 
POLASIG1 1041 (-) AATAAA S000080 
POLASIG2 260  (-) AATTAAA S000081 
POLASIG3 512  (+) AATAAT S000088 
POLASIG3 1055 (+) AATAAT S000088 
POLASIG3 910  (-) AATAAT S000088 
POLASIG3 973  (-) AATAAT S000088 
POLASIG3 1021 (-) AATAAT S000088 
POLASIG3 1024 (-) AATAAT S000088 
POLLEN1LELAT52 422  (+) AGAAA S000245 
POLLEN1LELAT52 572  (+) AGAAA S000245 
POLLEN1LELAT52 580  (+) AGAAA S000245 
POLLEN1LELAT52 619  (+) AGAAA S000245 
POLLEN1LELAT52 678  (+) AGAAA S000245 
POLLEN1LELAT52 1118 (+) AGAAA S000245 
POLLEN1LELAT52 1226 (+) AGAAA S000245 
POLLEN1LELAT52 1410 (+) AGAAA S000245 
POLLEN1LELAT52 94   (-) AGAAA S000245 
POLLEN1LELAT52 549  (-) AGAAA S000245 
POLLEN1LELAT52 603  (-) AGAAA S000245 
POLLEN1LELAT52 684  (-) AGAAA S000245 
POLLEN1LELAT52 732  (-) AGAAA S000245 
POLLEN1LELAT52 747  (-) AGAAA S000245 
POLLEN1LELAT52 1215 (-) AGAAA S000245 
POLLEN1LELAT52 1314 (-) AGAAA S000245 
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POLLEN1LELAT52 1540 (-) AGAAA S000245 
PREATPRODH 598  (-) ACTCAT S000450 
PREATPRODH 967  (-) ACTCAT S000450 
PROXBBNNAPA 313  (+) CAAACACC S000263 
PYRIMIDINEBOXHVEPB1 1381 (+) TTTTTTCC S000298 
PYRIMIDINEBOXOSRAMY1A 473  (+) CCTTTT S000259 
PYRIMIDINEBOXOSRAMY1A 1294 (+) CCTTTT S000259 
RAV1AAT 82   (+) CAACA S000314 
RAV1AAT 85   (+) CAACA S000314 
RAV1AAT 1566 (+) CAACA S000314 
RAV1AAT 1569 (+) CAACA S000314 
REALPHALGLHCB21 1474 (-) AACCAA S000362 
REBETALGLHCB21 1267 (+) CGGATA S000363 
RHERPATEXPA7 1299 (-) KCACGW S000512 
ROOTMOTIFTAPOX1 117  (+) ATATT S000098 
ROOTMOTIFTAPOX1 212  (+) ATATT S000098 
ROOTMOTIFTAPOX1 859  (+) ATATT S000098 
ROOTMOTIFTAPOX1 908  (+) ATATT S000098 
ROOTMOTIFTAPOX1 958  (+) ATATT S000098 
ROOTMOTIFTAPOX1 994  (+) ATATT S000098 
ROOTMOTIFTAPOX1 1321 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1470 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1498 (+) ATATT S000098 
ROOTMOTIFTAPOX1 448  (-) ATATT S000098 
ROOTMOTIFTAPOX1 497  (-) ATATT S000098 
ROOTMOTIFTAPOX1 794  (-) ATATT S000098 
ROOTMOTIFTAPOX1 858  (-) ATATT S000098 
ROOTMOTIFTAPOX1 895  (-) ATATT S000098 
ROOTMOTIFTAPOX1 940  (-) ATATT S000098 
ROOTMOTIFTAPOX1 957  (-) ATATT S000098 
ROOTMOTIFTAPOX1 988  (-) ATATT S000098 
ROOTMOTIFTAPOX1 993  (-) ATATT S000098 
ROOTMOTIFTAPOX1 1081 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1372 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1390 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1497 (-) ATATT S000098 
RYREPEATBNNAPA 101  (+) CATGCA S000264 
RYREPEATLEGUMINBOX 101  (+) CATGCAY S000100 
S1FBOXSORPS1L21 1087 (+) ATGGTA S000223 
S1FBOXSORPS1L21 813  (-) ATGGTA S000223 
SEBFCONSSTPR10A 1202 (-) YTGTCWC S000391 
SEF1MOTIF 790  (-) ATATTTAWW S000006 
SEF1MOTIF 1493 (-) ATATTTAWW S000006 
SEF3MOTIFGM 1068 (+) AACCCA S000115 
SEF4MOTIFGM7S 27   (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1027 (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1288 (-) RTTTTTR S000103 
SEF4MOTIFGM7S 369  (-) RTTTTTR S000103 
SEF4MOTIFGM7S 428  (-) RTTTTTR S000103 
SEF4MOTIFGM7S 1360 (-) RTTTTTR S000103 
SORLIP1AT 296  (+) GCCAC S000482 
SP8BFIBSP8BIB 916  (-) TACTATT S000184 
SREATMSD 776  (+) TTATCC S000470 
SURE2STPAT21 1122 (-) AATACTAAT S000185 
SURECOREATSULTR11 1202 (+) GAGAC S000499 
SV40COREENHAN 148  (-) GTGGWWHG S000123 
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T/GBOXATPIN2 298  (-) AACGTG S000458 
TAAAGSTKST1 385  (+) TAAAG S000387 
TAAAGSTKST1 1440 (-) TAAAG S000387 
TATABOX2 790  (+) TATAAAT S000109 
TATABOX2 1493 (+) TATAAAT S000109 
TATABOX2 639  (-) TATAAAT S000109 
TATABOX2 1012 (-) TATAAAT S000109 
TATABOX3 912  (+) TATTAAT S000110 
TATABOX3 953  (+) TATTAAT S000110 
TATABOX3 913  (-) TATTAAT S000110 
TATABOX3 954  (-) TATTAAT S000110 
TATABOX3 1078 (-) TATTAAT S000110 
TATABOX4 58   (+) TATATAA S000111 
TATABOX4 55   (-) TATATAA S000111 
TATABOX5 256  (+) TTATTT S000203 
TATABOX5 266  (+) TTATTT S000203 
TATABOX5 743  (+) TTATTT S000203 
TATABOX5 884  (+) TTATTT S000203 
TATABOX5 889  (+) TTATTT S000203 
TATABOX5 974  (+) TTATTT S000203 
TATABOX5 1025 (+) TTATTT S000203 
TATABOX5 1042 (+) TTATTT S000203 
TATABOX5 232  (-) TTATTT S000203 
TATABOX5 236  (-) TTATTT S000203 
TATABOX5 240  (-) TTATTT S000203 
TATABOX5 372  (-) TTATTT S000203 
TATABOX5 511  (-) TTATTT S000203 
TATABOX5 575  (-) TTATTT S000203 
TATABOX5 586  (-) TTATTT S000203 
TATABOX5 591  (-) TTATTT S000203 
TATABOX5 1054 (-) TTATTT S000203 
TATABOX5 1188 (-) TTATTT S000203 
TATABOX5 1229 (-) TTATTT S000203 
TATABOXOSPAL 874  (+) TATTTAA S000400 
TATABOXOSPAL 890  (+) TATTTAA S000400 
TATABOXOSPAL 975  (+) TATTTAA S000400 
TATABOXOSPAL 1043 (+) TATTTAA S000400 
TATCCAOSAMY 777  (+) TATCCA S000403 
TATCCAOSAMY 1392 (+) TATCCA S000403 
TATCCAOSAMY 1318 (-) TATCCA S000403 
WBBOXPCWRKY1 1157 (+) TTTGACY S000310 
WBBOXPCWRKY1 613  (-) TTTGACY S000310 
WBBOXPCWRKY1 1184 (-) TTTGACY S000310 
WBOXATNPR1 1158 (+) TTGAC S000390 
WBOXATNPR1 614  (-) TTGAC S000390 
WBOXATNPR1 1185 (-) TTGAC S000390 
WBOXHVISO1 613  (-) TGACT S000442 
WBOXHVISO1 1184 (-) TGACT S000442 
WBOXNTERF3 1159 (+) TGACY S000457 
WBOXNTERF3 1166 (+) TGACY S000457 
WBOXNTERF3 613  (-) TGACY S000457 
WBOXNTERF3 1184 (-) TGACY S000457 
WRKY71OS 485  (+) TGAC S000447 
WRKY71OS 1159 (+) TGAC S000447 
WRKY71OS 1166 (+) TGAC S000447 
WRKY71OS 614  (-) TGAC S000447 
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Element name Site/Strand/Sequence Identifier Link 
-300MOTIFZMZEIN 153  (-) RTGAGTCAT S000002 
AACACOREOSGLUB1 356  (-) AACAAAC S000353 
ABRELATERD1 641  (-) ACGTG S000414 
ABRELATERD1 1000 (-) ACGTG S000414 
ABRERATCAL 999  (-) MACGYGB S000507 
ACGTATERD1 127  (+) ACGT S000415 
ACGTATERD1 642  (+) ACGT S000415 
ACGTATERD1 1001 (+) ACGT S000415 
ACGTATERD1 127  (-) ACGT S000415 
ACGTATERD1 642  (-) ACGT S000415 
ACGTATERD1 1001 (-) ACGT S000415 
AMYBOX1 961  (-) TAACARA S000020 
AMYBOX2 288  (+) TATCCAT S000021 
AMYBOX2 776  (-) TATCCAT S000021 
ANAERO1CONSENSUS 524  (+) AAACAAA S000477 
ANAERO1CONSENSUS 357  (-) AAACAAA S000477 
ANAERO2CONSENSUS 1316 (+) AGCAGC S000478 
ANAERO3CONSENSUS 920  (+) TCATCAC S000479 
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ARR1AT 564  (+) NGATT S000454 
ARR1AT 1438 (+) NGATT S000454 
ARR1AT 42   (+) NGATT S000454 
ARR1AT 928  (+) NGATT S000454 
ARR1AT 1240 (+) NGATT S000454 
ARR1AT 1443 (+) NGATT S000454 
ARR1AT 190  (-) NGATT S000454 
ARR1AT 611  (-) NGATT S000454 
ARR1AT 816  (-) NGATT S000454 
ARR1AT 852  (-) NGATT S000454 
ARR1AT 1186 (-) NGATT S000454 
ARR1AT 1264 (-) NGATT S000454 
ASF1MOTIFCAMV 125  (+) TGACG S000024 
BIHD1OS 800  (+) TGTCA S000498 
BIHD1OS 1151 (+) TGTCA S000498 
BIHD1OS 90   (-) TGTCA S000498 
BIHD1OS 183  (-) TGTCA S000498 
BIHD1OS 744  (-) TGTCA S000498 
BIHD1OS 1168 (-) TGTCA S000498 
BOXIINTPATPB 54   (+) ATAGAA S000296 
BOXIINTPATPB 347  (-) ATAGAA S000296 
BOXIINTPATPB 1223 (-) ATAGAA S000296 
BOXIINTPATPB 1234 (-) ATAGAA S000296 
CAATBOX1 400  (+) CAAT S000028 
CAATBOX1 426  (+) CAAT S000028 
CAATBOX1 618  (+) CAAT S000028 
CAATBOX1 815  (+) CAAT S000028 
CAATBOX1 1050 (+) CAAT S000028 
CAATBOX1 1062 (+) CAAT S000028 
CAATBOX1 1114 (+) CAAT S000028 
CAATBOX1 1279 (+) CAAT S000028 
CAATBOX1 27   (-) CAAT S000028 
CAATBOX1 88   (-) CAAT S000028 
CAATBOX1 195  (-) CAAT S000028 
CAATBOX1 241  (-) CAAT S000028 
CAATBOX1 316  (-) CAAT S000028 
CAATBOX1 798  (-) CAAT S000028 
CAATBOX1 1142 (-) CAAT S000028 
CAATBOX1 1238 (-) CAAT S000028 
CAATBOX1 1293 (-) CAAT S000028 
CAATBOX1 1309 (-) CAAT S000028 
CAATBOX1 1334 (-) CAAT S000028 
CACTFTPPCA1 114  (+) YACT S000449 
CACTFTPPCA1 803  (+) YACT S000449 
CACTFTPPCA1 958  (+) YACT S000449 
CACTFTPPCA1 1213 (+) YACT S000449 
CACTFTPPCA1 1219 (+) YACT S000449 
CACTFTPPCA1 668  (+) YACT S000449 
CACTFTPPCA1 828  (+) YACT S000449 
CACTFTPPCA1 1203 (+) YACT S000449 
CACTFTPPCA1 131  (-) YACT S000449 
CACTFTPPCA1 207  (-) YACT S000449 
CACTFTPPCA1 541  (-) YACT S000449 
CACTFTPPCA1 717  (-) YACT S000449 
175 
 	  
CACTFTPPCA1 788  (-) YACT S000449 
CARGCW8GAT 93   (+) CWWWWWWWWG S000431 
CARGCW8GAT 171  (+) CWWWWWWWWG S000431 
CARGCW8GAT 93   (-) CWWWWWWWWG S000431 
CARGCW8GAT 171  (-) CWWWWWWWWG S000431 
CBFHV 1178 (+) RYCGAC S000497 
CCAATBOX1 1334 (-) CCAAT S000030 
CIACADIANLELHC 609  (+) CAANNNNATC S000252 
CIACADIANLELHC 1062 (+) CAANNNNATC S000252 
CIACADIANLELHC 1093 (+) CAANNNNATC S000252 
CURECORECR 760  (+) GTAC S000493 
CURECORECR 995  (+) GTAC S000493 
CURECORECR 1357 (+) GTAC S000493 
CURECORECR 760  (-) GTAC S000493 
CURECORECR 995  (-) GTAC S000493 
CURECORECR 1357 (-) GTAC S000493 
DOFCOREZM 272  (+) AAAG S000265 
DOFCOREZM 330  (+) AAAG S000265 
DOFCOREZM 460  (+) AAAG S000265 
DOFCOREZM 598  (+) AAAG S000265 
DOFCOREZM 861  (+) AAAG S000265 
DOFCOREZM 37   (-) AAAG S000265 
DOFCOREZM 345  (-) AAAG S000265 
DOFCOREZM 374  (-) AAAG S000265 
DOFCOREZM 394  (-) AAAG S000265 
DOFCOREZM 754  (-) AAAG S000265 
DOFCOREZM 805  (-) AAAG S000265 
DOFCOREZM 913  (-) AAAG S000265 
DOFCOREZM 960  (-) AAAG S000265 
DOFCOREZM 1221 (-) AAAG S000265 
DOFCOREZM 1232 (-) AAAG S000265 
DOFCOREZM 1284 (-) AAAG S000265 
DPBFCOREDCDC3 514  (+) ACACNNG S000292 
DPBFCOREDCDC3 638  (+) ACACNNG S000292 
DPBFCOREDCDC3 997  (+) ACACNNG S000292 
DRE2COREZMRAB17 1178 (+) ACCGAC S000402 
DRECRTCOREAT 1178 (+) RCCGAC S000418 
E2FCONSENSUS 735  (-) WTTSSCSS S000476 
EBOXBNNAPA 924  (+) CANNTG S000144 
EBOXBNNAPA 924  (-) CANNTG S000144 
EECCRCAH1 601  (+) GANTTNC S000494 
EECCRCAH1 473  (-) GANTTNC S000494 
GAREAT 961  (-) TAACAAR S000439 
GATABOX 286  (+) GATA S000039 
GATABOX 481  (+) GATA S000039 
GATABOX 765  (+) GATA S000039 
GATABOX 779  (+) GATA S000039 
GATABOX 80   (-) GATA S000039 
GATABOX 161  (-) GATA S000039 
GATABOX 288  (-) GATA S000039 
GATABOX 350  (-) GATA S000039 
GATABOX 615  (-) GATA S000039 
GATABOX 790  (-) GATA S000039 
GATABOX 846  (-) GATA S000039 
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GATABOX 1099 (-) GATA S000039 
GCN4OSGLUB1 154  (-) TGAGTCA S000277 
GLMHVCHORD 153  (+) RTGASTCAT S000451 
GLMHVCHORD 153  (-) RTGASTCAT S000451 
GT1CONSENSUS 57   (+) GRWAAW S000198 
GT1CONSENSUS 225  (+) GRWAAW S000198 
GT1CONSENSUS 254  (+) GRWAAW S000198 
GT1CONSENSUS 255  (+) GRWAAW S000198 
GT1CONSENSUS 297  (+) GRWAAW S000198 
GT1CONSENSUS 333  (+) GRWAAW S000198 
GT1CONSENSUS 334  (+) GRWAAW S000198 
GT1CONSENSUS 463  (+) GRWAAW S000198 
GT1CONSENSUS 864  (+) GRWAAW S000198 
GT1CONSENSUS 865  (+) GRWAAW S000198 
GT1CONSENSUS 1393 (+) GRWAAW S000198 
GT1CONSENSUS 389  (-) GRWAAW S000198 
GT1CONSENSUS 836  (-) GRWAAW S000198 
GT1CONSENSUS 948  (-) GRWAAW S000198 
GT1CONSENSUS 1019 (-) GRWAAW S000198 
GT1CONSENSUS 1035 (-) GRWAAW S000198 
GT1CONSENSUS 1227 (-) GRWAAW S000198 
GT1CONSENSUS 305  (-) GRWAAW S000198 
GT1CONSENSUS 368  (-) GRWAAW S000198 
GT1CONSENSUS 369  (-) GRWAAW S000198 
GT1CONSENSUS 710  (-) GRWAAW S000198 
GT1CONSENSUS 1097 (-) GRWAAW S000198 
GT1CONSENSUS 1386 (-) GRWAAW S000198 
GT1CONSENSUS 1404 (-) GRWAAW S000198 
GT1GMSCAM4 225  (+) GAAAAA S000453 
GT1GMSCAM4 255  (+) GAAAAA S000453 
GT1GMSCAM4 297  (+) GAAAAA S000453 
GT1GMSCAM4 463  (+) GAAAAA S000453 
GT1GMSCAM4 368  (-) GAAAAA S000453 
GT1GMSCAM4 1386 (-) GAAAAA S000453 
GT1GMSCAM4 1404 (-) GAAAAA S000453 
GTGANTG10 284  (+) GTGA S000378 
GTGANTG10 561  (+) GTGA S000378 
GTGANTG10 989  (+) GTGA S000378 
GTGANTG10 113  (-) GTGA S000378 
GTGANTG10 397  (-) GTGA S000378 
GTGANTG10 802  (-) GTGA S000378 
GTGANTG10 923  (-) GTGA S000378 
GTGANTG10 932  (-) GTGA S000378 
GTGANTG10 957  (-) GTGA S000378 
GTGANTG10 1101 (-) GTGA S000378 
GTGANTG10 1162 (-) GTGA S000378 
GTGANTG10 1210 (-) GTGA S000378 
GTGANTG10 1216 (-) GTGA S000378 
HEXMOTIFTAH3H4 125  (-) ACGTCA S000053 
IBOX 765  (+) GATAAG S000124 
IBOXCORE 765  (+) GATAA S000199 
IBOXCORE 1098 (-) GATAA S000199 
INRNTPSADB 938  (+) YTCANTYY S000395 
INRNTPSADB 1032 (+) YTCANTYY S000395 
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INRNTPSADB 1277 (+) YTCANTYY S000395 
INRNTPSADB 1407 (+) YTCANTYY S000395 
INRNTPSADB 324  (-) YTCANTYY S000395 
INRNTPSADB 449  (-) YTCANTYY S000395 
INRNTPSADB 468  (-) YTCANTYY S000395 
INRNTPSADB 211  (-) YTCANTYY S000395 
L1BOXATPDF1 66   (+) TAAATGYA S000386 
LTRE1HVBLT49 950  (-) CCGAAA S000250 
LTRECOREATCOR15 1179 (+) CCGAC S000153 
MARABOX1 60   (+) AATAAAYAAA S000063 
MARABOX1 521  (+) AATAAAYAAA S000063 
MARABOX1 868  (+) AATAAAYAAA S000063 
MARTBOX 363  (+) TTWTWTTWTT S000067 
MARTBOX 591  (-) TTWTWTTWTT S000067 
MARTBOX 872  (-) TTWTWTTWTT S000067 
MARTBOX 875  (-) TTWTWTTWTT S000067 
MARTBOX 877  (-) TTWTWTTWTT S000067 
MYB1AT 1250 (+) WAACCA S000408 
MYB2AT 650  (+) TAACTG S000177 
MYB2CONSENSUSAT 650  (+) YAACKG S000409 
MYBCORE 148  (+) CNGTTR S000176 
MYBCORE 1189 (-) CNGTTR S000176 
MYBCORE 650  (-) CNGTTR S000176 
MYBGAHV 961  (-) TAACAAA S000181 
MYBPLANT 1102 (+) MACCWAMC S000167 
MYBST1 778  (+) GGATA S000180 
MYBST1 161  (-) GGATA S000180 
MYBST1 288  (-) GGATA S000180 
MYBST1 790  (-) GGATA S000180 
MYCATERD1 924  (-) CATGTG S000413 
MYCATRD22 924  (+) CACATG S000174 
MYCCONSENSUSAT 924  (+) CANNTG S000407 
MYCCONSENSUSAT 924  (-) CANNTG S000407 
NODCON2GM 1131 (+) CTCTT S000462 
NODCON2GM 538  (-) CTCTT S000462 
NODCON2GM 1297 (-) CTCTT S000462 
OSE2ROOTNODULE 1131 (+) CTCTT S000468 
OSE2ROOTNODULE 538  (-) CTCTT S000468 
OSE2ROOTNODULE 1297 (-) CTCTT S000468 
PE2FNTRNR1A 735  (-) ATTCGCGC S000455 
POLASIG1 60   (+) AATAAA S000080 
POLASIG1 64   (+) AATAAA S000080 
POLASIG1 321  (+) AATAAA S000080 
POLASIG1 521  (+) AATAAA S000080 
POLASIG1 662  (+) AATAAA S000080 
POLASIG1 868  (+) AATAAA S000080 
POLASIG1 872  (+) AATAAA S000080 
POLASIG1 880  (+) AATAAA S000080 
POLASIG1 199  (-) AATAAA S000080 
POLASIG1 364  (-) AATAAA S000080 
POLASIG1 386  (-) AATAAA S000080 
POLASIG1 833  (-) AATAAA S000080 
POLASIG1 915  (-) AATAAA S000080 
POLASIG1 1412 (-) AATAAA S000080 
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POLASIG2 455  (+) AATTAAA S000081 
POLASIG2 619  (+) AATTAAA S000081 
POLASIG2 678  (+) AATTAAA S000081 
POLASIG2 1427 (+) AATTAAA S000081 
POLASIG2 379  (-) AATTAAA S000081 
POLASIG3 11   (+) AATAAT S000088 
POLASIG3 337  (+) AATAAT S000088 
POLASIG3 975  (+) AATAAT S000088 
POLASIG3 1051 (+) AATAAT S000088 
POLASIG3 24   (-) AATAAT S000088 
POLASIG3 701  (-) AATAAT S000088 
POLASIG3 704  (-) AATAAT S000088 
POLASIG3 1242 (-) AATAAT S000088 
POLLEN1LELAT52 56   (+) AGAAA S000245 
POLLEN1LELAT52 210  (+) AGAAA S000245 
POLLEN1LELAT52 224  (+) AGAAA S000245 
POLLEN1LELAT52 269  (+) AGAAA S000245 
POLLEN1LELAT52 296  (+) AGAAA S000245 
POLLEN1LELAT52 462  (+) AGAAA S000245 
POLLEN1LELAT52 693  (+) AGAAA S000245 
POLLEN1LELAT52 120  (-) AGAAA S000245 
POLLEN1LELAT52 137  (-) AGAAA S000245 
POLLEN1LELAT52 342  (-) AGAAA S000245 
POLLEN1LELAT52 346  (-) AGAAA S000245 
POLLEN1LELAT52 391  (-) AGAAA S000245 
POLLEN1LELAT52 806  (-) AGAAA S000245 
POLLEN1LELAT52 838  (-) AGAAA S000245 
POLLEN1LELAT52 942  (-) AGAAA S000245 
POLLEN1LELAT52 1021 (-) AGAAA S000245 
POLLEN1LELAT52 1222 (-) AGAAA S000245 
POLLEN1LELAT52 1233 (-) AGAAA S000245 
POLLEN1LELAT52 1388 (-) AGAAA S000245 
PREATPRODH 156  (+) ACTCAT S000450 
PREATPRODH 1303 (+) ACTCAT S000450 
PRECONSCRHSP70A 1179 (+) 
SCGAYNRNNNNNNNNNNNNNNNHD 
S000506 
PYRIMIDINEBOXOSRAMY1A 373  (+) CCTTTT S000259 
PYRIMIDINEBOXOSRAMY1A 753  (+) CCTTTT S000259 
PYRIMIDINEBOXOSRAMY1A 860  (-) CCTTTT S000259 
QARBNEXTA 999  (-) AACGTGT S000244 
RAV1AAT 48   (+) CAACA S000314 
RAV1AAT 1047 (+) CAACA S000314 
RAV1AAT 1111 (+) CAACA S000314 
RAV1AAT 888  (-) CAACA S000314 
RHERPATEXPA7 1162 (+) KCACGW S000512 
ROOTMOTIFTAPOX1 278  (+) ATATT S000098 
ROOTMOTIFTAPOX1 585  (+) ATATT S000098 
ROOTMOTIFTAPOX1 780  (+) ATATT S000098 
ROOTMOTIFTAPOX1 1307 (+) ATATT S000098 
ROOTMOTIFTAPOX1 14   (-) ATATT S000098 
ROOTMOTIFTAPOX1 401  (-) ATATT S000098 
ROOTMOTIFTAPOX1 822  (-) ATATT S000098 
ROOTMOTIFTAPOX1 844  (-) ATATT S000098 
RYREPEATBNNAPA 70   (-) CATGCA S000264 
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RYREPEATGMGY2 69   (-) CATGCAT S000105 
RYREPEATLEGUMINBOX 69   (-) CATGCAY S000100 
S1FBOXSORPS1L21 1116 (+) ATGGTA S000223 
SEBFCONSSTPR10A 799  (+) YTGTCWC S000391 
SEF1MOTIF 585  (+) ATATTTAWW S000006 
SEF3MOTIFGM 1107 (+) AACCCA S000115 
SEF4MOTIFGM7S 383  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 707  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 782  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 655  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1370 (+) RTTTTTR S000103 
SEF4MOTIFGM7S 747  (-) RTTTTTR S000103 
SEF4MOTIFGM7S 719  (-) RTTTTTR S000103 
SEF4MOTIFGM7S 882  (-) RTTTTTR S000103 
SORLREP3AT 502  (-) TGTATATAT S000488 
SP8BFIBSP8BIB 828  (+) TACTATT S000184 
SURECOREATSULTR11 216  (+) GAGAC S000499 
SURECOREATSULTR11 644  (-) GAGAC S000499 
T/GBOXATPIN2 1000 (-) AACGTG S000458 
TATABOX2 971  (+) TATAAAT S000109 
TATABOX5 117  (+) TTATTT S000203 
TATABOX5 200  (+) TTATTT S000203 
TATABOX5 365  (+) TTATTT S000203 
TATABOX5 387  (+) TTATTT S000203 
TATABOX5 705  (+) TTATTT S000203 
TATABOX5 834  (+) TTATTT S000203 
TATABOX5 946  (+) TTATTT S000203 
TATABOX5 1413 (+) TTATTT S000203 
TATABOX5 10   (-) TTATTT S000203 
TATABOX5 59   (-) TTATTT S000203 
TATABOX5 63   (-) TTATTT S000203 
TATABOX5 320  (-) TTATTT S000203 
TATABOX5 336  (-) TTATTT S000203 
TATABOX5 867  (-) TTATTT S000203 
TATABOX5 871  (-) TTATTT S000203 
TATABOX5 879  (-) TTATTT S000203 
TATABOX5 974  (-) TTATTT S000203 
TATABOXOSPAL 586  (+) TATTTAA S000400 
TATABOXOSPAL 8    (-) TATTTAA S000400 
TATCCAOSAMY 288  (+) TATCCA S000403 
TATCCAOSAMY 790  (+) TATCCA S000403 
TATCCAOSAMY 777  (-) TATCCA S000403 
TATCCAYMOTIFOSRAMY3D 288  (+) TATCCAY S000256 
TATCCAYMOTIFOSRAMY3D 776  (-) TATCCAY S000256 
TBOXATGAPB 959  (+) ACTTTG S000383 
TGACGTVMAMY 125  (+) TGACGT S000377 
TRANSINITDICOTS 1340 (-) AMNAUGGC S000201 
TRANSINITMONOCOTS 1340 (-) RMNAUGGC S000202 
WBOXATNPR1 89   (+) TTGAC S000390 
WBOXATNPR1 124  (+) TTGAC S000390 
WBOXATNPR1 743  (+) TTGAC S000390 
WBOXHVISO1 154  (+) TGACT S000442 
WBOXNTERF3 154  (+) TGACY S000457 
WBOXNTERF3 955  (-) TGACY S000457 
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WRKY71OS 90   (+) TGAC S000447 
WRKY71OS 125  (+) TGAC S000447 
WRKY71OS 154  (+) TGAC S000447 
WRKY71OS 183  (+) TGAC S000447 
WRKY71OS 744  (+) TGAC S000447 
WRKY71OS 1168 (+) TGAC S000447 
WRKY71OS 801  (-) TGAC S000447 
WRKY71OS 956  (-) TGAC S000447 
WRKY71OS 1152 (-) TGAC S000447 
 



































Element name Site/Strand/Sequence Identifier link 
-300ELEMENT 771  (+) TGHAAARK S000122 
-300ELEMENT 801  (+) TGHAAARK S000122 
-300ELEMENT 761  (-) TGHAAARK S000122 
2SSEEDPROTBANAPA 252  (+) CAAACAC S000143 
2SSEEDPROTBANAPA 466  (+) CAAACAC S000143 
2SSEEDPROTBANAPA 870  (+) CAAACAC S000143 
5659BOXLELAT5659 837  (+) GAAWTTGTGA S000280 
ACGTATERD1 1459 (+) ACGT S000415 
ACGTATERD1 1459 (-) ACGT S000415 
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ANAERO1CONSENSUS 199  (+) AAACAAA S000477 
ANAERO1CONSENSUS 204  (+) AAACAAA S000477 
ANAERO1CONSENSUS 210  (+) AAACAAA S000477 
ANAERO1CONSENSUS 1077 (+) AAACAAA S000477 
ANAERO1CONSENSUS 1318 (+) AAACAAA S000477 
ANAERO2CONSENSUS 411  (+) AGCAGC S000478 
ARR1AT 262  (+) NGATT S000454 
ARR1AT 853  (+) NGATT S000454 
ARR1AT 328  (+) NGATT S000454 
ARR1AT 538  (+) NGATT S000454 
ARR1AT 1387 (+) NGATT S000454 
ARR1AT 65   (-) NGATT S000454 
ARR1AT 846  (-) NGATT S000454 
ARR1AT 892  (-) NGATT S000454 
ARR1AT 969  (-) NGATT S000454 
ARR1AT 1072 (-) NGATT S000454 
ARR1AT 1262 (-) NGATT S000454 
ARR1AT 1295 (-) NGATT S000454 
ASF1MOTIFCAMV 1445 (-) TGACG S000024 
BIHD1OS 56   (-) TGTCA S000498 
BIHD1OS 266  (-) TGTCA S000498 
BIHD1OS 1187 (-) TGTCA S000498 
BOXIINTPATPB 309  (+) ATAGAA S000296 
BOXIINTPATPB 541  (-) ATAGAA S000296 
CAATBOX1 80   (+) CAAT S000028 
CAATBOX1 370  (+) CAAT S000028 
CAATBOX1 439  (+) CAAT S000028 
CAATBOX1 504  (+) CAAT S000028 
CAATBOX1 1182 (+) CAAT S000028 
CAATBOX1 1508 (+) CAAT S000028 
CAATBOX1 1520 (+) CAAT S000028 
CAATBOX1 106  (-) CAAT S000028 
CAATBOX1 228  (-) CAAT S000028 
CAATBOX1 264  (-) CAAT S000028 
CAATBOX1 449  (-) CAAT S000028 
CAATBOX1 1243 (-) CAAT S000028 
CACTFTPPCA1 163  (+) YACT S000449 
CACTFTPPCA1 874  (+) YACT S000449 
CACTFTPPCA1 903  (+) YACT S000449 
CACTFTPPCA1 916  (+) YACT S000449 
CACTFTPPCA1 1065 (+) YACT S000449 
CACTFTPPCA1 332  (+) YACT S000449 
CACTFTPPCA1 347  (+) YACT S000449 
CACTFTPPCA1 958  (+) YACT S000449 
CACTFTPPCA1 1009 (+) YACT S000449 
CACTFTPPCA1 1141 (+) YACT S000449 
CACTFTPPCA1 30   (-) YACT S000449 
CACTFTPPCA1 69   (-) YACT S000449 
CACTFTPPCA1 113  (-) YACT S000449 
CACTFTPPCA1 129  (-) YACT S000449 
CACTFTPPCA1 133  (-) YACT S000449 
CACTFTPPCA1 318  (-) YACT S000449 
CACTFTPPCA1 490  (-) YACT S000449 
CACTFTPPCA1 634  (-) YACT S000449 
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CACTFTPPCA1 1039 (-) YACT S000449 
CACTFTPPCA1 1042 (-) YACT S000449 
CACTFTPPCA1 1233 (-) YACT S000449 
CANBNNAPA 252  (+) CNAACAC S000148 
CANBNNAPA 466  (+) CNAACAC S000148 
CANBNNAPA 870  (+) CNAACAC S000148 
CCAATBOX1 79   (+) CCAAT S000030 
CCAATBOX1 438  (+) CCAAT S000030 
CCAATBOX1 1181 (+) CCAAT S000030 
CIACADIANLELHC 59   (+) CAANNNNATC S000252 
CIACADIANLELHC 95   (+) CAANNNNATC S000252 
CIACADIANLELHC 213  (+) CAANNNNATC S000252 
CIACADIANLELHC 1520 (+) CAANNNNATC S000252 
CMSRE1IBSPOA 728  (+) TGGACGG S000511 
CURECORECR 134  (+) GTAC S000493 
CURECORECR 346  (+) GTAC S000493 
CURECORECR 1203 (+) GTAC S000493 
CURECORECR 134  (-) GTAC S000493 
CURECORECR 346  (-) GTAC S000493 
CURECORECR 1203 (-) GTAC S000493 
DOFCOREZM 116  (+) AAAG S000265 
DOFCOREZM 215  (+) AAAG S000265 
DOFCOREZM 314  (+) AAAG S000265 
DOFCOREZM 418  (+) AAAG S000265 
DOFCOREZM 461  (+) AAAG S000265 
DOFCOREZM 513  (+) AAAG S000265 
DOFCOREZM 551  (+) AAAG S000265 
DOFCOREZM 590  (+) AAAG S000265 
DOFCOREZM 594  (+) AAAG S000265 
DOFCOREZM 637  (+) AAAG S000265 
DOFCOREZM 683  (+) AAAG S000265 
DOFCOREZM 774  (+) AAAG S000265 
DOFCOREZM 795  (+) AAAG S000265 
DOFCOREZM 805  (+) AAAG S000265 
DOFCOREZM 933  (+) AAAG S000265 
DOFCOREZM 1304 (+) AAAG S000265 
DOFCOREZM 1311 (+) AAAG S000265 
DOFCOREZM 303  (-) AAAG S000265 
DOFCOREZM 338  (-) AAAG S000265 
DOFCOREZM 364  (-) AAAG S000265 
DOFCOREZM 717  (-) AAAG S000265 
DOFCOREZM 722  (-) AAAG S000265 
DOFCOREZM 781  (-) AAAG S000265 
DOFCOREZM 818  (-) AAAG S000265 
DOFCOREZM 823  (-) AAAG S000265 
DOFCOREZM 918  (-) AAAG S000265 
DOFCOREZM 1004 (-) AAAG S000265 
DOFCOREZM 1011 (-) AAAG S000265 
DOFCOREZM 1197 (-) AAAG S000265 
DOFCOREZM 1366 (-) AAAG S000265 
DOFCOREZM 1489 (-) AAAG S000265 
DPBFCOREDCDC3 257  (+) ACACNNG S000292 
E2FCONSENSUS 619  (+) WTTSSCSS S000476 
E2FCONSENSUS 1046 (+) WTTSSCSS S000476 
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E2FCONSENSUS 623  (-) WTTSSCSS S000476 
EBOXBNNAPA 187  (+) CANNTG S000144 
EBOXBNNAPA 702  (+) CANNTG S000144 
EBOXBNNAPA 767  (+) CANNTG S000144 
EBOXBNNAPA 1216 (+) CANNTG S000144 
EBOXBNNAPA 1448 (+) CANNTG S000144 
EBOXBNNAPA 187  (-) CANNTG S000144 
EBOXBNNAPA 702  (-) CANNTG S000144 
EBOXBNNAPA 767  (-) CANNTG S000144 
EBOXBNNAPA 1216 (-) CANNTG S000144 
EBOXBNNAPA 1448 (-) CANNTG S000144 
EECCRCAH1 362  (+) GANTTNC S000494 
EECCRCAH1 864  (-) GANTTNC S000494 
EECCRCAH1 1097 (-) GANTTNC S000494 
ELRECOREPCRP1 678  (-) TTGACC S000142 
ERELEE4 866  (+) AWTTCAAA S000037 
GATABOX 14   (+) GATA S000039 
GATABOX 663  (+) GATA S000039 
GATABOX 736  (+) GATA S000039 
GATABOX 965  (+) GATA S000039 
GATABOX 1210 (+) GATA S000039 
GATABOX 1224 (+) GATA S000039 
GATABOX 1456 (+) GATA S000039 
GATABOX 236  (-) GATA S000039 
GATABOX 740  (-) GATA S000039 
GATABOX 941  (-) GATA S000039 
GATABOX 1235 (-) GATA S000039 
GATABOX 1289 (-) GATA S000039 
GT1CONSENSUS 37   (+) GRWAAW S000198 
GT1CONSENSUS 46   (+) GRWAAW S000198 
GT1CONSENSUS 274  (+) GRWAAW       S000198 
GT1CONSENSUS 626  (+) GRWAAW S000198 
GT1CONSENSUS 627  (+) GRWAAW S000198 
GT1CONSENSUS 686  (+) GRWAAW S000198 
GT1CONSENSUS 965  (+) GRWAAW S000198 
GT1CONSENSUS 1089 (+) GRWAAW S000198 
GT1CONSENSUS 1314 (+) GRWAAW S000198 
GT1CONSENSUS 24   (-) GRWAAW S000198 
GT1CONSENSUS 939  (-) GRWAAW S000198 
GT1CONSENSUS 1045 (-) GRWAAW S000198 
GT1CONSENSUS 1127 (-) GRWAAW S000198 
GT1CONSENSUS 1250 (-) GRWAAW S000198 
GT1CONSENSUS 1279 (-) GRWAAW S000198 
GT1CONSENSUS 1407 (-) GRWAAW S000198 
GT1CONSENSUS 1477 (-) GRWAAW S000198 
GT1CONSENSUS 1493 (-) GRWAAW S000198 
GT1CONSENSUS 339  (-) GRWAAW S000198 
GT1CONSENSUS 433  (-) GRWAAW S000198 
GT1CONSENSUS 434  (-) GRWAAW S000198 
GT1CONSENSUS 762  (-) GRWAAW S000198 
GT1CONSENSUS 1177 (-) GRWAAW S000198 
GT1GMSCAM4 274  (+) GAAAAA S000453 
GT1GMSCAM4 686  (+) GAAAAA S000453 
GT1GMSCAM4 1089 (+) GAAAAA S000453 
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GT1GMSCAM4 1314 (+) GAAAAA S000453 
GT1GMSCAM4 433  (-) GAAAAA S000453 
GT1GMSCAM4 762  (-) GAAAAA S000453 
GTGANTG10 130  (+) GTGA S000378 
GTGANTG10 734  (+) GTGA S000378 
GTGANTG10 843  (+) GTGA S000378 
GTGANTG10 1451 (+) GTGA S000378 
GTGANTG10 902  (-) GTGA S000378 
GTGANTG10 1064 (-) GTGA S000378 
GTGANTG10 1391 (-) GTGA S000378 
GTGANTG10 1416 (-) GTGA S000378 
IBOX 1210 (+) GATAAG S000124 
IBOXCORE 965  (+) GATAA S000199 
IBOXCORE 1210 (+) GATAA S000199 
IBOXCORE 940  (-) GATAA S000199 
INRNTPSADB 368  (+) YTCANTYY S000395 
INRNTPSADB 1397 (+) YTCANTYY S000395 
INRNTPSADB 139  (+) YTCANTYY S000395 
INRNTPSADB 1063 (+) YTCANTYY S000395 
INRNTPSADB 123  (-) YTCANTYY S000395 
INRNTPSADB 294  (-) YTCANTYY S000395 
INRNTPSADB 628  (-) YTCANTYY S000395 
INRNTPSADB 1092 (-) YTCANTYY S000395 
INRNTPSADB 832  (-) YTCANTYY S000395 
LTRE1HVBLT49 1409 (-) CCGAAA S000250 
MARTBOX 751  (+) TTWTWTTWTT S000067 
MARTBOX 757  (+) TTWTWTTWTT S000067 
MARTBOX 282  (-) TTWTWTTWTT S000067 
MARTBOX 283  (-) TTWTWTTWTT S000067 
MARTBOX 284  (-) TTWTWTTWTT S000067 
MARTBOX 285  (-) TTWTWTTWTT S000067 
MARTBOX 286  (-) TTWTWTTWTT S000067 
MARTBOX 287  (-) TTWTWTTWTT S000067 
MARTBOX 288  (-) TTWTWTTWTT S000067 
MARTBOX 505  (-) TTWTWTTWTT S000067 
MARTBOX 1322 (-) TTWTWTTWTT S000067 
MYB1AT 76   (+) WAACCA S000408 
MYB1AT 86   (+) WAACCA S000408 
MYB1AT 248  (+) WAACCA S000408 
MYB1AT 277  (+) WAACCA S000408 
MYB2CONSENSUSAT 767  (-) YAACKG S000409 
MYBCORE 767  (+) CNGTTR S000176 
MYBPLANT 249  (+) MACCWAMC S000167 
MYBST1 964  (+) GGATA S000180 
MYBST1 1223 (+) GGATA S000180 
MYBST1 1235 (-) GGATA S000180 
MYBST1 1289 (-) GGATA S000180 
MYCATERD1 1448 (+) CATGTG S000413 
MYCATRD22 1448 (-) CACATG S000174 
MYCCONSENSUSAT 187  (+) CANNTG S000407 
MYCCONSENSUSAT 702  (+) CANNTG S000407 
MYCCONSENSUSAT 767  (+) CANNTG S000407 
MYCCONSENSUSAT 1216 (+) CANNTG S000407 
MYCCONSENSUSAT 1448 (+) CANNTG S000407 
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MYCCONSENSUSAT 187  (-) CANNTG S000407 
MYCCONSENSUSAT 702  (-) CANNTG S000407 
MYCCONSENSUSAT 767  (-) CANNTG S000407 
MYCCONSENSUSAT 1216 (-) CANNTG S000407 
MYCCONSENSUSAT 1448 (-) CANNTG S000407 
NODCON1GM 594  (+) AAAGAT S000461 
NODCON2GM 315  (-) CTCTT S000462 
NODCON2GM 708  (-) CTCTT S000462 
NTBBF1ARROLB 1010 (+) ACTTTA S000273 
NTBBF1ARROLB 636  (-) ACTTTA S000273 
NTBBF1ARROLB 794  (-) ACTTTA S000273 
OSE1ROOTNODULE 594  (+) AAAGAT S000467 
OSE2ROOTNODULE 315  (-) CTCTT S000468 
OSE2ROOTNODULE 708  (-) CTCTT S000468 
P1BS 1108 (+) GNATATNC S000459 
P1BS 1108 (-) GNATATNC S000459 
PALBOXAPC 729  (-) CCGTCC S000137 
POLASIG1 81   (+) AATAAA S000080 
POLASIG1 508  (+) AATAAA S000080 
POLASIG1 792  (+) AATAAA S000080 
POLASIG1 752  (-) AATAAA S000080 
POLASIG1 758  (-) AATAAA S000080 
POLASIG1 1012 (-) AATAAA S000080 
POLASIG1 1276 (-) AATAAA S000080 
POLASIG1 1490 (-) AATAAA S000080 
POLASIG2 584  (+) AATTAAA S000081 
POLASIG2 1145 (+) AATTAAA S000081 
POLASIG2 1151 (+) AATTAAA S000081 
POLASIG2 445  (-) AATTAAA S000081 
POLASIG3 440  (+) AATAAT S000088 
POLASIG3 505  (+) AATAAT S000088 
POLASIG3 1509 (+) AATAAT S000088 
POLASIG3 1168 (-) AATAAT S000088 
POLASIG3 1171 (-) AATAAT S000088 
POLASIG3 1428 (-) AATAAT S000088 
POLLEN1LELAT52 273  (+) AGAAA S000245 
POLLEN1LELAT52 311  (+) AGAAA S000245 
POLLEN1LELAT52 515  (+) AGAAA S000245 
POLLEN1LELAT52 592  (+) AGAAA S000245 
POLLEN1LELAT52 685  (+) AGAAA S000245 
POLLEN1LELAT52 935  (+) AGAAA S000245 
POLLEN1LELAT52 983  (+) AGAAA S000245 
POLLEN1LELAT52 1088 (+) AGAAA S000245 
POLLEN1LELAT52 1309 (+) AGAAA S000245 
POLLEN1LELAT52 1313 (+) AGAAA S000245 
POLLEN1LELAT52 1    (-) AGAAA S000245 
POLLEN1LELAT52 365  (-) AGAAA S000245 
POLLEN1LELAT52 719  (-) AGAAA S000245 
POLLEN1LELAT52 824  (-) AGAAA S000245 
POLLEN1LELAT52 1129 (-) AGAAA S000245 
POLLEN1LELAT52 1252 (-) AGAAA S000245 
POLLEN1LELAT52 1281 (-) AGAAA S000245 
POLLEN1LELAT52 1479 (-) AGAAA S000245 
PREATPRODH 126  (-) ACTCAT S000450 
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PREATPRODH 631  (-) ACTCAT S000450 
PROLAMINBOXOSGLUB1 771  (+) TGCAAAG S000354 
PYRIMIDINEBOXHVEPB1 432  (+) TTTTTTCC S000298 
PYRIMIDINEBOXOSRAMY1A 337  (+) CCTTTT S000259 
PYRIMIDINEBOXOSRAMY1A 1196 (+) CCTTTT S000259 
PYRIMIDINEBOXOSRAMY1A 214  (-) CCTTTT S000259 
PYRIMIDINEBOXOSRAMY1A 1303 (-) CCTTTT S000259 
RAV1AAT 59   (+) CAACA S000314 
RAV1AAT 95   (+) CAACA S000314 
RAV1AAT 578  (+) CAACA S000314 
RAV1AAT 1505 (+) CAACA S000314 
RAV1AAT 1332 (-) CAACA S000314 
REALPHALGLHCB21 77   (+) AACCAA S000362 
REALPHALGLHCB21 87   (+) AACCAA S000362 
REALPHALGLHCB21 249  (+) AACCAA S000362 
REALPHALGLHCB21 278  (+) AACCAA S000362 
ROOTMOTIFTAPOX1 172  (+) ATATT S000098 
ROOTMOTIFTAPOX1 1225 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1273 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1372 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1405 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1268 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1287 (-) ATATT S000098 
RYREPEATBNNAPA 32   (-) CATGCA S000264 
RYREPEATBNNAPA 390  (-) CATGCA S000264 
RYREPEATGMGY2 389  (-) CATGCAT S000105 
RYREPEATLEGUMINBOX 389  (-) CATGCAY S000100 
RYREPEATLEGUMINBOX 31   (-) CATGCAY S000100 
S1FBOXSORPS1L21 598  (+) ATGGTA S000223 
S1FBOXSORPS1L21 20   (-) ATGGTA S000223 
SEF1MOTIF 1273 (+) ATATTTAWW S000006 
SEF4MOTIFGM7S 749  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 755  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1026 (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1174 (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1227 (+) RTTTTTR S000103 
SEF4MOTIFGM7S 207  (-) RTTTTTR S000103 
SEF4MOTIFGM7S 1190 (-) RTTTTTR S000103 
SEF4MOTIFGM7S 83   (-) RTTTTTR S000103 
SITEIIATCYTC 398  (+) TGGGCY S000474 
SITEIIATCYTC 400  (-) TGGGCY S000474 
SORLIP1AT 452  (-) GCCAC S000482 
SORLIP2AT 399  (+) GGGCC S000483 
SORLIP2AT 400  (-) GGGCC S000483 
SORLIP2AT 976  (-) GGGCC S000483 
SORLIP5AT 128  (+) GAGTGAG S000486 
SPHCOREZMC1 389  (-) TCCATGCAT S000154 
SREATMSD 964  (-) TTATCC S000470 
SURE1STPAT21 308  (+) AATAGAAAA S000186 
TAAAGSTKST1 115  (+) TAAAG S000387 
TAAAGSTKST1 636  (+) TAAAG S000387 
TAAAGSTKST1 794  (+) TAAAG S000387 
TAAAGSTKST1 1011 (-) TAAAG S000387 
TAAAGSTKST1 1489 (-) TAAAG S000387 
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TATABOX5 753  (+) TTATTT S000203 
TATABOX5 759  (+) TTATTT S000203 
TATABOX5 1013 (+) TTATTT S000203 
TATABOX5 1059 (+) TTATTT S000203 
TATABOX5 1172 (+) TTATTT S000203 
TATABOX5 1277 (+) TTATTT S000203 
TATABOX5 1491 (+) TTATTT S000203 
TATABOX5 148  (-) TTATTT S000203 
TATABOX5 791  (-) TTATTT S000203 
TATCCACHVAL21 1221 (-) TATCCAC S000416 
TATCCAOSAMY 1235 (+) TATCCA S000403 
TATCCAOSAMY 1289 (+) TATCCA S000403 
TATCCAOSAMY 1222 (-) TATCCA S000403 
TATCCAYMOTIFOSRAMY3D 1221 (-) TATCCAY S000256 
TBOXATGAPB 302  (+) ACTTTG S000383 
TBOXATGAPB 780  (+) ACTTTG S000383 
TBOXATGAPB 917  (+) ACTTTG S000383 
TELOBOXATEEF1AA1 649  (+) AAACCCTAA S000308 
UP2ATMSD 649  (+) AAACCCTA S000472 
WBBOXPCWRKY1 678  (-) TTTGACY S000310 
WBOXATNPR1 265  (+) TTGAC S000390 
WBOXATNPR1 1186 (+) TTGAC S000390 
WBOXATNPR1 93   (-) TTGAC S000390 
WBOXATNPR1 679  (-) TTGAC S000390 
WBOXHVISO1 92   (-) TGACT S000442 
WBOXHVISO1 572  (-) TGACT S000442 
WBOXNTCHN48 572  (-) CTGACY S000508 
WBOXNTERF3 92   (-) TGACY S000457 
WBOXNTERF3 572  (-) TGACY S000457 
WBOXNTERF3 678  (-) TGACY S000457 
WBOXNTERF3 1414 (-) TGACY S000457 
WRKY71OS 56   (+) TGAC S000447 
WRKY71OS 266  (+) TGAC S000447 
WRKY71OS 1187 (+) TGAC S000447 
WRKY71OS 93   (-) TGAC S000447 
WRKY71OS 573  (-) TGAC S000447 
WRKY71OS 679  (-) TGAC S000447 
WRKY71OS 1415 (-) TGAC S000447 
WRKY71OS 1446 (-) TGAC S000447 
 





































-10PEHVPSBD 593  (+) TATTCT S000392 
-10PEHVPSBD 724  (+) TATTCT S000392 
-300CORE 1073 (-) TGTAAAG S000001 
-300ELEMENT 715  (+) TGHAAARK S000122 
-300ELEMENT 1014 (-) TGHAAARK S000122 
ACGTATERD1 1466 (+) ACGT S000415 
ACGTATERD1 1466 (-) ACGT S000415 
AMYBOX1 970  (-) TAACARA S000020 
ARE1 261  (+) RGTGACNNNGC S000022 
ARR1AT 460  (+) NGATT S000454 
ARR1AT 491  (+) NGATT S000454 
ARR1AT 839  (+) NGATT S000454 
ARR1AT 940  (+) NGATT S000454 
ARR1AT 1275 (+) NGATT S000454 
ARR1AT 1296 (+) NGATT S000454 
ARR1AT 1412 (+) NGATT S000454 
ARR1AT 353  (+) NGATT S000454 
ARR1AT 1137 (+) NGATT S000454 
ARR1AT 306  (+) NGATT S000454 
ARR1AT 990  (+) NGATT S000454 
ARR1AT 1023 (+) NGATT S000454 
ARR1AT 9    (-) NGATT S000454 
ARR1AT 404  (-) NGATT S000454 
ARR1AT 647  (-) NGATT S000454 
ARR1AT 705  (-) NGATT S000454 
ARR1AT 878  (-) NGATT S000454 
ARR1AT 883  (-) NGATT S000454 
ARR1AT 978  (-) NGATT S000454 
ARR1AT 1079 (-) NGATT S000454 
ARR1AT 1369 (-) NGATT S000454 
BIHD1OS 1319 (+) TGTCA S000498 
BOXIINTPATPB 65   (+) ATAGAA S000296 
BOXIINTPATPB 595  (-) ATAGAA S000296 
BOXIINTPATPB 1142 (-) ATAGAA S000296 
CAATBOX1 12   (+) CAAT S000028 
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CAATBOX1 22   (+) CAAT S000028 
CAATBOX1 666  (+) CAAT S000028 
CAATBOX1 1020 (+) CAAT S000028 
CAATBOX1 1078 (+) CAAT S000028 
CAATBOX1 1424 (+) CAAT S000028 
CAATBOX1 1499 (+) CAAT S000028 
CAATBOX1 75   (-) CAAT S000028 
CAATBOX1 101  (-) CAAT S000028 
CAATBOX1 308  (-) CAAT S000028 
CAATBOX1 423  (-) CAAT S000028 
CAATBOX1 585  (-) CAAT S000028 
CAATBOX1 668  (-) CAAT S000028 
CAATBOX1 1109 (-) CAAT S000028 
CAATBOX1 1157 (-) CAAT S000028 
CAATBOX1 1323 (-) CAAT S000028 
CAATBOX1 1401 (-) CAAT S000028 
CACTFTPPCA1 321  (+) YACT S000449 
CACTFTPPCA1 1040 (+) YACT S000449 
CACTFTPPCA1 1263 (+) YACT S000449 
CACTFTPPCA1 173  (+) YACT S000449 
CACTFTPPCA1 252  (+) YACT S000449 
CACTFTPPCA1 432  (+) YACT S000449 
CACTFTPPCA1 603  (+) YACT S000449 
CACTFTPPCA1 927  (+) YACT S000449 
CACTFTPPCA1 961  (+) YACT S000449 
CACTFTPPCA1 1153 (+) YACT S000449 
CACTFTPPCA1 1163 (+) YACT S000449 
CACTFTPPCA1 1184 (+) YACT S000449 
CACTFTPPCA1 1359 (+) YACT S000449 
CACTFTPPCA1 160  (-) YACT S000449 
CACTFTPPCA1 771  (-) YACT S000449 
CACTFTPPCA1 890  (-) YACT S000449 
CACTFTPPCA1 1068 (-) YACT S000449 
CACTFTPPCA1 1123 (-) YACT S000449 
CACTFTPPCA1 1175 (-) YACT S000449 
CACTFTPPCA1 1257 (-) YACT S000449 
CACTFTPPCA1 1317 (-) YACT S000449 
CACTFTPPCA1 1340 (-) YACT S000449 
CACTFTPPCA1 1394 (-) YACT S000449 
CACTFTPPCA1 1449 (-) YACT S000449 
CAREOSREP1 1216 (-) CAACTC S000421 
CARGCW8GAT 323  (+) CWWWWWWWWG S000431 
CARGCW8GAT 323  (-) CWWWWWWWWG S000431 
CCAATBOX1 423  (-) CCAAT S000030 
CIACADIANLELHC 398  (+) CAANNNNATC S000252 
CIACADIANLELHC 769  (+) CAANNNNATC S000252 
CURECORECR 897  (+) GTAC S000493 
CURECORECR 897  (-) GTAC S000493 
DOFCOREZM 165  (+) AAAG S000265 
DOFCOREZM 296  (+) AAAG S000265 
DOFCOREZM 372  (+) AAAG S000265 
DOFCOREZM 458  (+) AAAG S000265 
DOFCOREZM 837  (+) AAAG S000265 
DOFCOREZM 860  (+) AAAG S000265 
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DOFCOREZM 871  (+) AAAG S000265 
DOFCOREZM 905  (+) AAAG S000265 
DOFCOREZM 1213 (+) AAAG S000265 
DOFCOREZM 1329 (+) AAAG S000265 
DOFCOREZM 1410 (+) AAAG S000265 
DOFCOREZM 139  (-) AAAG S000265 
DOFCOREZM 150  (-) AAAG S000265 
DOFCOREZM 434  (-) AAAG S000265 
DOFCOREZM 484  (-) AAAG S000265 
DOFCOREZM 515  (-) AAAG S000265 
DOFCOREZM 558  (-) AAAG S000265 
DOFCOREZM 743  (-) AAAG S000265 
DOFCOREZM 963  (-) AAAG S000265 
DOFCOREZM 1005 (-) AAAG S000265 
DOFCOREZM 1055 (-) AAAG S000265 
DOFCOREZM 1062 (-) AAAG S000265 
DOFCOREZM 1073 (-) AAAG S000265 
DOFCOREZM 1372 (-) AAAG S000265 
DPBFCOREDCDC3 672  (-) ACACNNG S000292 
DPBFCOREDCDC3 1255 (-) ACACNNG S000292 
EBOXBNNAPA 341  (+) CANNTG S000144 
EBOXBNNAPA 666  (+) CANNTG S000144 
EBOXBNNAPA 672  (+) CANNTG S000144 
EBOXBNNAPA 341  (-) CANNTG S000144 
EBOXBNNAPA 666  (-) CANNTG S000144 
EBOXBNNAPA 672  (-) CANNTG S000144 
EECCRCAH1 793  (+) GANTTNC S000494 
EECCRCAH1 1138 (+) GANTTNC S000494 
ELRECOREPCRP1 19   (-) TTGACC S000142 
ERELEE4 808  (+) AWTTCAAA S000037 
ERELEE4 1278 (-) AWTTCAAA S000037 
GAREAT 970  (-) TAACAAR S000439 
GATABOX 257  (+) GATA S000039 
GATABOX 430  (+) GATA S000039 
GATABOX 874  (+) GATA S000039 
GATABOX 887  (+) GATA S000039 
GATABOX 997  (+) GATA S000039 
GATABOX 1033 (+) GATA S000039 
GATABOX 1246 (+) GATA S000039 
GATABOX 1345 (+) GATA S000039 
GATABOX 1446 (+) GATA S000039 
GATABOX 186  (-) GATA S000039 
GATABOX 481  (-) GATA S000039 
GATABOX 663  (-) GATA S000039 
GATABOX 775  (-) GATA S000039 
GATABOX 801  (-) GATA S000039 
GATABOX 1052 (-) GATA S000039 
GATABOX 1070 (-) GATA S000039 
GT1CONSENSUS 68   (+) GRWAAW S000198 
GT1CONSENSUS 168  (+) GRWAAW S000198 
GT1CONSENSUS 311  (+) GRWAAW S000198 
GT1CONSENSUS 364  (+) GRWAAW S000198 
GT1CONSENSUS 874  (+) GRWAAW S000198 
GT1CONSENSUS 1221 (+) GRWAAW S000198 
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GT1CONSENSUS 1332 (+) GRWAAW S000198 
GT1CONSENSUS 661  (-) GRWAAW S000198 
GT1CONSENSUS 1139 (-) GRWAAW S000198 
GT1CONSENSUS 1484 (-) GRWAAW S000198 
GT1CONSENSUS 479  (-) GRWAAW S000198 
GT1CONSENSUS 577  (-) GRWAAW S000198 
GT1CONSENSUS 1015 (-) GRWAAW S000198 
GT1CONSENSUS 1050 (-) GRWAAW S000198 
GT1GMSCAM4 364  (+) GAAAAA S000453 
GT1GMSCAM4 1332 (+) GAAAAA S000453 
GT1GMSCAM4 577  (-) GAAAAA S000453 
GT1GMSCAM4 1015 (-) GAAAAA S000453 
GTGANTG10 262  (+) GTGA S000378 
GTGANTG10 1272 (+) GTGA S000378 
GTGANTG10 181  (-) GTGA S000378 
GTGANTG10 469  (-) GTGA S000378 
GTGANTG10 777  (-) GTGA S000378 
GTGANTG10 1039 (-) GTGA S000378 
HDZIP2ATATHB2 704  (+) TAATMATTA S000373 
HDZIP2ATATHB2 748  (+) TAATMATTA S000373 
HSELIKENTACIDICPR
1 
1406 (+) CNNGAANNNTTCNNG S000056 
HSELIKENTACIDICPR
1 
1406 (-) CNNGAANNNTTCNNG S000056 
IBOXCORE 874  (+) GATAA S000199 
IBOXCORE 997  (+) GATAA S000199 
IBOXCORE 480  (-) GATAA S000199 
IBOXCORE 662  (-) GATAA S000199 
IBOXCORE 1051 (-) GATAA S000199 
INRNTPSADB 1481 (+) YTCANTYY S000395 
INRNTPSADB 788  (-) YTCANTYY S000395 
LECPLEACS2 717  (+) TAAAATAT S000465 
LTRE1HVBLT49 362  (+) CCGAAA S000250 
LTRECOREATCOR15 119  (+) CCGAC S000153 
MARABOX1 609  (-) AATAAAYAAA S000063 
MARTBOX 365  (-) TTWTWTTWTT S000067 
MYBCOREATCYCB1 684  (-) AACGG S000502 
MYBGAHV 970  (-) TAACAAA S000181 
MYBPLANT 1539 (+) MACCWAMC S000167 
MYCATERD1 672  (+) CATGTG S000413 
MYCATRD22 672  (-) CACATG S000174 
MYCCONSENSUSAT 341  (+) CANNTG S000407 
MYCCONSENSUSAT 666  (+) CANNTG S000407 
MYCCONSENSUSAT 672  (+) CANNTG S000407 
MYCCONSENSUSAT 341  (-) CANNTG S000407 
MYCCONSENSUSAT 666  (-) CANNTG S000407 
MYCCONSENSUSAT 672  (-) CANNTG S000407 
NAPINMOTIFBN 689  (+) TACACAT S000070 
NAPINMOTIFBN 948  (+) TACACAT S000070 
NODCON1GM 458  (+) AAAGAT S000461 
NODCON1GM 837  (+) AAAGAT S000461 
NODCON1GM 871  (+) AAAGAT S000461 
NODCON1GM 1410 (+) AAAGAT S000461 
NODCON1GM 482  (-) AAAGAT S000461 
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NODCON1GM 741  (-) AAAGAT S000461 
NODCON1GM 1053 (-) AAAGAT S000461 
NODCON1GM 1060 (-) AAAGAT S000461 
NODCON1GM 1071 (-) AAAGAT S000461 
NODCON1GM 1370 (-) AAAGAT S000461 
NODCON2GM 105  (-) CTCTT S000462 
NODCON2GM 125  (-) CTCTT S000462 
NODCON2GM 1214 (-) CTCTT S000462 
NTBBF1ARROLB 557  (+) ACTTTA S000273 
OSE1ROOTNODULE 458  (+) AAAGAT S000467 
OSE1ROOTNODULE 837  (+) AAAGAT S000467 
OSE1ROOTNODULE 871  (+) AAAGAT S000467 
OSE1ROOTNODULE 1410 (+) AAAGAT S000467 
OSE1ROOTNODULE 482  (-) AAAGAT S000467 
OSE1ROOTNODULE 741  (-) AAAGAT S000467 
OSE1ROOTNODULE 1053 (-) AAAGAT S000467 
OSE1ROOTNODULE 1060 (-) AAAGAT S000467 
OSE1ROOTNODULE 1071 (-) AAAGAT S000467 
OSE1ROOTNODULE 1370 (-) AAAGAT S000467 
OSE2ROOTNODULE 105  (-) CTCTT S000468 
OSE2ROOTNODULE 125  (-) CTCTT S000468 
OSE2ROOTNODULE 1214 (-) CTCTT S000468 
P1BS 1148 (+) GNATATNC S000459 
P1BS 1148 (-) GNATATNC S000459 
POLASIG1 368  (+) AATAAA S000080 
POLASIG1 1195 (+) AATAAA S000080 
POLASIG1 1210 (+) AATAAA S000080 
POLASIG1 463  (-) AATAAA S000080 
POLASIG1 494  (-) AATAAA S000080 
POLASIG1 572  (-) AATAAA S000080 
POLASIG1 591  (-) AATAAA S000080 
POLASIG1 609  (-) AATAAA S000080 
POLASIG1 613  (-) AATAAA S000080 
POLASIG1 966  (-) AATAAA S000080 
POLASIG1 1106 (-) AATAAA S000080 
POLASIG2 527  (-) AATTAAA S000081 
POLASIG2 567  (-) AATTAAA S000081 
POLASIG3 749  (+) AATAAT S000088 
POLASIG3 1283 (+) AATAAT S000088 
POLASIG3 1    (-) AATAAT S000088 
POLASIG3 72   (-) AATAAT S000088 
POLASIG3 98   (-) AATAAT S000088 
POLASIG3 616  (-) AATAAT S000088 
POLASIG3 1178 (-) AATAAT S000088 
POLASIG3 1227 (-) AATAAT S000088 
POLLEN1LELAT52 67   (+) AGAAA S000245 
POLLEN1LELAT52 163  (+) AGAAA S000245 
POLLEN1LELAT52 167  (+) AGAAA S000245 
POLLEN1LELAT52 757  (+) AGAAA S000245 
POLLEN1LELAT52 1331 (+) AGAAA S000245 
POLLEN1LELAT52 1141 (-) AGAAA S000245 
POLLEN1LELAT52 1231 (-) AGAAA S000245 
PREATPRODH 918  (-) ACTCAT S000450 






295  (-) CCTTTT S000259 
QELEMENTZMZM13 263  (-) AGGTCA S000254 
RAV1AAT 143  (+) CAACA S000314 
RAV1AAT 825  (-) CAACA S000314 
REALPHALGLHCB21 424  (-) AACCAA S000362 
RHERPATEXPA7 153  (-) KCACGW S000512 
ROOTMOTIFTAPOX1 285  (+) ATATT S000098 
ROOTMOTIFTAPOX1 325  (+) ATATT S000098 
ROOTMOTIFTAPOX1 502  (+) ATATT S000098 
ROOTMOTIFTAPOX1 540  (+) ATATT S000098 
ROOTMOTIFTAPOX1 547  (+) ATATT S000098 
ROOTMOTIFTAPOX1 583  (+) ATATT S000098 
ROOTMOTIFTAPOX1 723  (+) ATATT S000098 
ROOTMOTIFTAPOX1 1034 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1090 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1096 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1225 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1311 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1399 (+) ATATT S000098 
ROOTMOTIFTAPOX1 282  (-) ATATT S000098 
ROOTMOTIFTAPOX1 314  (-) ATATT S000098 
ROOTMOTIFTAPOX1 381  (-) ATATT S000098 
ROOTMOTIFTAPOX1 444  (-) ATATT S000098 
ROOTMOTIFTAPOX1 539  (-) ATATT S000098 
ROOTMOTIFTAPOX1 720  (-) ATATT S000098 
ROOTMOTIFTAPOX1 1095 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1132 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1149 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1224 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1286 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1310 (-) ATATT S000098 
RYREPEATBNNAPA 670  (-) CATGCA S000264 
SEF3MOTIFGM 1544 (+) AACCCA S000115 
SEF4MOTIFGM7S 623  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 1084 (+) RTTTTTR S000103 
SEF4MOTIFGM7S 588  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 922  (+) RTTTTTR S000103 
SORLREP3AT 653  (-) TGTATATAT S000488 
SP8BFIBSP8AIB 208  (+) ACTGTGTA S000183 
SP8BFIBSP8BIB 603  (+) TACTATT S000184 
SP8BFIBSP8BIB 1153 (+) TACTATT S000184 
SURE2STPAT21 1172 (-) AATACTAAT S000185 
TAAAGSTKST1 457  (+) TAAAG S000387 
TAAAGSTKST1 870  (+) TAAAG S000387 
TAAAGSTKST1 1212 (+) TAAAG S000387 
TAAAGSTKST1 1328 (+) TAAAG S000387 
TAAAGSTKST1 558  (-) TAAAG S000387 
TAAAGSTKST1 743  (-) TAAAG S000387 
TAAAGSTKST1 1073 (-) TAAAG S000387 
TAAAGSTKST1 1372 (-) TAAAG S000387 
TATABOX2 1206 (+) TATAAAT S000109 
TATABOX3 618  (+) TATTAAT S000110 
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TATABOX3 1091 (+) TATTAAT S000110 
TATABOX3 1092 (-) TATTAAT S000110 
TATABOX4 637  (+) TATATAA S000111 
TATABOX4 1439 (-) TATATAA S000111 
TATABOX5 464  (+) TTATTT S000203 
TATABOX5 495  (+) TTATTT S000203 
TATABOX5 573  (+) TTATTT S000203 
TATABOX5 610  (+) TTATTT S000203 
TATABOX5 967  (+) TTATTT S000203 
TATABOX5 1179 (+) TTATTT S000203 
TATABOX5 1228 (+) TTATTT S000203 
TATABOX5 367  (-) TTATTT S000203 
TATABOX5 1194 (-) TTATTT S000203 
TATABOX5 1209 (-) TTATTT S000203 
TATABOX5 1282 (-) TTATTT S000203 
TATAPVTRNALEU 1438 (+) TTTATATA S000340 
TELOBOXATEEF1AA1 234  (-) AAACCCTAA S000308 
UP2ATMSD 235  (-) AAACCCTA S000472 
WBOXATNPR1 1402 (+) TTGAC S000390 
WBOXATNPR1 20   (-) TTGAC S000390 
WBOXHVISO1 39   (+) TGACT S000442 
WBOXHVISO1 1403 (+) TGACT S000442 
WBOXNTERF3 39   (+) TGACY S000457 
WBOXNTERF3 263  (+) TGACY S000457 
WBOXNTERF3 1403 (+) TGACY S000457 
WBOXNTERF3 19   (-) TGACY S000457 
WRKY71OS 39   (+) TGAC S000447 
WRKY71OS 263  (+) TGAC S000447 
WRKY71OS 1403 (+) TGAC S000447 
WRKY71OS 20   (-) TGAC S000447 
WRKY71OS 1320 (-) TGAC S000447 
WUSATAg 1266 (+) TTAATGG S000433 
 
 





































-10PEHVPSBD 609  (+) TATTCT S000392 
-10PEHVPSBD 494  (-) TATTCT S000392 
-10PEHVPSBD 1088 (-) TATTCT S000392 
-10PEHVPSBD 1558 (-) TATTCT S000392 
-300ELEMENT 665  (+) TGHAAARK S000122 
AACACOREOSGLUB1 288  (+) AACAAAC S000353 
AACACOREOSGLUB1 578  (-) AACAAAC S000353 
ABRELATERD1 1140 (+) ACGTG S000414 
ABRELATERD1 1061 (-) ACGTG S000414 
ABRELATERD1 1261 (-) ACGTG S000414 
ABRERATCAL 1139 (+) MACGYGB S000507 
ABRERATCAL 1260 (-) MACGYGB S000507 
ACGTATERD1 705  (+) ACGT S000415 
ACGTATERD1 1062 (+) ACGT S000415 
ACGTATERD1 1140 (+) ACGT S000415 
ACGTATERD1 1262 (+) ACGT S000415 
ACGTATERD1 705  (-) ACGT S000415 
ACGTATERD1 1062 (-) ACGT S000415 
ACGTATERD1 1140 (-) ACGT S000415 
ACGTATERD1 1262 (-) ACGT S000415 
AMYBOX1 579  (-) TAACARA S000020 
AMYBOX1 884  (-) TAACARA S000020 
ANAERO1CONSENSUS 123  (+) AAACAAA S000477 
ANAERO1CONSENSS 575  (-) AAACAAA S000477 
ARFAT 111  (-) TGTCTC S000270 
ARR1AT 207  (+) NGATT S000454 
ARR1AT 1319 (+) NGATT S000454 
ARR1AT 798  (+) NGATT S000454 
ARR1AT 973  (+) NGATT S000454 
ARR1AT 1386 (+) NGATT S000454 
ARR1AT 197  (-) NGATT S000454 
ARR1AT 295  (-) NGATT S000454 
ARR1AT 301  (-) NGATT S000454 
ARR1AT 352  (-) NGATT S000454 
ARR1AT 481  (-) NGATT S000454 
ARR1AT 679  (-) NGATT S000454 
ARR1AT 826  (-) NGATT S000454 
ARR1AT 890  (-) NGATT S000454 
ARR1AT 1011 (-) NGATT S000454 
ARR1AT 1051 (-) NGATT S000454 
ARR1AT 1132 (-) NGATT S000045 
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ARR1AT 1366 (-) NGATT S000454 
ASF1MOTIFCAMV 1345 (+) TGACG S000024 
BIHD1OS 465  (+) TGTCA S000498 
BIHD1OS 1248 (-) TGTCA S000498 
BOXIINTPATPB 68   (+) ATAGAA S000296 
BOXIINTPATPB 492  (+) ATAGAA S000296 
BOXIINTPATPB 630  (-) ATAGAA S000296 
BOXIINTPATPB 979  (-) ATAGAA S000296 
BOXLCOREDCPAL 1223 (+) ACCWWCC S000492 
BP5OSWX 1138 (+) CAACGTG S000436 
CAATBOX1 141  (+) CAAT S000028 
CAATBOX1 196  (+) CAAT S000028 
CAATBOX1 294  (+) CAAT S000028 
CAATBOX1 300  (+) CAAT S000028 
CAATBOX1 355  (+) CAAT S000028 
CAATBOX1 569  (+) CAAT S000028 
CAATBOX1 945  (+) CAAT S000028 
CAATBOX1 1042 (+) CAAT S000028 
CAATBOX1 1188 (+) CAAT S000028 
CAATBOX1 1230 (+) CAAT S000028 
CAATBOX1 1553 (+) CAAT S000028 
CAATBOX1 32   (-) CAAT S000028 
CAATBOX1 87   (-) CAAT S000028 
CAATBOX1 506  (-) CAAT S000028 
CAATBOX1 922  (-) CAAT S000028 
CAATBOX1 1019 (-) CAAT S000028 
CAATBOX1 1158 (-) CAAT S000028 
CAATBOX1 1204 (-) CAAT S000028 
CAATBOX1 1358 (-) CAAT S000028 
CAATBOX1 1418 (-) CAAT S000028 
CAATBOX1 1456 (-) CAAT S000028 
CAATBOX1 1508 (-) CAAT S000028 
CAATBOX1 1543 (-) CAAT S000028 
CACTFTPPCA1 163  (+) YACT S000449 
CACTFTPPCA1 213  (+) YACT S000449 
CACTFTPPCA1 247  (+) YACT S000449 
CACTFTPPCA1 484  (+) YACT S000449 
CACTFTPPCA1 627  (+) YACT S000449 
CACTFTPPCA1 934  (+) YACT S000449 
CACTFTPPCA1 1014 (+) YACT S000449 
CACTFTPPCA1 1150 (+) YACT S000449 
CACTFTPPCA1 1173 (+) YACT S000449 
CACTFTPPCA1 1251 (+) YACT S000449 
CACTFTPPCA1 1383 (+) YACT S000449 
CACTFTPPCA1 1534 (+) YACT S000449 
CACTFTPPCA1 275  (+) YACT S000449 
CACTFTPPCA1 590  (+) YACT S000449 
CACTFTPPCA1 838  (+) YACT S000449 
CACTFTPPCA1 1482 (+) YACT S000449 
CACTFTPPCA1 17   (-) YACT S000449 
CACTFTPPCA1 156  (-) YACT S000449 
CACTFTPPCA1 233  (-) YACT S000449 
CACTFTPPCA1 443  (-) YACT S000449 
CACTFTPPCA1 607  (-) YACT S000449 
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CACTFTPPCA1 659  (-) YACT S000449 
CACTFTPPCA1 692  (-) YACT S000449 
CACTFTPPCA1 767  (-) YACT S000449 
CACTFTPPCA1 778  (-) YACT S000449 
CACTFTPPCA1 1490 (-) YACT S000449 
CANBNNAPA 1069 (+) CNAACAC S000148 
CAREOSREP1 1325 (+) CAACTC S000421 
CARGCW8GAT 569  (+) CWWWWWWWWG S000431 
CARGCW8GAT 1395 (+) CWWWWWWWWG S000431 
CARGCW8GAT 569  (-) CWWWWWWWWG S000431 
CARGCW8GAT 1395 (-) CWWWWWWWWG S000431 
CBFHV 1317 (-) RYCGAC S000497 
CCA1ATLHCB1 292  (+) AAMAATCT S000149 
CCAATBOX1 1187 (+) CCAAT S000030 
CCAATBOX1 1229 (+) CCAAT S000030 
CCAATBOX1 1204 (-) CCAAT S000030 
CCAATBOX1 1508 (-) CCAAT S000030 
CGACGOSAMY3 1316 (-) CGACG S000205 
CPBCSPOR 769  (+) TATTAG S000491 
CPBCSPOR 391  (-) TATTAG S000491 
CPBCSPOR 1126 (-) TATTAG S000491 
CURECORECR 703  (+) GTAC S000493 
CURECORECR 1531 (+) GTAC S000493 
CURECORECR 703  (-) GTAC S000493 
CURECORECR 1531 (-) GTAC S000493 
DOFCOREZM 7    (+) AAAG S000265 
DOFCOREZM 59   (+) AAAG S000265 
DOFCOREZM 100  (+) AAAG S000265 
DOFCOREZM 119  (+) AAAG S000265 
DOFCOREZM 128  (+) AAAG S000265 
DOFCOREZM 174  (+) AAAG S000265 
DOFCOREZM 205  (+) AAAG S000265 
DOFCOREZM 231  (+) AAAG S000265 
DOFCOREZM 321  (+) AAAG S000265 
DOFCOREZM 441  (+) AAAG S000265 
DOFCOREZM 476  (+) AAAG S000265 
DOFCOREZM 622  (+) AAAG S000265 
DOFCOREZM 657  (+) AAAG S000265 
DOFCOREZM 765  (+) AAAG S000265 
DOFCOREZM 959  (+) AAAG S000265 
DOFCOREZM 1084 (+) AAAG S000265 
DOFCOREZM 1182 (+) AAAG S000265 
DOFCOREZM 1470 (+) AAAG S000265 
DOFCOREZM 1488 (+) AAAG S000265 
DOFCOREZM 63   (-) AAAG S000265 
DOFCOREZM 192  (-) AAAG S000265 
DOFCOREZM 364  (-) AAAG S000265 
DOFCOREZM 793  (-) AAAG S000265 
DOFCOREZM 840  (-) AAAG S000265 
DOFCOREZM 926  (-) AAAG S000265 
DOFCOREZM 1253 (-) AAAG S000265 
DOFCOREZM 1309 (-) AAAG S000265 
DOFCOREZM 1395 (-) AAAG S000265 
DOFCOREZM 1525 (-) AAAG S000265 
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DOFCOREZM 1539 (-) AAAG S000265 
DPBFCOREDCDC3 1172 (+) ACACNNG S000292 
EBOXBNNAPA 600  (+) CANNTG S000144 
EBOXBNNAPA 902  (+) CANNTG S000144 
EBOXBNNAPA 1173 (+) CANNTG S000144 
EBOXBNNAPA 1411 (+) CANNTG S000144 
EBOXBNNAPA 600  (-) CANNTG S000144 
EBOXBNNAPA 902  (-) CANNTG S000144 
EBOXBNNAPA 1173 (-) CANNTG S000144 
EBOXBNNAPA 1411 (-) CANNTG S000144 
EECCRCAH1 799  (+) GANTTNC S000494 
EECCRCAH1 50   (-) GANTTNC S000494 
ELRECOREPCRP1 1446 (+) TTGACC S000142 
ERELEE4 316  (+) AWTTCAAA S000037 
GARE2OSREP1 704  (-) TAACGTA S000420 
GAREAT 579  (-) TAACAAR S000439 
GAREAT 884  (-) TAACAAR S000439 
GATABOX 67   (+) GATA S000039 
GATABOX 308  (+) GATA S000039 
GATABOX 513  (+) GATA S000039 
GATABOX 526  (+) GATA S000039 
GATABOX 596  (+) GATA S000039 
GATABOX 698  (+) GATA S000039 
GATABOX 717  (+) GATA S000039 
GATABOX 860  (+) GATA S000039 
GATABOX 894  (+) GATA S000039 
GATABOX 1349 (+) GATA S000039 
GATABOX 1361 (+) GATA S000039 
GATABOX 395  (-) GATA S000039 
GATABOX 498  (-) GATA S000039 
GATABOX 528  (-) GATA S000039 
GATABOX 633  (-) GATA S000039 
GATABOX 1464 (-) GATA S000039 
GT1CONSENSUS 71   (+) GRWAAW S000198 
GT1CONSENSUS 103  (+) GRWAAW S000198 
GT1CONSENSUS 308  (+) GRWAAW S000198 
GT1CONSENSUS 382  (+) GRWAAW S000198 
GT1CONSENSUS 488  (+) GRWAAW S000198 
GT1CONSENSUS 666  (+) GRWAAW S000198 
GT1CONSENSUS 1178 (+) GRWAAW S000198 
GT1CONSENSUS 1349 (+) GRWAAW S000198 
GT1CONSENSUS 1361 (+) GRWAAW S000198 
GT1CONSENSUS 800  (-) GRWAAW S000198 
GT1CONSENSUS 434  (-) GRWAAW S000198 
GT1CONSENSUS 976  (-) GRWAAW S000198 
GT1CONSENSUS 992  (-) GRWAAW S000198 
GT1CONSENSUS 1265 (-) GRWAAW S000198 
GT1CORE 358  (-) GGTTAA S000125 
GT1GMSCAM4 666  (+) GAAAAA S000453 
GT1GMSCAM4 1178 (+) GAAAAA S000453 
GT1GMSCAM4 434  (-) GAAAAA S000453 
GT1GMSCAM4 976  (-) GAAAAA S000453 
GT1GMSCA4 992  (-) GAAAAA S000453 
GTGANTG10 109  (+) GTGA S000378 
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GTGANTG10 693  (+) GTGA S000378 
GTGANTG10 781  (+) GTGA S000378 
GTGANTG10 797  (+) GTGA S000378 
GTGANTG10 1565 (+) GTGA S000378 
GTGANTG10 55   (-) GTGA S000378 
GTGANTG10 162  (-) GTGA S000378 
GTGANTG10 212  (-) GTGA S000378 
GTGANTG10 483  (-) GTGA S000378 
GTGANTG10 626  (-) GTGA S000378 
GTGANTG10 639  (-) GTGA S000378 
GTGANTG10 1013 (-) GTGA S000378 
GTGANTG10 1060 (-) GTGA S000378 
GTGANTG10 1282 (-) GTGA S000378 
GTGANTG10 1382 (-) GTGA S000378 
GTGANTG10 1410 (-) GTGA S000378 
GTGANTG10 1550 (-) GTGA S000378 
IBOXCORE 308  (+) GATAA S000199 
IBOXCORE 1349 (+) GATAA S000199 
IBOXCORE 1361 (+) GATAA S000199 
INRNTPSADB 298  (+) YTCANTYY S000395 
INRNTPSADB 194  (+) YTCANTYY S000395 
INRNTPSADB 567  (+) YTCANTYY S000395 
INRNTPSADB 470  (-) YTCANTYY S000395 
INRNTPSADB 690  (-) YTCANTYY S000395 
L1BOXATPDF1 179  (-) TAAATGYA S000386 
L1BOXATPDF1 415  (-) TAAATGYA S000386 
LECPLEACS2 873  (+) TAAAATAT S000465 
LECPLEACS2 861  (-) TAAAATAT S000465 
MARARS 554  (+) WTTTATRTTTW S000064 
MARARS 1432 (+) WTTTATRTTTW S000064 
MARARS 339  (-) WTTTATRTTTW S000064 
MARTBOX 144  (+) TTWTWTTWTT S000067 
MARTBOX 405  (+) TTWTWTTWTT S000067 
MARTBOX 864  (+) TTWTWTTWTT S000067 
MARTBOX 915  (+) TTWTWTTWTT S000067 
MARTBOX 1077 (-) TTWTWTTWTT S000067 
MYB1AT 216  (+) WAACCA S000408 
MYB1AT 253  (-) WAACCA S000408 
MYB2CONSENSUSAT 902  (-) YAACKG S000409 
MYBATRD22 215  (+) CTAACCA S000175 
MYBCORE 902  (+) CNGTTR S000176 
MYBCORE 721  (-) CNGTTR S000176 
MYBGAHV 579  (-) TAACAAA S000181 
MYBGAHV 884  (-) TAACAAA S000181 
MYBST1 512  (+) GGATA S000180 
MYBST1 697  (+) GGATA S000180 
MYBST1 633  (-) GGATA S000180 
MYCATERD1 1411 (-) CATGTG S000413 
MYCATRD22 1411 (+) CACATG S000174 
MYCCONSENSUSAT 600  (+) CANNTG S000407 
MYCCONSENSUSAT 902  (+) CANNTG S000407 
MYCCONSENSUSAT 1173 (+) CANNTG S000407 
MYCCONSENSUSAT 1411 (+) CANNTG S000407 
MYCCONSENSUSAT 600  (-) CANNTG S000407 
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MYCCONSENSUSAT 902  (-) CANNTG S000407 
MYCCONSENSUSAT 1173 (-) CANNTG S000407 
MYCCONSENSUSAT 1411 (-) CANNTG S000407 
NODCON1GM 205  (+) AAAGAT S000461 
NODCON2GM 190  (+) CTCTT S000462 
NODCON2GM 1085 (-) CTCTT S000462 
NODCON2GM 1471 (-) CTCTT S000462 
NTBBF1ARROLB 1524 (+) ACTTTA S000273 
NTBBF1ARROLB 440  (-) ACTTTA S000273 
NTBBF1ARROLB 621  (-) ACTTTA S000273 
OSE1ROOTNODULE 205  (+) AAAGAT S000467 
OSE2ROOTNODULE 190  (+) CTCTT S000468 
OSE2ROOTNODULE 1085 (-) CTCTT S000468 
OSE2ROOTNODULE 1471 (-) CTCTT S000468 
POLASIG1 260  (+) AATAAA S000080 
POLASIG1 347  (+) AATAAA S000080 
POLASIG1 1080 (+) AATAAA S000080 
POLASIG1 1128 (+) AATAAA S000080 
POLASIG1 551  (-) AATAAA S000080 
POLASIG1 865  (-) AATAAA S000080 
POLASIG1 916  (-) AATAAA S000080 
POLASIG1 948  (-) AATAAA S000080 
POLASIG1 1540 (-) AATAAA S000080 
POLASIG2 542  (+) AATTAAA S000081 
POLASIG2 1024 (+) AATTAAA S000081 
POLASIG2 1031 (+) AATTAAA S000081 
POLASIG2 373  (-) AATTAAA S000081 
POLASIG2 400  (-) AATTAAA S000081 
POLASIG2 842  (-) AATTAAA S000081 
POLASIG2 1112 (-) AATTAAA S000081 
POLASIG2 1396 (-) AATTAAA S000081 
POLASIG2 1575 (-) AATTAAA S000081 
POLASIG3 539  (+) AATAAT S000088 
POLASIG3 1077 (+) AATAAT S000088 
POLASIG3 38   (-) AATAAT S000088 
POLASIG3 236  (-) AATAAT S000088 
POLASIG3 409  (-) AATAAT S000088 
POLASIG3 868  (-) AATAAT S000088 
POLASIG3 879  (-) AATAAT S000088 
POLASIG3 919  (-) AATAAT S000088 
POLLEN1LELAT52 4    (+) AGAAA S000245 
POLLEN1LELAT52 49   (+) AGAAA S000245 
POLLEN1LELAT52 70   (+) AGAAA S000245 
POLLEN1LELAT52 102  (+) AGAAA S000245 
POLLEN1LELAT52 121  (+) AGAAA S000245 
POLLEN1LELAT52 381  (+) AGAAA S000245 
POLLEN1LELAT52 423  (+) AGAAA S000245 
POLLEN1LELAT52 478  (+) AGAAA S000245 
POLLEN1LELAT52 762  (+) AGAAA S000245 
POLLEN1LELAT52 956  (+) AGAAA S000245 
POLLEN1LELAT52 436  (-) AGAAA S000245 
POLLEN1LELAT52 978  (-) AGAAA S000245 
POLLEN1LELAT52 994  (-) AGAAA S000245 
POLLEN1LELAT52 1066 (-) AGAAA S000245 
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POLLEN1LELAT52 1311 (-) AGAAA S000245 
PREATPRODH 1015 (+) ACTCAT S000450 
PYRIMIDINEBOXOSR
AMY1A 
1308 (+) CCTTTT S000259 
QARBNEXTA 1139 (+) AACGTGT S000244 
QELEMENTZMZM13 1447 (-) AGGTCA S000254 
RAV1AAT 287  (+) CAACA S000314 
RAV1AAT 616  (+) CAACA S000314 
RAV1AAT 646  (+) CAACA S000314 
RAV1AAT 653  (+) CAACA S000314 
RAV1AAT 721  (+) CAACA S000314 
RAV1AAT 1276 (+) CAACA S000314 
RAV1AAT 1297 (+) CAACA S000314 
REALPHALGLHCB21 217  (+) AACCAA S000362 
REALPHALGLHCB21 1205 (-) AACCAA S000362 
RHERPATEXPA7 1260 (+) KCACGW S000512 
RHERPATEXPA7 1060 (+) KCACGW S000512 
ROOTMOTIFTAPOX1 407  (+) ATATT S000098 
ROOTMOTIFTAPOX1 427  (+) ATATT S000098 
ROOTMOTIFTAPOX1 446  (+) ATATT S000098 
ROOTMOTIFTAPOX1 516  (+) ATATT S000098 
ROOTMOTIFTAPOX1 558  (+) ATATT S000098 
ROOTMOTIFTAPOX1 861  (+) ATATT S000098 
ROOTMOTIFTAPOX1 877  (+) ATATT S000098 
ROOTMOTIFTAPOX1 1091 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1286 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1430 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1436 (+) ATATT S000098 
ROOTMOTIFTAPOX1 1592 (+) ATATT S000098 
ROOTMOTIFTAPOX1 341  (-) ATATT S000098 
ROOTMOTIFTAPOX1 393  (-) ATATT S000098 
ROOTMOTIFTAPOX1 426  (-) ATATT S000098 
ROOTMOTIFTAPOX1 496  (-) ATATT S000098 
ROOTMOTIFTAPOX1 876  (-) ATATT S000098 
ROOTMOTIFTAPOX1 1090 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1425 (-) ATATT S000098 
ROOTMOTIFTAPOX1 1591 (-) ATATT S000098 
SEF1MOTIF 1430 (+) ATATTTAWW S000006 
SEF4MOTIFGM7S 518  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 846  (+) RTTTTTR S000103 
SEF4MOTIFGM7S 468  (-) RTTTTTR S000103 
SEF4MOTIFGM7S 1027 (-) RTTTTTR S000103 
SORLIP1AT 1148 (+) GCCAC S000482 
SORLIP1AT 1404 (+) GCCAC S000482 
SP8BFIBSP8BIB 14   (-) TACTATT S000184 
SURECOREATSULT11 111  (+) GAGAC S000499 
SV40COREENHAN 242  (-) GTGGWWHG S000123 
T/GBOXATPIN2 1139 (+) AACGTG S000458 
T/GBOXATPIN2 1061 (-) AACGTG S000458 
T/GBOXATPIN2 1261 (-) AACGTG S000458 
TAAAGSTKST1 440  (+) TAAAG S000387 
TAAAGSTKST1 621  (+) TAAAG S000387 
TAAAGSTKST1 1469 (+) TAAAG S000387 
TAAAGSTKST1 364  (-) TAAAG S000387 
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TAAAGSTKST1 1395 (-) TAAAG S000387 
TAAAGSTKST1 1525 (-) TAAAG S000387 
TAAAGSTKST1 1539 (-) TAAAG S000387 
TATABOX2 343  (+) TATAAAT S000109 
TATABOX2 986  (+) TATAAAT S000109 
TATABOX2 554  (-) TATAAAT S000109 
TATABOX2 833  (-) TATAAAT S000109 
TATABOX2 1432 (-) TATAAAT S000109 
TATABOX4 984  (+) TATATAA S000111 
TATABOX5 39   (+) TTATTT S000203 
TATABOX5 410  (+) TTATTT S000203 
TATABOX5 552  (+) TTATTT S000203 
TATABOX5 880  (+) TTATTT S000203 
TATABOX5 949  (+) TTATTT S000203 
TATABOX5 73   (-) TTATTT S000203 
TATABOX5 346  (-) TTATTT S000203 
TATABOX5 538  (-) TTATTT S000203 
TATABOX5 1076 (-) TTATTT S000203 
TATABOXOSPAL 559  (+) TATTTAA S000400 
TATABOXOSPAL 950  (+) TATTTAA S000400 
TATABOXOSPAL 536  (-) TATTTAA S000400 
TATAPVTRNALEU 984  (-) TTTATATA S000340 
TBOXATGAPB 1252 (+) ACTTTG S000383 
TBOXATGAPB 656  (-) ACTTTG S000383 
TRANSINITDICOTS 1514 (-) AMNAUGGC S000201 
TRANSINITMONOCOS 1514 (-) RMNAUGGC S000202 
WBOXATNPR1 1446 (+) TTGAC S000390 
WBOXATNPR1 466  (-) TTGAC S000390 
WBOXHVISO1 624  (-) TGACT S000442 
WBOXNTERF3 1447 (+) TGACY S000457 
WBOXNTERF3 1566 (+) TGACY S000457 
WBOXNTERF3 624  (-) TGACY S000457 
WRKY71OS 1248 (+) TGAC S000447 
WRKY71OS 1345 (+) TGAC S000447 
WRKY71OS 1447 (+) TGAC S000447 
WRKY71OS 1566 (+) TGAC S000447 
WRKY71OS 466  (-) TGAC S000447 
WRKY71OS 625  (-) TGAC S000447 
  
 APPENDIX H. 




LJFgene3 vs. LJFgene14	  
 
LJFgene3        ------------------------------------------------------------ 
LJFgene14       AAGTCCCACCTTCTTTTATTCATCACATGATTCACATCTCATTTCTTATTTTCGGGTCAC 
                                                                             
 
LJFgene3        -------------------TTTCGGTCTGTGAAGATATAT--GTCCATAAGTTCCTTAAT 
LJFgene14       TTTGTTAAATTATAAATAATTTCGTTCTGTGAAGGTACACACGTTCATAAGTTCCTTAAT 
                                   ***** ********* ** *   ** *************** 
 
LJFgene3        TTTCTCGAACCTTCATTTTCAGCTCCCAACAACAATGGCTTCAATGGCATCTTCAAGCTC 
LJFgene14       TTTCTCGAACCTTCATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTC 
                ******************************** *************************** 
 
LJFgene3        CTTCTGCAACCTCAAGTTCATCACCAAACCCAACAATGGTAGAAGAAGCTCTCTTCCCCG 
LJFgene14       CTTCTGCAACCTCAAGTTTATCACCAAACCCAACAATGGTAGAAGAAGCTCTCTTCGCCG 
                ****************** ************************************* *** 
 
LJFgene3        TATTGTATTCTGTCAGAAGCACCACGATAGCACACCCACCGACCAAATCAACCGAAGGTT 
LJFgene14       TATTGTATTTTGTCAGAAGCATCACGATGACACACCCACCGACCAAATCAACCGAAGGTT 
                ********* *********** ******  ****************************** 
 
LJFgene3        CTTATTTCTTCACACTCGCACTTTCTAATTCCTTTCTATGGATTATTCATATCTATTCAT 
LJFgene14       CTTACTTCTTCACACTCACACTTTCTATTTCCTTTCTATTGATTATTCG----------T 
                **** ************ ********* *********** ********           * 
 
LJFgene3        ACCCATCTTCTGAAATCTCTTTATATTTCAATTATTTTGTCTATTGAAGAGAACTCATAT 
LJFgene14       AACCATCTTCTGAAATCTCGTTACATTTCAATTCTTTTGTGTATTGAAGAGAACTCATAT 
                * ***************** *** ********* ****** ******************* 
 
LJFgene3        TGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTGAACTTCGGGTACCCCTCCTCTG 
LJFgene14       TGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGGTACCCCTCCTCTG 
                ************************************* ********************** 
 
LJFgene3        CTTGT------------TTTTGGAAAATTTTTGTTTTTCATTTTATTTTGAATGTAAATT 
LJFgene14       TTTTTGCTCTGTTTTTTTTTCTGGAAATTTTAGTTTTTCATTTTATTTTGAATGTAAATT 
                 ** *            ***  * ******* **************************** 
 
LJFgene3        GAATTCAAGATTTGATTTTGTTGGTGGGTTTGAAGACCCTTTTGGTTTTTAATTTCGGTT 
LJFgene14       AAATTCGAGATTTGATTTTGTTAGTGGGTGTTGAGACCCTTTTGGATTTTAGTTTGGGTT 
                 ***** *************** ****** *  ************ ***** *** **** 
 
LJFgene3        TTGTTTTGTATTGGACATGGGTGGTGGTTAAAAAAGAGAAAATTGAGTTTGTGTCTTGTG 
LJFgene14       GTGTTTTGTATTGGAAATGGGTGGT-----------------------TTGGGTTTTGTG 
                 ************** *********                       *** ** ***** 
 
LJFgene3        TTTTGATGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCA 
LJFgene14       TTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCA 
                ***** ****************************************************** 
 
LJFgene3        TTAGCTCTGTGCCCGGCAACGAAGAATTGCGTGTCAACCTCTGAGAATATCAGTGATCGC 
LJFgene14       TTAGCTCTGTGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGAGAATATCAGCGATCGC 
                *********** *** **** ***** ************************** ****** 
 
LJFgene3        ACACATTATGCTCCTCCATGGTAAAAGTTTCCTTCTTTTTCTTATTTTAATTTTCACCTT 
LJFgene14       ACACATTATGCTCCTCCATGGTAAAAGTTCCCTTCTTTTTCTTATTTTAATTTTCACCTT 
                ***************************** ****************************** 
 
LJFgene3        GGATTTATGGGATTATATGTATTAAATGCATTTTTTTAATTGTGTGTTTGGACAAACTAC 
LJFgene14       GGATTTATGGGATTATATGAATTGAATGCAATTTTTTAATTGTG--TTTGGATAAACAAC 
                ******************* *** ****** *************  ****** **** ** 
 
LJFgene3        TTAGTTAAGTGCTCATCTCATCATGTAAGTGCTTATGCATAAGTTGTTTCTATAATAAAA 
LJFgene14       TTAGTTAACTGCCCAT-----CATGTAAGTGCTTATGTATAAGGTTTTTCTATAGTAAAA 
                ******** *** ***     **************** ***** * ******** ***** 
 
LJFgene3        AAATAAAAATACATACGTATGAGTTGTTGTTGTAAGCTTTTTTCTTAAGTTATTCTGGAA 
LJFgene14       AAAT------------GTACAA------GTTGCAAGCTTTTTTCTTAATTTATTCTTGAA 
                ****            ***  *      **** *************** ******* *** 
 
LJFgene3        ATCTTATTGAAATAATCTGAAAACAACTTTTTTTTTTACATG-ATCTGCTGAAAACAACT 
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LJFgene14       ATCTTATTGAAATAATCTGAGAACAACTTTTTCTTTTTTACCTGTGATCTGAAAACAACT 
                ******************** *********** ****  *    *   ************ 
 
LJFgene3        TATAGACATATGGTAATCACATATCATTAAGTTAAGTTATTCCAAACACTTACATAAACA 
LJFgene14       CATAGACATATCATAA--ACTTGGGATATAGATAAATT----------TTTTCATAAACA 
                 **********  ***  ** *   **  ** *** **           ** ******** 
 
LJFgene3        CTTATAAGAGAAAAACAA-TAAGAAATAAAAACAAAATAAAATTTTCAATAAGTTAAAAT 
LJFgene14       CTTACAAGAGAAAAAAAAATACAAAAGAAAAATAAAATAAATTTTTCTATAAGCTAAAAT 
                **** ********** ** **  *** ***** ******** ***** ***** ****** 
 
LJFgene3        TAGTTTATAAAAGTTTTTTTTTATTATAGAAGCTCTCTTGTATTAGCCTCTCCTAAAGTT 
LJFgene14       TAGTGTATGTGTAAGCTAATTTGT------AGTTCTTTCATATTAGCTTCTCCAAAAGTT 
                **** ***        *  *** *      ** *** *  ******* ***** ****** 
 
LJFgene3        TTTTTTTCTTCATAATTTAGCTTAAAAAGAAACCTATTTCA----TTTTTTCATTTTATT 
LJFgene14       TTTTTTTTTTT-TAACTTATGCATAAGTTAAATTTAGCTTAAAGATAAATTTATTTCATT 
                ******* **  *** ***     **   ***  **  * *    *   ** **** *** 
 
LJFgene3        TTCTTCTCTTGTAAATGCTTTTGGAGAAGTTTGTCCAAACATACCTTTACACAAATACTT 
LJFgene14       TTCTTCTCTTGTAAATGCTTTTGGAGAAATGTATCCAAACAGACCTTTACACAAGTACTA 
                **************************** * * ******** ************ ****  
 
LJFgene3        ATAAGATAAGTCTAATTAAGCTTTTTCAAACACACTCAAAGTTAAAGTATTTCCATTTTG 
LJFgene14       ATAAGATAAGTCTAATTAAGCCTTTTCAAA-ACGCTCAAAGTTCAAGTATTTCCATTATG 
                ********************* ******** ** ********* ************* ** 
 
LJFgene3        TTGTTTTTTTGGGCCTTAATTTTCGGTTAACTAACTTGTGGTGTCTAAATTTCGTCTTGA 
LJFgene14       TTGATTCTTCGGGCCTTAATTTTCGGTTAAGTAACTTGTGGTGTCAAAATTGCGTGTTGA 
                *** ** ** ******************** ************** ***** *** **** 
 
LJFgene3        GGAGGGTCTGATAAACCAGATTTAGGAGATAAGTAAGCAGTCAGTGTTTATTTATTTATT 
LJFgene14       GGAGGGTCTGGTAAACCAGATTTAGGAGATAAGTAA----TCAGGGTTTATTTATTTAT- 
                ********** *************************    **** **************  
 
LJFgene3        TTTTGGATTTAGTCCAAAAGGAACCTATGGC-ATATTTGTGAGAATCACGTTGCAATA-- 
LJFgene14       ---TGGATTTAGTCCAAACGGAACCTATGGCCATATTTGTGAGAATCACGTTGCAATAAT 
                   *************** ************ **************************   
 
LJFgene3        -GACAATAGTGCACCTGGAACGATTTATCACGTTTTAAAC-------AAGTAGTGCAACC 
LJFgene14       AGACAATGGTGCACTTGGAACAATTTATCACGTTTTAAACCACGTGAAAGTAGTGCAGCC 
                 ****** ****** ****** ******************       ********** ** 
 
LJFgene3        GATATTGGACTATTGACTGTTGAACATTGTTGACTTGACATAAGAATTGGACAATTGGTC 
LJFgene14       GAAATTGGACTATTGACTGTTGAACAATGTTGACTTGACAT--GAATTGGACTATTGGTC 
                ** *********************** **************  ********* ******* 
 
LJFgene3        ACACACACATTGGCCGGTGAAAGTAGTGCAATCTTTACTTTTTATTTCTTTTT-GACAAA 
LJFgene14       ACACACA--TTGGCCGGTGAAAGCAGTGCAATCTTAACTTTTTCTTTTTTTTTTGACAAC 
                *******  ************** *********** ******* *** ***** *****  
 
LJFgene3        AAAATTTT---CTCTACCTTTGGCCCTTGT-TTGAGCATGGTCGCCACAAAATCCAAACT 
LJFgene14       TTTTTTTTTTTCTCTATCTTTGGTCCTTGTATTGAGCATGGTCCCACCAAAATCCAAACT 
                    ****   ***** ****** ****** ************ *  ************* 
 
LJFgene3        TTATTATTG--TATAGATGAATCATGATCTCACTTTGTTTTAGTATTTTCATTCTTTTTC 
LJFgene14       TTATTATTGGACATAGATGAATCATGATGTCACTTTGTTTTAATTTTTAGTTTCTTTTTC 
                *********   **************** ************* * ***   ********* 
 
LJFgene3        AGGAACTATAATCCTGAAGGTAGGAAAAAACCTGTGAACAGAGAGGAAGCAATGGAGGAA 
LJFgene14       AGGAACTATAATCCTGAAGGAAGGAAAAAACCTGTGAGCAGAGAGGAAGCAATGGAGGAA 
                ******************** **************** ********************** 
 
LJFgene3        CTGATAGACGTGGTAATAAATCTAACTGAACTGAAATTTTGAATTATATCACTGGATTGC 
LJFgene14       CTGATAGACGTGGTAATAAATCTAGCTGAACTGAAATCTTGAGTTATAACACTAGATTGC 
                ************************ ************ **** ***** **** ****** 
 
LJFgene3        AATTTTCTTTTCCTTCCCTCTTTTAATCAACATCGATTATAATTTATAAAATTTATAAAA 
LJFgene14       AATTTTCTTTTCCTTCCCTCATTTTATCAACATCGATTATAATTTATAAAATTTATAAAA 




LJFgene3        GGGGTGATAAACTGAAAGTAAATATACACTTTGTAATGCACTATTCCTAAC---ACACTT 
LJFgene14       GGAGTGATA--------GTAAATATACACTTTGTAACACACTATTCTTAACCCCACCCTT 
                ** ******        *******************  ******** ****   ** *** 
 
LJFgene3        TCTATTATTCATTAAAATTTATTGAAAATTACGAAGTCATGGGTGGAATTCATTGAATAA 
LJFgene14       TTTATTATTGGTTAAAATTTATCAGAAATTAGAAAGTCATGAGTGGAACTCATTGAATAA 
                * *******  ***********   ******  ******** ****** *********** 
 
LJFgene3        AGAGTAAGACCTACATGATTTTGTAATTTCTAATAAACTCTTACTATTAATAAAGAATGT 
LJFgene14       AGAGTGAGACCTATGTGATTTTATAATTTCTAATAAACT--TATTATTAATAG----TGT 
                ***** *******  ******* ****************  ** ********     *** 
 
LJFgene3        ATTTAAAAGGGTATGTTGTCAACATTTCTCTAATTTATAGTTGATTTGTGATAATAGCTG 
LJFgene14       ATTTAAAAGGATACATTGTGAACATTTCTCTAATTTATAATTGATTTGTAATAATAGCTG 
                ********** **  **** ******************* ********* ********** 
 
LJFgene3        GTTATTTGCACTTTTCCTTCCAATCATTGAAGTAAAGTTAAA-CCAGTTCCGGACAATTT 
LJFgene14       GTTATTTGCACTTTTCC----AATCATTGAAGTAAAGTTAAAACTAGTTCCGGATAATTT 
                *****************    ********************* * ********* ***** 
 
LJFgene3        TGCAGATAGAATCAACAACACCAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAG 
LJFgene14       TACAGATCGAATCAACAACACCAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAG 
                * ***** **************************************************** 
 
LJFgene3        ACTATATTCGTGTGGAGTACCAAAGCTCAATTTTGGGGGTAAGTGTAACTTACATCTAAG 
LJFgene14       ACTATATTCGTGTGGAGTACCAAAGCTCAATCTTGGGGGTAAGTGTAACTTACATCTAAG 
                ******************************* **************************** 
 
LJFgene3        GAAACTCATCACGAAGAAAAATGATAATTTTATACATTTGAGATGATATCAAGATTCAAG 
LJFgene14       GAAACTCATCTTGAAGAAAAATGATCATTTTATACATTTGAGATGATATCAAGA------ 
                **********  ************* ****************************       
 
LJFgene3        AACCATCTCTAATTTCCTTCCCTCCTTTTTCTGTCATGTGCTAACAGTTTGTAGATGATG 
LJFgene14       -ACCATCTCTAATTTCCTTCTCCCTTTTTTCTGTCATGTGCTAACAGTTTGTGGATGATG 
                 ******************* * * *************************** ******* 
 
LJFgene3        TTGAGTTCTGGTTCCCACCGGGTAAGGGTTCTACTGTGGAGTACCGATCTGCATCTCGGT 
LJFgene14       TTGAGTTCTGGTTTCCACCCGGTAAGGGTTCTACTGTGGAGTATCGATCTGCATCTCGGT 
                ************* ***** *********************** **************** 
 
LJFgene3        TAGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTGTGATTTCATAATT--C 
LJFgene14       TGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATGATTTCATAATTAAT 
                * ***************************************** *************    
 
LJFgene3        ATGTGTTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCCATGGTAAAACTCCTCTTTC 
LJFgene14       ATGTGCTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCCAGGGTAAAACTCC-CCTTC 
                ***** ************************************ *********** * *** 
 
LJFgene3        CTTCATGTCATGTCAAACATTTTATACTCAAGTAGATGATTCACTAAATTTGAGTCTCAA 
LJFgene14       CTTCATGTCATGTCAAACATTTTATACTTAAGTAG---ATTCACTAAATTTGAGTCTCAA 
                **************************** ******   ********************** 
 
LJFgene3        ATGTTTTAACTTTATTCTAAATTAGTCACTTATTTTAACTGAAGGTAAATTTGGTTAACT 
LJFgene14       ATGTTTTAACTTTATTCTAAATTAGTCACTTATTTTAACGGAAGGTAAATTTGGTTGACT 
                *************************************** **************** *** 
 
LJFgene3        ATGATCAGAAATACATTGACATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTAC 
LJFgene14       ATGATGAGAAATACGTTGATATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTAC 
                ***** ******** **** **************************************** 
 
LJFgene3        AATAAAGAGAGTATTTACTCCAGAGGATGTAAATCCCTTGCTAAATATTTTTGTGATGAA 
LJFgene14       AATAAAGAGAGTATTTACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTGTGATGAA 
                ***************************** ********* ******************** 
 
LJFgene3        AAATCTTGGTTGTTGACAGGCACTGCGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCA 
LJFgene14       AAATCTTGGTTGCTGACAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCA 
                ************ ************ ************************** ******* 
 
LJFgene3        AGACACCATATGATGAATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTAT 
LJFgene14       AGATACCATATGATTAATAAACTCAGGCTGAATTAGCATCAGCATCTAAGCAAATATTAT 




LJFgene3        TTCATATACTTTGTGACCTTGTATACATTTGTATTAGATACAAATCTCACAGGATCATTG 
LJFgene14       TTCATATACTTTG-GACCTTGTATACTTTTGTATTAGATACAAATCGCACAGGATCATTG 
                ************* ************ ******************* ************* 
 
LJFgene3        AAAGCAAACTTTTCTTTGATTATTGGAATTGTAGAGAAATCATTGAGAACAGTACTTCAA 
LJFgene14       CAAGCAAACTTTTCTTAGATTTTTGGAATTGTAGAGAAATCATTGAGAACAGTACTTCAA 
                 *************** **** ************************************** 
 
LJFgene3        ACTCTC--GGGGAAGGAATGAAATGAAGACCTTGCCCCATATCCTTCTTCAAGTTCATTA 
LJFgene14       ACTCTCTCGGGGAAGGAATGAAATGAAGACCTTGCGCCATATC-TTCTTCAAGTTCATTA 
                ******  *************************** ******* **************** 
 
LJFgene3        ATTGGTCCGCTTATTTACTCTTTCACCAAGTTCAATCTAACAATGTATCGTTCTTGTTTC 
LJFgene14       ATTGGTCCACTTATTTACACCTTCACCGAGTTCAATCTAATAATGTATGAATCTTGTTTC 
                ******** ********* * ****** ************ *******   ********* 
 
LJFgene3        AAGAATATTAATTTGTGTTTTGTTTCTAATGTGTTCTTCACGATTCACTTTTGTTGTAAG 
LJFgene14       AAGAAATTTAATTTGTGTTTTGTTTCAAACGTGTTCTTCATGATTCACTTTTGTTGTAAG 
                *****  ******************* ** ********** ******************* 
 
LJFgene3        TTTGACTTAGCTTCTTCATGTATTAAAACTTAACCTTGTGA------------------- 
LJFgene14       TTTGACTTTGCTTCTTCATGTATTAAAGCTTATCCTTGCGATCAATTTGGATGATGCTTT 
                ******** ****************** **** ***** **                    
 
LJFgene3        ------------------------------------------------------------ 
LJFgene14       AGGCCTTTCTGTCATCAAAATGTACGTACCTATGTCATGTTTTCAGAGGCTTTTTGATAT 
                                                                             
 
LJFgene3        --------------------- 
LJFgene14       CCTTGATGTCTTTACAAGAAA 
 
LJFgene3 vs. LJFgene1 
 
LJFgene3       -------------------CCATAAAAAAGA-------AAAAAAAAAAGTCCCACCGCCC 
LJFgene1       TAAAAAGGAGAAAGAAAAAACAAAAAAAAAATGTTGCGGAAACGAAGCGTCCCACCACCC 
                                   ** ****** *        ***  **  ******** *** 
 
LJFgene3       ACCTTCTTT-----------ATCACATGATTCACATCTCATTCCTTATATTTGGTTCACA 
LJFgene1       ACCTTCTTTTTATATTCATCATTACATGATTCACATCTCATTCCATATTTTCGGGTCACA 
               *********           ** ********************* *** ** ** ***** 
 
LJFgene3       TTCTTAAATTAT---AAATATTTCGGTC-TGTGAAGATATATGTCCATAAGTTCCTTAAT 
LJFgene1       TTCTCAAATTATTATAACTAATTTCGTCATGTGAAGATAC--GTTCATAAGTTCCTTAAT 
               **** *******   ** ** **  *** **********   ** *************** 
 
LJFgene3       TTTCTCGAACCTTCATTTTCAGCTCCCAACAACAATGGCTTCAATGGCATCTTCAAGCTC 
LJFgene1       TTTCTTGAACCTTTATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTC 
               ***** ******* ****************** *************************** 
 
LJFgene3       CTTCTGCAACCTCAAGTTCATCACCAAACCCAACAATGGTAGAAGAAGC---------TC 
LJFgene1       CTTCTGCAACCTCAAGTTTATCACCAAACCCAACAACAATGGTAGAACCAATGCTTCTTC 
               ****************** *****************   * * **** *         ** 
 
LJFgene3       TCTTCCCCGTATTGTATTCTGTCAGAAGCACCACGATAGCACACCCACCGACCAAATCAA 
LJFgene1       TCTTCCCCGTATTGTATTCTGTCAGAAGCACAACGATGACACCCCCACCGACCAAATCAA 
               ******************************* *****  *** ***************** 
 
LJFgene3       CCGAAGGTTCTTATTTCTTCACACTCGCACTTTCTAATTCCTT---TCTATGGATTATTC 
LJFgene1       CCGAAGGTTCTTACTTCTTCACACTCACACTCTCTCACTCCTTCTTTCTATTGATTATTT 
               ************* ************ **** *** * *****   ***** *******  
 
LJFgene3       ATATCTATTCATACCCATCTTCTGAAATCTCTTTATATTTCAATTATTTT-GTCTATTGA 
LJFgene1       ATAACTATTCATACCCATCTTCTGAAATCTCTTTACATTTCAATTCTTTTTGTGTATTGA 
               *** ******************************* ********* **** ** ****** 
 
LJFgene3       AGAGAACTCATATTGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTGAACTTCGGG 
LJFgene1       AGAGAACTCATATTGAGAAGCAGTGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGG 
               *********************** ************************** ********* 
 
LJFgene3       TACCCCTCCTCTGCTTGT----------------TTTTGGAAAATTTTTGTTTTTCATTT 
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LJFgene1       TACCCCTCCTCTGTTTTTCCTCGGTTTTTTTCTTTTTTGGAAAATTTAGTTTTTTCATTT 
               ************* ** *                *************   ********** 
 
LJFgene3       TATTTTGAATGTAAATTGAATTCAAGATTTGATTTTGTTGGTGGGTTTGAAGACCCTTTT 
LJFgene1       TATTTTGAATGTAAATTGTATTCAAGATTTGATTTTGTTGGTGGGTTTGGAGACCCTTTT 
               ****************** ****************************** ********** 
 
LJFgene3       GGTTTTTAATTTCGGTTTTGTTTTGTATTGGACATGGGTGGTGGTTAAAAAAGAGAAAAT 
LJFgene1       GGATTTTAGTTTCAGTTTTGTATTGTATTGGAAATGGGTGGTGGTTAAAAAAGAGAAAAT 
               ** ***** **** ******* ********** *************************** 
 
LJFgene3       TGAGTTTGTGTCTTGTGTTTTGATGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGC 
LJFgene1       TGAGTTTGGGTTTTGTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGC 
               ******** ** ********** ************************************* 
 
LJFgene3       AGAAAAACCCACCAGCATTAGCTCTGTGCCCGGCAACGAAGAATTGCGTGTCAACCTCTG 
LJFgene1       AGAAAAACCCACCAGCATTAGCTCTGTGTCCGGCAACTAAGAACTGCGTGTCAACCTCTG 
               **************************** ******** ***** **************** 
 
LJFgene3       AGAATATCAGTGATCGCACACATTATGCTCCTCCATGGTAAAAGTTTCCTTCTTTTTCTT 
LJFgene1       AGAATATCAGTGATCGCACACATTATGCTCCTCCATGGTTAAAGTTCCCCTCTTTTTCTT 
               *************************************** ****** ** ********** 
 
LJFgene3       ATTTTAATTTTCACCTTGGATTTATGGGATTATATGTATTAAATGCA--TTTTTTTAATT 
LJFgene1       ATTTTAATTTTCACCTTCGATTTATGGGATTATATGAATTAAATGCAATTTTTTTTACTT 
               ***************** ****************** **********  ******** ** 
 
LJFgene3       GTGTGTTTGGACAAACTACTTAGTTAAGTGCTCATCTCATCATGTAAGTGCTTATGCATA 
LJFgene1       GTCTGTTTGGATAAACAACTTAGTTAAGTATTCA-----TCATGTAAGTGCTTATGTATA 
               ** ******** **** ************  ***     ***************** *** 
 
LJFgene3       AGTTGTTTCTATAATAAA--AAAAT----------------------------------- 
LJFgene1       AGTTGTTTCTATAATAAATAAAAATGAGGAGGGAAAGTTATTCCAAAAATCACTTTAAAA 
               ******************  *****                                    
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       GAGGTACTCACTTTATTTTAATTATTGATTTTTTTAAAATTTAATGATTAAGATTAATTA 
                                                                            
 
LJFgene3       ------------------------AAAAATACATA------------------------- 
LJFgene1       TTTATTATAATTATTAGATTCTAAAAAAATAAATAATAAGGATAATAAATAACTCTAAAA 
                                       ******* ***                          
 
LJFgene3       ----------------------------------------CGTATGAGTTGTTGTTGTAA 
LJFgene1       AAATTATTCTTAGAGCAAGTTGATGTTTTCCTAAAAAAAATATATAAATTGTTTATATAA 
                                                         *** * *****  * *** 
 
LJFgene3       GCT-----TTTTTCTTAAGTTATTCTGGAAATCTTATTGAAATAATCTGAAAACAACTTT 
LJFgene1       GTCGTAAGCTTTTCGGAAATTATTCTTGAAATCTTATTGAAATAATCTGAAAACAACTTT 
               *        *****  ** ******* ********************************* 
 
LJFgene3       TTTTTTTACATGATCTGCTGAAAACAACTTATAGACATATGGTAATCACATATCATTAAG 
LJFgene1       TTTT--TACATGATTTG---AAAACAACTTATAGACATATCATAATCACATATCATTAAG 
               ****  ******** **   ********************  ****************** 
 
LJFgene3       TTA--------AGTTATTCCAAACACTTACAT-AAACACTTATAAGAGAAAAACAATAAG 
LJFgene1       TTATTTTATTAAGTCATTTTCATAATTTATTTCAAACACTTACATAAATACTTATAAGAG 
               ***        *** ***   *  * ***  * ********* *  *  *     *  ** 
 
LJFgene3       AAATAAAAACAAAATAAAATTTTCAATAAGTTAAAATTAGTTTATAAAAGTTTTTTTTTA 
LJFgene1       AAAATAAAATAAAATTAATTTCTTTATAAGCTATAA--AATTAGTTAATGTATAAGTCAA 
               ***  **** ***** ** ** *  ***** ** **  * **  * ** ** *   *  * 
 
LJFgene3       TTA-TAGAAGCTCTCTTGTATTAGCCTCTCCTAAAGTTTTTTTTTC--TTCATA------ 
LJFgene1       TAGGTAGAAGCTCTCTCGTATTAAC-TCTTCAAAAGTTTATTTTTTAACTTATATATAAG 
               *   ************ ****** * *** * ******* *****    * ***       
 
LJFgene3       ----ATTTAGCTTAAAA-AGAAACCTATTTCATTTTTTCATTTTATTTTCTTCTCTTGTA 
LJFgene1       CTAAATTTAACTTAAAAGAGAAACTTATTTCATTTTTTC-TCTTCCTTTCTTTTCTAGTA 




LJFgene3       AATGCTTTTGGAGAAGTTTGTCCAAACATACCTTTACACAAATACTTATAAGATAAGTCT 
LJFgene1       AATGTTTTTATAAAAGTTTACCCAAACAGAACTTTACACAAGTACTTATAAGATAAGTCT 
               **** ****  * ******  ******* * ********** ****************** 
 
LJFgene3       AATTAAGCTTTTTCAAACACACTCAAAGTTAAAGTATTTCCATTTTGTTGTTTTTTTGGG 
LJFgene1       AATTAAGCTTTTTCAAACATGCTCAAAGTTAAAGTGTTTCCA---TAATGTTTTTTTGGG 
               *******************  ************** ******   *  ************ 
 
LJFgene3       CCTTAATTTTCGGTTAACTAACTTGTGGTGTCTAAATTTCGTCTTGAGGAGGGTCTGATA 
LJFgene1       CCTTAATTTTCG-TCAAGTAACTTGTGATGTCAAAATTGCGTGTTGAGGAGGGTCTGGTC 
               ************ * ** ********* **** ***** *** ************** *  
 
LJFgene3       AACCAGATTTAGGAGATAAGTAAGCAGTCAGTGTTTATTTATTTATTTTTTGGATTTAGT 
LJFgene1       AACTAGATTTAGGAGATAATTAAGCAGTCAGGGTTTATTTATTTATT----GGATTTAAT 
               *** *************** *********** ***************    ******* * 
 
LJFgene3       CCAAAAGGAACCTATGGCATATTTGTGAGAATCACGTTGCAATAGACAATAGTGCACCTG 
LJFgene1       CCAAAAGGAACCTATGACATATTTGTGAGAATCACGTTGCAATAGATAATGGTGCACTTG 
               **************** ***************************** *** ****** ** 
 
LJFgene3       GAACGATTTATCACGTTTTAAAC-------AAGTAGTGCAACCGATATTGGACTATTGAC 
LJFgene1       GAACAATTTATCACGTTTTAAACCACGTGAAAGTAGTGCAACCGATATTGGACTATTGAC 
               **** ******************       ****************************** 
 
LJFgene3       TGTTGAACATTGTTGACTTGACATAAGAATTGGACAATTGGTCACACACACATTGGCCGG 
LJFgene1       TGTTGAACATTGTTGACTTGACATAAGAAATGAACTATTGGTCACACACGCATTGGCCGG 
               ***************************** ** ** ************* ********** 
 
LJFgene3       TGAAAGTAGTGCAATCTTTACTTTTTATTTCTTTTTGACAAAAAAATTTTCTCTACCTTT 
LJFgene1       TGAAAGTAGTGCAATCTTTACTTTTTCTTT--TTTTGAAATTTTTTTTTTCACTACCTTT 
               ************************** ***  ****** *      ***** ******** 
 
LJFgene3       GGCCCTTGT-TTGAGCATGGTCGCCACAAAATCCAAACTTTATTATTG--TATAGATGAA 
LJFgene1       GGTCCTTGTATTGAGCATGGTCCCACCAAAATCCAAACTTTATTATTGGACATAGATGAA 
               ** ****** ************ *  **********************   ********* 
 
LJFgene3       TCATGATCTCACTTTGTTTTAGTATTTTCATTCTTTTTCAGGAACTATAATCCTGAAGGT 
LJFgene1       TCATGATGTCACTTTGTTTTAATATTTTCATTCTTTTTCAGGAACTATAATCCTGAAGGT 
               ******* ************* ************************************** 
 
LJFgene3       AGGAAAAAACCTGTGAACAGAGAGGAAGCAATGGAGGAACTGATAGACGTGGTAATAAAT 
LJFgene1       AGGAAAAAACCTGTGAGCAGGGAAGAAGCAATGGAGGAACTTATAGACGTGGTAATAAAT 
               **************** *** ** ***************** ****************** 
 
LJFgene3       CTAACTGAACTGAAATTTTGAATTATATCACTGGATTGCAATTTTCTTTTCCTTCCCTCT 
LJFgene1       GCAACTGAACTGAAATCTTGAGTTA--TCACTGGATTGAAATTTTCTTTTCCTTCCCTCA 
                 ************** **** ***  *********** ********************  
 
LJFgene3       TTTAATCAACATCGATTATAATTTATAAAATTTATAAAAGGGGTGATAA----------- 
LJFgene1       TTTTATCAACATTGATTATAATTTATAAAATTTATGAAAGGAGTGATAGTGAATATACAC 
               *** ******** ********************** ***** ******             
 
LJFgene3       ----------------------------------------------ACTGAAAG------ 
LJFgene1       TTTGTAACACTATTTCTAATACACTTTCTATTATCGGTTAAAATTTATTGAAAACAGTGT 
                                                             * *****        
 
LJFgene3       ---TAAATA--------------------------------------------------- 
LJFgene1       TGTTAAATGGCGGCCATGGCGGCGCCATGGCGGAGTTGCGTAACGGTTTTCTGAAAAAAC 
                  *****                                                     
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       GCCACCGAATAACGGTGGCGTGGCGGATTAAAGATGGCGGCGCCATGGCGGCCGCCATAG 
                                                                            
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       CCATGGCGGCCATGGCGGATGTGGCGGGGAGGCGGAAAATGGCAGAATTTTTTTTTTTGT 
                                                                             
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       CCGCGGTAGGAGTTGGGCTGACCCGATCCAACCCTACCCGAAAACTTAATGAAAACCATG 




LJFgene3       --------TACACTTTGTAATGC------------------------------------- 
LJFgene1       ACCCCCCCTACCTTTCAGAACGCTGCTGCAACCCTCGAAGCTTCAACATAGCGCGACCTC 
                       ***  **   ** **                                      
 
LJFgene3       ----------ACTATTCCTA-----------------------------------ACACA 
LJFgene1       GGAACCAGCCACGACCCCTGCAACCAGCCTCGGAACCAGCCGCGCTTGACCCGCTGCACA 
                         ** *  ***                                     **** 
 
LJFgene3       C----------------------------------------------------------- 
LJFgene1       CAGCAGCCAGCAGCGACGACCCATGGCGTGAACGGCGGCGACGAGCACGGCGTGAACAAC 
               *                                                            
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       GGCGACGCGAACGGAGAAGACGACCCAGAACCGCGACCTCGACTTATACGGGTGGGTGGG 
                                                                             
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       CCAAAGCCTTTTTTTTGTTTTTGCTGCTTGACACCCCTTTTTTATGTCTGCAGCTTTTTT 
                                                                             
 
LJFgene3       ------TTTCTATT---------------------------------------------- 
LJFgene1       TCCGTTTTTCTATTTGACACCCCCTTTTACTTTCGACAGTCCCATTTTTAATTTTTTTTT 
                     ********                                               
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       CTATTTGACACCACAATTTTTTTTTCTGTTCAGTCCTCTTTTAAATGGCTGAACCATCAT 
                                                                             
 
LJFgene3       ----------------------------------------------ATTCATTAAAATTT 
LJFgene1       CCTCTTTAATGAGTTTATTTGGTGTTGGTACTTGATTATTGTATGAACTCATGAAACTTT 
                                                             * **** *** *** 
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       TTTAGTTTATTTGAATGCAATCCTTTGTTTTTTTCAATTTCAATGAGTTTATATATATGT 
                                                                             
 
LJFgene3       ------------------------------------------------------------ 
LJFgene1       TTTTTTTTTTTTTTGGTCCGCCATGACTTCCGCCATTTTCCGCTACGCCATCCGCCATAT 
                                                                             
 
LJFgene3       ----------------------------------------------------------AT 
LJFgene1       TTTTATGGCGGATTTTTTACTTTCCGCCATGAACCGCCATCCGCCATTAACAACATTGAT 
                                                                         ** 
 
LJFgene3       TGAAAATTACGAAGTCATGGGTGGAATTCATTGAATAAAGAGTAAGA-CCTACATGATTT 
LJFgene1       TGAAAATTATGAAGTCATGAGAGGAGCTCATTGAATAAAGAGTGAGAACTTACATGATTT 
               ********* ********* * ***  **************** *** * ********** 
 
LJFgene3       TGTAATTTCTAATAAACTCTTACTATTAATAAAGAATGTATTTAAAAGGGTATGTTGTC- 
LJFgene1       TGTAATTTCTAATAATTTTTTACTATTAATAAAGAGTGTATTTAAATGGGTATGTTTTTG 
               ***************  * **************** ********** ********* *   
 
LJFgene3       AACATTTCTCTAATTTATAGTTGATTTGTGATAATAGCTGGTTATTTGCACTTTTCCTTC 
LJFgene1       AACATTTTTCTAATTTCTAATCGATTTGTAATAATAGCTGGTTATTTGCACTTT----CC 
               ******* ******** ** * ******* ************************     * 
 
LJFgene3       CAATCATTGAAGTAAAGTTAAACCAGTTCCGGACAATTTTGCAGATAGAATCAACAACAC 
LJFgene1       CAATCATTGAAGTAAAGTTAAACCAGTTCCGGATAATTTTACAGATAGAATCAACAACAC 
               ********************************* ****** ******************* 
 
LJFgene3       CAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACC 
LJFgene1       CAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACC 
               ************************************************************ 
 
LJFgene3       AAAGCTCAATTTTGGGGGTAAGTGTAACTTACATCTAAGGAAACTCATCACGAAGAAAAA 
LJFgene1       AAAGCTCAATCTTGGGGGTAAGTGTAACTTACATCTAAGGAAACTCATCATGAAGAAAAA 
               ********** *************************************** ********* 
 
LJFgene3       TGATAATTTTATACATTTGAGATGATATCAAGATTCAAGAACCATCTCTAATTTCCTTCC 
LJFgene1       TTATCCTTTTATACATTTTAGATGATATCAAGATTCAAGAACCATCTTTAATTTCCTTCT 
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               * **  ************ **************************** ***********  
 
LJFgene3       CTCCTTTTTCTGTCATGTGCTAACAGTTTGTAGATGATGTTGAGTTCTGGTTCCCACCGG 
LJFgene1       CCCTTTTTTCTGTCATGTGCTAACAGTTTGTGGATGATGTTGAGTTCTGGTTTCCTCCGG 
               * * *************************** ******************** ** **** 
 
LJFgene3       GTAAGGGTTCTACTGTGGAGTACCGATCTGCATCTCGGTTAGGAAACTTTGATTTTGATG 
LJFgene1       GTAAGGGTTCTACTGTGGAGTATCGTTCTGCATCTCGGTTGGGAAACTTTGATTTTGATG 
               ********************** ** ************** ******************* 
 
LJFgene3       TGAACAGAAAAAGAATAAAGGTGTGATTTCATAATTCATGTGT--TTTCTCTATAGTTAG 
LJFgene1       TGAACAGAAAAAGAATAAAGGTATGATTCCATAATTCATATGTGCTTTCTCTATAGTTAG 
               ********************** ***** ********** ***  *************** 
 
LJFgene3       ATAAAGAAATTCTTGGTTCCATGGTAAAACTCCTCTTTCCTTCATGTCATGTCAAACATT 
LJFgene1       ATAAAGAAATTCTTGGTTCCAGGGTAAAACTCCCCTTTCCTTCATGTCATGTGAAGCATT 
               ********************* *********** ****************** ** **** 
 
LJFgene3       TTATACTCAAGTAGATGATTCACTAAATTTGAGTCTCAAATGTTTTAACTTTATTCTAAA 
LJFgene1       TTTTACTCAAGTAGAT---CCACTAAATTTGAGTCTCAAATGTTTTAACTTTATTCTAAA 
               ** *************    **************************************** 
 
LJFgene3       T----TAG-------------TCACTTATTTTAACTGAAGGTAAATTTGGTTAACTATGA 
LJFgene1       TGTTTTAACTTTATTTGAGTCTCAAATGTTTTAACTGAAGGTAAATTTGGTTAACTATGA 
               *    **              ***  * ******************************** 
 
LJFgene3       TCAGAAATACATTGACATTTTTTAATTGGTAGAGATAAAGAATATTTTTTATGTACAATA 
LJFgene1       TCAGAAATACATTAACA-------------AGAGTTGAAGAATATTTTTTATGTACAATA 
               ************* ***             **** * *********************** 
 
LJFgene3       AAGAGAGTATTTACTCCAGAGGATGTAAATCCCTTGCTAAATATTTTTGTGATGAAAAAT 
LJFgene1       AAGAGAGTATTTGCTCGAGAGAATGTAAATCCTTTTCTAAATATTTTTGTGATGAAAAAT 
               ************ *** **** ********** ** ************************ 
 
LJFgene3       CTTGGTTGTTGACAGGCACTGCGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGAC 
LJFgene1       AATGGTTGCTGGCAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGAC 
                 ****** ** ********* ************************************** 
 
LJFgene3       ACCATATGATGAATAAACTCAGGCAGAATTAACATCAGCATCTAAGCAAATATTATTTCA 
LJFgene1       ACCATATGATGAAAAAACTTAGGCAGAATTCACATCAGCATCTAAGAAAATATTGTTTCA 
               ************* ***** ********** *************** ******* ***** 
 
LJFgene3       TATACTTTGTGACCTTGTATACATTTGTATTAGATACAAA-TCTCACAGGATCATTGAAA 
LJFgene1       TATACATTGTAACCTTGTATACTTTTGTATTAGATACAAAATCTCACAAGATCATTGAAA 
               ***** **** *********** ***************** ******* *********** 
 
LJFgene3       GCAAACTTTTCTTTGATTATTGGAATTGTAGAGAAATCATTGAGAACAGTACTTCAAACT 
LJFgene1       GCAAACTCTTCAT-GATTATTGGAATTGTAGA--AATGATTGAGAACAGTACTTCAAACT 
               ******* *** * ******************  *** ********************** 
 
LJFgene3       CTCGGGG-AAGGAATGAAATGAAGACCTTGCCCCATATCCTTCTTCAAGTTCATTAATTG 
LJFgene1       CTCGGGGGAAGGAATGAAATGAAGATGTTACCC-ATATCTTT-TTGAACTTCATTAATTG 
               ******* *****************  ** *** ***** ** ** ** *********** 
 
LJFgene3       GTCCGCTTATTTACTCTTTCACCAAGTTCAATCTAACAATGTATCGTTCTTGTTTCAAGA 
LJFgene1       GTCCACTTATTTACTCTTTCGCTGAGTTCAATCTAACAATGTAGCATTCTTGTTTCAAGA 
               **** *************** *  ******************* * ************** 
 
LJFgene3       ATATTAATTTGTGTTTTGTTTCTAATGTGTTCTTCACGATTCACTTTTGTTGTAAGTTTG 
LJFgene1       ATTTTATGTTGTGTTGTTTTTCAAATGCATTTGCCATGATTCACCTTCGGTGCATATAGC 
               ** ***  ******* * **** ****  **   ** ******* ** * ** *  *    
 
LJFgene3       ACTTAGCTTCTTCATGTATTAAAACTTAACCTTGTGATCAAT--TTGGATACTTTAGGCC 
LJFgene1       ATTTGGAATCTGATTATAATAGGAGC-ATTGCGGAGACCAAAAACAGGGTGCATT----- 
               * ** *  ***   * ** **  *   *     * ** ***     ** * * **      
 
LJFgene3       TTTCTCTTATCAAAATGTACCTATGTCATGATCTCGAAATTGTTCAATCTCATTGATCCT 
LJFgene1       ------------------------------------------------------------ 
                                                                            
 
LJFgene3       AACTAGAAAATTCGTCCAA 
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LJFgene1       ------------------- 
 
LJFgene1 vs. LJFgene14 
 
LJFgene14       TATATATACACACACACACGAATAAACAAATTTTTTTAAGAGTAAATTACATAACATCTT 
LJFgene1        ------------------------------------------------------------ 
                                                                             
 
LJFgene14       GTGAGATTTTAAATTTTTTTATACATATTTAAAAAAAAAAGACTTACACAAATCTATCAA 
LJFgene1        ------------------------------------------------------------ 
                                                                             
 
LJFgene14       TTAAATTTTAAAAAATTACACACGTCTCATAACTGTTTTTGAATAAATACTAACTAAAAT 
LJFgene1        ------------------------------------------------------------ 
                                                                             
 
LJFgene14       TAAAAAAAATGTAGAAATGCATTATTATTTTTACCGAGTAAAAACATTCTTGATGCGCGA 
LJFgene1        ------------------------------------------------------------ 
                                                                             
 
LJFgene14       ATTTGACAAAAACCTTTTCGTACAGATAAGCATTTATGGATATTTTTAGTATCCAAAATT 
LJFgene1        ------------------------------------------------------------ 
                                                                             
 
LJFgene14       GTCACTTTCTCAAACAATCGAAATATATACTATTTATTTTCTAAATATCTAAATCCATAA 
LJFgene1        ---------------------------------------------------------TAA 
                                                                         *** 
 
LJFgene14       AAAGGAAAATAAATAAA-AAAATAAAAATGTTGCGGAAACGAAGT---------CCCACC 
LJFgene1        AAAGGAGAAAGAAAAAACAAAAAAAAAATGTTGCGGAAACGAAGCGTCCCACCACCCACC 
                ****** **  ** *** **** *********************          ****** 
 
LJFgene14       TTCTTTT---ATTCATCA---CATGATTCACATCTCATTTCTTATTTTCGGGTCACTTTG 
LJFgene1        TTCTTTTTATATTCATCATTACATGATTCACATCTCATTCCATATTTTCGGGTCACATTC 
                *******   ********   ****************** * ************** **  
 
LJFgene14       TTAAATTAT---AAATAATTTCGTTCTGTGAAGGTACACACGTTCATAAGTTCCTTAATT 
LJFgene1        TCAAATTATTATAACTAATTTCGTCATGTGAAGATAC----GTTCATAAGTTCCTTAATT 
                * *******   ** *********  ******* ***    ******************* 
 
LJFgene14       TTCTCGAACCTTCATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTCC 
LJFgene1        TTCTTGAACCTTTATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTCC 
                **** ******* *********************************************** 
 
LJFgene14       TTCTGCAACCTCAAGTTTATCACCAAACCCAACAATGGTAGAAGAAGC---------TCT 
LJFgene1        TTCTGCAACCTCAAGTTTATCACCAAACCCAACAACAATGGTAGAACCAATGCTTCTTCT 
                ***********************************   * * **** *         *** 
 
LJFgene14       CTTCGCCGTATTGTATTTTGTCAGAAGCATCACGATGACACACCCACCGACCAAATCAAC 
LJFgene1        CTTCCCCGTATTGTATTCTGTCAGAAGCACAACGATGACACCCCCACCGACCAAATCAAC 
                **** ************ ***********  ********** ****************** 
 
LJFgene14       CGAAGGTTCTTACTTCTTCACACTCACACTTTCTATTTCCTT---TCTATTGATTATTCG 
LJFgene1        CGAAGGTTCTTACTTCTTCACACTCACACTCTCTCACTCCTTCTTTCTATTGATTATTTA 
                ****************************** ***   *****   *************   
 
LJFgene14       TAAC----------CATCTTCTGAAATCTCGTTACATTTCAATTCTTTT-GTGTATTGAA 
LJFgene1        TAACTATTCATACCCATCTTCTGAAATCTCTTTACATTTCAATTCTTTTTGTGTATTGAA 
                ****          **************** ****************** ********** 
 
LJFgene14       GAGAACTCATATTGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGGT 
LJFgene1        GAGAACTCATATTGAGAAGCAGTGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGGT 
                ********************** ************************************* 
 
LJFgene14       ACCCCTCCTCTGTTTTTGCTCTGTTTTTTT---TTCTGGAAATTTTAGTTTTT-CATTTT 
LJFgene1        ACCCCTCCTCTGTTTTTCCTCGGTTTTTTTCTTTTTTGGAAAATTTAGTTTTTTCATTTT 
                ***************** *** ********   ** ****** ********** ****** 
 
LJFgene14       ATTTTGAATGTAAATTAAATTCGAGATTTGATTTTGTTAGTGGGTGTTGAGACCCTTTTG 
LJFgene1        ATTTTGAATGTAAATTGTATTCAAGATTTGATTTTGTTGGTGGGTTTGGAGACCCTTTTG 
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                ****************  **** *************** ****** * ************ 
 
LJFgene14       GATTTTAGTTTGGGTTGTGTTTTGTATTGGAAATGGGTGGT------------------- 
LJFgene1        GATTTTAGTTTCAGTTTTGTATTGTATTGGAAATGGGTGGTGGTTAAAAAAGAGAAAATT 
                ***********  *** *** ********************                    
 
LJFgene14       ----TTGGGTTTTGTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCA 
LJFgene1        GAGTTTGGGTTTTGTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCA 
                    ******************************************************** 
 
LJFgene14       GAAAAACCCACCAGCATTAGCTCTGTGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGA 
LJFgene1        GAAAAACCCACCAGCATTAGCTCTGTGTCCGGCAACTAAGAACTGCGTGTCAACCTCTGA 
                ******************************* **************************** 
 
LJFgene14       GAATATCAGCGATCGCACACATTATGCTCCTCCATGGTAAAAGTTCCCTTCTTTTTCTTA 
LJFgene1        GAATATCAGTGATCGCACACATTATGCTCCTCCATGGTTAAAGTTCCCCTCTTTTTCTTA 
                ********* **************************** ********* *********** 
 
LJFgene14       TTTTAATTTTCACCTTGGATTTATGGGATTATATGAATTGAATGCAATTTTTT--AATTG 
LJFgene1        TTTTAATTTTCACCTTCGATTTATGGGATTATATGAATTAAATGCAATTTTTTTTACTTG 
                **************** ********************** *************  * *** 
 
LJFgene14       T--GTTTGGATAAACAACTTAGTTAACTGCCCATCATGTAAGTGCTTATGTATAAGGTTT 
LJFgene1        TCTGTTTGGATAAACAACTTAGTTAAGTATTCATCATGTAAGTGCTTATGTATAAGTTGT 
                *  *********************** *   ************************* * * 
 
LJFgene14       TTCTATAGTAAA------------------------------------------------ 
LJFgene1        TTCTATAATAAATAAAAATGAGGAGGGAAAGTTATTCCAAAAATCACTTTAAAAGAGGTA 
                ******* ****                                                 
 
LJFgene14       ------------------------------------------------------------ 
LJFgene1        CTCACTTTATTTTAATTATTGATTTTTTTAAAATTTAATGATTAAGATTAATTATTTATT 
                                                                             
 
LJFgene14       ------------------------------------------------------------ 
LJFgene1        ATAATTATTAGATTCTAAAAAAATAAATAATAAGGATAATAAATAACTCTAAAAAAATTA 
                                                                             
 
LJFgene14       ------------------------------AAAATGTACAAGTTGC------AAGCT--- 
LJFgene1        TTCTTAGAGCAAGTTGATGTTTTCCTAAAAAAAATATATAAATTGTTTATATAAGTCGTA 
                                              ***** ** ** ***       ***      
 
LJFgene14       --TTTTTCTTAATTTATTCTTGAAATCTTATTGAAATAATCTGAGAACAACTTTTTCTTT 
LJFgene1        AGCTTTTCGGAAATTATTCTTGAAATCTTATTGAAATAATCTGAAAACAACTTTT----T 
                   *****  ** ******************************* **********    * 
 
LJFgene14       TTTACCTGTGATCTGAAAACAACTCATAGACATATCATAAAC--------TTGGGATATA 
LJFgene1        TTTAC--ATGATTTGAAAACAACTTATAGACATATCATAATCACATATCATTAAGTTATT 
                *****   **** *********** *************** *        **  * ***  
 
LJFgene14       --GATAAATT-TTTTCATAAACACTTACAAG-----AGAAAAAAAAATACAAAAGAAAA- 
LJFgene1        TTATTAAGTCATTTTCATAATTTATTTCAAACACTTACATAAATACTTATAAGAGAAAAT 
                    *** *  *********    ** ***      * * *** *  ** ** ******  
 
LJFgene14       ---ATAAAATAAATTTTTCTATAAGCTA--AAATTAGTGTATGTGTAAGCTAATTTGTAG 
LJFgene1        AAAATAAAATTAATTTCTTTATAAGCTATAAAATTAGTTAATGTATAAGTCAATAGGTAG 
                   ******* ***** * *********  ********  **** ****  ***  **** 
 
LJFgene14       ---TTCTTTCATATTAGCTTCTCCAAAAGTTTTTTTTTTTTTTAACTTATGCATAAGTTA 
LJFgene1        AAGCTCTCTCGTATTAACT-CTTCAAAAGTTTATTTTT----TAACTTATATATAAGCTA 
                    *** ** ***** ** ** ********* *****    ********  ***** ** 
 
LJFgene14       AATTTAGCTTAAA-GATAAATTTATTTCATTTT------------CTTCTCTTGTAAATG 
LJFgene1        AATTTAACTTAAAAGAGAAACTTATTTCATTTTTTCTCTTCCTTTCTTTTCTAGTAAATG 
                ****** ****** ** *** ************            *** *** ******* 
 
LJFgene14       CTTTTGGAGAAATGTATCCAAACAGACCTTTACACAAGTACTAATAAGATAAGTCTAATT 
LJFgene1        TTTTTATAAAAGTTTACCCAAACAGAACTTTACACAAGTACTTATAAGATAAGTCTAATT 
                 ****  * ** * ** ********* *************** ***************** 
 
LJFgene14       AAGCCTTTTCAAA-ACGCTCAAAGTTCAAGTATTTCCATTATGTTGATTCTTCGGGCCTT 
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LJFgene1        AAGCTTTTTCAAACATGCTCAAAGTTAAAGTGTTTCCATAATGT---TTTTTTGGGCCTT 
                **** ******** * ********** **** ******* ****   ** ** ******* 
 
LJFgene14       AATTTTCGGTTAAGTAACTTGTGGTGTCAAAATTGCGTGTTGAGGAGGGTCTGGTAAACC 
LJFgene1        AATTTTCG-TCAAGTAACTTGTGATGTCAAAATTGCGTGTTGAGGAGGGTCTGGTCAACT 
                ******** * ************ ******************************* ***  
 
LJFgene14       AGATTTAGGAGATAAGTAA----TCAGGGTTTATTTATTTATTGGATTTAGTCCAAACGG 
LJFgene1        AGATTTAGGAGATAATTAAGCAGTCAGGGTTTATTTATTTATTGGATTTAATCCAAAAGG 
                *************** ***    *************************** ****** ** 
 
LJFgene14       AACCTATGGCCATATTTGTGAGAATCACGTTGCAATAATAGACAATGGTGCACTTGGAAC 
LJFgene1        AACCTATGAC-ATATTTGTGAGAATCACGTTGCAATA---GATAATGGTGCACTTGGAAC 
                ******** * **************************   ** ***************** 
 
LJFgene14       AATTTATCACGTTTTAAACCACGTGAAAGTAGTGCAGCCGAAATTGGACTATTGACTGTT 
LJFgene1        AATTTATCACGTTTTAAACCACGTGAAAGTAGTGCAACCGATATTGGACTATTGACTGTT 
                ************************************ **** ****************** 
 
LJFgene14       GAACAATGTTGACTTGACAT--GAATTGGACTATTGGTCACACAC--ATTGGCCGGTGAA 
LJFgene1        GAACATTGTTGACTTGACATAAGAAATGAACTATTGGTCACACACGCATTGGCCGGTGAA 
                ***** **************  *** ** ****************  ************* 
 
LJFgene14       AGCAGTGCAATCTTAACTTTTTCTTTTTTTTTTGACAACTTTTTTTTTTTCTCTATCTTT 
LJFgene1        AGTAGTGCAATCTTTACTTTTTCTTTTTTT------GAAATTTTTTTTTTCACTACCTTT 
                ** *********** ***************       *  *********** *** **** 
 
LJFgene14       GGTCCTTGTATTGAGCATGGTCCCACCAAAATCCAAACTTTATTATTGGACATAGATGAA 
LJFgene1        GGTCCTTGTATTGAGCATGGTCCCACCAAAATCCAAACTTTATTATTGGACATAGATGAA 
                ************************************************************ 
 
LJFgene14       TCATGATGTCACTTTGTTTTAATTTTTAGTTTCTTTTTCAGGAACTATAATCCTGAAGGA 
LJFgene1        TCATGATGTCACTTTGTTTTAATATTTTCATTCTTTTTCAGGAACTATAATCCTGAAGGT 
                *********************** ***   *****************************  
 
LJFgene14       AGGAAAAAACCTGTGAGCAGAGAGGAAGCAATGGAGGAACTGATAGACGTGGTAATAAAT 
LJFgene1        AGGAAAAAACCTGTGAGCAGGGAAGAAGCAATGGAGGAACTTATAGACGTGGTAATAAAT 
                ******************** ** ***************** ****************** 
 
LJFgene14       CTAGCTGAACTGAAATCTTGAGTTATAACACTAGATTGCAATTTTCTTTTCCTTCCCTCA 
LJFgene1        GCAACTGAACTGAAATCTTGAGTTAT--CACTGGATTGAAATTTTCTTTTCCTTCCCTCA 
                  * **********************  **** ***** ********************* 
 
LJFgene14       TTTTATCAACATCGATTATAATTTATAAAATTTATAAAAGGAGTGATAGTAAATATACAC 
LJFgene1        TTTTATCAACATTGATTATAATTTATAAAATTTATGAAAGGAGTGATAGTGAATATACAC 
                ************ ********************** ************** ********* 
 
LJFgene14       TTTGTAACACACTATTCTTAACCCCACCCTTTTTATTATTGGTTAAAATTTATCAGAAAT 
LJFgene1        TTTGTAACA--CTATTTCTAA---TACACTTTCTATTATCGGTTAAAATTTATTGAAAAC 
                *********  *****  ***    ** **** ****** *************   ***  
 
LJFgene14       TAGAAAGTCATG-AGTGGAACTCATTGAATAAAGAGTGAGACCTATG-TGATTTTAT--- 
LJFgene1        AGTGTTGTTAAATGGCGGCCATGGCGGCGCCATGGCGGAGTTGCGTAACGGTTTTCTGAA 
                      ** *    * **   *    *    * *   ***     *   * **** *    
 
LJFgene14       AATTTCTAATAAACTTATTATTA-ATAGTGTATTTAAAAGGATA-CATTGTGAACATTTC 
LJFgene1        AAAACGCCACCGAATAACGGTGGCGTGGCGGATTAAAGATGGCGGCGCCATGGCGGCCGC 
                **      *   * * *   *    * * * *** ** * *    *    **       * 
 
LJFgene14       TCTAATT--------TATAATTGATTTGTAATAATAGCTGGTTAT--TTGCACTTTTCCA 
LJFgene1        CATAGCCATGGCGGCCATGGCGGATGTGGCGGGGAGGCGGAAAATGGCAGAATTTTTTTT 
                  **            **    *** **        ** *   **    * * ****    
 
LJFgene14       ATCATT-GAAGTAAAGTTAAAACTAGTTCCGGATAATTTTACAGATCGAATCAACAACAC 
LJFgene1        TTTGTCCGCGGTAGGAGTTGGGCTGACCCGATCCAACCCTAC--------CCGAAAACTT 
                 *  *  *  ***    *    **    *     **   ***         * * ***   
 
LJFgene14       CAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACC 
LJFgene1        AATGAAAACCATGACCCCCCCTACCTTTCAG--AACGCTGCTGCAACCCT-CGAAGCTTC 




LJFgene14       AA---AGCTCAATCTTGGGGGTAAGTGTAACT--TACATCTAAG---GAAACTCATCTTG 
LJFgene1        AACATAGCGCGACCTCGGAACCAGCCACGACCCCTGCAACCAGCCTCGGAACCAGCCGCG 
                **   *** * * ** **    *      **   * ** * *     * ***    *  * 
 
LJFgene14       AAGAAA--AATGATCATTTTATACATTTGAGATGATATCAAGAACCATCTCTAATTTCCT 
LJFgene1        CTTGACCCGCTGCACACAGCAGCCAGCAGCGACGACCCATGGCGTGAACGGCGGCGACGA 
                    *     **  **    *  **   * ** **      *    * *        *   
 
LJFgene14       TCTCCCTTTTTTCTGTCATG-TGCTAACAGTTTGTGGATGATGTTGAGTTCTGGTTTCCA 
LJFgene1        GCACGGCGTGAACAACGGCGACGCGAACGGA--GAAGACGACCCAGAACCGCGACCTCGA 
                 * *    *   *      *  ** *** *   *  ** **    **     *   ** * 
 
LJFgene14       CCCGGTAAGGGTTCTACTGTGGAGTATCGATCTGCATCTCGGTTGGGAAAC-TTTGATTT 
LJFgene1        CTTA-TACGGGTGGGTGGGCCAAAGCCTTTTTTTTGTTTTTGCTGCTTGACACCCCTTTT 
                *    ** ****      *   *       * *   * *  * **    **      *** 
 
LJFgene14       TGATGTGAACAGAAAAAGAATAAAGGTATGATTTCATAATTAATATGTGCTTTCTCT--- 
LJFgene1        TTATGTCTGCAGC-------TTTTTTTCCGTTTTTCTATTTGACACCCCCTTTTACTTTC 
                * ****   ***        *     *  * ***  ** ** * *    ****  **    
 
LJFgene14       -ATAGTTAGATAAAGAAATTCTTG----GTTCCAGGGTAAAACTCCCCTTCCT-TCATGT 
LJFgene1        GACAGTCCCATTTTTAATTTTTTTTTCTATTTGACACCACAATTTTTTTTTCTGTTCAGT 
                 * ***   **    ** ** **      **  *    * ** *    ** ** *   ** 
 
LJFgene14       CATGTC-----------AAACATTTTATACTTAAGTAGATTCACTAAATTTGAGT-CTCA 
LJFgene1        CCTCTTTTAAATGGCTGAACCATCATCCTCTTTAATGAGTTTATTTGGTGTTGGTACTTG 
                * * *            ** ***  *   *** * *   ** * *   * *  ** **   
 
LJFgene14       AATGTTTTA--ACTTTATTCTAAATTAGTCACTTATTTTAACGGAAGG--TAAATTTGGT 
LJFgene1        ATTATTGTATGAACTCATGAAACTTTTTTAGTTTATTTGAATGCAATCCTTTGTTTTTTT 
                * * ** **  *  * **   *  **  *   ****** ** * **    *   ***  * 
 
LJFgene14       TGACTATGATGAG-----AAATACGTTGATATTTTTTAATTGGTAGAGATAAAG---AAT 
LJFgene1        CAATTTCAATGAGTTTATATATATGTTTTTTTTTTTTTTTGGTCCGCCATGACTTCCGCC 
                  * *   *****     * *** ***  * ******  * *   *  ** *         
 
LJFgene14       ATTTTTTA-TGTACAATAAAGAGAGTATTTACTCCAGAGGATGCAAATCCCTTACTAAAT 
LJFgene1        ATTTTCCGCTACGCCATCCGCCATATTTTTATGGCGGATTTTTTACTTTCCGCCATGAAC 
                *****    *   * **        * ****   * **   *  *  * **    * **  
 
LJFgene14       ATT--TTTGTGATGAAAAATCTTGGTTGCTGACA--GGCACTGAGACAAGAGTTGGA-GA 
LJFgene1        CGCCATCCGCCATTAACAACATTGATTGAAAATTATGAAGTCATGAGAGGAGCTCATTGA 
                     *  *  ** ** **  *** ***   *    *       ** * *** *    ** 
 
LJFgene14       AGAAAGGATGGACATCT-CAAGATACCATA-TGATTAATAAACTCAGGCTGA-ATTAGCA 
LJFgene1        ATAAAGAGTGAGAACTTACATGATTTTGTAATTTCTAATAATTTTTTACTATTAATAAAG 
                * ****  **   *  * ** ***    ** *   ******  *    **   * **    
 
LJFgene14       TCAGCATCTAAGCAAATATTATTTCATATACTTTG--GACCTTGTATACTTTTGTATTAG 
LJFgene1        AGTGTATTTAAATGGGTATGTTTTTGAACATTTTTCTAATTTCTAATCGATTTGTAATAA 
                   * ** ***     ***  ***   * * ***    *  *   **   ****** **  
 
LJFgene14       ATACAAATC----GCACAG----GATCATTGCAAGCAAACTTTTCTTAGATTTTTGGAAT 
LJFgene1        TAGCTGGTTATTTGCACTTTCCCAATCATTG-AAGTAAAGTTAAACCAGTTCCGGATAAT 
                   *   *     ****       ******* *** *** **     ** *      *** 
 
LJFgene14       TGTAGAGAAATCATTGAGAACAGTACTTCAAACTCTCTCGGGGAAGG---AATGAAATGA 
LJFgene1        TTTACAGATAGAATCAACAACACCAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGA 
                * ** *** *  **  * ****  *    **  *    *  ***  *   ** * ** ** 
 
LJFgene14       AGACCTTGCGC-CATATCTTCTTCAAGTTCATTAATTGGTCCACTTAT---TTACACCT- 
LJFgene1        AGACTATATTCGTGTGGAGTACCAAAGCTCAATCTTGGGGGTAAGTGTAACTTACATCTA 
                ****  *   *   *    *    *** *** *  * **   *  * *   ***** **  
 
LJFgene14       -------TCACC--GAGTTCAATCTAATAATGTATGAATCTTG-----TTTCAAGAAATT 
LJFgene1        AGGAAACTCATCATGAAGAAAAATTATCCTTTTATACATTTTAGATGATATCAAGATTCA 
                       *** *  **    **  **    * ***  ** **      * ******     
 
LJFgene14       TAATTTGTGTTTTGTTTCAAACG---TGTTCTTCATGATTCACT-----TTTGTTGT--A 
LJFgene1        AGAACCATCTTTAATTTCCTTCTCCCTTTTTTCTGTCATGTGCTAACAGTTTGTGGATGA 




LJFgene14       AGTTTGACTTTGCTTCTTCATGTATTAAAGCTTATCCTTGCG--ATCAATTTGGATGATG 
LJFgene1        TGTTGAGTTCTGGTTTCCTCCGGGTAAGGGTTCTACTGTGGAGTATCGTTCTGCATCTCG 
                 ***    * ** **      *  * *  * *   *  **    ***  * ** **   * 
 
LJFgene14       CTTTAGG--CCTT---TCTGTCATCAAAATGTACGTACCTATGTCATGTTTTCAGAGGCT 
LJFgene1        GTTGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATGATTCCATAATTC 
                 **  *   * **   * **   * ** *   *   *   * *  *** ** ** *     
 
LJFgene14       TTTTG-ATATCCTTGATGTCTTTACAAGAAAAGTC--GGTGC--ATATAGCATTTGGAAT 
LJFgene1        ATATGTGCTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCCAGGGTAAAACTCCCCTT 
                 * **    * **  **   *  * **  *** **  *** *     **  * *     * 
 
LJFgene14       CTGGTTATAATA---GGAGCATT----------GCGGAG--ACTAAGTATAGGGTGCA-- 
LJFgene1        TCCTTCATGTCATGTGAAGCATTTTTTACTCAAGTAGATCCACTAAATTTGAGTCTCAAA 
                    * **   *   * ******          *  **   ***** * *  *   **   
 
LJFgene14       --TTTTGACTTTGGTAACTCTGTTTC----TCAATTCACTTCCATACGTTGTTCAGAAAT 
LJFgene1        TGTTTTAACTTTATTCTAAATGTTTTAACTTTATTTGAGTCTCAAATGTT--TTAACTGA 
                  **** *****  *     *****     * * ** * *  ** * ***  * *      
 
LJFgene14       TGTTCAATCTCATTGATCCTAACTAGAAA-ATTCGTCCAACAGC-AAAGAATGCAAAGCT 
LJFgene1        AGGTAAATTTGGTTAACTATGATCAGAAATACATTAACAAGAGTTGAAGAATATTTTTTA 
                 * * *** *  ** *   * *  ***** *      *** **   ******         
 
LJFgene14       AGCAACTCAAGGACGAATTTTGTTGGCTTCTAGATAGTGGTTTGGCTTAAT---TTTGAG 
LJFgene1        TGTACAATAAAGAGAGTATTTGCTCGAGAGAATGTAAATCCTTTTCTAAATATTTTTGTG 
                 * *    ** **     **** * *     *  **     **  ** ***   **** * 
 
LJFgene14       AATTTATTTGGTGGATTTTGG-ACGTA-TGAGGTTGAAGTTG----AGTTTTAATTGAAA 
LJFgene1        ATGAAAAATAATGGTTGCTGGCAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGGCA 
                *    *  *  *** *  *** * * * ****     *****    **     ** *  * 
 
LJFgene14       TTTC---------CTTGTCCAACAAATGCAAGCAGATTTAGCATCATGA---AAAAAGAT 
LJFgene1        TCTCAAGACACCATATGATGAAAAAACTTAGGCAGAATTCACATCAGCATCTAAGAAAAT 
                * **           **   ** ***   * ***** **  *****  *   ** ** ** 
 
LJFgene14       A---------ATGCAATAAAAAAAAAAAAAGGTTAGAACAGGATAGAGAAGCACTCTAAA 
LJFgene1        ATTGTTTCATATACATTGTAACCTTGTATACTTTTGTATTAGATACAAAATCTCACAAGA 
                *         ** ** *  **      * *  ** * *   **** * ** * * * * * 
 
LJFgene14       GCTATGAAAT-------------------------------------------------- 
LJFgene1        TCATTGAAAGCAAACTCTTCATGATTATTGGAATTGTAGAAATGATTGAGAACAGTACTT 
                 *  *****                                                    
 
LJFgene14       ------------------------------------------------------------ 
LJFgene1        CAAACTCTCGGGGGAAGGAATGAAATGAAGATGTTACCCATATCTTTTTGAACTTCATTA 
                                                                             
 
LJFgene14       ------------------------------------------------------------ 
LJFgene1        ATTGGTCCACTTATTTACTCTTTCGCTGAGTTCAATCTAACAATGTAGCATTCTTGTTTC 
                                                                             
 
LJFgene14       ------------------------------------------------------------ 
LJFgene1        AAGAATTTTATGTTGTGTTGTTTTTCAAATGCATTTGCCATGATTCACCTTCGGTGCATA 
                                                                             
 
LJFgene14       ---------------------------------------------------------- 
LJFgene1        TAGCATTTGGAATCTGATTATAATAGGAGCATTGCGGAGACCAAAAACAGGGTGCATT 
                                                                           
LJFgene8 vs. LJFgene3 
 
LJFgene8       ACCTCTAGTGTCCACTTAATGGTGAGATTTGAAATAATATGTATGAGATTCTAAGTTCAA 
LJFgene3       ------------------------------------------------------------ 
                                                                             
 
LJFgene8       ATATTAAGTGTCATTGTTAAAGAAAAAACAGTATGATAT-GCTGGAATTTACTAAC-TAT 
LJFgene3       ----------CCATAAAAAAGAAAAAAAAAAAGTCCCACCGCCCACCTTCTTTATCACAT 
                          ***    **  ****** *   *   *  **     **   ** *  ** 
 
LJFgene8       AATCTTTATAATAAGTTTAGCATTTAGTGTATATTGACTTGAAAGATTCTTGTAGCAATT 
217 
 	  
LJFgene3       GATTCACATCTCATTCCTTATATTTGGTTCACATT--CTTAAATTATAAATATTTCGGTC 
                **    **   *    *   **** **  * ***  *** **  **   * *  *  *  
 
LJFgene8       TGCAGCAGTTTTATATAGATAG------TAACATTCTTAAAT-TACGTTTATAAGTTCCT 
LJFgene3       TGT-GAAGATATATGTCCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCA 
               **  * ** * *** *  ***       ***  ****  **  * * ***  *  * **  
 
LJFgene8       TCATTTTCAGCTCCGAACAATGGCTTCTTCGTTCTCCTTCTGCACCCTCAAGTTTCGCAC 
LJFgene3       ACAACAATGGCTT----CAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTTCATCAC 
                **      ***     ******* *****   *********** *********   *** 
 
LJFgene8       CAAACCCAACGATAGTAGAAGCAGTGCTTCCTCTCTTCCCCGTATTCTATTCTGTCACAA 
LJFgene3       CAAACCCAACAATGGTAGAAGAAG------CTCTCTTCCCCGTATTGTATTCTGTCAGAA 
               ********** ** ******* **      **************** ********** ** 
 
LJFgene8       CCTCCACGATGACATTCACACACCCACTGACCAAATCAACCGAAGGTTCACTTCTCCACA 
LJFgene3       GCACCACGATAG------CACACCCACCGACCAAATCAACCGAAGGTTCTTATTTCTTCA 
                * *******        ********* *********************   * **  ** 
 
LJFgene8       CTCTCATGCACTTTCTCACAGCTTTCTAATTTCTATTGATTATTCATAATTATTCATGCA 
LJFgene3       CACTC--GCACTTTCTAA-----TTCC--TTTCTATGGATTATTCATATCTATTC----A 
               * ***  ********* *     ***   ******* ***********  *****    * 
 
LJFgene8       TACCCATCTTCTGAAATCTCTTTACACGTCAATGATTTTGTATCTTAAAGACAACTCATA 
LJFgene3       TACCCATCTTCTGAAATCTCTTTATATTTCAATTATTTTGTCTATTGAAGAGAACTCATA 
               ************************ *  ***** ******* * ** **** ******** 
 
LJFgene8       TTGAGAAGCAGCGAAATAGCGACCATCGGTGCCATCTTCGACTTCAGGTACCCCCGGCCC 
LJFgene3       TTGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTGAACTTCGGGTACCCCT--CCT 
               ************************** ***********  ***** ********   **  
 
LJFgene8       CTCCTCTGTTTTTTAGAAATTTTT-CTTTTCATTTTATTTTGAACGTAAATTTAATTCAA 
LJFgene3       CTGCT-TGTTTTTGGAAAATTTTTGTTTTTCATTTTATTTTGAATGTAAATTGAATTCAA 
               ** ** *******   ********  ****************** ******* ******* 
 
LJFgene8       GATTTGATTTTGTTAGTGAGTAGTGAGACCCTTTTGGTTTTTAGTATTAGTTTTGTTTTG 
LJFgene3       GATTTGATTTTGTTGGTGGGTTTGAAGACCCTTTTGGTTTTTAATTTCGGTTTTGTTTTG 
               ************** *** **    ****************** * *  *********** 
 
LJFgene8       TATTGAAAATGGGTAGTTATTAAAAAAGAGGGTATTGTGTGTTTTTTTTTTTTTTTTTTT 
LJFgene3       TATTGGACATGGGTGGTGGTTAAAAAAGAGAAAATTGAGT-----TTGTGTCTTGTGTTT 
               ***** * ****** **  ***********   **** **     ** * * ** * *** 
 
LJFgene8       TTGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCTTTA 
LJFgene3       TGATGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCATTA 
               *  ***************************************************** *** 
 
LJFgene8       GCTCTGTGTCCGGTAACTAGGAACTGCGTATCAACCTCTGAGAATATCAGTGATCGCACT 
LJFgene3       GCTCTGTGCCCGGCAACGAAGAATTGCGTGTCAACCTCTGAGAATATCAGTGATCGCACA 
               ******** **** *** * *** ***** *****************************  
 
LJFgene8       CATTATGCTCCTCTTTGGTAAAAACTTTCCTTGTTTTCCTCATTTTAATTTTAGCCTTCC 
LJFgene3       CATTATGCTCCTCCATGGTAAAAG-TTTCCTTCTTTTTCTTATTTTAATTTTCACCTTGG 
               *************  ********  ******* **** ** ***********  ****   
 
LJFgene8       TTTTCAAACCGCCAAGTTAATTTTTTAACCGTGTATTGGTGGTTTTTTTTTGGTCCTTGA 
LJFgene3       ATTT------ATGGGATTA----------TATGTATTAAATGCATTTTTTTAATTGTGTG 
                ***            ***            ******    *  *******  *  *    
 
LJFgene8       ATGATACATAGGATTTT-TCAAATAATTGGTTCAAAGACTAATTA--TATTTATAATATG 
LJFgene3       TTTGGACAAACTACTTAGTTAAGTGCTCATCTCATCATGTAAGTGCTTATGCATAAGTTG 
                *   *** *  * **  * ** *  *    ***     *** *   ***  ****  ** 
 
LJFgene8       TGATTGTAGTTGGTCAAAGGGGAAATTGTTTGATTTTTATCATGTATAAAATGTTTTTGG 
LJFgene3       TTTCTATAATAAA--AAAATAAAAATACATACGTATGAGTTGTTGTTGTAAGCTTTTTTC 
               *   * ** *     ***    ****   *   * *   *  *   *  **  *****   
 
LJFgene8       ACCAATAATAATAACAAATAAAATAAGATTAATTTTTAACTCAATTGGTTGATTAAGAGT 
LJFgene3       TTAAGTTATTCTGG-AAATCTTATTGAAATAATCTGAAAACAACTTTTTTTTTTACATG- 




LJFgene8       AAAAATATTTGTGATCTCTCATCAAAATAAAAAAATTTCTCTTCATTTTAAAACAAAAAT 
LJFgene3       --ATCTGCTGAAAACAACTTATAGACATATGGTAATCACATATCATT---AAGTTAAGTT 
                 *  *  *    *   ** **  * ***    ***  *   *****   **   **  * 
 
LJFgene8       CACATCTTTAAAATTTAAAAGTCAGGTCCACACTTAAGATACTTAACTTAAACATAGGTA 
LJFgene3       ---ATTCCAAACACTTACA---TAAACACTTATAAGAGAAAAACAA-TAAGAAATAAAAA 
                  **    ** * *** *    *    *  *    *** *   ** * * * ***   * 
 
LJFgene8       CTCAAACCAAAAATTTTCAAATATGTGAGATC---CCACACAAATTTTTATTTATTAGAA 
LJFgene3       C---AAAATAAAATTTTCAATAAGTTAAAATTAGTTTATAAAAGTTTTTTTTTATTATAG 
               *   **   ***********  *  * * **      * * ** ***** ******* *  
 
LJFgene8       ATCTTAAAATAAATTAAATGTTTATCAGGAATTTGAATGTATTTTAGCCTATTTTCGAAC 
LJFgene3       AAGCTCTCTTGTATTAGCCTCTCCTAAAGTTTTTTTTTCTTCATAATTTAGCTTAAAAAG 
               *   *    *  ****     *  * * *  ***   * *   * *      **   **  
 
LJFgene8       AAGGTTTTATCATACAAAATTTATGGATCCAACAAAATAAAAATAAGAAATTGTCATGGC 
LJFgene3       AAACCTATTTCATTTTTTCATTTTATTTTCTTCTC--------TTGTAAATGCTTTTGGA 
               **   * * ****       ** *   * *  *          *   ****  *  ***  
 
LJFgene8       TTGGTTTCCAAAACTGAACCTCATGTTCAAGAACACGTGGAAGCACAACTGCAGCTTTGT 
LJFgene3       GAAGTTTGTCCAAACATACCTT---TACACAAATACTTATAAG-ATAAGTCTAATTAAGC 
                  ****    **    ****    * **  ** ** *  *** * ** *  *  *  *  
 
LJFgene8       CTTAGCTCATCATCAAGCGCCAGTTAGCAATATTTTGCGGGAATAGACAATGAGACCAAA 
LJFgene3       TTT--TTCA--AACACACTCAAAGTTAAAGTATTTCCATTTTGTTGTTTTT-----TTGG 
                **   ***  * **  * * *  *   * *****        * *    *          
 
LJFgene8       ACCTTCATCATGCACAAGTCTATTTTAGTTGCACTAGGGTTTTGGAGCCTTTCACAAGAC 
LJFgene3       GCCTTAATTTTCGGTTAACTAACTT--GTGGTGTCTAAATTTCG---TCTTGAGGAGGGT 
                **** **  *     *    * **  ** *        *** *    ***    * *   
 
LJFgene8       CAAAACTAGATACGATTCATGCTAAAATAAAGCCTAAAGCCTTTTGGAATTATTCACAGC 
LJFgene3       CTGA--TAAACCAGATTTAGGAGATAAGTAAGCAGTCAGTGTTT---ATTTATTTATTTT 
               *  *  ** *   **** * *  * **  ****    **  ***   * ***** *     
 
LJFgene8       AAAATCCGATGTTGACATCAACCATATGTAACATTATAATATATTACTAGCCTTTAAAAT 
LJFgene3       TTGGATTTAGTCCAAAAGGAACC-TATGGCATATTTGTGAGAATCACG---TTGCAATAG 
                       *     * *  **** ****  * ***       ** **     *  ** *  
 
LJFgene8       TCAATTCCACATTCAACAAAATTTATTACCCTGTTCTCTCTACACTACGCAATTAGAAAA 
LJFgene3       ACAATAGTGCACCTGGAACGATTTATCAC---GTTTTAAACAAGTAGTGCAACC-GATAT 
                ****    **      *  ****** **   *** *    *      ****   ** *  
 
LJFgene8       CAAAAGGTTGAGCGGAGAAAAATCTAGAAAGTGCTTAGAAATTCAACTAAATTTTGTCAA 
LJFgene3       TGGACTATTGACTGTTGAACATTGTTGACTTGACATAAGAATTGGAC---AATTGGTCAC 
                  *   ****  *  *** * * * **     * **  ****  **   * ** ****  
 
LJFgene8       ACAGG-ACGAGCCAATAAATACGATTAATGACAGCTACGAGAAATGTATATTTTTAGTTT 
LJFgene3       ACACACATTGGCCGGTGAA----AGTAGTGCAATCTTTACTTTTTATTTCTTTTTGACAA 
               ***   *   ***  * **    * ** **  * **        * * * *****      
 
LJFgene8       AGAAACACGTCTTTAGTTATA--TCATAACAAAAAATAAAAATTAAAGTTGTGTTTAAAT 
LJFgene3       AAAAATTT-TCTCTACCTTTGGCCCTTGTTTGAGCATGGTCGCCACA---AAATCCAAAC 
               * ***    *** **  * *    * *     *  **       * *      *  ***  
 
LJFgene8       ATATGTTTTATTTAAAAAAATTAAAA----ATTAGGAAATTGTGTTTTAATTCATGACTT 
LJFgene3       TTTATTATTGTATAGATGAATCATGATCTCACTTTGTTTTAGTATTTTCATTCTTTTTCA 
                *   * ** * ** *  *** *  *    * *  *   * ** **** **** *      
 
LJFgene8       TAAGTTAAAGTCACGAA--TTAAAAGATGGCTTTAATAAAAGTAAATTTAAAAAATAAAT 
LJFgene3       GGAACTATAATCCTGAAGGTAGGAAAAAACCTGTGAACAGAGAGGAAGCAATGGAGGAAC 
                 *  ** * **  ***  *   ** *   ** * *  * **   *   **   *  **  
 
LJFgene8       AAAGAAGTCATGTTTGAAAATATACCTTTCGTTGAAATGTTGTGCTTT-----TAAAACA 
LJFgene3       TGATAGA-CGTGGTAATAAATCTAACTGA-ACTGAAATTTTGAATTATATCACTGGATTG 
                 * *   * ** *   **** ** **     ****** ***   * *     *  *    
 
LJFgene8       CAACTTGCTCATTTATTGATTTTTTAAAAATAAATTTACCTATTTTGGGATTTTTTTTTT 
LJFgene3       CAATTTTCTTTTCCTTCCCTCTTTTAA---TCAA--CATCGATTATAATTTATAAAATTT 




LJFgene8       ATAAAAAATGCACCACTCTAGTAAGTAAACCTTTTTTTTATATATAAAAAATTGCATTCA 
LJFgene3       ATAAAAGGGGTGATAAACT-GAAAGTAAATATACACTTTGTA-ATGCACTATT----CCT 
               ******   *    *  ** * *******  *    *** ** **  *  ***     *  
 
LJFgene8       GGTAAACAACATAATTAAGTGTTTACTGATTCATTGAAACACTTATGTATAAGTTGTTTA 
LJFgene3       AACACACTTTCTA-TTATTCATTAA--AATTTATTGAAA-ATTACGAAGTCATGGGTGGA 
                  * **    ** ***    ** *   *** ******* * *      * *   **  * 
 
LJFgene8       TGTGATTGAAGAGAAAATAAAGTTAAATTATTTTCTTATAAATTGTAATATGTTTTCATG 
LJFgene3       ATTCATTGAATAAAGAGTAAGACCTA--CATGATTTTGTAATTTCTAATAAACTCTTACT 
                 * ****** * * * ***     *   **  * ** *** ** *****   * * *   
 
LJFgene8       AGCTATGGAAAGTTTATTGAAATAAACTGAAAATAGATTGTGGATATTTCATAAATACAT 
LJFgene3       ATTAATAAAGAATGTATTTAAA-------AGGGTATGTTGTCAACATTTCTCTAAT---- 
               *   **  * * * **** ***       *   **  ****  * *****   ***     
 
LJFgene8       ATCTTAAAATTATTTTAAATATTCCAAACACTTATATAAATACTATAAGCACTTGTAATA 
LJFgene3       ---TTATAGTTGATTTGTG-ATAATAGCTGGTTATTTG--CACTTTTCCTTCCAATCATT 
                  *** * **  ***    **   *     **** *    *** *     *   * **  
 
LJFgene8       GAAGAAAGATAAGAATGTAAAATAAATTGATTTTTTTTCCATAAGTTGATTTAAGTTAAA 
LJFgene3       GAAGTAAA--------GTTAAACCAGTTCCGGACAATTTTGCAGATAGAATCAA--CAAC 
               **** **         ** ***  * **        **    *  * ** * **   **  
 
LJFgene8       ATCAACTTATGTATCATAACACCTCAGGTTTTGAAAAAGTTAAATGAGAGAGTTTTTAAC 
LJFgene3       ACCAG---ACAAATTTT--CACCACGGATAGTTGAAAGG------AAAGAAGACTATATT 
               * **    *   **  *  **** * * *  *  *** *       *   **  * **   
 
LJFgene8       AAAGTTAAGTGTATAAGTTAAATTTAAGAGAAAAACACAATTTAT-TCTACCTTTTCTTT 
LJFgene3       CGTGTGGAGTACCAAAGCTCAATTTTGGGGGTAAGTGTAACTTACATCTAAGGAAACTCA 
                  **  ***    *** * *****  * *  **    ** ***  ****      **   
 
LJFgene8       TCCCCATTTGTAATTGTTTATGGCCAATTTGATCCAAACAACATCTTTAGCCTAAATAAG 
LJFgene3       TCACGAAGAAAAAT-GATAAT--TTTATACATTTGAGATGATATCA--AGATTCAAGAAC 
               ** * *     *** * * **     **    *  * *  * ***   **  * ** **  
 
LJFgene8       CTCTTCCAATCACACTCTAAG-TTTAAGTATGAT-TACTA-TGATGTTTAGATTTCATTG 
LJFgene3       CATCTCTAATTTCCTTCCCTCCTTTTTCTGTCATGTGCTAACAGTTTGTAGATGATGTTG 
               *   ** ***  *  **     ***   * * ** * ***    * * *****    *** 
 
LJFgene8       TGTTGT--TTTTTATGACCTTAATTTTCCGTCGAGTAACGCCATATTTGAATTAAAGTTT 
LJFgene3       AGTTCTGGTTCCCACCGGGTAAGGGTTCTACTGTGGAGTACCG-ATCTGCATCTCGGTTA 
                *** *  **   *     * *   ***    * * *   **  ** ** **    ***  
 
LJFgene8       GTAAATTTTAGATGAAATTCATTTTGCAAACTGAATTTGTAAAATCAACTCTTCCTTTAC 
LJFgene3       GGAAACTTTGATTTTGA-------TGTGAACAGAAAAAGAATAA--AGGTGTGATTTCAT 
               * *** ***   *   *       **  *** ***   * * **  *  * *   ** *  
 
LJFgene8       TTCCAAAATCCAAACTTTATTATTGGACAAAGATGAATCGTGGAGTTACTTTGTTTTAAA 
LJFgene3       AATTCATGTGTTTTCTCTATAGTTAGATAAAGA-AATTCTTGG---TTCCATGGTAAAAC 
                    *  *     ** ***  ** ** *****  * ** ***   * *  ** *  **  
 
LJFgene8       TTTTTAATTTTAATTATTGT-TCAGGAACTACAATCCTGAAGGTAGGAAAAACCCTGTGA 
LJFgene3       TCCTCTTTCCTTCATGTCATGTCAAACATTTTATACTCAAGTAGATGATTCACTAAATTT 
               *  *   *  *   * *  * ***   * *  *  *   *    * **   **    *   
 
LJFgene8       GCAGAGAAGAGGCAATGGAGGAACTGATAGACGTGGTAATAAATCTAGCTGAAATCATAA 
LJFgene3       GAGTCTCAAATGTTTTAACTTTATTC-TAAATTAGTCACTTATTTTAACTGAAGGTAAAT 
               *      * * *   *      * *  ** *   *  * * * * ** *****   * *  
 
LJFgene8       GTTATTTTC-ATGAATGCATTGCAATTTCCCTTTCCTAGCCTGTGTA--TCAACAAATGT 
LJFgene3       TTGGTTAACTATGATCAGAAATACATTGACATTTTTTAATTGGTAGAGATAAAGAATATT 
                *  **  * ****    *     ***  * ***  **    **  *  * ** **   * 
 
LJFgene8       TATTATTTATAATAAGTTTAATTTTCATGCACTGACCGTATATAATAATT-TTATATTGA 
LJFgene3       TTTTATGTACAATAAAGAGAGTATTTACTC-CAGAGGATGTAAATCCCTTGCTAAATATT 
               * **** ** *****    * * ** *  * * **   * ** *    **  ** **    
 
LJFgene8       TATCTAATCATAAATCATCATT--TAAATTATTTTAAGATAATTAATTTAAAAGTTAATA 
LJFgene3       TTTGTGATGAAAAATCTTGGTTGTTGACAGGCACTGCGACAA--GAGTTGGAGAAGAAAG 
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               * * * ** * ***** *  **  * *       *  ** **   * **  *    **   
 
LJFgene8       AATTTACCGTATATAATGAATTATAATTGAATAATTGTATAAAAAATTTATAATGTCACT 
LJFgene3       GATGGGCATCTCAAGACACCATATGAT-GAATAAACTCAGGCAGAATTAACATCAGCATC 
                **   *     *  *     *** ** ******    *   * **** * *    **   
 
LJFgene8       GTATAATTCTTTTTCTCATTTATAATTTGGTTGTAAGTTGTAGCTTGTAATAGCAGGTTA 
LJFgene3       TAAGCAAATATTATTTCATATACTTTGTGACC-----TTGTATACATTTGTATTAGATA- 
                 *  *    ** * **** **   * **        *****     *  **  ** *   
 
LJFgene8       TTTACCTTTTTCCAATCATTGAAGTAAAGTTAAAATCCAGCTCTGGATAATTTTATAGAT 
LJFgene3       -CAAATCTCACAGGATCATTGAAAGCAAACTTTTCTTTGATTATTGG-AATTGTAGAGAA 
                  *   *      *********   **  *    *     * * *  **** ** ***  
 
LJFgene8       AGAATCAACAACACCAGACAAATTTACACCACGAATAGTTGAAAGGAAGGAAGACTATAT 
LJFgene3       ATCATTGAGAACAGTAC-----TTCAAACTCTCGGGGAAGGAATGAAATGAAGACCTTGC 
               *  **  * ****  *      ** * **           *** * ** ******  *   
 
LJFgene8       TCATGTGGAGTACCAAAGCTCAATCTTGGGGGTATGTGTAACTTACATCAAAAGGAAACT 
LJFgene3       CCCATATCCTTCTTCAAGTTCATTAATTGGTCCGCTTAT---TTACTCTTTCACCAAGTT 
                *        *    *** *** *  * **      * *   ****      *  **  * 
 
LJFgene8       CATCGTGGAGAAAAATAATAATTTTGTACATTTTAGATGATAATCAA-GAACCATCTCTA 
LJFgene3       CA--ATCTAACAATGTATCGTTCTTGTT--TCAAGAATATTAATTTGTGTTTTGTTTCTA 
               **   *  *  **  **    * ****   *     **  ****    *     * **** 
 
LJFgene8       ATCCCTTCTCCCCTCCTTTTTATTTTTTCTGCCATGTGCTAGCAGTTT-GTGCAT-GATG 
LJFgene3       ATGTGTTCTTCACGATTCACTTTTGTTGTAAGTTTGACTTAGCTTCTTCATGTATTAAAA 
               **   **** * *   *   * ** **       **   ****   **  ** **  *   
 
LJFgene8       TTGAGTTCTGGTTTCCACTGGGTAAGGGTTCTACTGTGGAGTATCGATCTGCATCTCGGT 
LJFgene3       CTTAACCTTGTGATCAATTTGGATACTTTAGGCCTTTCTCTTATCAAAATGTACCTATGT 
                * *    **   ** * * **  *   *    ** *    **** *  ** * **  ** 
 
LJFgene8       TGGGGAACTTTGATTTTGATGTGAATAAGAAAAGAATAAAGGTATGTTTGTATCATTCCT 
LJFgene3       CATG--ATCTCGAAATTGTTCAATCTCATTGATCCTAACTAGAAAATTCGTCCAA----- 
                  *  *  * **  *** *     * *   *     *   * *  ** **   *      
 
LJFgene8       TTGTGCTGTCTCGGTAGTTAACATGAAGAAATGATTAAAAGATATTTTGTCCTTTAGGTT 
LJFgene3       ------------------------------------------------------------ 
                                                                            
 
LJFgene8       TTTTGGTTATATTTAGTTTGATTTTTTATTTTTTAAAAGTTAAATTTAGTCCTTTATGTT 
LJFgene3       ------------------------------------------------------------ 
                                                                             
 
LJFgene8       TTTAAAACGAATCAAAATGATCACTATTTCGAGATGTAAAACTTTTTTATTAGATTTACT 
LJFgene3       ------------------------------------------------------------ 
                                                                             
 
LJFgene8       TACATGCAAATTATGCAACTTGACTAATGTTTGAAAAAAAAAATCATCAATATGATAAAA 
LJFgene3       ------------------------------------------------------------ 
                                                                             
 
LJFgene8       ATAATGAGTGTCACAAGCAATTAAAAA 
LJFgene3       --------------------------- 
                                            
 
LJFgene8 vs. LJFgene14 
 
LJFgene8        ------------------------------------------------------------ 
LJFgene14       TATATATACACACACACACGAATAAACAAATTTTTTTAAGAGTAAATTACATAACATCTT 
                                                                             
 
LJFgene8        ------------------------------------------------------------ 
LJFgene14       GTGAGATTTTAAATTTTTTTATACATATTTAAAAAAAAAAGACTTACACAAATCTATCAA 
                                                                             
 
LJFgene8        ------------------------------------------------------------ 
LJFgene14       TTAAATTTTAAAAAATTACACACGTCTCATAACTGTTTTTGAATAAATACTAACTAAAAT 




LJFgene8        ------------------------------------------------------------ 
LJFgene14       TAAAAAAAATGTAGAAATGCATTATTATTTTTACCGAGTAAAAACATTCTTGATGCGCGA 
                                                                             
 
LJFgene8        -----------------------------------------ACCTCTAGTGTCCACTTAA 
LJFgene14       ATTTGACAAAAACCTTTTCGTACAGATAAGCATTTATGGATATTTTTAGTATCCA--AAA 
                                                         *  * **** ****   ** 
 
LJFgene8        TGGTGAGATT-TGAAATAAT----ATGTATGAGATTCTAAGTTCAAATATTAAGTGTCAT 
LJFgene14       TTGTCACTTTCTCAAACAATCGAAATATATACTATTTATTTTCTAAATATCTAAATCCAT 
                * ** *  ** * *** ***    ** ***   ***     *  ******  *    *** 
 
LJFgene8        TGTTAAAGAAA-AAACAGTATGATA----TGCTG-------GAATTTACTAACTATAATC 
LJFgene14       AAAAAGGAAAATAAATAAAAAAATAAAAATGTTGCGGAAACGAAGTCCCACCTTCTTTTA 
                    *   *** *** *  *  ***    ** **       *** *  *    * *  *  
 
LJFgene8        TTTATAATAAGTTTAGCATTTAGTGTATATTGACTTGAAAGATTCTTGTAGCAATTTGCA 
LJFgene14       TTCATCACATGATTCACATCTCATTTCTTATTTTCGGGTCACTTTGTTAAATTATAAATA 
                ** ** * * * **  *** *  * * *  *     *     **  *  *   **    * 
 
LJFgene8        GCA--GTTTTATATAGATAGTAACATTCTTAAATTAC---GTTTATAAGTTCCTTCATTT 
LJFgene14       ATTTCGTTCTGTGAAGGTACACACGTTCATAAGTTCCTTAATTTTCTCGAACCTTCATTT 
                     *** * *  ** **   ** *** *** ** *    ***    *  ********* 
 
LJFgene8        TCAGCTCCGAACAAT------------GGCTTCTTCGTTCTCCTTCTGCACCCTCAAGTT 
LJFgene14       TCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTT 
                ******** ******            *** *****   *********** ********* 
 
LJFgene8        TCGCACCAAACCCAACGATAGTAGAAGCAGTGCTTCCTCTCTTCCCCGTATTCTATTCTG 
LJFgene14       TATCACCAAACCCAACAATGGTAGAAGAAG------CTCTCTTCGCCGTATTGTATTTTG 
                *  ************* ** ******* **      ******** ******* **** ** 
 
LJFgene8        TCACAACCTCCACGATGACATTCACACACCCACTGACCAAATCAACCGAAGGTTC--ACT 
LJFgene14       TCAGAAGCATCACGATGA------CACACCCACCGACCAAATCAACCGAAGGTTCTTACT 
                *** ** *  ********      ********* *********************  *** 
 
LJFgene8        TCTCCACACTCTCATGCACTTTCTCACAGCTTTCTAATTTCTATTGATTATTCATAATTA 
LJFgene14       TCTTCACACTC----ACACTTTCTA-----TTTCC--TTTCTATTGATTATTCGTAA--- 
                *** *******     ********      ****   **************** ***    
 
LJFgene8        TTCATGCATACCCATCTTCTGAAATCTCTTTACACGTCAATGATTTTGTATCTTAAAGAC 
LJFgene14       -----------CCATCTTCTGAAATCTCGTTACATTTCAATTCTTTTGTGTATTGAAGAG 
                           ***************** *****  *****  ****** * ** ****  
 
LJFgene8        AACTCATATTGAGAAGCAGCGAAATAGCGACCATCGGTGCCATCTTCGACTTCAGGTACC 
LJFgene14       AACTCATATTGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGGTACC 
                ********************************** ************ ***** ****** 
 
LJFgene8        CC----CGGCCCCTCCTCTGTTTTTT-----AGAAATTTTT-CTTTTCATTTTATTTTGA 
LJFgene14       CCTCCTCTGTTTTTGCTCTGTTTTTTTTTCTGGAAATTTTAGTTTTTCATTTTATTTTGA 
                **    * *    * ***********      ********   ***************** 
 
LJFgene8        ACGTAAATTTAATTCAAGATTTGATTTTGTTAGTGAGTAGTGAGACCCTTTTGGTTTTTA 
LJFgene14       ATGTAAATTAAATTCGAGATTTGATTTTGTTAGTGGGTGTTGAGACCCTTTTGGATTTTA 
                * ******* ***** ******************* **  ************** ***** 
 
LJFgene8        GTATTAGTTTTGTTTTGTATTGAAAATGGGTAGTTATTAAAAAAGAGGGTATTGTGTGTT 
LJFgene14       GTTTGGGTTGTGTTTTGTATTGGAAATGGGTGGTTT----------GGGTTTTGTGT--- 
                ** *  *** ************ ******** ***           **** ******    
 
LJFgene8        TTTTTTTTTTTTTTTTTTTGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGA 
LJFgene14       ---------------TTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGA 
                               *** ***************************************** 
 
LJFgene8        AAAACCCACCAGCTTTAGCTCTGTGTCCGGTAACTAGGAACTGCGTATCAACCTCTGAGA 
LJFgene14       AAAACCCACCAGCATTAGCTCTGTGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGAGA 
                ************* ***************  ***** ********* ************* 
 
LJFgene8        ATATCAGTGATCGCACTCATTATGCTCCTCTTTGGTAAAAACTTTCCTTGTTTTCCTCAT 
LJFgene14       ATATCAGCGATCGCACACATTATGCTCCTCCATGGTAAAAG-TTCCCTTCTTTTTCTTAT 
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                ******* ******** *************  ********  ** **** **** ** ** 
 
LJFgene8        TTTAATTTTAGCCTTCCTTTTCAAACCGCCAAGTTAATTTTTTAACCGTGTATTGGTGGT 
LJFgene14       TTTAATTTTCACCTTGGATTT-ATGGGATTATATGAATT----GAATGCAATTTTTTAAT 
                *********  ****   *** *       *  * ****     *  *    **  *  * 
 
LJFgene8        TTTTTTTTGGTCCTTGAATGATACATAGGATTTTTCAAATAATTGGTTCAAAGACTAATT 
LJFgene14       TGTGTTTGGATAAACAACTTAGTTA-ACTGCCCATCATGTAAGTG-CTTATGTATAAGGT 
                * * *** * *     * * *   * *       ***  *** **  * *   *  *  * 
 
LJFgene8        ATATTTATAATATGTGATTGTAGTTGGTCAAAGGGGAAATTGTTTGATTTTTATCATGTA 
LJFgene14       TTTTCTATAGTAAAAAAATGTA------CAAGTTGCAAGCTTTTTTCTTAAT-TTATTCT 
                 * * **** **    * ****      ***   * **  * ***  **  * * **    
 
LJFgene8        TAAAATGTTTTTGGACCAATAATAATAACAAATAAAATAAGATTAATTTTTAACT-CAAT 
LJFgene14       TGAAATCTTATTGAAATAATC-TGAGAACAACTTT-------TTCTTTTTTACCTGTGAT 
                * **** ** *** *  ***  * * ***** *         **  ****** **   ** 
 
LJFgene8        TGGTTGATTAAGAGTAAAAATATTTGTGATCTCTCATCAAAATAAAAAAATTTCTCTTCA 
LJFgene14       CTGAAAACAACTCATAGACATATCATAAACTTGGGATATAGATAAATTTTTTCATAAACA 
                  *   *  *    ** * ****     *  *   **  * *****    **  *   ** 
 
LJFgene8        TTTTAAAACAAAAATCACATCTTTAAAATTTAAAAGTCAGGTCCACACTTAAGATACTTA 
LJFgene14       CTTACAAGAGAAAAAAAAATACAAAAGAAAAATAAAATAAATTTTTCTATAAGCTAA--A 
                 **  **   ****  * **    ** *   * **   *  *       **** **   * 
 
LJFgene8        ACTTAAACATAGGTACTCAAACCAAAAATTTTCAAATATGTGAGATCCCACACAAATTTT 
LJFgene14       ATTAGTGTATGTGTAAGCTAATTTGTAGTTCTT--TCATATTAGCTTCTCCAAAAGTTTT 
                * *     **  ***  * **     * ** *     ** * ** * *  ** ** **** 
 
LJFgene8        TATTTATTAGAAATCTTAAAATAAATTAAATGTTTATCAGGAATTTGAATGTATTTTAGC 
LJFgene14       TTTTTTTTTTAACTTATGCA-TAAGTTAAAT--TTAGCTTAAAGATAAATTTATTTCATT 
                * *** **  ** *  *  * *** ******  *** *   **  * *** ***** *   
 
LJFgene8        CTATTTTCGAACAAGGTTTTATCATACAAAATTTATGGATCCAACAAAATAAAAATAAGA 
LJFgene14       TTCTTCTCTTGTAAATGCTTTTGG---AGAA---ATGTATCCAAACAGACCTTTACAC-A 
                 * ** **    **    ** *     * **   *** ******  * *     * *  * 
 
LJFgene8        AATTGTCATGGCTTGGTTTCCAAAACTGAACCTCATGTTCAAGAACACGTGGAAGCACAA 
LJFgene14       AGTACTAATAAGATAAGTCT---AATTAAGCCT----TTTCAAAACGC-TCAAAGTTCAA 
                * *  * **    *   *     ** * * ***    **  * *** * *  ***  *** 
 
LJFgene8        CTGCAGCT-TTGTCTTAGCTCATCA----TCAAGCGCCAGTTAGCAATATTTTGCGGGAA 
LJFgene14       GTATTTCCATTATGTTGATTCTTCGGGCCTTAATTTTCGGTTA--AGTAACTTGTGGTGT 
                 *    *  ** * **   ** **     * **    * ****  * **  *** **    
 
LJFgene8        TAGA-CAATGAGACCAAAACCTTCATCATGCACAAGTCTATTTTAGTTGCACTAGGGTTT 
LJFgene14       CAAAATTGCGTGTTGAGGAGGGTCTGGTAAACCAGATTTAGGAGATAAGTAATCAGGGTT 
                 * *     * *   *  *   **        **  * **    *   * * *  ** ** 
 
LJFgene8        TGGAGCCTTTCACAAGACCAAAACTAGATACGATTCATGCTAAAATAAAGCCTAAAGCCT 
LJFgene14       T--ATTTATTTATTGGATTTAGTCCAAACGGAACCTATGGCCATATTT-GTGAGAATCAC 
                *  *    ** *   **   *  * * *    *   ***   * **   *    ** *   
 
LJFgene8        TTTGGAATTATTCACAGCAAAATCCGATGTTGACATCAACCATATGTAACATTATAATAT 
LJFgene14       GTTGCAATAATAGACAATGGTGCACT-TGGAACAATTTATCACGTTTTAAACCACGTGAA 
                 *** *** **  ***        *  **     **  * **  * * * *  *    *  
 
LJFgene8        ATTACTAGCCTTTAAAATTCAATTCCACATTCAACAAAATTTATTACCCTGTTCTCTCTA 
LJFgene14       AGTAGT-GCAGCCGAAATTGGACTATTGACT-GTTGAACAATGTTGACTTGA----CATG 
                * ** * **     *****  * *    * *     **   * **  * **       *  
 
LJFgene8        CACTACGCAATTAGAAAACAAAAGGTTGAGCGGAGAAAAATCTAGAAAGTGCTTAGAAAT 
LJFgene14       AATTGGACTATTGGTCAC--ACACATTGGCCGGTGAAAGCAGTGCAAT---CTTAACTTT 
                 * *   * *** *  *   * *  ***  *** ****    *  **    ****    * 
 
LJFgene8        TCAACTAAATTTTGTCAAACAGGACGAGCCAATAAATACGATTAATGACAGCTACGAGAA 
LJFgene14       TTCTTTTTTTTTTGACAA----------CTTTTTTTTTTTCTCTATCTTTGGTCCTTGTA 
                *    *   ***** ***          *   *   *    *  **    * * *  * * 
 
LJFgene8        ATGTATATTTTTAGTTTAGAAACACGTCTTTAGTTATATCATAACAAAAAATAAAAATTA 
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LJFgene14       TTGAGCATGGTCCCACCAAAATCCAAACTTTA-TTATTGGACATAGATGAATCATGATGT 
                 **   **  *      * ** *    ***** ****   * *   *  *** *  **   
 
LJFgene8        AAGTTGTGTTTAAATATATGTTTTATTTAAAAAAATTAAAAATTAGGAAATTGTGTTTTA 
LJFgene14       CACTT-TGTTTTAATTTTTAGTTTCTTTTTCAGGAACTATAATCCTGAAGGAAGGAAAAA 
                 * ** ***** *** * *  *** ***   *  *   * ***   ***     *    * 
 
LJFgene8        ATTCATGACTTTAAGTTAAAGTCACGAATTAAAAGATGGCTTTAATAAAAGTAAATTTAA 
LJFgene14       ACCTGTGAGCA-GAGAGGAAGCAATGGAGGAACTGATAGACGTGGTAA---TAAATCTAG 
                *    ***     **   ***  * * *  **  *** *   *  ***   ***** **  
 
LJFgene8        --AAAATAAATAAAGAAGTCATGTT-TGAAAATATACCTTTCGTTGAAATGTTGTGCTTT 
LJFgene14       CTGAACTGAAATCTTGAGTTATAACACTAGATTGCAATTTTCTTTTCCTTCCCTCATTTT 
                   ** * **      *** **      * * *  *  **** **    *       *** 
 
LJFgene8        TAAAACACAACTTGCTCATTTATTGATTTTTTAAAAATAAATTTACCTATTTTGGGATTT 
LJFgene14       ATCAACATCGATTA-TAATTTATAAAATTTATAAAAGGAGTGATAGTAAATATACACTTT 
                   ****    **  * ******  * *** *****  *    **   * * *    *** 
 
LJFgene8        TTTTTTTATAAAAAATGCACCACTCTAGTAAGTAAACCTTTTTTTTATATATAAAAAATT 
LJFgene14       GT-----------AACACACTATTCTTA-ACCCCACCCTTTTTATTATTGGTTAAAATTT 
                 *           **  *** * ***   *    * ******* ****   * **** ** 
 
LJFgene8        GCATTCAGGTAAACAACATAATTAAGTGTTTA-CTGATTCATTGAAACACTTATGTATAA 
LJFgene14       A---TCAG--AAATTAGAAAGTCATGAGTGGAACTCATTGAATAAAG-AGTGAGACCTAT 
                    ****  ***  * * * * * * **  * ** *** * * **  * * *    **  
 
LJFgene8        GTTGTTTATGTGATTGAAGAGAAAATAAAGTTAAATTATTTTCTTATAAATTGTAATATG 
LJFgene14       GTGATTT-TATAATTTCTAATAAACTTATTATTAATAGTGTATTTAAAAG----GATACA 
                **  *** * * ***    * *** * *   * ***  * *  *** **      ***   
 
LJFgene8        TTTTCATGAGCTATGGAAAGTTTA-TTGAAATAAACTGAAAATAGATTGTGGATATTTCA 
LJFgene14       TTGTGAACATTTCTCTAATTTATAATTGATTTGTAATAATAGCTGGTTATTTGCACTTTT 
                ** * *  *  * *  **  * ** ****  *  * * * *   * ** *    * **   
 
LJFgene8        TAAATACATATCTTAAAATTATTTTAAATATTCCAAACACTTATATAAAT---ACTATAA 
LJFgene14       CCAATCATTGAAGTAAAGTTAAAACTAGT--TCCGGATAATTTTACAGATCGAATCAACA 
                  ***   *    **** ***     * *  ***  * * ** ** * **   *  *  * 
 
LJFgene8        GCACTTGTAATAGAAGAAAGATAAGAATGTAAAATAAATTGATTTTTTTTCCATAAGTTG 
LJFgene14       ACACCAGACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAG 
                 ***  *  * *     *  *     *  * ***  **   *   * * * * *  *  * 
 
LJFgene8        ATTTAAGTTAAAATCAACTTATGTATCATAACACCTCAGGTTTTGAAAAAGTTAAATGAG 
LJFgene14       TACCAAAGCTCAAT---CTTGGGGGTAAGTGTAACTTACATCTAAGGAAACTCATCTTGA 
                    **     ***   ***  *  * *    * ** *  * *    *** * *  *    
 
LJFgene8        AGAGTTTTTAACAAAGTTAAGTGTATAAGTTAAATTTAAGAGAAAAACACAATTTATTCT 
LJFgene14       AGAAAAATGATCATT-TTATACATTTGAGATGATATCAAGAACCATCTCTAATTTCCTTC 
                ***    * * **   ***    * * ** * *  * ****   *     *****  *   
 
LJFgene8        ACCTTTTCTTTTCCCCATTTGTAATTGTTTATGGCCAATTTGATCCAAACAACATCTTTA 
LJFgene14       TCCCTTTTTTCTGTCATGTGCTAACAGTTTGTGGATGAT---GTTGAGTTCTGGTTTCCA 
                 ** *** ** *  *   *  ***  **** ***   **    *  *       * *  * 
 
LJFgene8        GCCTAAATAAGCTCTTCCAATCACACTCTAAGTTTAAGTATGATTACTATGATGTTTAGA 
LJFgene14       CCCGGTAAGGGTTCTACTG--TGGAGTATCGATCT--GCATCTCGGTTGGGAAACTTTGA 
                 **   *   * *** *       * * *   * *  * **      *  **   ** ** 
 
LJFgene8        TTTCATTGTGTTGTTTTTTATGACCTTAATTTTCCGTCGAGTAACGCCATATTTGAATTA 
LJFgene14       TTTTGATGTGAA------CAGAAAAAGAAT----AAAGGTATGATTTCATAATTAATATG 
                ***   ****         *  *    ***        *  * *   **** ** *  *  
 
LJFgene8        AAGTTTGTAAATT-TTAGATGAAATTCATTTTGCAAACTGAATTTGTAAAATCAACTCTT 
LJFgene14       TGCTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCCAGGGT-----AAAACTCCCCTT 
                   *** *  **  ****** **     * ***    * *  *     *** *  * *** 
 
LJFgene8        CCTTTACTTCCAAAATCCAAACTTTATTATTGGACAAAGATGAATCGTGGAGTTACTTTG 
LJFgene14       CCTTCATGTC--ATGTCAAACATTTTATACTT----AAGTAGATTCACTAAATT--TGAG 




LJFgene8        TTTTAAATTTTTAATTTTAATTATTGTTCAGGAACTACAATCCTGAAGGTAGGAAAAACC 
LJFgene14       TCTCAAATGTTTTAACTTTATTCTAAATTAGTCACT--TATTTTAACGGAAGGTAAATTT 
                * * **** *** *  ** *** *   * **  ***   **  * * ** *** ***    
 
LJFgene8        ------CTGTGAGCAGAGAAGAGGCAATGGAGG--AACTGATAGACGTGGTAATAAATCT 
LJFgene14       GGTTGACTATGATGAGAAATACGTTGATATTTTTTAATTGGTAGAGATAAAGAATATTTT 
                      ** ***  *** *   *   **       ** ** ****  *    *  * * * 
 
LJFgene8        --AGCTGAAATCATAAGT-TATTTTCATGAATGCATTGCAATTTCCCTTTCCTAGCCTGT 
LJFgene14       TTATGTACAATAAAGAGAGTATTTACTCCAGAGGATGCAAATCCCTTACTAAATATTTTT 
                  *  *  *** *  **  ***** *   *  * **   ***  *    *       * * 
 
LJFgene8        GTATCAACAAATGTTA-TTATTTATAATAAGTTTAATTTTCATGCACTGACCGTATATAA 
LJFgene14       GTGATGAAAAATCTTGGTTGCTGACAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGG 
                **    * **** **  **  * * *   * *   *      *      *      **   
 
LJFgene8        TAATTTTATATTGATATCTAATCATAAATCATCATTTAAATTATTTTAAGATAATTAATT 
LJFgene14       ACATCTCAAGATACCATATGATTAATAAACTCAGGCTGAATTAGCATCAGC--ATCTAAG 
                  ** * *   *   ** * ** *  ** *      * *****   * **   **  *   
 
LJFgene8        TAAAAGTTAATAAATTTACCGTATATAATGAATTATAATTGAATAATTGTATAAAAAATT 
LJFgene14       CAAATATTATTTCATATACTTTGGACCTTG---TATACTTTTGTA-TTAGATACAAATCG 
                 ***  *** *  ** ***  *  *   **   **** **   ** **  *** ***    
 
LJFgene8        TATAATGTCACTGTA--TAATTCTTTTTCTCATTTATAATTTGGTTGTAAGTTGTAGCTT 
LJFgene14       CACAGGATCATTGCAAGCAAACTTTTCTTAGATTTTTGGAATTGTAGAGAA--ATCATTG 
                 * *   *** ** *   **   *** *   **** *    * ** *  *    *   *  
 
LJFgene8        GTAATAGCAGGTTATTTACCTTTTTCCAATCATTGAAGTAAAG--TTAAAATCCAGCTCT 
LJFgene14       AGAACAGTACTTCAAACTCTCTCGGGGAAGGAATGAAATGAAGACCTTGCGCCATATCTT 
                  ** ** *  * *    *  *     **  * **** * ***   *     *      * 
 
LJFgene8        GGATAATTTTATAGATAG----AATCAACAACACCA--GACAAATTTACACCACGAATAG 
LJFgene14       CTTCAAGTTCATTAATTGGTCCACTTATTTACACCTTCACCGAGTTCAATCTAATAATGT 
                    ** ** **  ** *    * * *   *****     * * ** *  * *  ***   
 
LJFgene8        TTGAAAGGAA----GGAAGACTATATTCATGTGGAGTACCAAAGCTCAATCTTGGGGGT- 
LJFgene14       ATGAATCTTGTTTCAAGAAATTTAATTTGTGTTTTGTTTCAAA-CGTGTTCTTCATGATT 
                 ****            * * *  ***  ***   **  **** *    ****   * *  
 
LJFgene8        -ATGTGTAACTTACATCAAAAGGAAACTCATCGTGGAGAAAAA-TAATAATTTTGTACAT 
LJFgene14       CACTTTTGTTGTAAGTTTGACTTTGCTTCTTCATGTATTAAAGCTTATCCTTGCGATCAA 
                 *  * *    **  *   *       ** ** ** *  ***  * **  **  *  **  
 
LJFgene8        TTTAGATGATAATCAAGAACCATCTCTAATC----CCTTCTCCCCTCCTTTTTATTTTT- 
LJFgene14       TTTGGATGATGCTTTAGGCCTTTCTGTCATCAAAATGTACGTACCTATGTCATGTTTTCA 
                *** ******  *  **  *  *** * ***      * *   ***   *  * ****   
 
LJFgene8        -----TCTGCCATGTGCTAGCAGTTTGTGCATGA------------TGTTGAGTTCTGGT 
LJFgene14       GAGGCTTTTTGATATCCTTGATGTCTTTACAAGAAAAGTCGGTGCATATAGCATTTGGAA 
                     * *   ** * ** *  ** * * ** **            * * *  **  *   
 
LJFgene8        TTCCACTG-GGTAAGGGTTCTACTGTGG---AGTATCGATCTGCATCTCGG-TTGGGGAA 
LJFgene14       TCTGGTTATAATAGGAGCATTGCGGAGACTAAGTATAGGG-TGCATTTTGACTTTGGTAA 
                *     *    ** * *   * * * *    ***** *   ***** * *  ** ** ** 
 
LJFgene8        CTTTGATTTTGATGTGAATAAGAAAAGA-ATAAAGGTATGTTTGTATCATTCCTTTGTGC 
LJFgene14       CTCTGTTTCTCAATTCACTTCCATACGTTGTTCAGAAATTGTTCAATC--TCATTGATCC 
                ** ** ** * *  * * *   * * *   *  **  **  **  ***  ** **  * * 
 
LJFgene8        TGTCTCGGTAGTTAA--CATGAAGAAATGATTAAAAGATATTTTGTCCTTTAGGTTTTTT 
LJFgene14       TAACTAGAAAATTCGTCCAACAGCAAAGAATGCAAAGCTAGCAACTCAAGGACGAATTTT 
                *  ** *  * **    **  *  ***  **  **** **     **    * *  **** 
 
LJFgene8        GGTTATATTTAGTTTGATTTTTTATTTTTTAAAAGTTAAATTTAGTCCTTTATGTTTTTA 
LJFgene14       GTTGGCTTCTAGATAGTGGTTTGGCT---TAATTTTGAGAATT--TATTTGGTGGATTTT 
                * *    * *** * *   ***   *   ***   * * * **  *  **  **  ***  
 
LJFgene8        AAACGAATCAAAATGATCACTATTTCGAGATGTAAAACTTTTTTATTAGATTTACTTACA 
LJFgene14       GGACGTATGAGGTTGAAGTTGAGTTTTAATTG--AAATTTCCTTGTCCAACAAA--TGCA 




LJFgene8        TGCAAATTATGCAACTTGACTAATGTT--TGAAAAAAAAAATCATCAATATGATAAAAAT 
LJFgene14       AGCAGATTTAGCATCATGAAAAAAGATAATGCAATAAAAAAAAAAAAAGGTTAGAACAGG 
                 *** ***  *** * ***  ** * *  ** ** ******  *  **  * * ** *   
 
LJFgene8        AATGAGTGTCAC----AAGCAATTAAAAA 
LJFgene14       ATAGAGAAGCACTCTAAAGCTATGAAAT- 
                *  ***   ***    **** ** ***   
LJFgene8 vs. LJFgene1 
 
LJFgene8       ACCTCTAGTGTCCACTTAATGGTGAGATTTGAAATAATATGTATGAGATTCTAAGTTCAA 
LJFgene1       -------------------------------------TAAAAAGGAGAAAGAAAAAACAA 
                                                    **   * ****    **   *** 
 
LJFgene8       ATATTAAGTGTCATTGTTAAAGAAAAAACAGTATGATATGCTGGAATTTACTAACTATAA 
LJFgene1       AAAAAAAATGTTGCGG----AAACGAAGCGTCCCACCACCC----ACCTTCTTTTTATAT 
               * *  ** ***    *    * *  ** *        *  *    *  * **   ****  
 
LJFgene8       TCTTTATAATAAGTTTAGCATTT-AGTGTATATTGACTTGAAAGATTCTTGTAGCAATTT 
LJFgene1       TCATCATTACATGATTCACATCTCATTCCATATTTTCGGGTCACATTCTCA-AATTATTA 
               ** * ** * * * **  *** * * *  *****  *  *  * *****   *   ***  
 
LJFgene8       GCAGCAGTTTTAT-ATAGATAGTAACATTCTTAAATTAC---GTTTATAAGTTCCTTCAT 
LJFgene1       TAACTAATTTCGTCATGTGAAGATACGTTCATAAGTTCCTTAATTTTCTTGAACCTTTAT 
                 *  * ***  * **    **  ** *** *** ** *    ***    *  **** ** 
 
LJFgene8       TTTCAGCTCCGAACAAT------------GGCTTCTTCGTTCTCCTTCTGCACCCTCAAG 
LJFgene1       TTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAG 
               ********** ******            *** *****   *********** ******* 
 
LJFgene8       TTTCGCACCAAACCCAACGATA---GTAGAAGCAGTGCTTCCTCTCTTCCCCGTATTCTA 
LJFgene1       TTTATCACCAAACCCAACAACAATGGTAGAACCAATGCTTCTTCTCTTCCCCGTATTGTA 
               ***  ************* * *   ****** ** ****** *************** ** 
 
LJFgene8       TTCTGTCACAACCTCCACGATGACATTCACACACCCACTGACCAAATCAACCGAAGGTTC 
LJFgene1       TTCTGTCAGAAGCACAACGATGA------CACCCCCACCGACCAAATCAACCGAAGGTTC 
               ******** ** * * *******      *** ***** ********************* 
 
LJFgene8       --ACTTCTCCACACTCTCATGCACTTTCTCACAGCTTTCTAATTTCTATTGATTATTCAT 
LJFgene1       TTACTTCTTCACACTC----ACACTCTCTCAC----TCCTTCTTTCTATTGATTATTTAT 
                 ****** *******     **** ******    * **  *************** ** 
 
LJFgene8       AATTATTCATGCATACCCATCTTCTGAAATCTCTTTACACGTCAATGATTTT-GTATCTT 
LJFgene1       AACTATTC----ATACCCATCTTCTGAAATCTCTTTACATTTCAATTCTTTTTGTGTATT 
               ** *****    ***************************  *****  **** ** * ** 
 
LJFgene8       AAAGACAACTCATATTGAGAAGCAGCGAAATAGCGACCATCGGTGCCATCTTCGACTTCA 
LJFgene01       GAAGAGAACTCATATTGAGAAGCAGTGAAATAGCGACCATTGGTGCCATCTTCAACTTCG 
                **** ******************* ************** ************ *****  
 
LJFgene8       GGTACCCC----CGGCCCCTCCTCTGTTTTTT--------AGAAATTTT--TCTTTTCAT 
LJFgene1       GGTACCCCTCCTCTGTTTTTCCTCGGTTTTTTTCTTTTTTGGAAAATTTAGTTTTTTCAT 
               ********    * *    ***** *******         **** ***  * ******* 
 
LJFgene8       TTTATTTTGAACGTAAATTTAATTCAAGATTTGATTTTGTTAGTGAGTAGTGAGACCCTT 
LJFgene1       TTTATTTTGAATGTAAATTGTATTCAAGATTTGATTTTGTTGGTGGGTTTGGAGACCCTT 
               *********** *******  ******************** *** **   ********* 
 
LJFgene8       TTGGTTTTTAGTATTAGTTTTGTTTTGTATTGAAAATGGGTAGTTATTAAAAAAGAGGGT 
LJFgene1       TTGGATTTTAGTTTCAGTTTTGTATTGTATTGGAAATGGGTGGTGGTTAAAAAAGAGAAA 
               **** ******* * ******** ******** ******** **  ***********    
 
LJFgene8       ATTGTGTGTTTTTTTTTTTTTTTTTTTTTGTGGTGCAGTGGGAAAAAACCTGATTATCTT 
LJFgene1       ATTGAGT-----TTGGGTTTTGTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTT 
               **** **     **   **** * **** ******************************* 
 
LJFgene8       GGAGTGCAGAAAAACCCACCAGCTTTAGCTCTGTGTCCGGTAACTAGGAACTGCGTATCA 
LJFgene1       GGAGTGCAGAAAAACCCACCAGCATTAGCTCTGTGTCCGGCAACTAAGAACTGCGTGTCA 
               *********************** **************** ***** ********* *** 
 
LJFgene8       ACCTCTGAGAATATCAGTGATCGCACTCATTATGCTCCTCTTTGGTAAAAACTTTCCTTG 
226 
 	  
LJFgene1       ACCTCTGAGAATATCAGTGATCGCACACATTATGCTCCTCCATGGTTAAAG-TTCCCCTC 
               ************************** *************  **** ***  ** ** *  
 
LJFgene8       TTTTCCTCATTTTAATTTTAGCCTTCCTTTTCAAACCGCCAAGTTAATTTTTTAACCGTG 
LJFgene1       TTTTTCTTATTTTAATTTTCACCTTCGATTT-ATGGGATTATATGAATTAAATGCAATTT 
               **** ** ***********  *****  *** *       *  * ****   *     *  
 
LJFgene8       TATTGGTGGTTTTTTTTTGGTCCTTGAATGATACATAGGATTTTTCAAATAATTGGTTCA 
LJFgene1       TTTTTACTTGTCTGTTTGGATAAACAACTTAGTTA-AGTATTCATCATGTAAGTG-CTTA 
               * **      * * *** * *     * * *   * ** ***  ***  *** **  * * 
 
LJFgene8       AAGACTAATTATATTTATAATATGTGATTGTAGTTGGTCAAAGGGGAA--ATTGTTTGAT 
LJFgene1       TGTATAAGTTGTTTCTATAATAAATAAAAATGAGGAGGGAAAGTTATTCCAAAAATCACT 
                  *  * ** * * *******  * *   *     *  ****       *    *   * 
 
LJFgene8       TTTTATCATGTATAAAATGTTTTTGGACCAATAATAATAACAAA---TAA--AATAAGAT 
LJFgene1       TTAAAAGAGGTACTCACTTTATTTTAATTATTGATTTTTTTAAAATTTAATGATTAAGAT 
               **  *  * ***   * * * ***  *  * * **  *   ***   ***  * ****** 
 
LJFgene8       TAATTTTTAACT-CAATTGGTTGATT--AAGAGTAAAAATATTTGTGATCTCTCATCAAA 
LJFgene1       TAATTATTTATTATAATTATTAGATTCTAAAAAAATAAATAATAAGGATAATAAATAACT 
               ***** ** * *  ****  * ****  ** *  * ***** *   ***     ** *   
 
LJFgene8       ATAAAAAAATTTCTCTTCATTTTAAAACAAAAATCACATCTTTAAAATTTAAAAGTCAGG 
LJFgene1       CTAAAAAAATTATTCTT-AGAGCAAGTTGATGTTTTCCTAAAAAAAATATATAAATTGTT 
                **********  **** *    **    *   *  * *    ***** ** ** *     
 
LJFgene8       TCCACACTTAAGATACTTAACTTAAACATAGGTACTCAAACCAAAAATTTTCAAATATGT 
LJFgene1       TATATAAGTCGTAAGCTT--TTCGGAAATTATTCTTGAAATC----TTATTGAAATA--- 
               *  * *  *   *  ***   *   * **   *  * *** *     * ** *****    
 
LJFgene8       GAGATCCCACACAAATTTTTATTTATTAGAAATCTTAAAATAAATTAAATGTTTATCAGG 
LJFgene1       ---ATCTGAAAACAACTTTTTTTTACATGA--TTTGAAAACAACTTATAGACATATCATA 
                  ***  * *  ** **** ****   **  * * **** ** *** *    *****   
 
LJFgene8       AATTTGAATGTATTTTAGCCTATTTTCGAACAAGGTTTTATCATACA----AAATTTATG 
LJFgene1       A--TCACATATCATTAAGTTATTTTATTAAGTCATTTTCATAATTTATTTCAAACACTTA 
               *  *   ** *  ** **    ***   **     *** ** **  *    ***    *  
 
LJFgene8       GATCCA-ACAAAATAAAAATAAGAAATTGTCATGGCTTGGTTTCCAAAACTGAACCTCAT 
LJFgene1       CATAAATACTTATAAGAGAAAATAAAATAAAATTAATTTCTTTATAAGCTATAAAATTA- 
                **  * **  *  * * * ** *** *   **   **  ***  **     **  * *  
 
LJFgene8       GTTCAAGAACACGTGGAAGCACAACTGCAGCTTTGTCTTAGCTCATCATCAAGC-GCCAG 
LJFgene1       GTTAATGTATAAGTCAATAGGTAGAAGCTCTCTCGTATTAACTCTTCAAAAGTTTATTTT 
               *** * * * * **  *     *   **    * ** *** *** ***  *          
 
LJFgene8       TTAGCA-ATATTTTGCGGGAATAGACAATGAGACCAAAACCTTCATCATGCACAAGTCTA 
LJFgene1       TTAACTTATATATAAGCTAAATTTAACTTAAAAGAGAAACTTATTTCATTTTTTCTCTTC 
               *** *  **** *      ***  *   * * *   **** *   ****         *  
 
LJFgene8       TTTTAGTTGC-ACTAG--GGTTTTGGAGCCTTTCACAAGACCAAAACTAGATACGATTCA 
LJFgene1       CTTTCTTTTCTAGTAAATGTTTTTATAAAAGTTTACCCAAACAGAACTTTACACAAGTAC 
                ***  ** * * **   * ****  *    ** **   * ** ****  * ** * *   
 
LJFgene8       TGCTAAAATAAAGCCTA--AAGCCTTTTGGAAT-TATTCACAGCAAAATCCGATGTTGAC 
LJFgene1       TTATAAGATAAGTCTAATTAAGCTTTTTCAAACATGCTCAAAGTTAAAGT--GTTTCCAT 
               *  *** ****  *  *  **** ****  **  *  *** **  ***     * *  *  
 
LJFgene8       ATCAACCATATGTAACATTATAATATATTACTAGCCTTTAAAATTCAA-TTCCACATTCA 
LJFgene1       AATGTTTTTTTGGGCCTTAATTTTCGTCAAGTAACTTGTGATGTCAAAATTGCGTGTTGA 
               *       * **   * * **  *     * ** * * * *  *  ** ** *   ** * 
 
LJFgene8       ACAAAATTTATTACCCTGTTCTCTCTACAC---TACGCAATTAGAAAACAAAAGGTTGAG 
LJFgene1       GGAGGGTCTGGTCAACTAGATTTAGGAGATAATTAAGCAGTCAGGGTTTATTTATTTA-- 
                 *   * *  *   **    *    * *    ** *** * **     *     **    
 
LJFgene8       CGGAGAAAAATCTAGAAAGTGCTTAGAA---ATTCAACTAAATT---TTGTCAAACAGGA 
LJFgene1       TTGGATTTAATCCAAAAGGAACCTATGACATATTTGTGAGAATCACGTTGCAATAGATAA 




LJFgene8       CGAGCCAATAAATACGATTAATGAC------AGCTACGAGAAATGTATATTTTTAGTTTA 
LJFgene1       TGGTGCACTTGGAACAATTTATCACGTTTTAAACCACGTGAAAGTAGTGCAACCGATATT 
                *   ** *    ** *** ** **      * * *** ****    *        * *  
 
LJFgene8       GAAACACGTCTTTAGTTATATCAT-AACAAAAAATAAAAATTAAAGTTGTGTTTAAATAT 
LJFgene1       GGACTATTGACTGTTGAACATTGTTGACTTGACATAAGAAATGAACTATTGGTCACACAC 
               * *  *     *     * **  *  **   * **** ** * ** *  ** * * * *  
 
LJFgene8       ATGTT--TTATTTAAAAAAATTAAAAATTAGGAAATTGTGTTTT---AATTCATGACTTT 
LJFgene1       GCATTGGCCGGTGAAAGTAGTGCAATCTTTACTTTTTCTTTTTTTGAAATTTTTTTTTTC 
                  **      * ***  * *  **  **      ** * ****   ****  *   **  
 
LJFgene8       A--AGTTAAAGTCACGAATTAAAAGATGGCTTTAATAAAAGTAAA--TTTA--------- 
LJFgene1       ACTACCTTTGGTCCTTGTATTGAGCATGGTCCCACCAAAATCCAAACTTTATTATTGGAC 
               *  *  *   ***      *  *  ****    *  ****   **  ****          
 
LJFgene8       AAAAATAAATAAAGAAGTCA---TGTTTGAAAATATACCTT-TCGTTGAAATGTTGTGCT 
LJFgene1       ATAGATGAATCATGATGTCACTTTGTTTTAATATTTTCATTCTTTTTCAGGAACTATAAT 
               * * ** *** * ** ****   ***** ** ** * * ** *  ** *     * *  * 
 
LJFgene8       TTTAAA------ACACAACTTGCT-------------CATTTATTGATTTTTTAAA---- 
LJFgene1       CCTGAAGGTAGGAAAAAACCTGTGAGCAGGGAAGAAGCAATGGAGGAACTTATAGACGTG 
                 * **      * * *** **               ** *    **  ** ** *     
 
LJFgene8       --AATAAATTTACCTATTTTGGGATTTTTTTTTTATAAAAAATGCACCACTCTAGTAAGT 
LJFgene1       GTAATAAATGCAACTGAACTGAAATCTTGAGTTATCACTGGATTGAAATTTTCTTTTCCT 
                 *******  * **    **  ** **   **   *    **  *    *    *   * 
 
LJFgene8       AAACCTTTTTTTTATATATAAAAAATTGCAT-TCAGGTAAACAACATAATTAAGTGTTTA 
LJFgene1       TCCCTCATTTTATCAACATTGATTATAATTTATAAAATTTATGAAAGGAGTGATAGTGAA 
                  *   **** *  * **  *  **    * * *  *  *  * *  * * *  **  * 
 
LJFgene8       CTGATTCATTGAAACACTTATGTATAAGTTGTTTATGTGATTGAAGAGAAAATAAAGTTA 
LJFgene1       TATACACTTTGTAACACTATTTCTAATACACTTTCTATTATCGGTTAAAATTTATTGAAA 
                  *  * *** ******  *    *     *** * * ** *   * **  **  *  * 
 
LJFgene8       A-ATTATTTTCTTATAAATTGTAATATGTTTTCATG----AGCTATGGAA-AGTTTATTG 
LJFgene1       ACAGTGTTGTTAAATGGCGGCCATGGCGGCGCCATGGCGGAGTTGCGTAACGGTTTTCTG 
               * * * ** *   **       *    *    ****    ** *  * **  ****  ** 
 
LJFgene8       AAATAA----ACTGAAAATAGATTGTG-GATATTTCATAAATAC--ATATCTTAA-AATT 
LJFgene1       AAAAAACGCCACCGAATAACGGTGGCGTGGCGGATTAAAGATGGCGGCGCCATGGCGGCC 
               *** **    ** *** *  * * * * *     * * * **        * *        
 
LJFgene8       ATTTTAAATATTCCAAACACTTATATAAATACTATAAGCACTTGTAATAGAAGAAA---- 
LJFgene1       GCCATAGCCATGGCGGCCA-TGGCGGATGTGGCGGGGAGGCGGAAAATGGCAGAATTTTT 
                   **   **  *   ** *     *  *          *    *** * ****      
 
LJFgene8       ------------GATAAGAAT---GTAAAATAAATTGATTTTTTTTCCATAAGTTGATTT 
LJFgene1       TTTTTTGTCCGCGGTAGGAGTTGGGCTGACCCGATCCAACCCTACCCGAAAACTTAATGA 
                           * ** ** *   *   *    **  *    *   * * ** ** **   
 
LJFgene8       AAGTTAAAATCAACT-TATGTATCATAACACCTCAG--GTTTTGAAAAAGTTAAATGAGA 
LJFgene1       AAACCATGACCCCCCCTACCTTTCAGAACGCTGCTGCAACCCTCGAAGCTTCAACATAGC 
               **   *  * *  *  **  * *** *** *  * *      *  **   * **   **  
 
LJFgene8       GAGTTTTT--AACAAAGTTAAGTGTATAAGTTAAATTTAAGAGAAAAACACAATTTATTC 
LJFgene1       GCGACCTCGGAACCAGCCACGACCCCTGCAACCAGCCTCGGAACCAGCCGCG-CTTGACC 
               * *   *   *** *           *      *   *  **   *  * *   **   * 
 
LJFgene8       TACCTTTTCTTTTCCCCATTTGTAATTGTTTATGGCCAATTTGATCCAAACAACATCTTT 
LJFgene1       CGCTGCACACAGCAGCCAGCAGCGACGACCCATGGCG---TGAACGGCGGCGACGAGCAC 
                 *            ***   *  *      *****    *  *      * **       
 
LJFgene8       AGCCTAAATAAGCTCTTC-CAATCACACTCTAAGTTTAAGTATGATTACTATGATGTTTA 
LJFgene1       GGCGTGAACAACGGCGACGCGAACGGAGAAGACGACCCAGAACCGCGACCTCGACTTATA 
                ** * ** **   *  * * * *  *    * *    ** *     **   **  * ** 
 
LJFgene8       GATTTCATTGTGTTG-----TTTTTTATGACCTTAATTTTCCGTCGAGTAACGCCATATT 
LJFgene1       CGGGTGGGTGGGCCAAAGCCTTTTTTTTGTTTTTGCTGCTTGACACCCCTTTTTTATGTC 




LJFgene8       TGAATTAAAGTTTGTAAATTT-TAGATGAAATTCA-TTTTGCAAACTGAATTTGTAAAAT 
LJFgene1       TGCAGCTTTTTTTCCGTTTTTCTATTTGACACCCCCTTTTACTTTCGACAGTCCCATTTT 
               ** *      ***     *** **  *** *  *  **** *   *   * *   *   * 
 
LJFgene8       CAACTCTTCCTTTACTTCCAAAATCCAAACTTTATTATTGGACAAAGATGAATCGTGGAG 
LJFgene1       TAATTTTTTTTTCTATTTGACACCACAATTTTTTTTTCTGTTCAGTCCTCTTTTAAATGG 
                ** * **  **   **  * *   ***  *** **  **  **    *   *      * 
 
LJFgene8       TTACTTTGTTTTAAATTTT--TAATTTTAATTATTGTTCAGGAACTACAATCCTGAAGGT 
LJFgene1       CTGAACCATCATCCTCTTTAATGAGTTTATTTGGTGTTGGTACTTGATTATTGTATGAAC 
                *      *  *    ***  * * **** **  ****        *  **  *       
 
LJFgene8       AGGAAAAACCCTGTGAGCAGAGAAGAG-GCAATGGAGGAACTGATAGACGTGGTAATAAA 
LJFgene1       TCATGAAACTTTTTTAGTTTATTTGAATGCAATCCTTTGTTTTTTTCA-ATTTCAATGAG 
                    ****  * * **   *   **  *****        *  *  *  *   *** *  
 
LJFgene8       TCTAGCTGAAATCATAAGTTATTTTCATGAATGCATTGCAATTTCCCTTTCCTAGCCTGT 
LJFgene1       TTTA--TATATATGTTTTTTTTTTTTTTTGGTCCGCCATGACTTCCGCCATTTT-CCGCT 
               * **  *  *    *   ** ****  *   * *      * ****      *  **  * 
 
LJFgene8       GTATCAACAAATGTTATTATTTATAATAAGTTTAATTTTCATGCACTGACCGTATATAAT 
LJFgene1       ACGCCATCCGCCATATTTTTATGGCGGATTTTTTACTTTCCGCCATGAACCGCCATCCGC 
                   ** *     *  ** * *     *  *** * ****   **   ****         
 
LJFgene8       AATT--TTATATTGATATCTAATCATAAA-TCATCATTTAAATTATTTTAAGATAATTAA 
LJFgene1       CATTAACAACATTGATTGAAAATTATGAAGTCATGAGAGGAGCTCATTGAA--TAAAGAG 
                ***    * ******    *** ** ** **** *    *  *  ** **  ***  *  
 
LJFgene8       TTTAAAAGTTAATAAATTTACCGTATATAATGAATTATAATTGAATAATTGTATAAAAAA 
LJFgene1       TGAGAACTTACATGATTTTGTAATTTCTAATAATTTTTTACT--ATTAATAAAGAGTGTA 
               *   **  *  ** * ***    * * **** * ** * * *  ** * *  * *    * 
 
LJFgene8       TTTATAATGTCAC-TGTATAATTCTTTTTCTCATTTATAATTTGGTTGTAAGTTGTAGCT 
LJFgene1       TTTAAATGGGTATGTTTTTGAACATTTTTCTAATTTCTAATCGATTTGTAA--------- 
               **** *  *  *  * * * *   ******* **** ****    ******          
 
LJFgene8       TGTAATAGCAGGTTATTTACCTTTTTCCAATCATTGAAGTAAAGTTAAAATCCAGCTCTG 
LJFgene1       --TAATAGCTGGTTATTTGCACTTTCCCAATCATTGAAGTAAAGTTAAA--CCAGTTCCG 
                 ******* ******** *  *** ***********************  **** ** * 
 
LJFgene8       GATAATTTTATAGATAGAATCAACAACACCAGACAAATTTACACCACGAATAGTTGAAAG 
LJFgene1       GATAATTTTACAGATAGAATCAACAACACCAGACAAATTTTCACCACGGATAGTTGAAAG 
               ********** ***************************** ******* *********** 
 
LJFgene8       GAAGGAAGACTATATTCATGTGGAGTACCAAAGCTCAATCTTGGGGGTATGTGTAACTTA 
LJFgene1       GAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCAATCTTGGGGGTAAGTGTAACTTA 
               *** ************* ******************************* ********** 
 
LJFgene8       CATCAAAAGGAAACTCATCGTGGAGAAAAATAATAATTTTGTACATTTTAGATGATAATC 
LJFgene1       CATCTAA-GGAAACTCATCATGAAGAAAAATTATCCTTTTATACATTTTAGATGATA-TC 
               **** ** *********** ** ******** **  **** **************** ** 
 
LJFgene8       AAGAACCATCTCTAATCCCTTCTCCCCTCCTTTTTATTTTTTCTGCCATGTGCTAGCAGT 
LJFgene1       AAGATTCAAGAACCATCTTTAATTTCCTTCTCCCT--TTTTTCTGTCATGTGCTAACAGT 
               ****  **      ***  *  *  *** **   *  ******** ********* **** 
 
LJFgene8       TTGTGCATGATGTTGAGTTCTGGTTTCCACTGGGTAAGGGTTCTACTGTGGAGTATCGAT 
LJFgene1       TTGTGGATGATGTTGAGTTCTGGTTTCCTCCGGGTAAGGGTTCTACTGTGGAGTATCGTT 
               ***** ********************** * *************************** * 
 
LJFgene8       CTGCATCTCGGTTGGGGAACTTTGATTTTGATGTGAATAAGAAAAGAATAAAGGTATGTT 
LJFgene1       CTGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATGAT 
               **************** ******************** *  ***************** * 
 
LJFgene8       TGTATCATTCCTTTGTGCTGTCTCGGTAGTTAACATGAAGAAAT----GATTAAAAGATA 
LJFgene1       TCCATAATTCATATGTGCTTTCTCTATAGTTAG-ATAAAGAAATTCTTGGTTCCAGGGTA 
               *  ** **** * ****** ****  ******  ** *******    * **  * * ** 
 
LJFgene8       TTTTGTCCTTTAGGTTTTTTGGTTATATTTAGTTTGATTTTTTATTTTTTAAAAGTTAAA 
LJFgene1       AAACTCCCCTT--TCCTTCATGTCATGTGAAGCATTTTTTACTCAAGTAGATCCACTAAA 
229 
 	  
                     ** **     **   ** ** *  **  *  ***  *    *  *     **** 
 
LJFgene8       TTTAGTCCTTTATGTTTTTAAAACGAATCAAAATGATC--ACTATTTCGAGATGTAAAAC 
LJFgene1       TTTGAGTCTCAAATGTTTTAACTTTATTCTAAATGTTTTAACTTTATTTGAGTCTCAAAT 
               ***    **  *   ******    * ** ***** *   *** * *     * * ***  
 
LJFgene8       TTTTTTATT------AGATTTACTTACATGCAAATTATGCAACTTGACTAATGTTTGAAA 
LJFgene1       GTTTTAACTGAAGGTAAATTTGGTTAACTATGATCAGAAATACATTAACAAGAGTTGAAG 
                **** * *      * ****  ***  *   *        ** * *  **   *****  
 
LJFgene8       AAAAAAATCATCAATATGATAAAAATAATGAGTGTCACAAGCAATTAAAAA--------- 
LJFgene1       AATATT-TTTTATGTACAATAAAGAGAGTATTTGCTCGAGAGAATGTAAATCCTTTTCTA 
               ** *   *  *   **  ***** * * *   **    *   ***  ***           
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       AATATTTTTGTGATGAAAAATAATGGTTGCTGGCAGGCACTGAGACAAGAGTTGGAGAAG 
                                                                            
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       AAAGGATGGGCATCTCAAGACACCATATGATGAAAAAACTTAGGCAGAATTCACATCAGC 
                                                                             
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       ATCTAAGAAAATATTGTTTCATATACATTGTAACCTTGTATACTTTTGTATTAGATACAA 
                                                                             
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       AATCTCACAAGATCATTGAAAGCAAACTCTTCATGATTATTGGAATTGTAGAAATGATTG 
                                                                             
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       AGAACAGTACTTCAAACTCTCGGGGGAAGGAATGAAATGAAGATGTTACCCATATCTTTT 
                                                                             
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       TGAACTTCATTAATTGGTCCACTTATTTACTCTTTCGCTGAGTTCAATCTAACAATGTAG 
                                                                             
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       CATTCTTGTTTCAAGAATTTTATGTTGTGTTGTTTTTCAAATGCATTTGCCATGATTCAC 
                                                                             
 
LJFgene8       ------------------------------------------------------------ 
LJFgene1       CTTCGGTGCATATAGCATTTGGAATCTGATTATAATAGGAGCATTGCGGAGACCAAAAAC 
                                                                             
 
LJFgene8       ---------- 
LJFgene1       AGGGTGCATT 
                           
LJFgene9 vs. LJFgene3 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       CCATAAAAAAGAAAAAAAAAAAGTCCCACCGCCCACCTTCTTTATCACATGATTCACATC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TCATTCCTTATATTTGGTTCACATTCTTAAATTATAAATATTTCGGTCTGTGAAGATATA 
                                                                             
 
LJFgene9       --------------AGCATTGGTTCGCACCTAAGGCACC--TTCCCAATTCAGCTTCTAA 
LJFgene3       TGTCCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAACAACAATGGCTT 
                                ***   *** ****       *   ******      *      
 
LJFgene9       CGATGACACTTTGTAGCACGTTTTCCAACTTCAA---CATTCACATATTAAAAAACAACA 
LJFgene3       CAATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTTCATCACCAAACCCAACAATGGTA 
               * *** **  **  *** * ** * **** ****   ***   ** *   ** **    * 
 
LJFgene9       AGGGTTCCTTTTCTCGTCGATTTCAACTCTCTCAGAAGCTGGATGACGATAATTTCATTG 
LJFgene3       GAAGAAGCTCTCTTCCCCGTATTGTATTCTGTCAGAAGCACCACGATAGCACACCCACCG 




LJFgene9       ATAAAATCAAACGAAGGTTCTCACTGATTCTCCCTTTAATTTGCCA----CCTCACATGA 
LJFgene3       ACCAAATCAACCGAAGGTTCTTATTTCTTCACACTCGCACTTTCTAATTCCTTTCTATGG 
               *  ******* ********** * *  *** * **   * ** * *    * *   ***  
 
LJFgene9       ATTGTATAATATATATTTATATTTATGCT------------TGACCTTGAATTGTTCC-T 
LJFgene3       ATTAT-TCATATCTATTCATACCCATCTTCTGAAATCTCTTTATATTTCAATTATTTTGT 
               *** * * **** **** ***   **  *            *    ** **** **   * 
 
LJFgene9       ATCTTAAAGAGAGCTCATACTGGAAAGTGGAGAATTAGCAACCATTGGTGCCATCTTCAA 
LJFgene3       CTATTGAAGAGAACTCATATTGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTGAA 
                * ** ****** ****** **  ***  * *** **** ***************** ** 
 
LJFgene9       CTTTAGGTACACTGCTTTATTGTTTTCACAATGAGAATAGGTGACCAAAATTTAATTAAT 
LJFgene3       CTTCGGGTACCCCTCCTCTGCTTGTTTTTGG---------------AAAATTT--TTGTT 
               ***  ***** *  * *     * **                    *******  **  * 
 
LJFgene9       TCTTATAATATTTGAAAATATTTCGAGAAATTTTATGTAAAATTAACTCTTTTTCTTTAA 
LJFgene3       TTTCATTTTATTTTGAA-TGT------AAATTGAATTCAAGATTTGATTTTGTTGGT--G 
               * * **  *****  ** * *      *****  **  ** ***   * ** **  *    
 
LJFgene9       GATTTATGTGATTACTTCATAGCAAATTCTTGTCAAGTTTTAAGAACTTTTGAGTTTTGA 
LJFgene3       GGTTTGAAGACCCTTTTGGTTTTTAATTTCGGTTTTGTTTTG-----TATTGGACATGGG 
               * ***          **  *    ****   **   *****      * ***    * *  
 
LJFgene9       TGTGTGTTTTCTATTGGAAATATGTGGGGATATATTATTTTGGATTTTATGCTTCTTTGC 
LJFgene3       TG-GTGGTTAAAAAAGAGAAAAT-TGAGTTTGTGT--CTTGTGTTTTGATGGT-----GC 
               ** *** **   *  *  ** ** ** *  * * *   **  * *** *** *     ** 
 
LJFgene9       AGAGGCAAAAAGCCAGATTATCTTGGAGTGCAGAAAAATCAACCGGCATTAGCACTATGT 
LJFgene3       AGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCAGCATTAGCTCTGTGC 
               ** ** ***** ** *********************** * *** ******** ** **  
 
LJFgene9       CCGGCAACTAAGAACTGCATATCGACATCTGAAAATGTCACTAACCTCACACATTACACT 
LJFgene3       CCGGCAACGAAGAATTGCGTGTCAACCTCTGAGAATATCAGTGATCGCACACATTATGCT 
               ******** ***** *** * ** ** ***** *** *** * * * *********  ** 
 
LJFgene9       CCTCCTTGGTGAAATTTCCTTCTTTATTTTTTTATTTATTAAAGTTTTAACTTTGGTTTA 
LJFgene3       CCTCCATGGTAAAAGTT--TCCTTCTTTTTCTTATTTT---AATTTTCACCTTGGATTTA 
               ***** **** *** **  * ***  **** ******    ** *** * *** * **** 
 
LJFgene9       TGATATTATCTGAATC---TGAATTGGCTGCAAAGCCTG------CAATTTGTT--ATTG 
LJFgene3       TGGGATTATATGTATTAAATGCATTTTTTTAATTGTGTGTTTGGACAAACTACTTAGTTA 
               **  ***** ** **    ** ***   *  *  *  **      ***  *  *   **  
 
LJFgene9       AATATATATTGTTGTTGAGTTTAATTTTACAC-TGAATAACTTTTAAAATAATTATTATA 
LJFgene3       AGTGCTCATC-TCATCATGTAAGTGCTTATGCATAAGTTGTTTCTATAATAAAAAA-ATA 
               * *    **  *  *   **      ***  * * * *   ** ** *****  *  *** 
 
LJFgene9       AAAATCAATAAAATTA--TTATCTATATAAAAAATATGATTAGATGATAAAGTAAAACTT 
LJFgene3       AAAATACATACGTATGAGTTGTTGTTGTAAGCTTTTTTCTTAAGTTATTCTGGAAATCTT 
               *****  ***    *   ** *   * ***    * *  ***  * **   * *** *** 
 
LJFgene9       TTGTATGGTATTAATACATGAATTATTTTTTGTCCAGAATTTTTCAGATTG--TCATAAA 
LJFgene3       ATTGAAATAATCTGAAAACAACTTTTTTTTTTACATGATCTGCTGAAAACAACTTATAGA 
                *  *    **    * *  * ** ******  *  **  *  * * *     * *** * 
 
LJFgene9       T---------TTGCATTTTGATAAAGTGTATAATTC-ACTCAATTTCAAAATAACTGACT 
LJFgene3       CATATGGTAATCACATATCATTAAGTTAAGTTATTCCAAACACTTACATAAACACTTATA 
                         *  *** *   ***  *   * **** *  ** ** ** **  *** *   
 
LJFgene9       TTTTAACACCAATTTGG--------CAAAATGTTGCTTATGGAACAATTTAATTAATT-A 
LJFgene3       AGAGAAAAACAATAAGAAATAAAAACAAAATAAAATTTTCAATAAGTTAAAATTAGTTTA 
                   ** * ****  *         ******     **     *   *  ***** ** * 
 
LJFgene9       TCACATTTTAAAACCATTG--AAAGTTCAATTGGTGTTGCCGTGTTGGGCGCATTGAGCC 
LJFgene3       TAAAAGTTTTTTTTTATTATAGAAGCTCTCTTGTATTAGCCTCTCCTAAAGTTTTTTTTT 
               * * * ***      ***    *** **  ***   * ***         *  **      
 
LJFgene9       CTT--------AACTTAGGAAATGTATTATCTCATGTTGAATTTGCTTTTTTTTTTTTTT 
LJFgene3       CTTCATAATTTAGCTTAAAAAGAAACCTATTTCATTTTTTCATT-TTATTTTCTTCTCTT 
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               ***        * ****  **      *** **** **    **  * **** ** * ** 
 
LJFgene9       TTATTTCTCTTCAGCTAAGTTCCGAGCATTGAGCCTTTA-------ACTTAGGAAAT--G 
LJFgene3       GTAAATGCTTTTGGAGAAGTTTGTCCAAACATACCTTTACACAAATACTTATAAGATAAG 
                **  *   **  *  *****      *     ******       *****  * **  * 
 
LJFgene9       TATTATCACA-TGTTGGGTATAGATTATTAATTAAGAGAACA----TTGATTATTCTACA 
LJFgene3       TCTAATTAAGCTTTTTCAAACACACTCAAAGTTAAAGTATTTCCATTTTGTTGTTTTTTT 
               * * ** *   * **    * * * *   * ****   *       **  ** ** *    
 
LJFgene9       GGAACT-------------ACAATCCTGAAGG---------------TAGGAAAGATCAT 
LJFgene3       GGGCCTTAATTTTCGGTTAACTAACTTGTGGTGTCTAAATTTCGTCTTGAGGAGGGTCTG 
               **  **             ** * * **  *                *  * * * **   
 
LJFgene9       GTGAGCAAAG---AGGCAATGGAGGAACTGATAG-ATGTGGTAATTT-TAATTAGGATCA 
LJFgene3       ATAAACCAGATTTAGGAGATAAGTAAGCAGTCAGTGTTTATTTATTTATTTTTTGGATTT 
                * * * *     ***  **     * * *  **  * *  * **** *  ** ****   
 
LJFgene9       TGTTAAGTCTTAAGCTA---CTTAGTTA-AAGAATCAATAAACAATTTTTT-TAGGAAAT 
LJFgene3       AGTCCAAAAGGAACCTATGGCATATTTGTGAGAATCACGTTGCAATAGACAATAGTGCAC 
                **  *     ** ***   * ** **   *******     ****      ***   *  
 
LJFgene9       CACG--TGATTAATTACATTAGAAATCA-CAGTTACACTGGCAAT--ACTGTTATATA-- 
LJFgene3       CTGGAACGATTTATCACGTTTTAAACAAGTAGTGCAACCGATATTGGACTATTGACTGTT 
               *  *   **** ** ** **  ***  *  ***   ** *  * *  *** **   *    
 
LJFgene9       -AAAACTATTTATTTTA------AATTGGTTGACTAGTATCTTAAGAAC--ACTTATTAA 
LJFgene3       GAACATTGTTGACTTGACATAAGAATTGGACAATTGGTCACACACACATTGGCCGGTGAA 
                ** * * ** * ** *      ******   * * **  *  *   *    *   * ** 
 
LJFgene9       AAAAGTGTA---TTGAGTTTTTGTATCTCAATAGGAGTATAATTAAGACTATTTATAG-- 
LJFgene3       AGTAGTGCAATCTTTACTTTTTATTTCTTTTTGACAAAAAAATTTTCTCTACCTTTGGCC 
               *  **** *   ** * ***** * ***   *   *  * ****    ***  * * *   
 
LJFgene9       -TTGGTTTGTTATAGCTACTGATGAGTTTTCAAATCATTAAAGT-TACAAAAATCAG--- 
LJFgene3       CTTGTTTGAGCATGGTCGCCACAAAATCCAAACTTTATTATTGTATAGATGAATCATGAT 
                *** **    ** *   *     * *    *  * ****  ** ** *  *****     
 
LJFgene9       ------TTACTATTGTTTTTTATTTTACAGATAGAATCGACAATACTACCAGAAAATTTT 
LJFgene3       CTCACTTTGTTTTAGTATTTTCATTCTTTTTCAGGAACTATAATCCTGA-AGGTAGGAAA 
                     **  * * ** ****  **       ** * * * *** **   **  *      
 
LJFgene9       ACACCAAGGATTGTAGAAAGAACAGAAGATTATCT--TAGAT----TGGAATACCAAAGT 
LJFgene3       AAACCTGTGAACAGAGAGGAAGCAATGGAGGAACTGATAGACGTGGTAATAAATCTAACT 
               * ***   **    ***   * **   **  * **  ****     *   * * * ** * 
 
LJFgene9       GTATACAAGCCACAAATTTTA-------ACTTCAATGTCACCAATATCATTGTATGCAGA 
LJFgene3       GAACTGAAATTTTGAATTATATCACTGGATTGCAATTTTCTTTTCCTTCCCTCTTTTAAT 
               * *   **      **** **       * * **** *        *       *  *   
 
LJFgene9       AAAAATGAATAGTAACTT------TTTACTATTAGACTGAAAAGCCTGCATCAAGCATTG 
LJFgene3       CAACATCGATTATAATTTATAAAATTTATAAAAGGGGTGATAAACTGAAAGTAAATATAC 
                ** **  **  *** **      ****  *   *  *** ** *    *  **  **   
 
LJFgene9       AA---GGAATGGAGTTTCTTTGAT---CATTGGACTGCCCATC-----TCATAGTAACTC 
LJFgene3       ACTTTGTAATGCACTATTCCTAACACACTTTCTATTATTCATTAAAATTTATTGAAAATT 
               *    * **** * * *   * *    * **  * *   ***      * ** * ** *  
 
LJFgene9       A-----TCTTGAA-GCAATTAATGCAGTAAAAACTAACTCATCGTGAAAAGTTCATTCTC 
LJFgene3       ACGAAGTCATGGGTGGAATTCATTGAATAAAGAGTAAGACCTACATGATTTTGTAATTTC 
               *     ** **   * **** **  * **** * ***  * *     *   *  * * ** 
 
LJFgene9       TGCTTTATTTAAATTTTTA-CAGCAAGTAGATTGGAATGCATG-GTTTTTGCCATGT--- 
LJFgene3       TAATAAACTCTTACTATTAATAAAGAATGTATTTAAAAGGGTATGTTGTCAACATTTCTC 
               *  *  * *   * * ***  *   * *  ***  ** *  *  *** *   *** *    
 
LJFgene9       ---TTTATACTTGACAAA-GATAAT-GCAAACTATAAACAC----------AAGCAGCGG 
LJFgene3       TAATTTATAGTTGATTTGTGATAATAGCTGGTTATTTGCACTTTTCCTTCCAATCATTGA 
                  ****** ****     ****** **    ***   ***          ** **  *  
 
LJFgene9       AGCTGGTATGCACTTGGTTTGAGATAGGATAATGATATATTG------------------ 
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LJFgene3       AGTAAAGTTAAACCAGTTCCGGACAATTTTGCAGATAGAATCAACAACACCAGACAAATT 
               **      *  **  * *  *    *   *   **** * *                    
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCAAT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TTTGGGGGTAAGTGTAACTTACATCTAAGGAAACTCATCACGAAGAAAAATGATAATTTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       ATACATTTGAGATGATATCAAGATTCAAGAACCATCTCTAATTTCCTTCCCTCCTTTTTC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TGTCATGTGCTAACAGTTTGTAGATGATGTTGAGTTCTGGTTCCCACCGGGTAAGGGTTC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TACTGTGGAGTACCGATCTGCATCTCGGTTAGGAAACTTTGATTTTGATGTGAACAGAAA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       AAGAATAAAGGTGTGATTTCATAATTCATGTGTTTTCTCTATAGTTAGATAAAGAAATTC 
                                                                             
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TTGGTTCCATGGTAAAACTCCTCTTTCCTTCATGTCATGTCAAACATTTTATACTCAAGT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       AGATGATTCACTAAATTTGAGTCTCAAATGTTTTAACTTTATTCTAAATTAGTCACTTAT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TTTAACTGAAGGTAAATTTGGTTAACTATGATCAGAAATACATTGACATTTTTTAATTGG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TAGAGATAAAGAATATTTTTTATGTACAATAAAGAGAGTATTTACTCCAGAGGATGTAAA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TCCCTTGCTAAATATTTTTGTGATGAAAAATCTTGGTTGTTGACAGGCACTGCGACAAGA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       GTTGGAGAAGAAAGGATGGGCATCTCAAGACACCATATGATGAATAAACTCAGGCAGAAT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TAACATCAGCATCTAAGCAAATATTATTTCATATACTTTGTGACCTTGTATACATTTGTA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TTAGATACAAATCTCACAGGATCATTGAAAGCAAACTTTTCTTTGATTATTGGAATTGTA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       GAGAAATCATTGAGAACAGTACTTCAAACTCTCGGGGAAGGAATGAAATGAAGACCTTGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       CCCATATCCTTCTTCAAGTTCATTAATTGGTCCGCTTATTTACTCTTTCACCAAGTTCAA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TCTAACAATGTATCGTTCTTGTTTCAAGAATATTAATTTGTGTTTTGTTTCTAATGTGTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
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LJFgene3       CTTCACGATTCACTTTTGTTGTAAGTTTGACTTAGCTTCTTCATGTATTAAAACTTAACC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene3       TTGTGATCAATTTGGATACTTTAGGCCTTTCTCTTATCAAAATGTACCTATGTCATGATC 
                                                                             
 
LJFgene9       ---------------------------------------------- 
LJFgene3       TCGAAATTGTTCAATCTCATTGATCCTAACTAGAAAATTCGTCCAA 
 
LJFgene9 vs. LJFgene14 
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       AAGTCCCACCTTCTTTTATTCATCACATGATTCACATCTCATTTCTTATTTTCGGGTCAC 
                                                                             
 
LJFgene9        -------------------------------------------------------AGCAT 
LJFgene14       TTTGTTAAATTATAAATAATTTCGTTCTGTGAAGGTACACACGTTCATAAGTTCCTTAAT 
                                                                          ** 
 
LJFgene9        TGGTTCGCACCTAAGGCACC--TTCCCAATTCAGCTTCTAACGATGACACTTTGTAGCAC 
LJFgene14       TTTCTCGAACCTTCATTTTCAGCTCCCAACAATAATGGCTTCAATGGCATCTTCAAGCTC 
                *   *** ****       *   ******      *     * *** **  **  *** * 
 
LJFgene9        GTTTTCCAACTTCAA---CATTCACATATTAAAAAACAACAAGGGTTCCTTTTCTCGTCG 
LJFgene14       CTTCTGCAACCTCAAGTTTATCACCAAACCCAACAATGGTAGAAGAAGCTCTCTTCGCCG 
                 ** * **** ****    **   ** *   ** **    *   *   ** *  *** ** 
 
LJFgene9        ATTTCAACTCTCTCAGAAGCTGGATGACGATAATTTCATTGATAAAATCAAACGAAGGTT 
LJFgene14       TATTGTATTTTGTCAGAAGCATCACGATGACACACCCACCGACCAAATCAACCGAAGGTT 
                  **  * * * ********   * ** ** *    **  **  ******* ******** 
 
LJFgene9        CTCACTGATTCTCCCTTTAATTTGCCACCTCACATGAATTG------TATAATATATATT 
LJFgene14       CTTACTTCTTCACACTCACACTTTCTATTTCCTTTCTATTGATTATTCGTAACCATCTTC 
                ** ***  *** * **   * ** * *  **   *  ****        ***      *  
 
LJFgene9        TATATTTATGCTTGACCTTGAATTGTTCCTATCTTAAAGAGAGCTCATACTGGAAAGTGG 
LJFgene14       TGAAATCTCGTTACATTTCAATTCTTTTGTGTATTGAAGAGAACTCATATTGAGAAGCAG 
                *  * *   * *  *  *  * *  **  * * ** ****** ****** **  ***  * 
 
LJFgene9        AGAATTAGCAACCATTGGTGCCATCTTCAACTTTAGGTACACTGCTTTATTGTTTTCACA 
LJFgene14       CGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGGTACCC--CTCCTCTGTTTTTGC- 
                 *** **** ***********************  ***** *  **    ******  *  
 
LJFgene9        ATGAGAATAGGTGACCAAAATTTAATTAATTCTTATAATATTTGAAAATATTTCGAGAAA 
LJFgene14       -TCTGTTTTTTTTTCTGGAAATT--TTAGTTTTT----CATTT-----TATTTTGA---- 
                 *  *  *   *  *   ** **  *** ** **     ****     ***** **     
 
LJFgene9        TTTTATGTAAAATTAACTCTTTTTCTTTAAGATTTATGTGATTACTTCATAGCAAATTCT 
LJFgene14       ----ATGTAAATTAAATTC---------GAGATTT----GATT--TTGTTAGTGGGTG-T 
                    ******* * ** **          ******    ****  **  ***    *  * 
 
LJFgene9        TGTCAAGTTTTAAGAACTTTTGAGTTTTGATGTGTGTTTTCTATTGGAAATATGTGGGGA 
LJFgene14       TGAGACCCTTTTGGA---TTTTAGTTTGGGT-TGTGTTTTGTATTGGAAATGGGTGG--- 
                **  *   ***  **   *** ***** * * ******** **********  ****    
 
LJFgene9        TATATTATTTTGGATTTTATGCTTCTTTG---CAGAGGCAAAAAGCCAGATTATCTTGGA 
LJFgene14       --------TTTGGGTTTTGTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGA 
                        ***** **** ** **   **   *** ** ***** ** ************ 
 
LJFgene9        GTGCAGAAAAATCAACCGGCATTAGCACTATGTCCGGCAACTAAGAACTGCATATCGACA 
LJFgene14       GTGCAGAAAAACCCACCAGCATTAGCTCTGTGTCCGCCAACTAAGAACTGCGTGTCAACC 
                *********** * *** ******** ** ****** ************** * ** **  
 
LJFgene9        TCTGAAAATGTCACTAACCTCACACATTACACTCCTCCTTGGTGAAATTTCCTTCTTTAT 
LJFgene14       TCTGAGAATATCAGCGATCGCACACATTATGCTCCTCCATGGTAAAAGTTCCCTTCT--T 
                ***** *** ***   * * *********  ******* **** *** **** *  *  * 
 
LJFgene9        TTTTTTATTTATTAAAGTTTTAACTTTGGTTTATGATATTATCTGAATCTGAATTGGCTG 
LJFgene14       TTTCTTATTTT---AATTTTCACCTTGGATTTATGGGATTATATGAAT-TGAATGCAATT 




LJFgene9        CAAAGCCTGCAATTTGTTATTGAATATATATTGTTGTTGA--GTTTAATT--TTACACTG 
LJFgene14       TTTTAATTGTGTTTGGATAAACAACTTAGTTAACTGCCCATCATGTAAGTGCTTATGTAT 
                       **   ** * **   **  **  *   **   *   * *** *  ***      
 
LJFgene9        AATAACTTT-TAAAATAATTAT-TATAAAAATCAATAAAATTATT----ATCTATATAAA 
LJFgene14       AAGGTTTTTCTATAGTAAAAAAATGTACAAGTTGCAAGCTTTTTTCTTAATTTATTCTTG 
                **    *** ** * ***  *  * ** ** *    *   ** **    ** ***      
 
LJFgene9        AAATATGATT-AGATGAT--AAAGTAAAACTTTTGTATGGTAT---TAATACATGAATTA 
LJFgene14       AAATCTTATTGAAATAATCTGAGAACAACTTTTTCTTTTTTACCTGTGATCTGAAAACAA 
                **** * *** * ** **   *    **  **** * *  **    * **     **  * 
 
LJFgene9        TTTTTTGTC---CAGAATTTTTCAGATTGTCATAAATTTGCATTTTGATA-----AAGTG 
LJFgene14       CTCATAGACATATCATAAACTTGGGATATAGATAAATTTTTTCATAAACACTTACAAGAG 
                 *  * * *       *   **  ***    ********     *  * *     *** * 
 
LJFgene9        TATAATTCACTCAATTTCAAAATAACTGACTTTTTAACACCAATTTGGCAAAATGTTGCT 
LJFgene14       AAAAAAAAATACAAAAGAAAAATAAAATAAATTTTTCTATAAGCTAAAATTAGTGT-ATG 
                 * **   *  ***    *******   *  ****   *  *  *      * ***     
 
LJFgene9        TATGGAACAATTTAATTAATTATCACATTTTAAAACCATTGAAAGTTCAATTGGTGTTGC 
LJFgene14       TGTAAGCTAATTTG--TAGTTCTTTCATATTAGCTTCTCCAAAAGTTTTTTTTTTTTTTA 
                * *     *****   ** ** *  *** ***    *    ******   **  * **   
 
LJFgene9        CGTGTTGGGCGCATTGAGCCCTTAACTTAGG---AAATGTATTA-----TCTCATGTTGA 
LJFgene14       ACTTATGCATAAGTTAAA--TTTAGCTTAAAGATAAATTTATTTCATTTTCTTCTCTTGT 
                  *  **      ** *    *** ****     **** ****      ***  * ***  
 
LJFgene9        ATTTGCTTTTTTT----TTTTTTTTTATTTCTCTTCAGCTAAGTTCCGAGCA-------- 
LJFgene14       AAATGCTTTTGGAGAAATGTATCCAAACAGACCTTTACACAAGTACTAATAAGATAAGTC 
                *  *******       * * *    *     *** *   **** *  *  *         
 
LJFgene9        ---TTGAGCCTTT----AACTTAGGAAAT----GTATTATCAC-ATGTTGGGTAT--AGA 
LJFgene14       TAATTAAGCCTTTTCAAAACGCTCAAAGTTCAAGTATTTCCATTATGTTGATTCTTCGGG 
                   ** *******    ***     ** *    *****  **  ******  * *   *  
 
LJFgene9        TTATTAATTAAGAGAACATTGATTATTCTACAGGAACTACAATCCT--GAAGGTAGGAAA 
LJFgene14       CCTTAATTTTCGGTTAAGTAACTTGTGGTGTCAAAATTGCGTGTTGAGGAGGGTCTGGTA 
                   * * **  *   *  *   ** *  *     ** * *        ** ***  *  * 
 
LJFgene9        GATCATGTG-AGCAAAGAGGCAATGGAGG---AACTGATAGATGTGGTAATTTTAATTAG 
LJFgene14       AACCAGATTTAGGAGATAAGTAATCAGGGTTTATTTATTTATTGGATTTAGTCCAAACGG 
                 * **  *  ** * * * * ***   **   *  *  *   **   * * *  **   * 
 
LJFgene9        GATC-ATGTTAAGTCTTAAGCTACTTA-GTTAAAGAATCAATAAACAATTTTTTTAGGAA 
LJFgene14       AACCTATGGCCATATTTGTGAGAATCACGTTGCAATAATAGACAATGGTGCACTTGGAAC 
                 * * ***   *   **  *  * * * ***  *  *  *   **   *    ** * *  
 
LJFgene9        A-----TCACGTGATTAATTACATTAGAA-ATCACAGTTACACTGGCAATACTGTTATAT 
LJFgene14       AATTTATCACGTTTTAAACCACGTGAAAGTAGTGCAGCCGAAATTGGACTATTGACTGTT 
                *     ******  * **  ** * * *  *   ***    * * * * ** **     * 
 
LJFgene9        AAAAACTATTTATTT----TAAATTGGTTGACTAGTATCTTAAGAACACTTATTAAAAAA 
LJFgene14       GAACAATGTTGACTTGACATGAATTGGACTATTGGTCACACACATTGGCCGGTGAAAGCA 
                 ** * * ** * **    * ******   * * **  *  *      *   * ***  * 
 
LJFgene9        GTGTA---TTGAGTTTTTGTATCTCAATAGGAGTATAATTAAGACTATTTATAGTTGGT- 
LJFgene14       GTGCAATCTTAACTTTTTCTTTTTTTTTTGACAACTTTTTTTTTTTCTCTATCTTTGGTC 
                *** *   ** * ***** * * *   * *     *  **     * * ***  *****  
 
LJFgene9        -TTGTTATAGCTACTG----ATGAGTTTTCAAA-----TCATTAAAGTTACAAAAATCA- 
LJFgene14       CTTGTATTGAGCATGGTCCCACCAAAATCCAAACTTTATTATTGGACATAGATGAATCAT 
                 ****  *    *  *    *  *   * ****     * ***  *  ** *  *****  
 
LJFgene9        GTTACTATTGTTTTTTATTTTACAGAT--------AGAATCGACAATACTACCAGAAAAT 
LJFgene14       GATGTCACTTTGTTTTAATTTTTAGTTTCTTTTTCAGGAACTATAATCCTGA-AGGAAGG 
                * *   * * * ***** ***  ** *        ** * * * *** **   ** **   
 
LJFgene9        TTTACACCAAGGATTGTAGAAAGAACAGAAGATTATCT--TAGAT----TGGAATACCAA 
LJFgene14       AAAAAACCTGTGAGCAGAGAGGAAGCAATGGAGGAACTGATAGACGTGGTAATAAATCTA 
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                   * ***   **    ***   * **   **  * **  ****     *   * * * * 
 
LJFgene9        AGTGTATACAAGCCACAAATTTTAACTTCA-ATGTCACCAATATCATTGTATGCAGAAAA 
LJFgene14       GCTGAACTGAAATCTTGAGTTATAACACTAGATTGCAATTTTCTTTTCCTTCCCTCATTT 
                  ** *   **  *   * ** ****   * **  **    * *  *  *   *  *    
 
LJFgene9        AATGAATAGTAACTTTTTACTATTAGACTGA-AAAGCCTGCATCAAGCATTGAAGGAATG 
LJFgene14       TATCAACATCGATTATAATTTATAAAATTTATAAAAGGAGTGATAGTAAATATACACTTT 
                 ** ** *   * * *    *** * * * * ***    *    *   * *  *    *  
 
LJFgene9        GAGTTTCTTTGATCATTGGACTGCCCATCTCATAGTAACTCA---TCTTGAAGCAATTAA 
LJFgene14       GTAACACACTATTCTTAACCCCACCCTTTTTATTATTGGTTAAAATTTATCAGAAATTAG 
                *     *  *  ** *    *  *** * * **  *   * *   * *   ** *****  
 
LJFgene9        TGCAGTAAAAACT-AACTCATCG--TGAAAAGT----------TCATTCTCTGCTTTAT- 
LJFgene14       AAAGTCATGAGTGGAACTCATTGAATAAAGAGTGAGACCTATGTGATTTTATAATTTCTA 
                      *  *    ******* *  * ** ***          * *** * *  *** *  
  
LJFgene9        -TTAAATTTTTACAGCAAGTAGATT----GGAATGCATGGT---TTTTGCCATGTTTTAT 
LJFgene14       ATAAACTTATTATTAATAGTGTATTTAAAAGGATACATTGTGAACATTTCTCTAATTTAT 
                 * ** ** ***     ***  ***     * ** *** **     ** *  *  ***** 
 
LJFgene9        ACTTGACAAA-GATAAT-GCAAACTATAAACAC------AAGCAGCGGAGCTGGTATGCA 
LJFgene14       AATTGATTTGTAATAATAGCTGGTTATTTGCACTTTTCCAATCATTGAAGTAAAGTTAAA 
                * ****      ***** **    ***   ***      ** **  * **      *  * 
 
LJFgene9        CTTGGTTTGAGATAGGATAAT-GATATATTG----------------------------- 
LJFgene14       ACTAGTTCCGGATAATTTTACAGATCGAATCAACAACACCAGACAAATTTTCACCACGGA 
                  * ***   ****   * *  ***  * *                               
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       TAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCAATCTTGGGGGTAA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       GTGTAACTTACATCTAAGGAAACTCATCTTGAAGAAAAATGATCATTTTATACATTTGAG 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       ATGATATCAAGAACCATCTCTAATTTCCTTCTCCCTTTTTTCTGTCATGTGCTAACAGTT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       TGTGGATGATGTTGAGTTCTGGTTTCCACCCGGTAAGGGTTCTACTGTGGAGTATCGATC 
                                                                             
  
LJFgene9        ------------------------------------------------------------ 
LJFgene14       TGCATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATGATT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       TCATAATTAATATGTGCTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCCAGGGTAAA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       ACTCCCCTTCCTTCATGTCATGTCAAACATTTTATACTTAAGTAGATTCACTAAATTTGA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       GTCTCAAATGTTTTAACTTTATTCTAAATTAGTCACTTATTTTAACGGAAGGTAAATTTG 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       GTTGACTATGATGAGAAATACGTTGATATTTTTTAATTGGTAGAGATAAAGAATATTTTT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       TATGTACAATAAAGAGAGTATTTACTCCAGAGGATGCAAATCCCTTACTAAATATTTTTG 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
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LJFgene14       TGATGAAAAATCTTGGTTGCTGACAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       CATCTCAAGATACCATATGATTAATAAACTCAGGCTGAATTAGCATCAGCATCTAAGCAA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       ATATTATTTCATATACTTTGGACCTTGTATACTTTTGTATTAGATACAAATCGCACAGGA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       TCATTGCAAGCAAACTTTTCTTAGATTTTTGGAATTGTAGAGAAATCATTGAGAACAGTA 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       CTTCAAACTCTCTCGGGGAAGGAATGAAATGAAGACCTTGCGCCATATCTTCTTCAAGTT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       CATTAATTGGTCCACTTATTTACACCTTCACCGAGTTCAATCTAATAATGTATGAATCTT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       GTTTCAAGAAATTTAATTTGTGTTTTGTTTCAAACGTGTTCTTCATGATTCACTTTTGTT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       GTAAGTTTGACTTTGCTTCTTCATGTATTAAAGCTTATCCTTGCGATCAATTTGGATGAT 
                                                                             
 
LJFgene9        ------------------------------------------------------------ 
LJFgene14       GCTTTAGGCCTTTCTGTCATCAAAATGTACGTACCTATGTCATGTTTTCAGAGGCTTTTT 
                                                                             
 
LJFgene9        -------------------------- 
LJFgene14       GATATCCTTGATGTCTTTACAAGAAA 
                                           
LJFgene9 vs. LJFgene1 
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TTCCATATTTTCGGGTCACATTCTCAAATTATTATAACTAATTTCGTCATGTGAAGATAC 
                                                                             
 
LJFgene9       -------------AGCATTGGTTCGCACCTAAGGCACC--TTCCCAATTCAGCTTCTAAC 
LJFgene1       GTTCATAAGTTCCTTAATTTTCTTGAACCTTTATTTTCAGCTCCCAACAATAATGGCTTC 
                               ***   * * ****       *   ******      *     * 
 
LJFgene9       GATGACACTTTGTAGCACGTTTTCCAACTTCAA---CATTCACATATTAAAAAACAA--- 
LJFgene1       AATGGCATCTTCAAGCTCCTTCTGCAACCTCAAGTTTATCACCAAACCCAACAACAATGG 
                *** **  **  *** * ** * **** ****    **   ** *   ** *****    
 
LJFgene9       ------CAAGGGTTCCTTTTCTCGTCGATTTCAACTCTCTCAGAAGCTGGATGACGATAA 
LJFgene1       TAGAACCAATGCTTCTTCTCTTCCCCGTATTGTATTCTGTCAGAAGCACAACGATGACAC 
                     *** * *** * *  **  **  **  * *** ********   * ** ** *  
 
LJFgene9       TTTCATTGATAAAATCAAACGAAGGTTCTCACTGATTCTCCCTTTAATT-------TGCC 
LJFgene1       CCCCACCGACCAAATCAACCGAAGGTTCTTACTTCTTCACACTCACACTCTCTCACTCCT 
                  **  **  ******* ********** ***  *** * **   * *       * *  
 
LJFgene9       ACCTCACATGAATTGTATA-----ATATATATTTATATT------TATGCTTGACCTTGA 
LJFgene1       TCTTTCTATTGATTATTTATAACTATTCATACCCATCTTCTGAAATCTCTTTACATTTCA 
                * *   **  *** * **     **  ***   ** **      * *  **    ** * 
 
LJFgene9       ATTGTTCCTATCT--TAAAGAGAGCTCATACTGGAAAGTGGAGAATTAGCAACCATTGGT 
LJFgene1       ATTCTTTTTGTGTATTGAAGAGAACTCATATTGAGAAGCAGTGAAATAGCGACCATTGGT 
               *** **  * * *  * ****** ****** **  ***  * *** **** ********* 
 
LJFgene9       GCCATCTTCAACTTTAGGTACACTGCTTTATTGTTTTCACAATGAGAATAGGTGACC-AA 
LJFgene1       GCCATCTTCAACTTCGGGTACCCCTCCTCTGTTTTTCCTCGGTTTTTTTCTTTTTTGGAA 




LJFgene9       AATTTAATTAATTCTTATAATATTTGAAAATATTTCGAGAAATTTTATGTAAAATTAACT 
LJFgene1       AATTTAGTTTTTTCATTTTAT-TTTGAATGTA--------AATTGTATTCAAGATT---T 
               ****** **  *** * * ** ******  **        **** ***  ** ***   * 
 
LJFgene9       CTTTTTCTTTAAGATTTATGTGATTACTTCATAGCAAATTCTTGTCAAGTTTTAAGAACT 
LJFgene1       GATTTTGTTGGTGGGTTTGGAGACCCTTT-----TGGATTTT-----AGTTTCAG----T 
                 **** **   *  **  * **    **        *** *     ***** *     * 
 
LJFgene9       TTTGAGTTTTGATGTGTGTTTTCTATTGGAAATATGTGGGGATATATTATTTTGGATTTT 
LJFgene1       TTTGTATTGTATTG-GAAATGGGTGGTGGTTAAAAAAGAGAAAAT-TGAGTTTGGGTTTT 
               ****  ** *  ** *   *   *  ***  * *   * * * ** * * ***** **** 
 
LJFgene9       ATGCTTCTTTG---CAGAGGCAAAAAGCCAGATTATCTTGGAGTGCAGAAAAATCAACCG 
LJFgene1       GTGTTTTGGTGGTGCAGTGGGAAAAAACCTGATTATCTTGGAGTGCAGAAAAACCCACCA 
                ** **   **   *** ** ***** ** *********************** * ***  
 
LJFgene9       GCATTAGCACTATGTCCGGCAACTAAGAACTGCATATCGACATCTGAAAATGTCACTAAC 
LJFgene1       GCATTAGCTCTGTGTCCGGCAACTAAGAACTGCGTGTCAACCTCTGAGAATATCAGTGAT 
               ******** ** ********************* * ** ** ***** *** *** * *  
 
LJFgene9       CTCACACATTACACTCCTCCTTGGTGAAATTTCCTTCTTTATTTTTTTATTTATTAAAGT 
LJFgene1       CGCACACATTATGCTCCTCCATGGTTAAAGTTCCCCTCT--TTTTCTTATTTT---AATT 
               * *********  ******* **** *** ****    *  **** ******    ** * 
 
LJFgene9       TTTAACTTTGGTTTATGATATTATCTGAATCTGAATTGGCTGCAAAGCCTGCAATTTGTT 
LJFgene1       TTCACCTTCGATTTATGGGATTATATG------AATTAAATGCAATTTTTTTTACTTGTC 
               ** * *** * ******  ***** **      ****   *****    *   * ****  
 
LJFgene9       A--TTGAATATATATTGTTGTTGAGT-TTAATTTTACACTGAATAACTTTTAAAATAATT 
LJFgene1       TGTTTGGATAAACAACTTAGTTAAGTATTCATCATGTAAGTGCTTATGTATAAGTTGTTT 
                  *** *** * *   * *** *** ** **  *  *     * *  * ***  *  ** 
 
LJFgene9       --ATTATAAAAATCAATAAA-ATTATTATCTATATAAAAAATATGATTAGATGATAAAGT 
LJFgene1       CTATAATAAATAAAAATGAGGAGGGAAAGTTATTCCAAAAATCACTTTAAAAGAGGTACT 
                 ** ***** *  *** *  *     *  ***   ******    *** * **   * * 
 
LJFgene9       AAAACTTTTGTATGGTATTAATACATGAATTATTTTTTGTCCAGAATTTTTCAGATTGTC 
LJFgene1       CACTTTATTTTA-ATTATTGATTTTTTTAAAATTTAATGATTAAGATTAATTAT-TTATT 
                *   * ** **   **** **   *  *  ****  **   *  ***  * *  ** *  
 
LJFgene9       ATAAAT-TTGCATTTTGATAAAGTGTATAATT-------CACTCAATTTCAAAATAACTG 
LJFgene1       ATAATTATTAGATTCTAAAAAAATAAATAATAAGGATAATAAATAACTCTAAAAAAATTA 
               **** * **  *** * * *** *  *****         *   ** *  **** ** *  
 
LJFgene9       ACTTTTTAACA--CCAAT--TTGGCAAAATGTTGCTTATGGAACAATTTAATTAATTATC 
LJFgene1       TTCTTAGAGCAAGTTGATGTTTTCCTAAAAAAAATATATAAATTGTTTATATAAGTCGTA 
                  **  * **     **  **  * ***       ***  *    **  ** * *  *  
 
LJFgene9       ACATTTT--AAAACCATTG--AAAGTTCAATTGGTGTTGCCGTGTTGGGCGCATTGAGCC 
LJFgene1       AGCTTTTCGGAAATTATTCTTGAAATCTTATTGAAATAATCTGAAAACAACTTTTTTTTA 
               *  ****   ***  ***    ** *   ****   *   *            **      
 
LJFgene9       CTTAACTTAGGAA--ATGTAT---TATCTCATGTTGA-ATTTGCTTTTTTTTTTTTTTTT 
LJFgene1       CATGATTTGAAAACAACTTATAGACATATCATAATCACATATCATTAAGTTATTTTATTA 
               * * * **   **  *  ***    ** ****  * * ** *  **   ** **** **  
 
LJFgene9       ATTTCTCTTCA-GCTAAGTTCCGAGCATT-----GAGCCTTTAACTTAGGAAATGTATTA 
LJFgene1       AGTCATTTTCATAATTTATTTCAAACACTTACATAAATACTTATAAGAGAAAATAAAATA 
               * *  * ****   *   ** * * ** *      *    ***    ** ****  * ** 
 
LJFgene9       TCAC-ATGTTGGGTATAGATTATTAATTAAGAGAAC--ATTGATTATTCTACAGGAACTA 
LJFgene1       AAATTAATTTCTTTATAAGCTATAAAATTAGTTAATGTATAAGTCAATAGGTAGAAGCTC 
                 *  *  **   ****   *** ** * **  **   **   * * *    ** * **  
 
LJFgene9       CA--ATCCTGAAGGTAGGAAAGATCATGTGA------GCAAAGAGGCAATGGAGGAACTG 
LJFgene1       TCTCGTATTAACTCTTCAAAAGTTTATTTTTTAACTTATATATAAGCTAAATTTAACTTA 
                    *  * *   *   **** * ** *          * * * ** *      *  *  
 
LJFgene9       ATAGATGTGGTAATTTTAATTAGGATCATGTTAAGTCTT-----AAGCTACTTAGTTAAA 
LJFgene1       AAAGAGAAACTTATTTCATTTTTTCTCTTCCTTTCTTTTCTAGTAAATGTTTTTATAAAA 
238 
 	  
               * ***     * **** * **    ** *  *   * **     **     **  * *** 
 
LJFgene9       GAATCAATAAACAATTTTTT---TAGGAAATCACGTGATTAATTACATTAGA-------A 
LJFgene1       GTTTACCCAAACAGAACTTTACACAAGTACTTATAAGATAAGTCTAATTAAGCTTTTTCA 
               *  *    *****    ***    * * * * *   *** * *   ****         * 
 
LJFgene9       ATCACAGTTACACTGGCAATACTGTTATATAAAAACTAT-----TTATTTTAAATTGGTT 
LJFgene1       AACATGCTCAAAGTTAAAGTGTTTCCATAATGTTTTTTTGGGCCTTAATTTTCGTCAAGT 
               * **   * * * *   * *  *   ***       * *     *** ***   *    * 
 
LJFgene9       GACTAGT-ATCTTAAGAACACTTATTAAAAAAG-TGTATTGAGTTTTTGTATCTCAATAG 
LJFgene1       AACTTGTGATGTCAAAATTGCGTGTTGAGGAGGGTCTGGTCAACTAGATTTAGGAGATAA 
                *** ** ** * ** *   * * ** *  * * * *  * *  *    *      ***  
 
LJFgene9       GAGTATAATTAAGACT-ATTTAT--AGTTGGTTTGTT---ATAGCTACTGATGA-GTTTT 
LJFgene1       TTAAGCAGTCAGGGTTTATTTATTTATTGGATTTAATCCAAAAGGAACCTATGACATATT 
                     * * * *  * ******  * * * ***  *   * **  **  ****  * ** 
 
LJFgene9       CAAATCATTAAAGTTACAAAAATCAGTTAC---------------TATTGTTTTTTATTT 
LJFgene1       TGTGAGAATCACGTTGCAATAGATAATGGTGCACTTGGAACAATTTATCACGTTTTAAAC 
                     * * * *** *** *   * *                  ***    *****    
 
LJFgene9       TACA-GATAGAATCGACAATACTACCAGAAAATTTTACACCAAGGATTGTAGAAAGAACA 
LJFgene1       CACGTGAAAGTAGTGCAACCGATATTGGACTATTGACTGTTGAACATTGTTGACTTGACA 
                **  ** ** *  *  *    **   **  ***        *  ***** **    *** 
 
LJFgene9       GAAGA--TTATCT-TAGATTGGA-ATACCAAAGTGTATACAAGC--CACAAATTTTAACT 
LJFgene1       TAAGAAATGAACTATTGGTCACACACGCATTGGCCGGTGAAAGTAGTGCAATCTTTACTT 
                ****  * * ** * * *   * *  *    *    *  ***     ***  ****  * 
 
LJFgene9       TCAATGTCACCAATATCATTGTATGCAGAAAAAATGA-----ATAGTAA-CTTTTTACTA 
LJFgene1       TTTCTTTTTTTGAAATTTTTTTTTTCACTACCTTTGGTCCTTGTATTGAGCATGGTCCCA 
               *   * *     * **  ** * * **  *    **       ** * * * *  * * * 
 
LJFgene9       TTAGACTGAAAAGCCTGC-ATCAAGCATTGAAGGA--ATGGAGTTTCTTTGATC-ATTGG 
LJFgene1       CCAAAATCCAAACTTTATTATTGGACATAGATGAATCATGATGTCACTTTGTTTTAATAT 
                 * * *  ***   *   **    *** ** * *  ***  **  ***** *  * *   
 
LJFgene9       ACTGCCCATCTCATAGTAACTC--ATCTTGAAG------------CAATTAATGCAGTAA 
LJFgene1       TTTCATTCTTTTTCAGGAACTATAATCCTGAAGGTAGGAAAAAACCTGTGAGCAGGGAAG 
                 *     * *   ** ****   *** *****            *  * *     * *  
 
LJFgene9       AAACTA-------ACTCATCGTGAAAAGTTCATTCTCTGCTTTATTTAAATTTTTA-CAG 
LJFgene1       AAGCAATGGAGGAACTTATAGACGTGGTAATAAATGCAACTGAACTGAAATCTTGAGTTA 
               ** * *       *** ** *          *    *  **  * * **** ** *     
 
LJFgene9       CAAGTAGATTGGAATGCATGGTTTTTGCCAT-GTTTTATACTTGACAAAGATAATGCAAA 
LJFgene1       TCACTGGATTGAAATTTTCTTTTCCTTCCCTCATTTTATCAACATTGATTATAATTTATA 
                 * * ***** ***      **  * ** *  ******        *  *****  * * 
 
LJFgene9       CTATAAACACAAGCAGCGG-AGCTGGTATGCACTTGGTT---TGAGATAGGATA-ATGAT 
LJFgene1       AAATTTATGAAAGGAGTGATAGTGAATATACACTTTGTAACACTATTTCTAATACACTTT 
                 **  *   *** ** *  **    *** ***** **      *  *   *** *   * 
 
LJFgene9       ATATTG------------------------------------------------------ 
LJFgene1       CTATTATCGGTTAAAATTTATTGAAAACAGTGTTGTTAAATGGCGGCCATGGCGGCGCCA 
                ****                                                        
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TGGCGGAGTTGCGTAACGGTTTTCTGAAAAAACGCCACCGAATAACGGTGGCGTGGCGGA 
                                                                            
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TTAAAGATGGCGGCGCCATGGCGGCCGCCATAGCCATGGCGGCCATGGCGGATGTGGCGG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GGAGGCGGAAAATGGCAGAATTTTTTTTTTTGTCCGCGGTAGGAGTTGGGCTGACCCGAT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
239 
 	  
LJFgene1       CCAACCCTACCCGAAAACTTAATGAAAACCATGACCCCCCCTACCTTTCAGAACGCTGCT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GCAACCCTCGAAGCTTCAACATAGCGCGACCTCGGAACCAGCCACGACCCCTGCAACCAG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       CCTCGGAACCAGCCGCGCTTGACCCGCTGCACACAGCAGCCAGCAGCGACGACCCATGGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GTGAACGGCGGCGACGAGCACGGCGTGAACAACGGCGACGCGAACGGAGAAGACGACCCA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GAACCGCGACCTCGACTTATACGGGTGGGTGGGCCAAAGCCTTTTTTTTGTTTTTGCTGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TTGACACCCCTTTTTTATGTCTGCAGCTTTTTTTCCGTTTTTCTATTTGACACCCCCTTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TACTTTCGACAGTCCCATTTTTAATTTTTTTTTCTATTTGACACCACAATTTTTTTTTCT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GTTCAGTCCTCTTTTAAATGGCTGAACCATCATCCTCTTTAATGAGTTTATTTGGTGTTG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GTACTTGATTATTGTATGAACTCATGAAACTTTTTTAGTTTATTTGAATGCAATCCTTTG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TTTTTTTCAATTTCAATGAGTTTATATATATGTTTTTTTTTTTTTTTGGTCCGCCATGAC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TTCCGCCATTTTCCGCTACGCCATCCGCCATATTTTTATGGCGGATTTTTTACTTTCCGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       CATGAACCGCCATCCGCCATTAACAACATTGATTGAAAATTATGAAGTCATGAGAGGAGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TCATTGAATAAAGAGTGAGAACTTACATGATTTTGTAATTTCTAATAATTTTTTACTATT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       AATAAAGAGTGTATTTAAATGGGTATGTTTTTGAACATTTTTCTAATTTCTAATCGATTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GTAATAATAGCTGGTTATTTGCACTTTCCCAATCATTGAAGTAAAGTTAAACCAGTTCCG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GATAATTTTACAGATAGAATCAACAACACCAGACAAATTTTCACCACGGATAGTTGAAAG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GAAAGAAGACTATATTCGTGTGGAGTACCAAAGCTCAATCTTGGGGGTAAGTGTAACTTA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       CATCTAAGGAAACTCATCATGAAGAAAAATTATCCTTTTATACATTTTAGATGATATCAA 




LJFgene9       ------------------------------------------------------------ 
LJFgene1       GATTCAAGAACCATCTTTAATTTCCTTCTCCCTTTTTTCTGTCATGTGCTAACAGTTTGT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GGATGATGTTGAGTTCTGGTTTCCTCCGGGTAAGGGTTCTACTGTGGAGTATCGTTCTGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       ATCTCGGTTGGGAAACTTTGATTTTGATGTGAACAGAAAAAGAATAAAGGTATGATTCCA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TAATTCATATGTGCTTTCTCTATAGTTAGATAAAGAAATTCTTGGTTCCAGGGTAAAACT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       CCCCTTTCCTTCATGTCATGTGAAGCATTTTTTACTCAAGTAGATCCACTAAATTTGAGT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       CTCAAATGTTTTAACTTTATTCTAAATGTTTTAACTTTATTTGAGTCTCAAATGTTTTAA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       CTGAAGGTAAATTTGGTTAACTATGATCAGAAATACATTAACAAGAGTTGAAGAATATTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TTTATGTACAATAAAGAGAGTATTTGCTCGAGAGAATGTAAATCCTTTTCTAAATATTTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       TGTGATGAAAAATAATGGTTGCTGGCAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       GGCATCTCAAGACACCATATGATGAAAAAACTTAGGCAGAATTCACATCAGCATCTAAGA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       AAATATTGTTTCATATACATTGTAACCTTGTATACTTTTGTATTAGATACAAAATCTCAC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       AAGATCATTGAAAGCAAACTCTTCATGATTATTGGAATTGTAGAAATGATTGAGAACAGT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       ACTTCAAACTCTCGGGGGAAGGAATGAAATGAAGATGTTACCCATATCTTTTTGAACTTC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene1       ATTAATTGGTCCACTTATTTACTCTTTCGCTGAGTTCAATCTAACAATGTAGCATTCTTG 
                                                                             
 
LJFgene9       ---------------------- 
LJFgene1       TTTCAAGAATTTTATGTTGTGT 
                                       
LJFgene9 vs. LJFgene8 
 
LJFgene9       ------------------------------------------------------AGCATT 
LJFgene8       ATTGACTTGAAAGATTCTTGTAGCAATTTGCAGCAGTTTTATATAGATAGTAACATTCTT 
                                                                     *   ** 
 
LJFgene9       GGTTCGCACCTAAGGCACCTTCCCAATTCAGCTTCTAACGATGACACTTTGTAGCACGTT 
LJFgene8       AAATTACGTTTATAAGTTCCTTCATTTTCAGCTCCGAACAATGGCTTCTTCGTTCTCCTT 
                  *  *   **      * * *   ******* * *** *** *   **    * * ** 
 
LJFgene9       TTCCAACTTCAACATTCACAT---ATTAAAAAACAACAAGGG------TTCCTTTTCTCG 
LJFgene8       CTGCACCCTCAAGTTTCGCACCAAACCCAACGATAGTAGAAGCAGTGCTTCCTCTCTTCC 
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                * ** * ****  *** **    *   **  * *  *   *      ***** *  **  
 
LJFgene9       TCGATTTCAACTCTCTCAGAAGCTGGATGACGATAATT------TCATTGATAAAATCAA 
LJFgene8       CCGTATTCTATTCTGTCACAACCTCCACGATGACATTCACACACCCACTGACCAAATCAA 
                **  *** * *** *** ** **  * ** ** * *        ** ***  ******* 
 
LJFgene9       ACGAAGGTTCTCACTGATTCTCCCTTTAATTTGCCACCTCACATGAATTGTATAATATAT 
LJFgene8       CCGAAGGTTC--ACTTCTCCACACTCTCATGCACTTTCTCAC---AGCTTTCTAATTTCT 
                *********  ***  * * * ** * **   *   *****   *  * * **** * * 
 
LJFgene9       ATTTAT-ATTTATGCTTGACCTTGAATTGTTCCTATCTTAAAGAGAGCTCATACTGGAAA 
LJFgene8       ATTGATTATTCATAATTATTCATGCATA---CCCATCTTCTGAAATCTCTTTACACGTCA 
               *** ** *** **  **   * ** **    ** *****    *       ***  *  * 
 
LJFgene9       GTGGAGAATTAGCAACCATTGGTGCCATCTTCAACTTTAGGTACACTGCT-TTATTGTTT 
LJFgene8       ATGATTTTGTATCTTAAAGACAACTCATATTGAGAAGCAGCGAAATAGCGACCATCGGTG 
                **      ** *    *       *** ** *     **  * *  **    ** * *  
 
LJFgene9       TCACAAT-GAGAATAGGTGACCAAAATTTAATTAATTCTTATAATATTTGAAAATATTTC 
LJFgene8       CCATCTTCGACTTCAGGTACCCCCGGCCC------CTCCTCTGTTTTTTAGAAATTTTTC 
                **   * **    ****  **              ** * *  * ***  **** **** 
 
LJFgene9       GAGAAATTTTATGTAAAATTAACTCTTTTTCTTTAAGATTT-ATGTGATTACTTCATAGC 
LJFgene8       TTTTCATTTTATTTTGAACGTAAA--TTTAATTCAAGATTTGATTTTGTTAGTGAGTAGT 
                    ******* *  **   *    ***  ** ******* ** *  *** *   ***  
 
LJFgene9       AAATTCTTGTCAAGTTTTAAGAACTTTTGAGTTTTG------ATGTGTGTTTTCTATTGG 
LJFgene8       GAGACCCTTTTGGTTTTTAGTATTAGTTTTGTTTTGTATTGAAAATGGGTAGTTATTAAA 
                *   * * *    *****  *    **  ******      *  ** **  *   *    
 
LJFgene9       AAATATGTGGGGATATATTATTTTGGATTTTATGCTTCTT--TGCAGAGGCAAAAAGCCA 
LJFgene8       AAAGAGGGTATTGTGTGTTTTTTTTTTTTTTTTTTTTTGTGGTGCAGTGGGAAAAAACCT 
               *** * *      * * ** ****   **** *  **  *  ***** ** ***** **  
 
LJFgene9       GATTATCTTGGAGTGCAGAAAAATCAACCGGCATTAGCACTATGTCCGGCAACTAAGAAC 
LJFgene8       GATTATCTTGGAGTGCAGAAAAACCCACCAGCTTTAGCTCTGTGTCCGGTAACTAGGAAC 
               *********************** * *** ** ***** ** ******* ***** **** 
 
LJFgene9       TGCATATCGACATCTGAAAATGTCACTAACCTCACACATTACACTCCTCCTTGGTGAAA- 
LJFgene8       TGCGTATCAACCTCTGAGAATATCAGTGATCGCACTCATTATGCTCCTCTTTGGTAAAAA 
               *** **** ** ***** *** *** * * * *** *****  ****** ***** ***  
 
LJFgene9       -TTTCCTTCTTTATTT--TTTTATTT-------------------------ATTAAAGTT 
LJFgene8       CTTTCCTTGTTTTCCTCATTTTAATTTTAGCCTTCCTTTTCAAACCGCCAAGTTAATTTT 
                ******* ***   *  ***** **                          ****  ** 
 
LJFgene9       TTAACTTTG-GTTTATGATATTATCTGAATC--TGAATTGGCTGCAAAGCCT-----GCA 
LJFgene8       TTAACCGTGTATTGGTGGTTTTTTTTTGGTCCTTGAATGATACATAGGATTTTTCAAATA 
               *****  **  **  ** * ** * *   **  *****       *     *       * 
 
LJFgene9       ATTTGTT-----ATTGAATATAT------------ATTGTTGTTGA-------------- 
LJFgene8       ATTGGTTCAAAGACTAATTATATTTATAATATGTGATTGTAGTTGGTCAAAGGGGAAATT 
               *** ***     * * * *****            ***** ****                
 
LJFgene9       GTTTAATTTT-ACACTGAATAA----CTTTTAAAATAATTATTATAAAAATCAA--TAAA 
LJFgene8       GTTTGATTTTTATCATGTATAAAATGTTTTTGGACCAATAATAATAACAAATAAAATAAG 
               **** ***** *   ** ****     ****  *  *** ** **** **  **  ***  
 
LJFgene9       ATTATTATCTATATAAAAAATATGATTAGATGATAAAGTA-------------------- 
LJFgene8       ATTAATTTTTAACTCAATTGGTTGATTAAGAGTAAAAATATTTGTGATCTCTCATCAAAA 
               **** * * **  * **     ******   *  *** **                     
 
LJFgene9       ----AAACTTTTGTATGGTATTAATACATGAATTATTTTTT-----------------GT 
LJFgene8       TAAAAAAATTTCTCTTCATTTTAAAACAAAAATCACATCTTTAAAATTTAAAAGTCAGGT 
                   *** ***    *  * **** ***  *** *  * **                 ** 
 
LJFgene9       CCAGAATT-------------------------------TTTCAGATTGTCATAAATTTG 
LJFgene8       CCACACTTAAGATACTTAACTTAAACATAGGTACTCAAACCAAAAATTTTCAAATATGTG 
               *** * **                                   * *** *** * ** ** 
 
LJFgene9       CATTTTGATAAAGTGTATAATTCACTC--AATTTCAAAATAA-CTGACTTTTTAACACCA 
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LJFgene8       AGATCCCACACAAATTTTTATTTATTAGAAATCTTAAAATAAATTAAATGTTTATCAGGA 
                  *   * * *   * * *** * *   *** * *******  * * * **** **  * 
 
LJFgene9       ATTTGGCAAAATGTT-GCTTATG---GAACAATTTAATTAATTATCACATTT-TAAAACC 
LJFgene8       ATTTGAATGTATTTTAGCCTATTTTCGAACAAGGTTTTATCATACAAAATTTATGGATCC 
               *****     ** ** ** ***    ******  *  *    **  * **** *  * ** 
 
LJFgene9       ATTGAAAGTTCAATTGGTG-TTGCCGTG--TTGGGCGC----ATTGAGCCCTTAACTTAG 
LJFgene8       AACAAAATAAAAATAAGAAATTGTCATGGCTTGGTTTCCAAAACTGAACCTCATGTTCAA 
               *   ***    ***  *   *** * **  ****   *    * *** **      * *  
 
LJFgene9       GAA-ATGTATTATCTCATGTTGAATTTGCTTTTTTTTTTTTTTTTATTTCTCTTCAGCTA 
LJFgene8       GAACACGTGGAAGCACAACTGCAGCTTTGTCTTAGCTCATCATCAAGCGCCAGTTAGCAA 
               *** * **   * * **  *  *  **  * **   *  *  *  *   *   * *** * 
 
LJFgene9       AGTTCCG-AGCATTGAGCCTTTAACTTAGGAAATGTATTAT-CACATGTTGGGTATAGAT 
LJFgene8       TATTTTGCGGGAATAGACAATGAGACCAAAACCTTCATCATGCACAAGTCTATTTTAGTT 
                 **  *  * * *   *  * *    *  *  *  ** ** **** **    * *** * 
 
LJFgene9       -TATTAA--TTAAGAGAACATTGATTATTCTACAGG-AACTACAATCCTGAAGGTAGGAA 
LJFgene8       GCACTAGGGTTTTGGAGCCTTTCACAAGACCAAAACTAGATACGATTCATGCTAAAATAA 
                 * **   **  *    * ** *  *  * * *   *  *** ** *       *  ** 
 
LJFgene9       AGATCATG----TGAGCAAAGAGGCAATGGAGGAACTGATAGATGTGGTAATTTTAATTA 
LJFgene8       AGCCTAAAGCCTTTTGGAATTATTCACAGCAAAATCCGATGTTGACATCAACCATATGTA 
               **   *      *  * **  *  **  * *  * * ***         **   **  ** 
 
LJFgene9       GGATCATGTTAAGTCTTAAGCT------ACTTAGTTAAAGAATCAATAAACAATTTTTTT 
LJFgene8       ACATTATAATATATTACTAGCCTTTAAAATTCAATTCCACATTCAACAAAATTTATTACC 
                 ** **  **  *    ***       * * * **  * * **** ***   * **    
 
LJFgene9       AGGAAATCACGTGATTAATTACATTAGAAATCACA--GTTACACTGGCAATACTGT---- 
LJFgene8       CTGTTCTCTCTACACTACGCA-ATTAGAAAACAAAAGGTTGAGCGGAGAAAAATCTAGAA 
                 *   ** *   * **   * ******** ** *  ***   * *  ** * * *     
 
LJFgene9       --TATATAAAAACT------ATTTATTTTAAATTGGTTGA-CTAGTATCT-----TAAGA 
LJFgene8       AGTGCTTAGAAATTCAACTAAATTTTGTCAAACAGGACGAGCCAATAAATACGATTAATG 
                 *   ** *** *      * ** * * ***  **  ** * * **  *     ***   
 
LJFgene9       ACACTTATTAAAAAAGTGTATTG--AGTTTTTGTAT-----CTCAATAGGAGTATAATTA 
LJFgene8       ACAGCTACGAGAAATGTATATTTTTAGTTTAGAAACACGTCTTTAGTTATATCATAACAA 
               ***  **  * *** ** ****   *****    *       * * *   *  ****  * 
 
LJFgene9       AGACTATTTATAGTTGGTTTGTTATAGCTACTGATGAGTTTTCAAATCATTAAAGTTACA 
LJFgene8       AAAATAAAAATTAAAGTTGTGTTTAAATATATGTTTTATTTAAAAAAATTAAAAATTAGG 
               * * **   **    * * ****  *     ** *   ***  ***   * *** ***   
 
LJFgene9       AAAATCAGTTACTATTGTT--TTTTATTTTACAGATA-GAATCGACA-ATACTACCAGAA 
LJFgene8       AAATTGTGTTTTAATTCATGACTTTAAGTTAAAGTCACGAATTAAAAGATGGCTTTAATA 
               *** *  ***   ***  *   ****  *** **  * ****  * * **      *  * 
 
LJFgene9       AATTTTACACCAAGGATTGTAGAAAGAA-------CAGAAGAT-TATCTTAGATTGGAAT 
LJFgene8       AAAGTAAATTTAAAAAATAAATAAAGAAGTCATGTTTGAAAATATACCTTTCGTTGAAAT 
               **  * *    **  * *  * ******         *** ** ** ***   *** *** 
 
LJFgene9       ACCAAAGTGT----ATACAAGCCACAAATTT--TAACTTC--------AATGTCACCAAT 
LJFgene8       GTTGTGCTTTTAAAACACAACTTGCTCATTTATTGATTTTTTAAAAATAAATTTACCTAT 
                      * *    * ****    *  ****  * * **         **  * *** ** 
 
LJFgene9       ATCA-----TTGTATGCAGAAAAAATGAA------TAGTAACT---TTTTACTATTAGAC 
LJFgene8       TTTGGGATTTTTTTTTTATAAAAAATGCACCACTCTAGTAAGTAAACCTTTTTTTTATAT 
                *       ** * *  * ******** *      ****** *     **  * *** *  
 
LJFgene9       TGAAAAGCCTGCATCAAGC--ATTGAAGGAATGGAGTTTCT-TTGAT-CATTGGACTGCC 
LJFgene8       ATAAAAAATTGCATTCAGGTAAACAACATAATTAAGTGTTTACTGATTCATTGAAACACT 
                 ****   *****  **   *   *   ***  *** * *  **** ***** *   *  
 
LJFgene9       CATCTCATAGTAACTCATCT--TGAAGCAATTAATGCAGTAAAA--ACTAACTCATCGTG 
LJFgene8       TATGTATAAGTTGTTTATGTGATTGAAGAGAAAATAAAGTTAAATTATTTTCTTATAAAT 




LJFgene9       AAAAGTTCATTCTC-TGCTTTATTTAAATTTT--TACAGCAAGTAGATTGGAATGCATGG 
LJFgene8       TGTAATATGTTTTCATGAGCTATGGAAAGTTTATTGAAATAAACTGAAAATAGATTGTGG 
                  * *   ** ** **   ***  *** ***  *  *  **   **    *     *** 
 
LJFgene9       TTTTTGCCATGTTTTATACTTGACAAAGATAATGCAAACTATAAACACAAGCAGCGGAGC 
LJFgene8       ATATTTCATAAATACATATCTTAAAATTATTTTAAATATTCCAAACACTTATATAAATAC 
                * ** *     *  ***  * * **  **  *  * * *  ******    *      * 
 
LJFgene9       TGGTATGCACTTG-GTTTGAGATAGGATAATGATATATTG-------------------- 
LJFgene8       TA-TAAGCACTTGTAATAGAAGAAAGATAAGAATGTAAAATAAATTGATTTTTTTTCCAT 
               *  ** *******   * **   * *****  ** **                        
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       AAGTTGATTTAAGTTAAAATCAACTTATGTATCATAACACCTCAGGTTTTGAAAAAGTTA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       AATGAGAGAGTTTTTAACAAAGTTAAGTGTATAAGTTAAATTTAAGAGAAAAACACAATT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TATTCTACCTTTTCTTTTCCCCATTTGTAATTGTTTATGGCCAATTTGATCCAAACAACA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TCTTTAGCCTAAATAAGCTCTTCCAATCACACTCTAAGTTTAAGTATGATTACTATGATG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TTTAGATTTCATTGTGTTGTTTTTTATGACCTTAATTTTCCGTCGAGTAACGCCATATTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       GAATTAAAGTTTGTAAATTTTAGATGAAATTCATTTTGCAAACTGAATTTGTAAAATCAA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       CTCTTCCTTTACTTCCAAAATCCAAACTTTATTATTGGACAAAGATGAATCGTGGAGTTA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       CTTTGTTTTAAATTTTTAATTTTAATTATTGTTCAGGAACTACAATCCTGAAGGTAGGAA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       AAACCCTGTGAGCAGAGAAGAGGCAATGGAGGAACTGATAGACGTGGTAATAAATCTAGC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TGAAATCATAAGTTATTTTCATGAATGCATTGCAATTTCCCTTTCCTAGCCTGTGTATCA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       ACAAATGTTATTATTTATAATAAGTTTAATTTTCATGCACTGACCGTATATAATAATTTT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       ATATTGATATCTAATCATAAATCATCATTTAAATTATTTTAAGATAATTAATTTAAAAGT 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TAATAAATTTACCGTATATAATGAATTATAATTGAATAATTGTATAAAAAATTTATAATG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TCACTGTATAATTCTTTTTCTCATTTATAATTTGGTTGTAAGTTGTAGCTTGTAATAGCA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       GGTTATTTACCTTTTTCCAATCATTGAAGTAAAGTTAAAATCCAGCTCTGGATAATTTTA 




LJFgene9       ------------------------------------------------------------ 
LJFgene8       TAGATAGAATCAACAACACCAGACAAATTTACACCACGAATAGTTGAAAGGAAGGAAGAC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TATATTCATGTGGAGTACCAAAGCTCAATCTTGGGGGTATGTGTAACTTACATCAAAAGG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       AAACTCATCGTGGAGAAAAATAATAATTTTGTACATTTTAGATGATAATCAAGAACCATC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TCTAATCCCTTCTCCCCTCCTTTTTATTTTTTCTGCCATGTGCTAGCAGTTTGTGCATGA 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       TGTTGAGTTCTGGTTTCCACTGGGTAAGGGTTCTACTGTGGAGTATCGATCTGCATCTCG 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       GTTGGGGAACTTTGATTTTGATGTGAATAAGAAAAGAATAAAGGTATGTTTGTATCATTC 
                                                                             
 
LJFgene9       ------------------------------------------------------------ 
LJFgene8       CTTTGTGCTGTCTCGGTAGTTAACATGAAGAAATGATTAAAAGATATTTTGTCCTTTAGG 
                                                                             
LJFgene9       ----------------------------------------------------------- 





















LJFgene3 plus 1000nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 





LJFgene3 plus 1000nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 
LJFgene8 plus 1000nt extension from both 5’ and 3’ gene model boundaries (y-axis) 
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LJFgene1 plus 1000nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 





LJFgene14 plus 2200nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 
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LJFgene14 plus 2200nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 
LJFgene1 plus 2200nt extension from both 5’ and 3’ gene model boundaries (y-axis). 




LJFgene14 plus 1000nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 
LJFgene8 plus 1000nt extension from both 5’ and 3’ gene model boundaries (y-axis)	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LJFgene1 plus 1000nt extension from both 5’ and 3’ gene model boundaries (x-axis) vs. 
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n101401_S.      ------------------------------------------------------------ 
Pp1s10_47V      --------------MPPILVLASSFTGSKLHIPSALQDKVSISEVSNASPGIIVCQQKED 
LJFgene3        MSISSLIFSNLHFQLPTTMASMASSSSFCN-LKFITKPNN-GRR--SSLPRIVFCQKHHD 
LJFgene1        ------------------MASMASSSSFCN-LKFITKPNNNGRTNASSLPRIVFCQKHND 
LJFgene14       ------------------------------------------------------------ 
Phvul.010G      ------------------MASLIPSSSFCSYLKVCTKPSN-GRISASSFPRILCCQKHHH 
LJFgene8        ---------------------MASSFSFCT-LKFRTKPND-SRSSASSLPRILFCHNLHD 
Medtr4g023      ------------------MASTSSSTTFCNLKFHSTRPNN---NNVSFLPRILHMKQEEE 
LJFgene9        ------------------------------------------------------------ 
AT3G60810.      ------------------MASMASPTTCLYHHKCRRKLVFYARRISASIPETSYDKHP-- 
LOC_Os03g6      ----------------------MAPPPPCCVLVVRCCSGSLPSPPPPPPPRPSPSNNLR- 
Cre11.g468      ---------------------MLQAQKRVVFGQAQRRSAVA-VVRTAPVARRMVCQAANW 
Vocar20006      ---------------------MQLQRSPCSRAVAQRKCALKPAMRIAAPALQVACQAGRW 
Pp1s223_13      ------------------MMPIPHACAAPWQRNCHRIVASIPAAEGSSFPKIAAGSVGAQ 
                                                                             
 
n101401_S.      -------------------------------------S-GTRPDYLGIQ----KNPPSLA 
Pp1s10_47V      EQVSGQIRKEAVAAKISRRETILRSSGSALMLAFFNFA-GERPDYLGVQ----SNPPSLA 
LJFgene3        ST---------PTDQINRRELILRSSEIATIGAILNFG-GKKPDYLGVQ----KNPPALA 
LJFgene1        DT---------PTDQINRRELILRSSEIATIGAIFNFG-GKKPDYLGVQ----KNPPALA 
LJFgene14       ---------------------------MGGLGFVFWWCSGKKPDYLGVQ----KNPPALA 
Phvul.010G      DV---------PTDQINRRELILRSSEIATIGAIFNLS-GKKPDYLGVQ----KNPPALA 
LJFgene8        DIHT-------PTDQINRRQLILRSSEIATIGAIFDFS-GKKPDYLGVQ----KNPPALA 
Medtr4g023      DN---------NTNQINRRQLILRSSEIATIGAIFNFS-GKKPEYLGVQ----KNSSALA 
LJFgene9        ----------------------------ATIGAIFNFR-GKKPDYLGVQ----KNQPALA 
AT3G60810.      -------------KLIGRRDIILRSSELAMIGAIFQLS-GKKPDYLGVQ----KNE-RLA 
LOC_Os03g6      ---------------IARREFVLRSSELATLAAIFHLS-GTKPRYLGVQ----KSPPSLA 
Cre11.g468      K--------GDSEEKLQPKEIVLRSVNVMVLGALLSIGAAPRPGNLGIIDY-GAGVQTLN 
Vocar20006      QA-------GENDEKLQPKEVILRSVNMAVVAALLTIGAAPRPSNLGIQDY-GAGIQTLS 
Pp1s223_13      ESNQKIN--ILLAGVVSAAVCVNVSLQGCAVAASTNVPNNGRTWFPWEQTTPEQFEPEQG 
                                                         :.                  
 
n101401_S.      LCPPTPNCISTSE-EANDPSHYVPPWTYNPEDGRGRKN-PATREQAMKELLAVISSTK-P 
Pp1s10_47V      LCPPTPGCISTSE-ELNDPTHYVPPWTYNPPDGRGRKN-PASKEKAMAELIDAIKSTK-P 
LJFgene3        LCPATKNCVSTSE-NISDRTHYAPPWNYNP---EGRKK-PVNREEAMEELIDVIESTT-P 
LJFgene1        LCPATKNCVSTSE-NISDRTHYAPPWNYNP---EGRKK-PVSREEAMEELIDVIESTT-P 
LJFgene14       LCPPTKNCVSTSE-NISDRTHYAPPWNYNP---EGRKK-PVSREEAMEELIDVIESTT-P 
Phvul.010G      LCPATKNCVSTSE-NISDRTHYAPPWNYNP---EGRKN-PVSKEEAMEELIDVIESTT-P 
LJFgene8        LCPVTRNCVSTSE-NISDRTHYAPLWNYNP---EGRKN-PVSREEAMEELIDVIESTT-P 
Medtr4g023      LCPATKNCVSTSE-NVNDLTHYAPPWNYNP---EGRKS-PVSREEAVEELIEVIELTR-P 
LJFgene9        LCPATKNCISTSE-NVTNLTHYTPPWNYNP---EGRKD-HVSK-EAMEELIDVIESTILP 
AT3G60810.      LCPATNNCISTSE-NISDRVHYAPPWNYN----GGRKT-PVNRQVAMKELLNVIKSVK-P 
LOC_Os03g6      LCPATNNCVSTCE-DITDSIHYAPPWNYNPK--DGRRAKPITKHEAINQLIQVVTQTK-P 
Cre11.g468      LCPPSPNCIATSE-EGNDRTHYAPPLTYNPEDGRGKKG-PASQEKAMGELVEAVKKLK-P 
Vocar20006      LCPSTPNCIATSE-EGNDREHYAPPLTYNPQDGRGRKN-PATQEQAMAELVSVVKTLQ-P 
Pp1s223_13      TCSTCIGVVDDTLGSCSATTNCVSSFDDRPSFFTAPWEFPGSLRAAVSNLQEALEGSG-- 
                 *.   . :     . .   : ..    .     .      .   *: :*  .:       
 
n101401_S.      ENYTPNIVKNTDDYVYVEYQSPYLGFVDDVEFWFP-PGNRSLVEYRSASRVGSS-DFDAN 
Pp1s10_47V      DNFTPRIVKQTDDYVYVEYSSPLVGFVDDVEFWFP-PGNRSLVEYRSASRRDAI-DFGFN 
LJFgene3        DKFSPRIVERKEDYIRVEYQSSILGFVDDVEFWFP-PGKGSTVEYRSASRLGNF-DFDVN 
LJFgene1        DKFSPRIVERKEDYIRVEYQSSILGFVDDVEFWFP-PGKGSTVEYRSASRLGNF-DFDVN 
LJFgene14       DKFSPRIVERKEDYIRVEYQSSILGFVDDVEFWFP-PGKGSTVEYRSASRLGNF-DFDVN 
Phvul.010G      DKFTPRIVERKEDYIRVEYQSSILGFVDDVEFWFP-PNKGSTVEYRSASRLGNF-DFDLN 
LJFgene8        DKFTPRIVERKEDYIHVEYQSSILGFVHDVEFWFP-LGKGSTVEYRSASRLGNF-DFDVN 
Medtr4g023      DKFTPKIVERKEDYVRVEYRSSILGFVDDVEFWFP-PGKGSIVEYRSASRLGNF-DFDVN 
LJFgene9        ENFTPRIVERTEDYLRLEYQS-----VYKPQILTS-MSPISLYAEKMNSNFLLL-D---- 
AT3G60810.      DKFTPRIVEKKDDYVHVEYESPILGLVDDVEFLFT-PGKNSKVEYRSASRKGNF-DFDVN 
LOC_Os03g6      DNFTPRLVEKTDDYVRVEYESPIFGFVDDVEFWFP-PGNKSIVQYRSASRSGFI-DFNAN 
Cre11.g468      DGFTPKIIKQTDDYLYVEYESPLMGFIDDVEFWFK-PGPGSRVEYRSASRVGES-DGNIN 
Vocar20006      DGFTPKIIKQTPNYLYVEYESPIMGFIDDVEFWFK-PGPGARVEYRSASRVGES-DGNIN 
Pp1s223_13      ----AFIKEKSDRYIYAVFKGD-DGVSDDVEFLFSDPSVDATVNVRSASRAKDYKDSGRN 
                    . : :..  *:   : .       . ::     .  :    :  *.     *     
 
n101401_S.      RKRIRALRKALEKKGWQSIGF---------------------------------- 
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Pp1s10_47V      RKRIKALRQALERYGWESIGF---------------------------------- 
LJFgene3        RKRIKALRQELEKKGWASQDTI--------------------------------- 
LJFgene1        RKRIKALRQELEKKGWASQDTI--------------------------------- 
LJFgene14       RKRIKALRQELEKKGWTSQDTI--------------------------------- 
Phvul.010G      RKRIKALRQELEKKGWASEDTI--------------------------------- 
LJFgene8        KKRIKVC---LYHSFVLSR------------------------------------ 
Medtr4g023      RKRIKALRQELEKKGWASQDTTI-------------------------------- 
LJFgene9        ------------------------------------------------------- 
AT3G60810.      RKRIKALRQELEKKGWVSENSF--------------------------------- 
LOC_Os03g6      KKRVKALRLALENKGWASESTI--------------------------------- 
Cre11.g468      RKRIKAIRQELETKGWRSTGF---------------------------------- 
Vocar20006      RKRIRAIRQELEKEGWRSTGF---------------------------------- 
Pp1s223_13      RKRLEALRMELGWEQVPILRNRQRRLFFIESPWDTFGPEPPPTIDYKNGIDFVPD 
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n101401_S.    ------------------------------------------------------------ 
Pp1s10_47V    ------------------------------------------ATGCCTCCCATCTTGGTT 
LJFgene3      ATGTCCATAAGTTCCTTAATTTTCTCGAACCTTCATTTTCAGCTCCCAACAACAATGGCT 
LJFgene1      ------------------------------------------------------ATGGCT 
LJFgene14     ------------------------------------------------------------ 
Phvul.010G    ------------------------------------------------------ATGGCT 
LJFgene8      ------------------------------------------------------------ 
Medtr4g023    ------------------------------------------------------ATGGCA 
LJFgene9      ------------------------------------------------------------ 
AT3G60810.    ------------------------------------------------------ATGGCT 
LOC_Os03g6    ------------------------------------------------------------ 
Cre11.g468    ------------------------------------------------------------ 
Vocar20006    ------------------------------------------------------------ 
Pp1s223_13    ------------------------------------------------------ATGATG 
 
n101401_S.    ------------------------------------------------------------ 
Pp1s10_47V    CTTGCTTCGTCCTTCACTGGTTCCAAACTCCACATACCATCCGCACTTCAGGATAAGGTT 
LJFgene3      TCAATGGCATCTTCAAGCTCCTTCTGCAAC---CTCAAGTTCATCACCAAACCCAACAAT 
LJFgene1      TCAATGGCATCTTCAAGCTCCTTCTGCAAC---CTCAAGTTTATCACCAAACCCAACAAC 
LJFgene14     ------------------------------------------------------------ 
Phvul.010G    TCACTGATACCTTCAAGCTCTTTCTGTAGCTATCTCAAGGTTTGCACCAAACCCAGCAAT 
LJFgene8      ---ATGGCTTCTTCGTTCTCCTTCTGCACC---CTCAAGTTTCGCACCAAACCCAACGAT 
Medtr4g023    TCAACATCATCTTCAACCACATTCTGCAACCTCAAGTTTCACTCCACACGACCCAACAAC 
LJFgene9      ------------------------------------------------------------ 
AT3G60810.    TCCATGGCGTCACCGACCACTTGCTTGTACCACCACAAATGCCGGAGAAAACTTGTTTTC 
LOC_Os03g6    ------ATGGCGCCGCCGCCGCCGTGTTGTGTGCTAGTGGTACGCTGCTGTTCCGGATCC 
Cre11.g468    ---ATGCTGCAGGCCCAGAAGCGTGTTGTGTTTGGCCAGGCCCAGCGCCGCAGCGCTGTT 
Vocar20006    ---ATGCAGCTTCAGAGGTCTCCGTGCAGCAGGGCCGTCGCCCAGCGCAAGTGCGCATTA 
Pp1s223_13    CCAATTCCGCATGCATGTGCTGCCCCTTGGCAGCGGAATTGTCATCGCATTGTAGCGTCC 
 
n101401_S.    ------------------------------------------------------------ 
Pp1s10_47V    TCTATTTCTGAGGTTTCCAATGCTTCTCCTGGTATTATCGTATGTCAACAAAAAGAAGAT 
LJFgene3      ---GGTAGAAGA------AGCTCTCTTCCCCGTATTGTATTCTGTCAGAAGCACCACGAT 
LJFgene1      AATGGTAGAACCAATGCTTCTTCTCTTCCCCGTATTGTATTCTGTCAGAAGCACAACGAT 
LJFgene14     ------------------------------------------------------------ 
Phvul.010G    ---GGTAGAATCAGTGCTTCCTCTTTTCCTCGCATTCTCTGCTGTCAGAAGCACCACCAT 
LJFgene8      ---AGTAGAAGCAGTGCTTCCTCTCTTCCCCGTATTCTATTCTGTCACAACCTCCACGAT 
Medtr4g023    ---------AACAATGTTTCCTTTCTTCCTCGCATTCTTCACATGAAACAGGAGGAGGAG 
LJFgene9      ------------------------------------------------------------ 
AT3G60810.    TATGCCCGTCGTATCAGTGCCTCGATTCCAGAGACTTCATATGACAAACATCCG------ 
LOC_Os03g6    CTCCCTTCGCCGCCGCCGCCGCCGCCGCCCAGACCCTCTCCCTCCAACAACCTCAGA--- 
Cre11.g468    GCC---GTTGTTCGCACTGCCCCTGTGGCTCGCCGCATGGTCTGCCAGGCGGCCAACTGG 
Vocar20006    AAGCCCGCGATGCGCATTGCTGCACCGGCGCTGCAGGTGGCGTGCCAGGCTGGGCGTTGG 
Pp1s223_13    ATTCCAGCCGCAGAGGGTTCAAGCTTCCCGAAGATTGCTGCAGGTAGTGTAGGAGCACAG 
 
n101401_S.    ------------------------------------------------------------ 
Pp1s10_47V    GAACAGGTATCAGGGCAAATACGGAAAGAGGCTGTGGCTGCAAAGATATCACGAAGAGAA 
LJFgene3      AGCACA---------------------------CCCACCGACCAAATCAACCGAAGAGAA 
LJFgene1      GACACC---------------------------CCCACCGACCAAATCAACCGAAGAGAA 
LJFgene14     ------------------------------------------------------------ 
Phvul.010G    GATGTT---------------------------CCCACCGACCAAATCAACCGAAGAGAA 
LJFgene8      GACATTCACACA---------------------CCCACTGACCAAATCAACCGAAGACAA 
Medtr4g023    GACAAC---------------------------AACACCAACCAAATCAATCGAAGACAA 
LJFgene9      ------------------------------------------------------------ 
AT3G60810.    ---------------------------------------AAGCTAATTGGTCGAAGAGAT 
LOC_Os03g6    ---------------------------------------------ATCGCCAGAAGAGAG 
Cre11.g468    AAG------------------------GGCGACAGCGAGGAGAAGCTCCAGCCCAAGGAG 
Vocar20006    CAGGCG---------------------GGCGAGAACGATGAGAAGCTCCAACCCAAGGAA 
Pp1s223_13    GAAAGTAATCAGAAGATTAAT------ATCCTGCTGGCTGGTGTGGTGAGTGCCGCCGTG 
 
n101401_S.    ---------------------------------------------------AGT---GGA 
Pp1s10_47V    ACAATTTTGAGATCTAGTGGTTCCGCGCTGATGTTGGCCTTCTTCAACTTCGCC---GGC 
LJFgene3      CTCATATTGAGAAGCAGCGAAATAGCGACCATTGGTGCCATCTTGAACTTCGGT---GGG 
LJFgene1      CTCATATTGAGAAGCAGTGAAATAGCGACCATTGGTGCCATCTTCAACTTCGGT---GGG 
LJFgene14     ---------------------ATGGGTGGTTTGGGTTTTGTGTTTTGGTGGTGCAGTGGG 
255 
 	  
Phvul.010G    CTCATATTGAGAAGCAGTGAAATAGCGACCATTGGTGCCATCTTCAACCTCAGT---GGA 
LJFgene8      CTCATATTGAGAAGCAGCGAAATAGCGACCATCGGTGCCATCTTCGACTTCAGT---GGG 
Medtr4g023    CTCATATTGAGGAGCAGTGAAATAGCAACGATTGGTGCCATCTTCAATTTCAGT---GGG 
LJFgene9      ------------------------GCAACCATTGGTGCCATCTTCAACTTTAGA---GGC 
AT3G60810.    ATCATTCTTAGGAGCAGTGAATTAGCTATGATCGGAGCCATATTCCAGCTTAGT---GGG 
LOC_Os03g6    TTTGTGCTGAGGAGCAGTGAGCTCGCCACGCTCGCTGCCATCTTCCACTTGAGC---GGC 
Cre11.g468    ATTGTGCTCCGCTCCGTGAACGTTATGGTTCTGGGCGCGCTGCTGTCCATCGGCGCGGCC 
Vocar20006    GTCATCCTCCGGTCCGTGAACATGGCCGTCGTGGCCGCGCTCCTGACAATCGGAGCTGCT 
Pp1s223_13    TGTGTCAACGTGAGCCTCCAGGGGTGCGCTGTGGCAGCCAGCACTAATGTGCCCAACAAT 
 
n101401_S.    ACGCGACCTGACTATCTTGGAATACAA------------AAAAATCCGCCGTCCCTTGCG 
Pp1s10_47V    GAAAGACCAGACTACCTAGGTGTACAG------------TCGAACCCACCGTCTCTTGCA 
LJFgene3      AAAAAACCTGATTATCTTGGAGTGCAG------------AAAAACCCACCAGCATTAGCT 
LJFgene1      AAAAAACCTGATTATCTTGGAGTGCAG------------AAAAACCCACCAGCATTAGCT 
LJFgene14     AAAAAACCTGATTATCTTGGAGTGCAG------------AAAAACCCACCAGCATTAGCT 
Phvul.010G    AAAAAACCAGATTATCTTGGAGTGCAG------------AAAAACCCACCAGCATTAGCT 
LJFgene8      AAAAAACCTGATTATCTTGGAGTGCAG------------AAAAACCCACCAGCTTTAGCT 
Medtr4g023    AAGAAGCCTGAATATCTTGGAGTTCAG------------AAAAACTCATCAGCATTGGCT 
LJFgene9      AAAAAGCCAGATTATCTTGGAGTGCAG------------AAAAATCAACCGGCATTAGCA 
AT3G60810.    AAAAAACCAGATTATCTAGGAGTACAA------------AAGAACGAG---AGATTGGCT 
LOC_Os03g6    ACGAAGCCAAGGTACCTGGGCGTGCAG------------AAGAGTCCTCCATCGCTGGCT 
Cre11.g468    CCTCGCCCGGGCAACCTGGGCATCATCGACTAC---GGCGCAGGCGTGCAGACCCTGAAC 
Vocar20006    CCGCGTCCTAGCAATCTTGGCATTCAGGATTAC---GGCGCCGGTATCCAGACGCTGTCT 
Pp1s223_13    GGCCGGACGTGGTTTCCGTGGGAGCAGACCACGCCGGAGCAATTTGAGCCAGAGCAAGGC 
 
n101401_S.    CTGTGCCCTCCAACTCCGAATTGCATTTCAACCTCTGAA---GAAGCAAACGATCCATCT 
Pp1s10_47V    CTGTGCCCACCAACTCCTGGTTGTATCTCCACCTCAGAG---GAGCTGAACGACCCCACC 
LJFgene3      CTGTGCCCGGCAACGAAGAATTGCGTGTCAACCTCTGAG---AATATCAGTGATCGCACA 
LJFgene1      CTGTGTCCGGCAACTAAGAACTGCGTGTCAACCTCTGAG---AATATCAGTGATCGCACA 
LJFgene14     CTGTGTCCGCCAACTAAGAACTGCGTGTCAACCTCTGAG---AATATCAGCGATCGCACA 
Phvul.010G    CTGTGTCCAGCAACAAAGAACTGTGTATCAACCTCTGAG---AATATCAGTGATCGCACG 
LJFgene8      CTGTGTCCGGTAACTAGGAACTGCGTATCAACCTCTGAG---AATATCAGTGATCGCACT 
Medtr4g023    CTGTGTCCAGCAACTAAGAATTGTGTATCAACCTCTGAG---AATGTCAATGATCTCACC 
LJFgene9      CTATGTCCGGCAACTAAGAACTGCATATCGACATCTGAA---AATGTCACTAACCTCACA 
AT3G60810.    CTATGTCCTGCCACTAATAACTGTATCTCCACTTCTGAG---AATATCAGTGATCGAGTG 
LOC_Os03g6    CTGTGCCCTGCCACCAACAATTGCGTTTCCACTTGTGAG---GACATCACTGACTCCATT 
Cre11.g468    CTGTGCCCTCCCTCGCCCAACTGCATTGCCACCTCCGAG---GAGGGCAACGACCGCACC 
Vocar20006    CTCTGCCCGTCTACCCCCAACTGCATCGCGACATCGGAG---GAGGGCAATGACCGCGAG 
Pp1s223_13    ACCTGCTCCACATGCATCGGCGTTGTGGATGACACTTTGGGGTCTTGCAGTGCCACCACC 
 
n101401_S.    CACTACGTACCTCCGTGGACGTATAATCCAGAAGATGGACGTGGAAGAAAAAAC---CCC 
Pp1s10_47V    CATTATGTTCCTCCATGGACGTACAATCCTCCAGATGGCCGTGGTCGGAAGAAC---CCT 
LJFgene3      CATTATGCTCCTCCATGGAACTATAATCCT---------GAAGGTAGGAAAAAA---CCT 
LJFgene1      CATTATGCTCCTCCATGGAACTATAATCCT---------GAAGGTAGGAAAAAA---CCT 
LJFgene14     CATTATGCTCCTCCATGGAACTATAATCCT---------GAAGGAAGGAAAAAA---CCT 
Phvul.010G    CATTATGCTCCTCCTTGGAACTATAATCCT---------GAAGGCAGGAAAAAT---CCT 
LJFgene8      CATTATGCTCCTCTTTGGAACTACAATCCT---------GAAGGTAGGAAAAAC---CCT 
Medtr4g023    CATTATGCTCCTCCTTGGAACTATAATCCT---------GAAGGCAGGAAAAGT---CCA 
LJFgene9      CATTACACTCCTCCTTGGAACTACAATCCT---------GAAGGTAGGAAAGAT---CAT 
AT3G60810.    CATTATGCTCCACCATGGAACTATAAT------------GGAGGAAGGAAAACA---CCT 
LOC_Os03g6    CACTACGCTCCCCCATGGAACTATAACCCCAAG------GACGGACGCAGGGCTAAACCC 
Cre11.g468    CACTATGCCCCTCCCCTGACCTACAACCCCGAGGATGGCCGCGGCAAGAAGGGC---CCG 
Vocar20006    CACTACGCGCCCCCGCTCACGTACAACCCGCAGGATGGTCGTGGCCGCAAGAAC---CCC 
Pp1s223_13    AACTGTGTTTCCTCCTTCGACGACAGGCCGAGCTTCTTCACAGCACCGTGGGAGTTTCCG 
 
n101401_S.    GCCACCAGAGAGCAGGCCATGAAAGAGCTTCTCGCTGTTATATCTTCAACCAAG---CCG 
Pp1s10_47V    GCTTCTAAAGAAAAAGCTATGGCGGAGCTCATTGATGCTATCAAGTCAACAAAG---CCG 
LJFgene3      GTGAACAGAGAGGAAGCAATGGAGGAACTGATAGACGTGATAGAATCAACAACA---CCA 
LJFgene1      GTGAGCAGGGAAGAAGCAATGGAGGAACTTATAGACGTGATAGAATCAACAACA---CCA 
LJFgene14     GTGAGCAGAGAGGAAGCAATGGAGGAACTGATAGACGTGATCGAATCAACAACA---CCA 
Phvul.010G    GTGAGCAAAGAGGAAGCCATGGAGGAACTGATAGACGTGATTGAATCAACAACA---CCA 
LJFgene8      GTGAGCAGAGAAGAGGCAATGGAGGAACTGATAGACGTGATAGAATCAACAACA---CCA 
Medtr4g023    GTGAGCAGAGAAGAGGCAGTGGAGGAACTAATAGAAGTGATAGAATTAACAAGA---CCA 
LJFgene9      GTGAGCAAA---GAGGCAATGGAGGAACTGATAGATGTGATAGAATCGACAATACTACCA 
AT3G60810.    GTGAACAGGCAAGTTGCAATGAAAGAGCTTCTTAATGTGATTAAGTCGGTGAAA---CCG 
256 
 	  
LOC_Os03g6    ATCACCAAACATGAAGCCATCAACCAGCTCATTCAAGTCGTCACACAAACAAAG---CCT 
Cre11.g468    GCCAGCCAGGAGAAGGCCATGGGCGAGCTGGTGGAGGCGGTCAAGAAGCTCAAG---CCC 
Vocar20006    GCTACTCAGGAACAGGCCATGGCCGAGTTGGTGTCTGTGGTCAAGACCCTTCAG---CCG 
Pp1s223_13    GGATCTTTGAGGGCTGCTGTTAGTAATTTACAAGAAGCTTTAGAGGGTTCCGGA------ 
 
n101401_S.    GAAAACTATACTCCAAACATCGTCAAGAACACTGACGATTACGTCTACGTTGAGTATCAA 
Pp1s10_47V    GACAACTTCACGCCTCGAATCGTTAAGCAGACTGATGATTACGTTTATGTCGAGTACTCA 
LJFgene3      GACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAA 
LJFgene1      GACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAA 
LJFgene14     GACAAATTTTCACCACGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTACCAA 
Phvul.010G    GACAAATTTACACCAAGGATAGTTGAAAGGAAAGAAGACTATATTCGTGTGGAGTATCAA 
LJFgene8      GACAAATTTACACCACGAATAGTTGAAAGGAAGGAAGACTATATTCATGTGGAGTACCAA 
Medtr4g023    GACAAATTTACACCAAAAATAGTTGAAAGGAAAGAAGACTATGTTCGAGTTGAGTATCGA 
LJFgene9      GAAAATTTTACACCAAGGATTGTAGAAAGAACAGAAGATTATCTTAGATTGGAATACCAA 
AT3G60810.    GATAAATTTACACCGCGGATTGTGGAGAAGAAGGATGACTACGTTCATGTGGAATATGAA 
LOC_Os03g6    GACAACTTCACTCCTCGCCTAGTAGAGAAAACAGATGACTATGTTCGAGTTGAATACGAG 
Cre11.g468    GACGGCTTCACCCCCAAGATCATCAAGCAGACCGACGACTACCTGTACGTCGAGTACGAG 
Vocar20006    GACGGATTCACCCCCAAGATCATCAAGCAGACCCCGAACTACTTGTACGTGGAGTACGAG 
Pp1s223_13    ------------GCTTTCATCAAGGAGAAGAGTGACAGATACATTTACGCAGTTTTCAAA 
 
n101401_S.    TCTCCCTATCTGGGTTTTGTAGACGATGTCGAGTTTTGGTTCCCG---CCTGGGAATCGA 
Pp1s10_47V    AGCCCTCTTGTTGGCTTTGTGGACGATGTCGAATTTTGGTTTCCT---CCTGGCAATCGG 
LJFgene3      AGCTCAATTTTGGGGTTTGTAGATGATGTTGAGTTCTGGTTCCCA---CCGGGTAAGGGT 
LJFgene1      AGCTCAATCTTGGGGTTTGTGGATGATGTTGAGTTCTGGTTTCCT---CCGGGTAAGGGT 
LJFgene14     AGCTCAATCTTGGGGTTTGTGGATGATGTTGAGTTCTGGTTTCCA---CCCGGTAAGGGT 
Phvul.010G    AGCTCAATCTTGGGGTTTGTGGATGATGTTGAGTTCTGGTTTCCA---CCTAATAAGGGT 
LJFgene8      AGCTCAATCTTGGGGTTTGTGCATGATGTTGAGTTCTGGTTTCCA---CTGGGTAAGGGT 
Medtr4g023    AGCTCAATCTTGGGGTTTGTAGACGATGTTGAGTTTTGGTTCCCA---CCAGGTAAGGGC 
LJFgene9      AGT---------------GTATACAAGCCACAAATTTTAACTTCA---ATGTCACCAATA 
AT3G60810.    AGTCCAATCTTGGGGTTAGTAGACGATGTTGAATTCTTGTTCACT---CCTGGGAAGAAC 
LOC_Os03g6    AGTCCTATATTCGGGTTTGTAGATGATGTGGAGTTCTGGTTCCCT---CCTGGTAACAAA 
Cre11.g468    AGCCCGCTCATGGGGTTCATTGACGATGTGGAGTTCTGGTTCAAG---CCCGGCCCCGGC 
Vocar20006    AGCCCCATTATGGGGTTCATCGACGATGTGGAGTTCTGGTTCAAG---CCAGGTCCCGGC 
Pp1s223_13    GGAGAT---GATGGCGTTAGCGACGATGTGGAATTCTTATTCAGTGATCCCTCTGTTGAT 
 
n101401_S.    TCGCTGGTTGAGTACAGGTCGGCTTCTCGCGTGGGATCGTCG---GATTTCGATGCTAAT 
Pp1s10_47V    TCGTTGGTAGAGTATCGATCTGCATCTCGGAGAGATGCCATA---GACTTTGGCTTCAAC 
LJFgene3      TCTACTGTGGAGTACCGATCTGCATCTCGGTTAGGAAACTTT---GATTTTGATGTGAAC 
LJFgene1      TCTACTGTGGAGTATCGTTCTGCATCTCGGTTGGGAAACTTT---GATTTTGATGTGAAC 
LJFgene14     TCTACTGTGGAGTATCGATCTGCATCTCGGTTGGGAAACTTT---GATTTTGATGTGAAC 
Phvul.010G    TCTACTGTGGAGTATCGATCAGCATCTCGGCTGGGGAACTTT---GATTTTGATCTGAAT 
LJFgene8      TCTACTGTGGAGTATCGATCTGCATCTCGGTTGGGGAACTTT---GATTTTGATGTGAAT 
Medtr4g023    TCAATCGTGGAGTATCGATCTGCGTCAAGGTTGGGAAACTTT---GATTTTGATGTGAAT 
LJFgene9      TCATTGTATGCAGAAAAAATGAATAGTAACTTTTTACTATTA---GAC------------ 
AT3G60810.    TCGAAAGTGGAATATCGATCTGCATCCCGTAAAGGGAACTTC---GACTTTGATGTCAAT 
LOC_Os03g6    TCCATTGTTCAGTACCGATCAGCATCTCGATCAGGATTCATT---GACTTCAACGCCAAC 
Cre11.g468    AGCCGCGTGGAGTACCGCAGCGCCAGCCGCGTGGGCGAGTCG---GACGGCAACATCAAC 
Vocar20006    GCCCGAGTGGAGTACCGCTCCGCGTCACGCGTTGGGGAGTCT---GACGGCAACATCAAC 
Pp1s223_13    GCAACTGTAAATGTGAGGTCTGCCTCTCGTGCTAAAGATTACAAAGACAGCGGCAGAAAT 
 
n101401_S.    CGCAAGAGAATCAGAGCTTTGCGAAAGGCGCTGGAGAAGAAAGGCTGGCAATCGATTGGC 
Pp1s10_47V    CGCAAGCGAATTAAGGCTCTGCGTCAAGCTCTGGAGCGCTATGGATGGGAATCTATTGGA 
LJFgene3      AGAAAAAGAATAAAGGCACTGCGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGAC 
LJFgene1      AGAAAAAGAATAAAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGGCATCTCAAGAC 
LJFgene14     AGAAAAAGAATAAAGGCACTGAGACAAGAGTTGGAGAAGAAAGGATGGACATCTCAAGAT 
Phvul.010G    AGAAAAAGAATAAAGGCACTGCGACAAGAGCTGGAGAAGAAAGGATGGGCATCTGAAGAC 
LJFgene8      AAGAAAAGAATAAAGGTATGT---------TTGTATCATTCCTTTGTGCTGTCTCGG--- 
Medtr4g023    AGAAAAAGAATAAAGGCATTGCGACAAGAGTTAGAGAAGAAAGGATGGGCATCTCAAGAT 
LJFgene9      ------------------------------------------------------------ 
AT3G60810.    AGAAAGCGAATAAAGGCATTGCGACAAGAGCTAGAGAAGAAGGGATGGGTATCAGAGAAC 
LOC_Os03g6    AAGAAAAGAGTCAAGGCGCTCAGGTTGGCACTGGAAAACAAAGGCTGGGCTTCAGAAAGC 
Cre11.g468    CGCAAGCGCATCAAGGCCATCCGCCAGGAGCTGGAGACCAAGGGCTGGCGCAGCACGGGC 
Vocar20006    CGCAAGCGCATCCGGGCCATCCGCCAGGAGCTCGAGAAGGAGGGTTGGCGCAGCACCGGC 




n101401_S.    TTC--------------------------------------------------------- 
Pp1s10_47V    TTC--------------------------------------------------------- 
LJFgene3      ACCATA------------------------------------------------------ 
LJFgene1      ACCATA------------------------------------------------------ 
LJFgene14     ACCATA------------------------------------------------------ 
Phvul.010G    ACAATT------------------------------------------------------ 
LJFgene8      ------------------------------------------------------------ 
Medtr4g023    ACTACTATA--------------------------------------------------- 
LJFgene9      ------------------------------------------------------------ 
AT3G60810.    AGCTTC------------------------------------------------------ 
LOC_Os03g6    ACCATC------------------------------------------------------ 
Cre11.g468    TTC--------------------------------------------------------- 
Vocar20006    TTC--------------------------------------------------------- 
Pp1s223_13    AACCGGCAGAGGCGGCTCTTTTTCATTGAATCTCCGTGGGACACTTTCGGTCCGGAGCCA 
 
n101401_S.    --------------------------------------------- 
Pp1s10_47V    --------------------------------------------- 
LJFgene3      --------------------------------------------- 
LJFgene1      --------------------------------------------- 
LJFgene14     --------------------------------------------- 
Phvul.010G    --------------------------------------------- 
LJFgene8      --------------------------------------------- 
Medtr4g023    --------------------------------------------- 
LJFgene9      --------------------------------------------- 
AT3G60810.    --------------------------------------------- 
LOC_Os03g6    --------------------------------------------- 
Cre11.g468    --------------------------------------------- 
Vocar20006    --------------------------------------------- 
Pp1s223_13    CCTCCTACGATTGACTATAAAAATGGAATAGACTTTGTGCCGGAC 
	   	  
 APPENDIX L. 




Ortholog	  SNAP	  analysis	  
Compare	   vs	   	  Sd	   	  Sn	   	  S	   	  N	   	  ps	   	  pn	   	  ds	   	  dn	   	  ds/dn	   	  ps/pn	  
	  Smo	   	  Ppa47v6	   94.67	   55.33	   110.00	   352.00	   0.86	   0.16	   	  NA	   0.00	   	  NA	   5.47	  
	  Smo	   	  LJFgene3	   85.00	   73.00	   103.00	   350.00	   0.83	   0.21	   	  NA	   0.00	   	  NA	   3.96	  
	  Smo	   	  LJFgene1	   90.00	   74.00	   102.33	   350.67	   0.88	   0.21	   	  NA	   0.00	   	  NA	   4.17	  
	  Smo	   	  LJFgene14	   90.00	   71.00	   102.33	   350.67	   0.88	   0.20	   	  NA	   0.00	   	  NA	   4.34	  
	  Smo	   	  Pvu	   88.83	   74.17	   102.67	   350.33	   0.87	   0.21	   	  NA	   0.00	   	  NA	   4.09	  
	  Smo	   	  LJFgene8	   89.00	   85.00	   99.83	   338.17	   0.89	   0.25	   	  NA	   0.00	   	  NA	   3.55	  
	  Smo	   	  Mtr	   84.00	   73.00	   102.50	   350.50	   0.82	   0.21	   	  NA	   0.00	   	  NA	   3.93	  
	  Smo	   	  LJFgene9	   68.83	   113.17	   81.33	   281.67	   0.85	   0.40	   	  NA	   0.00	   	  NA	   2.11	  
	  Smo	   	  Ath	   86.83	   82.17	   100.50	   346.50	   0.86	   0.24	   	  NA	   0.00	   	  NA	   3.64	  
	  Smo	   	  Osa	   88.50	   87.50	   105.83	   353.17	   0.84	   0.25	   	  NA	   0.00	   	  NA	   3.38	  
	  Smo	   	  Cre	   86.33	   95.67	   107.50	   354.50	   0.80	   0.27	   	  NA	   0.00	   	  NA	   2.98	  
	  Smo	   	  Vca	   92.67	   89.33	   108.00	   354.00	   0.86	   0.25	   	  NA	   0.00	   	  NA	   3.40	  
	  Smo	   	  Ppa13v6	   85.17	   211.83	   105.33	   356.67	   0.81	   0.59	   	  NA	   0.00	   	  NA	   1.36	  
	  Ppa47v6	   	  LJFgene3	   117.33	   185.67	   157.83	   529.17	   0.74	   0.35	   3.55	   0.47	   7.50	   2.12	  
	  Ppa47v6	   	  LJFgene1	   110.17	   178.83	   150.50	   509.50	   0.73	   0.35	   2.80	   0.47	   5.91	   2.09	  
	  Ppa47v6	   	  LJFgene14	   82.17	   95.83	   110.50	   375.50	   0.74	   0.26	   3.57	   0.31	   11.45	   2.91	  
	  Ppa47v6	   	  Pvu	   115.50	   180.50	   151.33	   508.67	   0.76	   0.35	   	  NA	   0.00	   	  NA	   2.15	  
	  Ppa47v6	   	  LJFgene8	   112.17	   185.83	   147.00	   492.00	   0.76	   0.38	   	  NA	   0.00	   	  NA	   2.02	  
	  Ppa47v6	   	  Mtr	   117.17	   175.83	   149.00	   505.00	   0.79	   0.35	   	  NA	   0.00	   	  NA	   2.26	  
	  Ppa47v6	   	  LJFgene9	   70.67	   122.33	   88.00	   302.00	   0.80	   0.41	   	  NA	   0.00	   	  NA	   1.98	  
	  Ppa47v6	   	  Ath	   115.50	   177.50	   146.17	   492.83	   0.79	   0.36	   	  NA	   0.00	   	  NA	   2.19	  
	  Ppa47v6	   	  Osa	   122.00	   178.00	   151.83	   484.17	   0.80	   0.37	   	  NA	   0.00	   	  NA	   2.19	  
	  Ppa47v6	   	  Cre	   129.67	   205.33	   158.33	   504.67	   0.82	   0.41	   	  NA	   0.00	   	  NA	   2.01	  
	  Ppa47v6	   	  Vca	   144.83	   192.17	   159.00	   510.00	   0.91	   0.38	   	  NA	   0.00	   	  NA	   2.42	  
	  Ppa47v6	   	  Ppa13v6	   112.00	   325.00	   155.83	   513.17	   0.72	   0.63	   2.38	   1.40	   1.71	   1.13	  
	  LJFgene3	   	  LJFgene1	   18.50	   9.50	   142.00	   512.00	   0.13	   0.02	   0.14	   0.02	   7.62	   7.02	  
	  LJFgene3	   	  LJFgene14	   19.00	   23.00	   106.67	   382.33	   0.18	   0.06	   0.20	   0.06	   3.24	   2.96	  
	  LJFgene3	   	  Pvu	   40.83	   46.17	   142.83	   511.17	   0.29	   0.09	   0.36	   0.10	   3.74	   3.17	  
	  LJFgene3	   	  LJFgene8	   31.50	   49.50	   136.17	   487.83	   0.23	   0.10	   0.28	   0.11	   2.54	   2.28	  
	  LJFgene3	   	  Mtr	   56.50	   61.50	   141.83	   509.17	   0.40	   0.12	   0.57	   0.13	   4.31	   3.30	  
	  LJFgene3	   	  LJFgene9	   47.00	   92.00	   85.33	   304.67	   0.55	   0.30	   0.99	   0.39	   2.57	   1.82	  
	  LJFgene3	   	  Ath	   94.83	   117.17	   136.33	   490.67	   0.70	   0.24	   1.97	   0.29	   6.85	   2.91	  
	  LJFgene3	   	  Osa	   111.67	   126.33	   142.17	   481.83	   0.79	   0.26	   	  NA	   0.00	   	  NA	   3.00	  
	  LJFgene3	   	  Cre	   127.00	   205.00	   145.00	   494.00	   0.88	   0.42	   	  NA	   0.00	   	  NA	   2.11	  
	  LJFgene3	   	  Vca	   131.17	   205.83	   146.50	   498.50	   0.90	   0.41	   	  NA	   0.00	   	  NA	   2.17	  
	  LJFgene3	   	  Ppa13v6	   119.67	   314.33	   144.50	   503.50	   0.83	   0.62	   	  NA	   0.00	   	  NA	   1.33	  
	  LJFgene1	   	  LJFgene14	   15.00	   23.00	   105.83	   383.17	   0.14	   0.06	   0.16	   0.06	   2.51	   2.36	  
	  LJFgene1	   	  Pvu	   38.33	   40.67	   144.50	   518.50	   0.27	   0.08	   0.33	   0.08	   3.95	   3.38	  
	  LJFgene1	   	  LJFgene8	   25.83	   49.17	   137.83	   495.17	   0.19	   0.10	   0.22	   0.11	   2.02	   1.89	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  LJFgene1	   	  Mtr	   56.00	   57.00	   141.83	   512.17	   0.39	   0.11	   0.56	   0.12	   4.65	   3.55	  
	  LJFgene1	   	  LJFgene9	   49.17	   89.83	   84.83	   305.17	   0.58	   0.29	   1.11	   0.37	   2.97	   1.97	  
	  LJFgene1	   	  Ath	   91.33	   119.67	   138.00	   498.00	   0.66	   0.24	   1.61	   0.29	   5.54	   2.75	  
	  LJFgene1	   	  Osa	   116.83	   128.17	   144.17	   488.83	   0.81	   0.26	   	  NA	   0.00	   	  NA	   3.09	  
	  LJFgene1	   	  Cre	   130.50	   209.50	   147.00	   501.00	   0.89	   0.42	   	  NA	   0.00	   	  NA	   2.12	  
	  LJFgene1	   	  Vca	   133.00	   213.00	   148.33	   505.67	   0.90	   0.42	   	  NA	   0.00	   	  NA	   2.13	  
	  LJFgene1	   	  Ppa13v6	   123.83	   321.17	   146.50	   510.50	   0.85	   0.63	   	  NA	   0.00	   	  NA	   1.34	  
	  LJFgene14	   	  Pvu	   29.00	   30.00	   106.50	   382.50	   0.27	   0.08	   0.34	   0.08	   4.08	   3.47	  
	  LJFgene14	   	  LJFgene8	   26.00	   51.00	   102.50	   368.50	   0.25	   0.14	   0.31	   0.15	   2.02	   1.83	  
	  LJFgene14	   	  Mtr	   43.00	   40.00	   106.17	   382.83	   0.41	   0.10	   0.58	   0.11	   5.18	   3.88	  
	  LJFgene14	   	  LJFgene9	   48.83	   107.17	   84.00	   306.00	   0.58	   0.35	   1.12	   0.47	   2.37	   1.66	  
	  LJFgene14	   	  Ath	   74.67	   65.33	   103.67	   379.33	   0.72	   0.17	   2.42	   0.20	   12.37	   4.18	  
	  LJFgene14	   	  Osa	   91.17	   86.83	   108.50	   380.50	   0.84	   0.23	   	  NA	   0.00	   	  NA	   3.68	  
	  LJFgene14	   	  Cre	   99.33	   130.67	   109.33	   376.67	   0.91	   0.35	   	  NA	   0.00	   	  NA	   2.62	  
	  LJFgene14	   	  Vca	   107.50	   130.50	   109.50	   376.50	   0.98	   0.35	   	  NA	   0.00	   	  NA	   2.83	  
	  LJFgene14	   	  Ppa13v6	   86.50	   231.50	   107.33	   381.67	   0.81	   0.61	   	  NA	   0.00	   	  NA	   1.33	  
	  Pvu	   	  LJFgene8	   41.50	   69.50	   138.33	   494.67	   0.30	   0.14	   0.38	   0.16	   2.46	   2.14	  
	  Pvu	   	  Mtr	   57.67	   70.33	   142.67	   511.33	   0.40	   0.14	   0.58	   0.15	   3.82	   2.94	  
	  Pvu	   	  LJFgene9	   46.67	   85.33	   84.83	   305.17	   0.55	   0.28	   0.99	   0.35	   2.83	   1.97	  
	  Pvu	   	  Ath	   90.67	   117.33	   138.33	   497.67	   0.66	   0.24	   1.55	   0.28	   5.49	   2.78	  
	  Pvu	   	  Osa	   122.17	   134.83	   145.00	   488.00	   0.84	   0.28	   	  NA	   0.00	   	  NA	   3.05	  
	  Pvu	   	  Cre	   126.50	   206.50	   147.83	   500.17	   0.86	   0.41	   	  NA	   0.00	   	  NA	   2.07	  
	  Pvu	   	  Vca	   139.67	   203.33	   149.17	   504.83	   0.94	   0.40	   	  NA	   0.00	   	  NA	   2.32	  
	  Pvu	   	  Ppa13v6	   120.83	   321.17	   147.33	   509.67	   0.82	   0.63	   	  NA	   0.00	   	  NA	   1.30	  
	  LJFgene8	   	  Mtr	   55.67	   82.33	   136.17	   490.83	   0.41	   0.17	   0.59	   0.19	   3.11	   2.44	  
	  LJFgene8	   	  LJFgene9	   48.50	   91.50	   84.67	   305.33	   0.57	   0.30	   1.08	   0.38	   2.83	   1.91	  
	  LJFgene8	   	  Ath	   95.50	   138.50	   136.33	   484.67	   0.70	   0.29	   2.04	   0.36	   5.67	   2.45	  
	  LJFgene8	   	  Osa	   114.00	   142.00	   140.50	   471.50	   0.81	   0.30	   	  NA	   0.00	   	  NA	   2.69	  
	  LJFgene8	   	  Cre	   129.17	   225.83	   145.50	   490.50	   0.89	   0.46	   	  NA	   0.00	   	  NA	   1.93	  
	  LJFgene8	   	  Vca	   126.33	   221.67	   145.67	   493.33	   0.87	   0.45	   	  NA	   0.00	   	  NA	   1.93	  
	  LJFgene8	   	  Ppa13v6	   117.17	   316.83	   143.00	   496.00	   0.82	   0.64	   	  NA	   0.00	   	  NA	   1.28	  
	  Mtr	   	  LJFgene9	   52.83	   89.17	   85.00	   305.00	   0.62	   0.29	   1.32	   0.37	   3.57	   2.13	  
	  Mtr	   	  Ath	   96.50	   126.50	   136.00	   494.00	   0.71	   0.26	   2.19	   0.31	   6.99	   2.77	  
	  Mtr	   	  Osa	   125.83	   134.17	   143.33	   483.67	   0.88	   0.28	   	  NA	   0.00	   	  NA	   3.16	  
	  Mtr	   	  Cre	   132.83	   211.17	   145.67	   496.33	   0.91	   0.43	   	  NA	   0.00	   	  NA	   2.14	  
	  Mtr	   	  Vca	   131.67	   214.33	   146.83	   501.17	   0.90	   0.43	   	  NA	   0.00	   	  NA	   2.10	  
	  Mtr	   	  Ppa13v6	   122.83	   317.17	   145.50	   508.50	   0.84	   0.62	   	  NA	   0.00	   	  NA	   1.35	  
	  LJFgene9	   	  Ath	   62.00	   107.00	   82.33	   301.67	   0.75	   0.35	   	  NA	   0.00	   	  NA	   2.12	  
	  LJFgene9	   	  Osa	   65.67	   113.33	   86.67	   303.33	   0.76	   0.37	   	  NA	   0.00	   	  NA	   2.03	  
	  LJFgene9	   	  Cre	   85.83	   154.17	   88.50	   301.50	   0.97	   0.51	   	  NA	   0.00	   	  NA	   1.90	  
	  LJFgene9	   	  Vca	   80.33	   148.67	   89.33	   300.67	   0.90	   0.49	   	  NA	   0.00	   	  NA	   1.82	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  LJFgene9	   	  Ppa13v6	   65.50	   220.50	   85.33	   304.67	   0.77	   0.72	   	  NA	   0.00	   	  NA	   1.06	  
	  Ath	   	  Osa	   121.00	   138.00	   140.33	   474.67	   0.86	   0.29	   	  NA	   0.00	   	  NA	   2.97	  
	  Ath	   	  Cre	   126.17	   216.83	   145.33	   490.67	   0.87	   0.44	   	  NA	   0.00	   	  NA	   1.96	  
	  Ath	   	  Vca	   126.50	   205.50	   146.00	   493.00	   0.87	   0.42	   	  NA	   0.00	   	  NA	   2.08	  
	  Ath	   	  Ppa13v6	   118.33	   317.67	   143.17	   498.83	   0.83	   0.64	   	  NA	   0.00	   	  NA	   1.30	  
	  Osa	   	  Cre	   105.50	   208.50	   152.33	   483.67	   0.69	   0.43	   1.93	   0.64	   3.00	   1.61	  
	  Osa	   	  Vca	   111.17	   204.83	   152.17	   483.83	   0.73	   0.42	   2.74	   0.62	   4.39	   1.73	  
	  Osa	   	  Ppa13v6	   123.67	   299.33	   149.83	   489.17	   0.83	   0.61	   	  NA	   0.00	   	  NA	   1.35	  
	  Cre	   	  Vca	   88.17	   104.83	   159.50	   515.50	   0.55	   0.20	   1.00	   0.24	   4.22	   2.72	  
	  Cre	   	  Ppa13v6	   114.50	   312.50	   156.50	   518.50	   0.73	   0.60	   2.78	   1.22	   2.28	   1.21	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